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1.1 PEROXISOMES – AN OVERVIEW 
1.1.1 Introducing a highly versatile organelle  
Unlike mitochondria or the Golgi apparatus, both of which were discovered in the very end of 
the 19th century, peroxisomes were only identified using electron microscopy in 1954 by 
Rhodin as a part of his PhD thesis and then termed microbodies (Rhodin, 1954) (Fig. 1.1). 
Originally regarded as a “fossil organelle” or the cell’s “garbage pail”, they have gained 
considerable interest upon their subsequent biochemical characterization by de Duve and 
Baudhuin who discovered that the peroxisomal matrix contains a  high number of hydrogen 
peroxide (H2O2)-producing oxidases as well as catalase, an H2O2-degrading enzyme (De Duve 
& Baudhuin, 1966)  (Fig. 1.1 B). This observation coined the more functional name 
“peroxisome” for the organelle. 
Fig. 1.1: Ultrastructure of peroxisomes.  
(A) Ultrathin sections of peroxisomes in the methylotrophic yeast Hansenula polymorpha after growth on 
methanol (Krikken et al., 2009). (B) Rat liver peroxisomes labelled with specific antibodies against catalase 
followed by protein A-gold staining (Fahimi, 1992). Note that gold particles representing catalase distribute over 
the entire matrix sparing the crystalline cores. (C) Peroxisomes in rat hepatoma cells stained by alkaline DAB 
cytochemistry (Schrader & Yoon, 2007). Note the close association of peroxisomes (black structures) and 
mitochondria (M) with the endoplasmic reticulum (ER). M, mitochondria; N, nucleus; P, peroxisome; V, 
vacuole. Bars, 0.5µm (A, C). Magnification (B) × 58,000.  
 
The identification of catalase as a key peroxisomal enzyme led to the introduction of the 
alkaline 3, 3’-diaminobenzidine (DAB) reaction for catalase that enabled the morphological 
characterization of peroxisomes by electron microscopy (Fahimi, 1968; Fahimi, 1969; 
Novikoff & Goldfischer, 1969) (Fig. 1.1 C). Subsequently, peroxisomes were shown to be 
ubiquitous organelles like mitochondria (Hruban et al., 1972), however, they disappear during 
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the development of red blood cells and sperm (Luers et al., 2006) and are absent in 
Apicomplexa phylum and amitochondriate parasites (Schluter et al., 2006).  
In general, peroxisomes can be described as ubiquitous, single-membrane bound organelles 
that are devoid of DNA and contain a fine granular matrix (Fig. 1.1). About 85 genes in Homo 
sapiens and 61 genes in Saccharomyces cerevisiae have been identified that encode 
peroxisomal proteins, many of which are linked to peroxisome metabolism. Peroxisomes play 
a central role in lipid metabolism and detoxification, but also in the synthesis of ether 
phospholipids, bile acids and cholesterol (1.1.2), rendering them essential for cellular 
homeostasis and development. Their essential contribution to human health is exemplified by 
the severe consequences of peroxisomal dysfunctions (1.1.4). Despite this common ground, 
one of the most striking features of peroxisomes is their enormous plasticity, both on a 
metabolic and a morphological level. Peroxisomal enzyme composition varies immensely 
across species, even leading to the generation of specialized peroxisomal structures such as 
e.g. the glycosomes of trypanosomatids, the glyoxysomes of plants and the Woronin body of 
filamentous fungi, a very specialized peroxisome that serves the sole purpose of sealing septal 
pores upon injury (Jedd & Chua, 2000; Michels et al., 2005; Michels et al., 2006; Reumann & 
Weber, 2006). Interestingly, peroxisomal protein composition also varies within tissues 
and/or developmental stages of the same organism (Islinger et al., 2010), thus the term 
“multipurpose organelle” has proven to be a more than accurate designation for peroxisomes 
(Opperdoes, 1988; Islinger et al., 2010). Although peroxisomes display this striking 
heterogeneity in regard to their enzyme content, proteins involved in organelle biogenesis and 
maintenance – the so-called peroxins (Pex) - are evolutionary conserved throughout species. 
Pex genes have been identified based on genetic complementation in peroxisome-deficient 
yeast and mammalian cells (34 in yeast with approximately 20 mammalian and 23 plant 
homologues) (Kiel et al., 2006; Platta & Erdmann, 2007). Most of them are peroxisomal 
membrane proteins or associated with the membrane (1.1.5) (Table 1.2). Peroxisomes 
additionally show a remarkable plasticity in regard to their number and morphology. For 
instance, mammalian liver and kidney contain a high density of peroxisomes (accounting for 
around 2 % of the total hepatic protein content (Leighton et al., 1968)), whereas yeast cells in 
general only contain a few. Moreover, mammalian peroxisomes display a very heterogeneous 
morphology, since they may appear as spherical organelles with a diameter of around 0.1 – 
0.2 µm, representing the common textbook image, but also enlarge to form rod-shaped (0.3 – 
0.5 µm), long tubular structures (up to 5 µm) or even tubular-reticular networks (Yamamoto 
& Fahimi, 1987; Schrader et al., 1994; Schrader et al., 2000; Purdue & Lazarow, 2001). A 
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variety of peroxisomal shapes can also be observed on the ultrastructural level. Rat liver 
peroxisomes e.g. contain dense cores of urate oxidase, while bovine kidney peroxisomes 
display crystalline inclusions of α-hydroxyacid oxidase B, resulting in a rather polyhedric 
shape of the organelle (Hruban & Swift, 1964; Zaar et al., 1991). The Woronin bodies of 
Neurospora crassa on the other hand appear as hexagonal crystals (Jedd & Chua, 2000).  
Despite their enormous plasticity and dynamic behaviour, peroxisomes do not exist as 
isolated entities, but are intimately linked to other organelles such as lipid droplets, the ER 
and especially mitochondria (Schrader & Yoon, 2007; Camoes et al., 2009) (1.3) (Fig. 1.1 C). 
Peroxisome homeostasis in general needs to remain adaptable to the metabolic state of the cell 
which is ensured by a combination of peroxisome multiplication or proliferation, the removal 
of excess organelles by autophagy (pexophagy) as well as by processes of peroxisome 
inheritance and motility (1.2).  
 
1.1.2 Peroxisomal metabolism 
Peroxisomes are essential for human health and development, since they fulfil a variety of 
metabolic functions, both in the breakdown and synthesis of key substrates. Over 50 enzymes 
have been identified in the peroxisomal matrix that catalyze the β-oxidation of very long 
chain fatty acids (VLCFAs), prostaglandins and eicosanoids, the oxidation of D-amino acids, 
alcohols, polyamines and uric acid (in non-primates) as well as the α-oxidation of branched 
chain fatty acids. Furthermore, peroxisomes play a key role in the detoxification of 
xenobiotics, reactive oxygen species (ROS), glyoxylate and the biosynthesis of ether lipids, 
cholesterol and bile acids (van den Bosch et al., 1992; Ferdinandusse et al., 2002; Hogenboom 
et al., 2004; Kunze et al., 2006; van der Klei et al., 2006; Wanders & Waterham, 2006b) (Fig. 
1.2). Several specialized functions have evolved with plants, yeast and protozoa generally 
displaying a broader spectrum of activities. These include an involvement in photorespiration, 
jasmonic acid and auxin synthesis in plants as well as penicillin synthesis in fungi (Tolbert, 
1981; van den Bosch et al., 1992; Heupel & Heldt, 1994; Kiel et al., 2005b; Nyathi & Baker, 
2006). The fact that e.g. the biosynthesis of penicillin in fungal peroxisomes can be 
environmentally induced renders peroxisome research an attractive field of interest for 
biotechnology (Kiel et al., 2005b). Besides the classical functions listed above, peroxisomes 
have recently been shown to participate in the synthesis of biotin in fungi and to contribute to 
anti-viral innate immunity (Dixit et al., 2010; Tanabe et al., 2011).  
As the various peroxisomal substrates are consumed by FAD-(or FMN)-coupled O2-
containing oxidases that produce H2O2 as a by-product, peroxisomes harbour an oxidative 
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metabolism. Detoxification of ROS is performed by catalase and a large set of resident 
peroxisomal antioxidant enzymes (1.1.3) (Fig. 1.2).  
 
Fig. 1.2: Overview of the major 
peroxisomal metabolic pathways. 
Peroxisomal metabolism in the mammalian 
liver (adapted from Baumgart et al., 1997; 












Peroxisomal lipid metabolism 
While fatty acid β-oxidation occurs exclusively peroxisomal in yeasts and plants, it coexists 
with the mitochondrial fatty acid β-oxidation in animal cells (Cooper & Beevers, 1969; Kunau 
et al., 1988; Poirier et al., 2006; Shen & Burger, 2009). However, only the peroxisomal acyl-
CoA oxidases (AOX) show substrate specificity for very long chain fatty acids (VLCFA, ≥ 
C24) and branched chain fatty acids (Mannaerts & Van Veldhoven, 1993; Mannaerts et al., 
2000; Reddy & Hashimoto, 2001). Nonetheless, the basic set of fatty acid β-oxidation 
reactions  carried out by both organelles remains the same and at the end of each cycle, fatty 
acids are shortened by two carbon atoms which are released as acetyl-CoA (Lazarow & De 
Duve, 1976; Wanders, 2004; Wanders & Waterham, 2006b) (Fig. 1.2). Upon reduction of 
fatty acid chain length to octanoyl-CoA, propionyl-CoA and acetyl-CoA, fatty acids are 
conjugated to carnitine and shuttled to mitochondria for full oxidation and energy production 
via the mitochondrial electron transfer chain (Ferdinandusse et al., 1999; Reddy & 
Hashimoto, 2001). Alternatively, they may serve as substrates for the generation of complex 
lipids within peroxisomes. Besides the prominent VLCFA docosahexaenoic acid (C26:0), 
peroxisomal substrates include pristanic acid, the bile acid intermediates di- and 
trihydroxycholestanoic acid (DHCA, THCA) and long-chain dicarboxylic acids. 3-methyl 
fatty acids such as phytanic acid or xenobiotics cannot directly serve as a substrate for the β-
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oxidation machinery, hence they are degraded by peroxisomal α-oxidation, i.e. that they are 
oxidatively decarboxylated to generate 2-methyl-fatty acids which can be β-oxidized 
(Casteels et al., 2003; Jansen & Wanders, 2006; Wanders & Waterham, 2006a). In higher 
eukaryotes, peroxisomes are the sole site of α-oxidation.  
 
Ether phospholipid synthesis 
The term ether phospholipid denominates a special class of phospholipids which contain an 
ether-linkage instead of an ester linkage at the sn-1 position of glycerol. Ether lipids may 
contain an 1-O-alkyl linkage or an 1-O-alk-enyl linkage, the latter class is referred to as 
plasmalogens. Plasmalogens are important constituents of the neuronal myelin sheath, thus 
loss of peroxisomal functions is often accompanied by neurodegenerative processes (Faust et 
al., 2005; Hulshagen et al., 2008) (1.1.4). The biosynthesis of ether phospholipids involves the 
cooperation of peroxisomal and ER resident enzymes. Initial synthesis of acyl 
dihydroxyacetone phosphate (DHAP) and the generation of the eponymous ether bond is 
carried out by peroxisomal enzymes, while the generated alkyl-DHAP is then conversed into 
alkyl-glyceraldehyde 3-phosphate either in peroxisomes or at the ER. The final steps of ether 
phospholipid synthesis are performed exclusively at the ER (Heymans et al., 1983; Brites et 
al., 2004; Gorgas et al., 2006; Wanders & Waterham, 2006a). 
 
Glyoxylate detoxification 
Peroxisomes detoxify glyoxylate by the action of the enzyme alanine 
glyoxylate:aminotransferase (AGT) which catalyzes the transamination of glyoxylate to 
glycine with alanine. Unless it is detoxified, glyoxylate will be reduced to glycolate or 
oxidized to oxalate; in contrast to the water soluble glycolate, oxalate precipitates as calcium 
oxalate (Danpure, 2006). 
 
1.1.3 Peroxisomes and reactive oxygen species  
Although mitochondria are usually considered to be the major producer of ROS within the 
cell, peroxisomes contribute considerably to cellular ROS homeostasis due to their oxidative 
metabolism. In fact, they consume 20 % of the total amount of oxygen in rat liver while they 
produce 35 % of the cell’s H2O2 (Boveris et al., 1972). Superoxide radicals are also generated 
within peroxisomes by the action of xanthine oxidase acting in purine catabolism in rat liver 
peroxisomes (Angermuller et al., 1987; Engerson et al., 1987). Additionally, reactive nitrogen 
species (RNS) are produced within peroxisomes by the inducible form of nitric oxide 
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synthase (iNOS) that catalyzes the oxidation of L-arginine to nitric oxide (Stolz et al., 2002) 
(Table 1.1). In order to handle the massive generation of ROS, peroxisomes harbour not only 
catalase, their key enzyme, but a large set of other antioxidant enzymes, such as copper/zinc 
and manganese superoxide dismutase (SOD), glutathione peroxidase, peroxiredoxins and 
epoxide hydrolase (Dhaunsi et al., 1992; Singh et al., 1994; Singh, 1996; Immenschuh & 
Baumgart-Vogt, 2005; Bonekamp et al., 2009; Antonenkov et al., 2010; Bonekamp et al., 
2011a; Fransen et al., 2011) (Table 1.1) 
Table 1.1: Overview of ROS/RNS generated in mammalian peroxisomes (PO).  
NOHLA, Nω-hydroxy-L-arginine, SOD, superoxide dismutase (adapted from Bonekamp et al., 2009) 
 
Interesting findings regarding a dynamic, morphological response of peroxisomes to oxidative 
stress have been made in the plant system. Using live-cell imaging, plant peroxisomes were 
shown to respond to increasing oxidative stress in a two-fold manner: upon exposure to 
hydrogen peroxide or hydroxyl radicals, they were shown to develop small membrane 
protrusions – so-called peroxules - out of the previously spherical peroxisome in a time span 
of 10-120 seconds. Longer exposure or higher dosage of stressors resulted in a decline in 
peroxisome movement and their increased elongation and division (Sinclair et al., 2009). 
Similarly, mammalian peroxisomes respond to UV irradiation and H2O2 exposure with an 
elongation of the compartment (Schrader et al., 1999), hence peroxisomal elongation and/or 
proliferation might serve as a first line of defence counteracting oxidative stress. Changes in 
peroxisomal motility and a slight increase in number were also observed in plant cells after 
cadmium exposure (Rodriguez-Serrano et al., 2009). Notably, only the generation of intra-
peroxisomal oxidative stress triggered a peroxisomal response and the resulting motility 
change was assumed to improve inter-organellar cross-talk, uptake of metabolites or to 
scavenge ROS in places of need. Due to the highly oxidative environment, peroxisomes 
require several safeguarding mechanisms ensuring proper organelle function: catalase itself 
was shown to be closely associated with more oxidation-prone proteins, but also increased its 
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activity in response to acute stress up to a certain threshold (Anand et al., 2009). Moreover, a 
peroxisomal Lon protease was identified in rat and H. polymorpha whose deletion led to an 
increase in protein oxidation, possibly removing damaged proteins to ensure functionality and 
thus contributing to intra-peroxisomal quality control (Kikuchi et al., 2004; Aksam et al., 
2007). Apart from that, severely damaged organelles are removed by autophagy. Peroxisomes 
have further been linked to oxidative stress-related conditions such as neurodegeneration, 
carcinogenesis and aging (Cimini et al., 2009; Kou et al., 2011; Titorenko & Terlecky, 2011). 
In the case of aging, the fidelity of the peroxisomal matrix import system diminishes with age 
due to initial ROS-dependent modifications, resulting in a senescent cellular phenotype 
(Legakis et al., 2002; Terlecky et al., 2006). Moreover, the age-dependent “loss” of catalase 
leads to an accumulation of H2O2 and other ROS in peroxisomes which may facilitate H2O2 
diffusion to the cytoplasm, where it may modulate signalling pathways and/or promote 
oxidative damage (Legakis et al., 2002). Aging also impairs the activities of other 
peroxisomal proteins, as was uncovered by mass-spectrometric analyses of kidney and liver 
peroxisomes (Mi et al., 2007).  
 
1.1.4 Peroxisomal disorders 
The pivotal role of peroxisomes in human health and development can be deduced from the 
severe phenotype of peroxisomal disorders, a group of inherited diseases in which either 
peroxisome biogenesis or single enzyme functions are disturbed. Based on this distinction, 
they are commonly subdivided into the peroxisome biogenesis disorders (PBDs) or 
peroxisomal (single) enzyme deficiencies (PEDs) (Steinberg et al., 2006; Wanders & 
Waterham, 2006a).  
The PBDs are nowadays grouped into the Zellweger spectrum disorders (ZSD) and the 
rhizomelic chondrodysplasia punctata 1 (RCPD 1). ZSD is a collective term incorporating the 
Zellweger spectrum (ZS), neonatal adrenoleukodystrophy (NALD) and infantile Refsum 
disease (IRD), as patients suffer from the same clinical presentation of liver disease, 
neurodevelopmental delay, retinopathy and perceptive deafness within the first month of life, 
albeit to different degrees (Brosius & Gartner, 2002; Faust et al., 2005; Wanders & 
Waterham, 2005; Steinberg et al., 2006; Fidaleo, 2010). The ZS, initially referred to as 
cerebro-hepato-renal syndrome, shows the severest phenotype with an incidence of 1:50.000 
births. Its initial characterization demonstrated the essential role of peroxisomes in human 
health (Goldfischer et al., 1973). ZSDs arise due to mutations in different peroxins, the 
peroxisomal membrane proteins required for peroxisome maintenance (1.1.5) (Table 1.2). 
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Mutations in at least 12 different peroxins were linked to the pathology of ZSD (Sacksteder & 
Gould, 2000; Steinberg et al., 2006). As Zellweger patients suffer from a complete absence of 
peroxisomes, toxic peroxisomal substrates (such as VLCFA, THCA and DHCA) accumulate 
while there is a shortage of essential peroxisomal products (such as plasmalogens) in every 
tissue. The consequences are especially detrimental in the brain, spinal cord and peripheral 
nerves in line with the central role of peroxisomes in the generation of plasmalogens which 
are essential for the formation of the myelin sheath (Faust et al., 2005; Hulshagen et al., 2008; 
Baes & Aubourg, 2009). As the accompanying developmental defects already start in utero, 
only supportive postnatal treatments are available based on dietary supplements and 
restrictions that merely counteract milder forms. The fact that ZSD presents with a low 
number of cases and a high variability restrains the development of new treatments. The other 
form of PBDs, RCPD1,  presents differently from ZSD and is linked to mutations in PEX7, 
the gene encoding the import receptor for a subset of peroxisomal matrix proteins (Gould & 
Valle, 2000) (1.1.5.1).  
The PEDs are grouped according to the biochemical pathway affected, e.g. ether lipid 
biosynthesis, peroxisomal β-oxidation, peroxisomal α-oxidation, glyoxylate detoxification 
and ROS metabolism (Wanders & Waterham, 2006a). The most common PED is the X-linked 
adrenoleukodystrophy (X-ALD) with an incidence of 1:15.000 males in France. Patients 
present with an accumulation of VLCFAs in the plasma, fibroblasts and other cell-types, 
resulting from mutations in the ABCD1 gene which encodes the adrenoleukodystrophy 
protein (ALDP). ALDP is an ABC transporter in the peroxisomal membrane, closely related 
to other metabolite transporters such as PMP70, and mediates the import of acyl-CoA esters 
of VLCFA into peroxisomes. Interestingly, its role was confirmed only recently (van 
Roermund et al., 2008; Wanders et al., 2010). In X-ALD, the accumulated VLCFAs were 
suggested to increase oxidative stress and thus lead to oxidative modification in nervous 
tissues (Schonfeld & Wojtczak, 2008). Furthermore, the VLCFA C26:0 may promote 
oxidative stress via mild inhibition of the mitochondrial electron transfer chain (ETC), which 
in combination with compromised cellular GSH levels, results in oxidative lesions (Fourcade 
et al., 2008).  Other PEDs affecting peroxisomal β-oxidation were identified such as e.g. the 
AOX deficiency or D-bifunctional protein (DBP) deficiency. Interestingly, patient fibroblasts 
of AOX or DBP-deficient patients revealed peroxisomes that were enlarged in size and 
reduced in number (Chang et al., 1999). Except for X-ALD, all peroxisomal disorders are 
inherited in an autosomal-recessive manner. Similar to PBDs, PED treatment remains limited 
to supportive therapy based on the restriction of peroxisomal substrates or supplementation of 
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products. However, treatment options are available for patients suffering from primary 
oxaluria type I, a disease that results from AGT impairment. Interestingly, AGT mutations 
have been identified that introduce a mitochondrial targeting signal into the enzyme, leading 
to its mistargeting and subsequent loss of action (Danpure, 2006). As a result, oxalate deposits 
are formed in the kidneys (impairing renal function), but ultimately the failure in oxalate 
clearance results in its deposition in all tissues. As a treatment option, high oxalate 
concentrations can be diminished by inhibiting oxalate synthesis and increasing oxalate 
solubility (Danpure, 2005).  
In addition to the classical peroxisomal disorders, other pathologies are now closer linked to 
peroxisomal function than previously assumed, including Alzheimer’s disease (AD), diabetes 
and cancer. Interestingly, peroxisome proliferation has neuroprotective effect counteracting β-
amyloid (Abeta) toxicity (Santos et al., 2005). Thus, the modulation of peroxisomal and 
peroxisome-related proteins after acute and chronic insults with the toxic Abeta peptide was 
investigated to determine the neuroprotective role of peroxisomes upon Abeta-related 
oxidative injury (Cimini et al., 2009). Additionally, peroxisomal generation of H2O2 is 
involved in fatty acid-induced toxicity in insulin-producing pancreatic β-cells, thus 
contributing to the complex pathology of type 2 diabetes (Gehrmann et al., 2010; Elsner et al., 
2011). Human carcinoma cells often display a significant reduction or even complete absence 
of peroxisomes (Lauer et al., 1999; Frederiks et al., 2010). These conditions might 
compromise cellular antioxidant capacity and facilitate further oxidative DNA damage, thus 
contributing to a more malignant behaviour. Furthermore, disorders affecting proteins of the 
peroxisomal growth and division machinery (the dynamin-like protein 1), and thus 
peroxisome dynamics, have been identified and are addressed in detail later on (Waterham et 
al., 2007) (1.2.2.2).  
 
1.1.5 Peroxisomal protein import 
As peroxisomes are devoid of DNA, and thus all peroxisomal proteins are encoded in the 
nucleus, matrix and membrane proteins are synthesized on free ribosomes in the cytosol and 
imported post-translationally into pre-existing organelles (Lazarow & Fujiki, 1985). The 
processes of peroxisomal matrix and membrane protein import are mediated by independent 
sets of evolutionary conserved peroxins (Distel et al., 1996). Up until now, around 34 
peroxins have been identified in lower eukaryotes (based on studies using S. cerevisiae, P. 
pastoris, Y. lipolytica and N. crassa), while around 18 mammalian and 23 plant peroxins have 
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been characterized (Kiel et al., 2006; Platta & Erdmann, 2007). An overview is given in Table 
1.2. 
Peroxin  Organism Localization Domains Proposed function 
Pex1p m p f y membrane  
(cytosol) 
AAA ATPase Matrix protein import, 
export of Pex5p 
Pex2p m p f y integral PMP RING finger Matrix protein import, 
translocation 
Pex3p m p f y integral PMP  Membrane biogenesis, 
PMP import 
Pex4p  p f y peripheral 
PMP 
E2 enzyme Matrix protein import, 
Pex5p ubiquitination 
Pex5p m p f y Cytosol/ 
membrane 
TPRs Matrix protein import, 
PTS1 (and PTS2) 
receptor 
Pex6p m p f y membrane  
(cytosol) 
AAA ATPase Matrix protein import, 
export of Pex5p 
Pex7p m p f y Cytosol/ 
membrane 
WD40 repeats Matrix protein import, 
PTS2 receptor 
Pex8p   f y peripheral 
PMP (matrix) 
 Matrix protein import 
Pex9p    Yl (ORF wrongly identified, antisense sequence of Pex26p) 
Pex10p m p f y integral PMP RING finger Matrix protein import, 
translocation 
Pex11p m p f y (integral) PMP  Proliferation and 
division 
Pex12p m p f y integral PMP RING finger Matrix protein import 
translocation 
Pex13p m p f y integral PMP SH3 Matrix protein import, 
docking 
Pex14p m p f y (integral) PMP Coiled-coil Matrix protein import, 
docking 
Pex15p    Sc integral PMP  Matrix protein import, 
Pex1p/Pex6p anchor 
Pex16p m p f Yl (integral) PMP  Membrane biogenesis 
Pex17p    y peripheral 
PMP 
Coiled-coil Matrix protein import, 
docking 
Pex18p    Sc Cytosol/ 
membrane 
 Matrix protein import, 
PTS2 import 






Pex20p   f y Cytosol/ 
membrane 
 Matrix protein import, 
PTS2 import 
Pex21p    Sc Cytosol/ 
membrane 
 Matrix protein import, 
PTS2 import 
Pex22p  p f y integral PMP  Matrix protein import, 
Pex4p anchor 
Pex23p   f y integral PMP Dysferlin Proliferation 
Pex24p   f y integral PMP  Proliferation 
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Pex25p    y peripheral 
PMP 
 Proliferation 
Pex26p m  f  integral PMP  Matrix protein import, 
Pex1p/Pex6p anchor 
Pex27p    Sc peripheral 
PMP 
 Proliferation 
Pex28p    Sc integral PMP  Proliferation  
(Pex24p ortholog) 
Pex29p    y integral PMP  Proliferation 
 
 
Pex30p    Sc integral PMP Dysferlin Proliferation 
(Pex23p ortholog) 
Pex31p    Sc integral PMP Dysferlin Proliferation 
Pex32p    y integral PMP Dysferlin Proliferation 
Pex33p   Nc  membrane Coiled-coil Matrix protein import, 
Biogenesis  
Pex34p    y integral PMP  Proliferation 
Table 1.2: Overview of the peroxins (Pex).  
Organisms: m, mammals; p, plants; f, filamentous fungi; y, yeasts; Nc, N. crassa; Sc, S. cerevisiae; Yl, Y. 
lipolytica. RING, really interesting new gene; SH3, Src-Homology 3. 
 
1.1.5.1 Import of peroxisomal matrix proteins 
Peroxisomal matrix protein import is accomplished using four consecutive steps: the binding 
of the cargo protein to its import receptor, the docking of the receptor-cargo complex to the 
peroxisomal membrane, membrane translocation of the cargo and receptor recycling (for 
review, see Ma & Subramani, 2009; Lanyon-Hogg et al., 2010; Rucktaschel et al., 2011) (Fig. 
1.3).  
Depending on their inherent peroxisomal targeting signal (PTS), peroxisomal matrix proteins 
utilize either the PTS1-Pex5p or the PTS2-Pex7p-mediated import pathway. The majority of 
peroxisomal proteins contain a PTS1 at their extreme C-terminus. It was initially identified as 
the tri-peptide sequence SKL in firefly luciferase (Gould et al., 1987), but has been expanded 
to the general consensus sequence [S/A/C]-[K/R/H]-[L/M] (Gould et al., 1989; Aitchison et 
al., 1991; Elgersma et al., 1996; Purdue & Lazarow, 1996; Kragler et al., 1998; 
Lametschwandtner et al., 1998). Some proteins (e.g. mammalian catalase) require additional 
interactions or upstream sequences to enhance Pex5p-binding specificity (Maynard & Berg, 
2007; Ma & Subramani, 2009). Upon completion of protein synthesis, the PTS1 is recognized 
by its specific import receptor, the cytosolic Pex5p (Brocard et al., 1994; Terlecky et al., 
1995). In mammals, a short (Pex5S) and a long mRNA isoform (Pex5L) are expressed; 
interestingly, the long isoform functions as a Pex7p co-receptor (Otera et al., 2000). The C-
terminal part of Pex5p mediates cargo binding via specific interactions between its TPR 
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repeats and the PTS1 peptide. There is an ongoing discussion about the stochiometry of 
Pex5p. It was shown to act as a monomer in solution (Costa-Rodrigues et al., 2004; Shiozawa 
et al., 2009), but also dimeric or tetrameric structures have been reported (Madrid et al., 
2004). The second peroxisomal targeting signal, the N-terminal PTS2, was first identified in 
rat liver thiolase and is a conserved nonapeptide with the consensus sequence [R/K]-[L/V/I]-
X5-[H/Q]-[L/A] (Swinkels et al., 1991; Rachubinski & Subramani, 1995). Notably, its 
presence varies greatly across species. While the PTS2-Pex7p-mediated import pathway is 
completely absent in the nematode C. elegans (Motley et al., 2000), it is only maintained in 
the yeast S. cerevisiae for the import of 3-ketoacyl thiolase and Gpd1 (Grunau et al., 2009; 
Jung et al., 2010), whereas about 60 proteins (a third of all matrix proteins) contain a PTS2 in 
A. thaliana (Reumann et al., 2009). Unlike the PTS1, the PTS2 is cleaved from the nascent 
protein upon import (Helm et al., 2007; Kurochkin et al., 2007). PTS2 proteins are recognized 
by their import receptor Pex7p, a member of the WD40 class of proteins. Although Pex7p 
itself appears to act as a monomer, it requires the assistance of auxiliary co-receptors (Rehling 
et al., 1996; Mukai & Fujiki, 2006; Grunau et al., 2009; Lanyon-Hogg et al., 2010). Pex5pL 
functions as a co-receptor for Pex7p in mammals and plants (Otera et al., 2000), while 
Pex18p/Pex21p (S. cerevisiae) or  Pex20p (H. polymorpha, N. crassa, P. pastoris and Y. 
lipolytica) are utilized in different yeast species (Einwachter et al., 2001; Otzen et al., 2005; 
Leon et al., 2006b). These co-factors share structural similarities (Dodt et al., 2001; Schliebs 
& Kunau, 2006). Other proteins lacking a PTS such as S. cerevisiae acyl-CoA oxidase or 
mammalian Cu/ZnSOD enter peroxisomes using other pathways, for example by employing a 
piggy back mechanism via association with PTS1 proteins (McNew & Goodman, 1994; Yang 
et al., 2001; van der Klei & Veenhuis, 2006; Islinger et al., 2009).  
 
Fig. 1.3: Peroxisomal matrix protein 
import.  
The receptor cycle in the yeast S. 
cerevisiae (see text for details) (adapted 
from Rucktaschel et al., 2011). Note that 
Pex17p and Pex8p do not exist in 
mammals. Moreover, Pex18p/Pex21p 
action is replaced by Pex5pL and the 
function of Pex22p/Pex4p is fulfilled by 
UbcH5a/b/c. In mammals, Pex26p 
anchors Pex6p at the membrane instead 
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After cargo binding, the cargo-receptor complex docks at the peroxisomal membrane upon 
interaction with the resident docking complex, composed of the proteins Pex13p, Pex14p and 
additionally Pex17p in yeast. Importantly, neither Pex13p nor Pex14p have the capability to 
bind cargo directly, thus Pex5p needs to stay complexed with its cargo during the import 
procedure. Membrane translocation of peroxisomal matrix proteins is thought to occuran 
extended shuttle mechanism that allows the receptor-cargo complex to pass completely the 
membrane (Kunau, 2001).  In line with this, Pex5p, Pex7p and Pex20p are cycling receptors 
that always remain protease-protected to a certain degree (Gouveia et al., 2003; Leon et al., 
2006a; Leon et al., 2006b). Notably, peroxisomes possess the striking ability to import fully 
folded and even oligomeric proteins (Glover et al., 1994; McNew & Goodman, 1994). 
Furthermore, even gold particles coated with a PTS1 of 9 nm size are imported (Walton et al., 
1995), which is achieved without disruption of membrane compartmentalisation or any 
indication of the existence of static membrane pores (analogous to nuclear pores). To 
accommodate these features, a transient membrane pore composed of Pex5p oligomers has 
been proposed to form at the peroxisomal membrane (Erdmann & Schliebs, 2005) for whose 
existence evidence has been provided recently (Meinecke et al., 2010). Nevertheless, another 
elegant model was proposed which suggests that peroxisomal cargo can reach the 
peroxisomal membrane enfolded by Pex5p due to its natively unfolded state and might thus 
be translocated due to membrane embedding by Pex5p monomers (Grou et al., 2009a).  The 
membrane translocation step itself is independent of ATP (Gouveia et al., 2003; Miyata & 
Fujiki, 2005). Cargo release into the peroxisomal lumen was suggested to be mediated by 
Pex8p, a protein which contains both PTS and therefore competes with Pex5p and Pex7p; 
however it has only been identified in yeast and fungi so far (Rehling et al., 2000). Cargo 
receptor recycling is an ATP-dependent process that requires the action of two protein 
subcomplexes and includes mono-ubiquitination of Pex5p. The so-called receptor-release 
complex consists of Pex1p and Pex6p, two proteins of the AAA family of ATPases, and 
additionally Pex4p and Pex22p in yeast (Ma & Subramani, 2009; Rucktaschel et al., 2011). 
Pex1p interacts with Pex6p which is anchored at the peroxisomal membrane by Pex15p (S. 
cerevisiae) or Pex26p (mammals) (Matsumoto et al., 2003). The RING-finger proteins 
(Pex2p, Pex10p and Pex12p) are E3 protein-ubiquitin ligases, while Pex22p serves as a 
docking site for the E2 ubiquitin-conjugating enzyme Pex4p (Wiebel & Kunau, 1992; Platta 
et al., 2009). Mammals lack the Pex4p/Pex22p complex and instead utilize the cytosolic 
UbcH5a/b/c family (Grou et al., 2008). To initiate receptor release, a conserved cysteine 
residue in the N-terminus of Pex5p is mono-ubiquitinated by Pex12p (Williams et al., 2007; 
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Grou et al., 2009b) upon which it is extracted from the peroxisomal membrane by the action 
of Pex1p and Pex6p (Miyata & Fujiki, 2005; Platta et al., 2005). Subsequent de-ubiquitination 
of Pex5p can either occur by de-ubiquitinating enzymes or non-enzymatic processes (Grou et 
al., 2009b). If there is a delay in receptor release, Pex5p is poly-ubiquitinated, resulting in its 
degradation by the 26S proteasome (Kiel et al., 2005a; Platta et al., 2007) which provides a 
quality control mechanism for peroxisomal protein import. Poly-ubiquitination of Pex5p is 
thought to occur by the action of Pex2p and Pex10p (Williams et al., 2008; Platta et al., 2009). 
Ubiquitination of the PTS2 co-receptors Pex18p and Pex20p was also observed (Brown & 
Baker, 2008).  
1.1.5.2 Insertion of peroxisomal membrane proteins 
If peroxisomal matrix protein import is impaired, cells still contain peroxisomal remnant 
structures, the so-called ghosts, which retain a full set of peroxisomal membrane proteins 
(PMPs) (Santos et al., 1988; Brown & Baker, 2003; Schrader & Fahimi, 2008). Thus, 
peroxisomal membrane protein insertion is mediated in a manner completely distinct from 
matrix protein import (Fig. 1.4). The complete absence of peroxisomal membranes is only 
observed upon deletion or impairment of the peroxins Pex3p, Pex16p and Pex19p (Hohfeld et 
al., 1991; Baerends et al., 1996; Eitzen et al., 1997; Honsho et al., 1998; Matsuzono et al., 
1999), identifying those as key factors of peroxisome membrane biogenesis. In contrast to the 
well-defined peroxisomal matrix targeting signals, no clear consensus sequence was identified 
for PMPs. However, specific membrane targeting sequences (mPTS) were determined in a 
variety of proteins displaying a different topology (Van Ael & Fransen, 2006). Depending on 
the protein, the mPTS varies greatly in length, but is usually comprised of a transmembrane 
segment and a cluster of basic amino acids (Baerends et al., 2000; Honsho & Fujiki, 2001; 
Jones et al., 2001; Rottensteiner et al., 2004). Peripheral peroxisomal membrane proteins 
harbour an mPTS and a protein interaction domain (Girzalsky et al., 2006). Most PMPs are 
targeted to the peroxisomal membrane in a manner dependent on Pex19p interaction (Class I 
PMPs) (Sacksteder et al., 2000; Snyder et al., 2000; Fransen et al., 2001; Halbach et al., 2005; 
Hadden et al., 2006; Halbach et al., 2006). Pex19p is farnesylated and shuttles between the 
cytosol and the peroxisomal membrane (Kammerer et al., 1997; Gotte et al., 1998; 
Rucktaschel et al., 2009). The multifunctional Pex19p simultaneously serves as  an import 
receptor as well as a chaperone for newly-synthesized PMPs and has further been 
characterized as both an insertion factor and assembly/disassembly factor at the peroxisomal 
membrane (Fransen et al., 2001; Fransen et al., 2004; Jones et al., 2004; Shibata et al., 2004). 
While the C-terminal part of Pex19p facilitates PMP binding (Mayerhofer et al., 2002; 
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Shibata et al., 2004; Fransen et al., 2005; Matsuzono et al., 2006), the N-terminal part 
mediates peroxisomal membrane targeting through interaction with Pex3p.  
 
 
Fig. 1.4: Peroxisomal membrane protein insertion.   
(upper panel) Topogenesis of peroxisomal membrane 
proteins. Two routes are proposed for the targeting of 
peroxisomal membrane proteins (PMPs). Class I proteins 
are directly imported into existing peroxisomes. Class II 
proteins are first targeted to ER where they concentrate in 
pre-peroxisomal vesicles which then are targeted to 
existing peroxisomes or function as an origin for de novo 
formation of peroxisomes.  
(lower panel) Pex19p-dependent import of PMPs. Class I 
peroxisomal membrane proteins (PMPs) harbour a 
peroxisomal membrane protein targeting signal (mPTS) 
which is recognized in the cytosol by the import receptor 
and/or PMP-specific chaperone Pex19p. Cargo-loaded 
Pex19p docks to the peroxisomal membrane via association 
with its docking factor Pex3p. Then the PMP is inserted 
into the membrane in an unknown manner but presumably 
with assistance of Pex19p, Pex3p and, in some organisms, 













Upon binding of Pex19p to newly-synthesized PMPs, the cargo-receptor complex is recruited 
to the peroxisomal membrane via the docking factor Pex3p, an integral membrane protein 
(Fang et al., 2004; Fransen et al., 2005; Matsuzono et al., 2006). It binds the cargo-receptor 
complex with a higher affinity than Pex19p alone which thus facilitates docking of the 
complex to the peroxisomal membrane (Soukupova et al., 1999; Ghaedi et al., 2000a; Ghaedi 
et al., 2000b; Hunt & Trelease, 2004; Haan et al., 2006; Pinto et al., 2006). In addition to that, 
Pex3p was implied to be involved in peroxisome inheritance in S. cerevisiae (Chang et al., 
2009; Munck et al., 2009). Subsequently, the PMP is inserted into the peroxisomal membrane 
by an unknown mechanism and Pex19p is recycled back to the cytosol (Matsuzono & Fujiki, 
2006).  
The exact function of the membrane biogenesis factor Pex16p remains elusive. It is only 
present in higher eukaryotes and the yeast Y. lipolytica, however, protein topology of Pex16p 
between species differs substantially: it is defined as an integral membrane protein in 
mammals, but supposedly resides within the peroxisomal lumen in Y. lipolytica (Eitzen et al., 
1. INTRODUCTION_____________________________________________________________ 
16 
1997; Honsho et al., 1998; Honsho et al., 2002) where it was suggested to act as an intra-
peroxisomal regulator of organelle fission (Eitzen et al., 1997). Interestingly, mammalian 
Pex16p was shown to be co-translationally inserted into the ER prior to its trafficking to 
peroxisomes (Kim et al., 2006). In line with this, a small number of PMPs, such as Pex3p and 
Pex16p, was suggested to be inserted into peroxisomes in a Pex19p-independent manner 
(Class II PMPs) due to their lack of a Pex19p-binding domain (Fujiki et al., 2006). They are 
initially targeted to the ER, but, in order to release e.g. Pex3p from the ER, Pex19p is required 
(Hoepfner et al., 2005; Kragt et al., 2005; Tam et al., 2005). However, full-length Pex3p was 
also shown to directly interact with Pex19p and then be inserted into the peroxisomal 
membrane in a Pex16p-dependent fashion (Matsuzaki & Fujiki, 2008). Therefore, peroxisome 
membrane biogenesis can be initiated by the formation of a pre-peroxisomal membrane that 
carries either Pex3p or Pex16p, both of which are capable to develop into mature 
peroxisomes. Depending on the peroxin present (Pex3p or Pex16p), the respective missing 
PMP is targeted and inserted in a Pex19p-dependent manner to generate import competent 
peroxisomes.  
 
1.2 PEROXISOME DYNAMICS 
1.2.1 Models of peroxisome biogenesis: “growth and division” vs. “de novo 
synthesis” 
 
Peroxisomes were once implied to originate from virtually any organelle, including the Golgi 
complex, lysosomes and the ER (Novikoff & Essner, 1960; Rouiller & Jezequel, 1963; 
Novikoff & Shin, 1964). Subsequently, peroxisomal proteins were shown to be synthesized 
on free ribosomes in the cytosol (Goldman & Blobel, 1978) and then imported post-
translationally into peroxisomes, therefore, the classical “growth and division” model was 
proposed (Lazarow & Fujiki, 1985). According to the latter, peroxisomes grow by import of 
protein and lipid components into pre-existing peroxisomes and their subsequent division into 
smaller organelles, rendering them autonomous like mitochondria. The protein machinery 
orchestrating peroxisomal growth and division will be discussed in detail in the next section 
(1.2.2).  
In the last decade, strong evidence was provided for an alternative mechanism of peroxisomal 
de novo formation from the ER (Mullen et al., 2001; Titorenko & Rachubinski, 2001b; van 
der Klei & Veenhuis, 2002; Geuze et al., 2003; Mullen & Trelease, 2006; Tabak et al., 2006; 
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Titorenko & Mullen, 2006; Hettema & Motley, 2009; Saraya et al., 2010; Nuttall et al., 2011). 
A close relationship between the ER and peroxisomes has long been indicated; e.g. 
ultrastructural studies demonstrated close contacts between peroxisomes and the ER 
(Novikoff & Novikoff, 1972), including direct, luminal connections between the organelles in 
mouse dendritic cells (Geuze et al., 2003). Furthermore, some peroxisomal proteins such as 
Pex16p are known to travel to the ER prior to peroxisomes in Y. lipolytica, mammals and 
plants (Titorenko & Rachubinski, 1998; Karnik & Trelease, 2005; Kim et al., 2006). The 
exciting observation that yeast or mammalian cells devoid of peroxisomes due to deletions of 
Pex3p, Pex16p or Pex19p (1.1.5.2) are able to form peroxisomes de novo from the ER upon 
re-introduction of the respective missing gene finally challenged the prevailing model of an 
autonomous peroxisomal growth and division {Faber, 2002, Haan, 2006`, Hoepfner`, 2005`, 
Kim`, 2006`, Kragt`, 2005`, Matzuzuno`, 1999`, Muntau`, 2000`, South`, 1999`, Titorenko`, 
2001}. In different yeast species, de novo formation of peroxisomes was initiated by re-
introduction of Pex3p which localized to specific spots at the ER membrane where it budded 
off in a Pex19p-dependent manner to generate a pre-peroxisomal structure (Hoepfner et al., 
2005; Tam et al., 2005; Haan et al., 2006; Titorenko & Mullen, 2006). After subsequent 
assembly of the membrane and matrix protein import machinery, pre-peroxisomes acquire 
import-competence. In regard to the composition of pre-peroxisomal vesicles, at least de novo 
formation itself is independent of COPI- or COPII-dependent transport (Matsuzono et al., 
1999; South et al., 2000; Voorn-Brouwer et al., 2001; Kim et al., 2006), although the COPII 
vesicle component Sec16B was recently shown to be involved in the ER export of Pex16p 
and Pex3p (Yonekawa et al., 2011). Peroxisome biogenesis from the ER is further suggested 
to be facilitated by the ER components Sec20, Sec39 and Dsl1 as well as Pex19p (and yet 
unidentified components) in S. cerevisiae (Perry & Rachubinski, 2007; Perry et al., 2009; 
Agrawal et al., 2011; Lam et al., 2011) and Emp24, Pex25p as well as Rho1 in H. polymorpha 
(Saraya et al., 2011). The contribution of the ER to PMP trafficking or peroxisomal de novo 
formation under wild-type conditions remains controversial. Elegant pulse-chase experiments 
in S. cerevisiae indicated that peroxisomes divide by growth and division under wild-type 
conditions, but that loss of peroxisomes can then be compensated by a slower, de novo 
pathway (Motley & Hettema, 2007). However, others suggest a major contribution of the de 
novo pathway in yeast and mammalian wild-type cells (Kim et al., 2006; Nagotu et al., 2010; 
van der Zand et al., 2010). Despite the ongoing debate on the extent of de novo formation to 
peroxisome biogenesis, it is clear that the ER provides lipids (and proteins) to peroxisomes 
and is intimately linked to peroxisome homeostasis. Instead of vesicular trafficking, exchange 
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of components  between the two organelles might be facilitated via contact sites or direct 
luminal connections, as peroxisomes were observed in close apposition with the ER (Geuze et 
al., 2003 2003, Tabak, 2008). In line with this, a non-vesicular transfer of phospholipids 
between the ER and peroxisomes was shown to be completely independent of Pex3p or any 
Sec components (Raychaudhuri & Prinz, 2008).  
 
Fig. 1.5: Schematic view of peroxisome dynamics 
and interactions in mammalian cells. 
Most peroxisomal matrix and membrane proteins 
(Class I PMPs) are synthesized on free 
polyribosomes in the cytosol and are post-
translationally imported into pre-existing 
organelles. Other membrane proteins (Class II 
PMPs, early peroxins; e.g., Pex3p) are routed to 
peroxisomes via the ER. A retrograde peroxisome-
to-ER transport might also exist. A novel vesicular 
mitochondria-to-peroxisome trafficking route has 
been described. A well defined sequence of 
morphological changes of peroxisomes, including 
elongation (growth), constriction, and final fission 
(division) contributes to peroxisome proliferation in 
mammalian cells. Pex11βp is involved in the 
elongation (tubulation) of peroxisomes, whereas 
DLP1, Mff and Fis1 mediate peroxisomal (and 
mitochondrial) fission. Proper intracellular 
distribution of peroxisomes formed by fission 
requires microtubules (MT) and motor proteins. 
Excess organelles are degraded by autophagy 
(pexophagy, mitophagy). 




1.2.2 The division machinery 
Mammalian peroxisomes display a remarkably dynamic morphology. While they may appear 
as spherical organelles within the cytoplasm, they form tubular structures that acquire a 
“bead-on-a-string”-like morphology prior to their fragmentation into smaller organelles 
(Schrader et al., 1996a; Schrader et al., 1998b; Koch et al., 2003; Koch et al., 2004). This 
sequence of events is indicative of peroxisomal growth and division and occurs in a multi-step 
fashion by the action of a set of evolutionary conserved proteins throughout the yeast, 
mammalian and plant systems. Initial elongation of the peroxisomal membrane is mediated by 
the Pex11 family of proteins, and after subsequent constriction by a yet unidentified 
mechanism, final fission is carried out by dynamin-like GTPases (such as mammalian DLP1) 
that are recruited to the peroxisomal membrane by distinct membrane adaptors (Fis1, Mff) 
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(Fig. 1.5).  Additionally, peroxisomes may also interconnect to form tubulo-reticular networks 
and a variety of morphologically distinct types of peroxisomes have been observed in 
different organs of mammalian organisms and cell lines (Hicks & Fahimi, 1977; Gorgas, 
1987; Yamamoto & Fahimi, 1987; Roels et al., 1991; Fahimi et al., 1993; Schrader et al., 
1994; Litwin & Bilinska, 1995; Schrader et al., 1996a; Schrader et al., 2000). In addition to 
growth and division, more complex structures such as elongated tubules or a peroxisomal 
reticulum may be related to other peroxisomal processes (e.g in metabolism, membrane 
signalling or stress protection), but information on the exact correlation between peroxisome 
dynamics/morphology and function is scarce.  
 
1.2.2.1 The Pex11 family of proteins 
The members of the Pex11 family of proteins represent a number of peroxisomal membrane 
proteins in fungi, plants and mammals that control peroxisome proliferation and regulate 
peroxisome morphology, size and number (Erdmann & Blobel, 1995; Marshall et al., 1995; 
Abe & Fujiki, 1998; Abe et al., 1998; Schrader et al., 1998b; Lingard & Trelease, 2006). They 
are conserved in yeasts, plants and mammals and several proteins and/or isoforms have been 
identified in each kingdom (Schrader & Fahimi, 2006; Hettema & Motley, 2009; Hu, 2010; 
Schrader et al., 2011). While Pex11 proteins were identified based on their capacity to 
modulate peroxisomal membrane elongation and peroxisome abundance, it has to be noted 
that not all Pex11 isoforms in a given species promote peroxisome membrane elongation or 
proliferation. In line with this, membrane association and topology may vary across 
organisms, ranging from a peripheral association in S. cerevisiae to multi-membrane spanning 
proteins in plants and mammals for (overview, see Schrader et al., 2011). The following 
section will provide an overview of the different Pex11 proteins across species and will give 
an insight into their mechanism of action.  
Initially identified in C. boidinii as a inducible membrane protein upon peroxisome 
proliferation (and termed PMP31/32), the functional significance of Pex11p was only 
recognized upon deletion of its homologue in the yeast S. cerevisiae (ScPex11p) which led to 
the formation of one or two giant peroxisomes (Goodman et al., 1986; McCammon et al., 
1990; Moreno et al., 1994; Erdmann & Blobel, 1995; Marshall et al., 1995; Sakai et al., 1995; 
Ma et al., 2006)} Besides Pex11p, additional proteins with weak similarity to the latter that 
influence peroxisome maintenance have been identified and termed Pex11-related or Pex11-
like proteins (Thoms & Erdmann, 2005; Schrader et al., 2011). These include  the oleic acid-
inducible Pex25p and the non-inducible Pex27p in S. cerevisiae as well as GIM5a and GIM5b 
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in Trypanosoma brucei (Maier et al., 2001; Smith et al., 2002; Rottensteiner et al., 2003a; 
Tam et al., 2003; Voncken et al., 2003; Huber et al., 2011; Saraya et al., 2011). Moreover, 
ScPex28p/Pex29p, ScPex30p, ScPex31p/Pex32p as well as YlPex23p/Pex24p were shown to 
modulate peroxisome number (Brown et al., 2000; Tam & Rachubinski, 2002; Vizeacoumar 
et al., 2003). Other yeast species such as H. polymorpha contain Pex11C that shares a higher 
similarity with ScPex11p (Kiel et al., 2006), resembling the situation in mammals. Similarly, 
filamentous fungi also express three Pex11 isoforms that are involved in peroxisome 
proliferation and Woronin body differentiation (Kabeya et al., 2005; Kiel et al., 2005b; Kiel et 
al., 2006; Escano et al., 2009). Plants possess five obvious homologues of Pex11p (Pex11a-e) 
which display differences in their expression pattern and some functional redundancy 
(Lingard & Trelease, 2006; Orth et al., 2007; Hu, 2010). In the mammalian system, three 
Pex11p isoforms were identified that control peroxisome proliferation under both basal and 
induced conditions: Pex11pα, Pex11pβ and Pex11pγ (Abe & Fujiki, 1998; Abe et al., 1998; 
Passreiter et al., 1998; Schrader et al., 1998b; Li et al., 2002a; Tanaka et al., 2003; Shimizu et 
al., 2004). While Pex11pβ is constitutively expressed in all tissues, both Pex11pα and 
Pex11pγ display tissue-specific expression patterns, but are most prominent in the liver 
(Passreiter et al., 1998; Schrader et al., 1998b; Li et al., 2002a; Li et al., 2002b; Tanaka et al., 
2003). Among the three isoforms, only Pex11pα is induced by peroxisome proliferators 
activating the nuclear transcription factor PPARα (1.2.4) and is thus regarded as the 
regulatable mammalian Pex11p isoform (Shimizu et al., 2004). Nonetheless, Pex11pα was 
shown to be dispensable for PPARα-mediated peroxisome proliferation in Pex11α knock-out 
mice and only required to mediate peroxisome proliferation after treatment with non-classical 
PPARα independent proliferators (Li et al., 2002a). Furthermore, the Pex11α knock-out (KO) 
mouse is viable and shows no obvious effects on peroxisome number or metabolism (Li et al., 
2002a), Pex11β KO, however, causes neonatal lethality and defects similar to the ZS 
phenotype (Li et al., 2002b), confirming its role as the central regulator of peroxisome 
proliferation in mammals. As expected, peroxisome abundance in Pex11β KO mice is 
reduced, but peroxisomal protein import and metabolism are only slightly affected. A recent 
comparative analysis of primary neuronal cultures and brain samples from wild-type mice, 
Pex11β homozygous and heterozygous knock-outs indicated a higher degree of cell death in 
heterozygous than in wild-type mice (Ahlemeyer et al., 2012). Moreover, heterozygotes also 
showed delayed neuronal differentiation, indicating that deletion of a single allele of Pex11β 
already causes neuronal defects in mice, a factor underappreciated so far. Thus, as 
dysfunctions in PEX11 do not result in any large scale alterations of peroxisomal metabolism, 
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patients with a PEX11 defect might have remained undetected so far. All mammalian Pex11 
isoforms are tightly associated with the peroxisomal membrane and are capable of forming 
homo-dimers (Li & Gould, 2003; Kobayashi et al., 2007; Koch et al., 2010). Hetero-dimers 
were also observed, however, no interaction between Pex11pα and Pex11pβ was detected 
(Koch et al., 2010). Furthermore, an interaction of Pex11pβ with Fis1, a tail-anchored protein 
involved in the recruitment of DLP1 (1.2.2.3), has been demonstrated (Kobayashi et al., 2007; 
Koch et al., 2010) (Fig. 1.6). Interestingly, mammalian Pex11pβ was not only shown to be 
able to promote peroxisome elongation upon expression, but was also observed to concentrate 
at constriction sites, indicating a non-uniform distribution of the protein at the peroxisomal 
membrane (Schrader et al., 1998b). Recently, its role as a key component in an multistep-
maturation process of asymmetric peroxisomal growth and division was further characterized 
(Delille et al., 2010). Employing a dominant-negative Pex11pβ-mYFP (which blocked 
peroxisome growth and division at an early stage) and subsequent ultrastructural and pulse-
chase analysis, Pex11pβ was indicated to initially localize to spherical, pre-existing organelles 
where initiates the formation of a nose-like protrusion at only one side of the peroxisome. The 
protrusion extends to form a membrane tubule that acquires a specific set of PMPs, segments 
and becomes import-competent for peroxisomal matrix proteins prior to its final fission by the 
action of Fis1 and DLP1 (Fig. 1.6). Importantly, predominantly newly-synthesized matrix 
proteins are imported into the newly formed constrictions, pointing to an inherent mechanism 
of peroxisomal quality control linked to growth and division (Delille et al., 2010). Transient 
expression of various Pex11 family members of different origins led to the formation of 
similar membrane protrusions in mammalian cells which developed into large stacks of 
peroxisomal membranes (Koch et al., 2010). This pattern of Pex11p-dependent formation of 
specific membrane subdomains and its role in inducing a differential distribution of PMPs 
was also detected in the yeast H. polymorpha  (Cepinska et al., 2011).  
The membrane deforming capacities of the various Pex11 proteins were recently linked to the 
presence of several N-terminal motifs within Pex11p that are conserved in yeast, fungi and 
human proteins and display amphipathic properties (Opalinski et al., 2011). Negatively 
charged liposomes, resembling the phospholipid composition of peroxisomes, were shown to 
hyper-tubulate upon the addition of a Pex11 peptide containing the most conspicuous 
amphipathic helix of P. chrysogenum.  The conservation of the amphipathic properties and its 
helical structure is essential to mediate tubulation, an intrinsic property apparently conserved 
throughout species (Opalinski et al., 2011). Thus, Pex11p-induced membrane remodelling is 
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induced by the insertion of an amphipathic helix into one leaflet of the lipid bilayer which 
causes membrane asymmetry and bending (Drin & Antonny, 2010) (Fig. 1.6).  
 
Fig. 1.6: Model of peroxisomal growth and division in mammalian cells.  
A well defined sequence of morphological changes of peroxisomes, including elongation (growth), constriction, 
and final fission (division) contributes to peroxisome proliferation in mammalian cells. Targeting to and/or 
activation of Pex11pβ at pre-existing peroxisomes initiates membrane remodelling and the formation of a tubular 
membrane extension on one side of the peroxisome. (a) Peroxisomal membrane remodelling via Pex11p is 
induced by the insertion of an amphipathic helix into one leaflet of the lipid bilayer which causes membrane 
asymmetry and bending (based on data obtained with HpPex11p). Homodimerization may keep Pex11p in an 
inactive form. Subsequently, the extension grows and acquires a specific set of PMPs (e.g. Pex11pβ, Fis1), 
before it constricts and starts to import predominantly newly-synthesized matrix proteins. Pex11pβ and the Mff-
DLP1 complex concentrate at the sites of con-striction, possibly driven by alterations in membrane curvature. (b) 
Cytosolic DLP1 is recruited by the membrane receptor Mff. After targeting, DLP1 self-assembles into large ring-
like structures that hydrolyze GTP and sever the peroxisomal membrane. Fis1 may fulfil a regulatory function. 
(from Schrader et al., 2011).   
 
In regard to the regulation of Pex11p itself by post-translational modifications and/or 
mechanisms, monomeric ScPex11p was suggested to be inactivated by homo-dimerization, 
hence dimerization was proposed to regulate membrane remodelling (Marshall et al., 1996). 
Furthermore, phosphorylation of ScPex11p at a S165/167 residue was recently shown to be 
required for Pex11p action (Knoblach & Rachubinski, 2010). However, studies on the post-
translational regulation of Pex11 protein activity remain restricted to the yeast system up until 
now.   
 
1.2.2.2 Peroxisome fission 
The final fission step of peroxisomal growth and division is executed by the action of 
dynamin-like mechano-enzymes, i.e. the proteins dnm1 (and vps1) in yeast species, 
DLP1/Drp1 in mammals and DRP3A, DRP3B and DRP5B in plants (Hoepfner et al., 2001; 
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Koch et al., 2003; Li & Gould, 2003; Mano et al., 2004; Kuravi et al., 2006; Fujimoto et al., 
2009; Kaur & Hu, 2009; Zhang & Hu, 2010). The dynamin superfamily of large GTPases 
includes the classical dynamins, dynamin-like proteins, Mx proteins and mitofusins in 
eukaryotic cells. They facilitate budding and scission events of transport vesicles, cytokinesis 
as well as the organelle division and fusion (for review, see Praefcke & McMahon, 2004; 
Heymann & Hinshaw, 2009). Classical dynamins contain five characteristic domains: the 
highly conserved GTPase domain as well as a middle domain and a GTP effector domain 
which are involved in the oligomerization and subsequent stimulation of GTPase activity. 
Additionally, they possess a PH domain facilitating lipid binding and a PRD mediating 
protein-protein interactions. Dynamin-like proteins lack one or more of the five classical 
domains and/or have acquired additional ones. Dynamins act as mechano-enzymes that 
constrict and deform membranes upon GTP hydrolysis (Sweitzer & Hinshaw, 1998; Takei et 
al., 1998; Takei et al., 1999). Mammalian dynamin-like protein 1 (abbreviated as DLP1 in the 
following) was localized to a variety of organelles, including the perinuclear region and the 
ER (Imoto et al., 1998; Yoon et al., 1998), but is primarily involved in the division of both 
mitochondria and peroxisomes (Bleazard et al., 1999; Labrousse et al., 1999; Sesaki & 
Jensen, 1999; Yoon et al., 2001; Koch et al., 2003; Li & Gould, 2003; Yoon, 2004). 
Furthermore, it contributes to the sorting of GPI-anchored, apical transport carriers at the 
Golgi complex (Bonekamp et al., 2010). Notably, DLP1 was the first protein identified to be a 
shared component of peroxisomal and mitochondrial fission (Schrader, 2006; Delille et al., 
2009)(Fig. 1.7). The concept of sharing fission components between the two organelles 
extends to other kingdoms, as e.g. dnm1 in S. cerevisiae and DRP3B in A. thaliana are also 
implied in both peroxisomal and mitochondrial division (Kuravi et al., 2006; Fujimoto et al., 
2009). Interestingly, the yeast S. cerevisiae uses two different types of DLPs, vps1 and dnm1, 
to mediate peroxisome fission. Both can complement each other, however, vps1 is utilized on 
glucose-grown conditions, while peroxisome proliferation induced upon growth on oleate 
depends on dnm1 (Motley & Hettema, 2007). At the peroxisomal membrane, mammalian 
DLP1 aligns in a spot-like pattern around the elongated, constricted tubules (Koch et al., 
2003; Li & Gould, 2003; Koch et al., 2004); in this respect, membrane constriction might 
facilitate DLP1 association. DLP1 silencing by RNAi leads to the generation of elongated, 
constricted peroxisomes that display a prominent “beads-on-a–string”-like morphology, 
indicating that constriction of the peroxisomal membrane occurs by an independent, yet 
unidentified mechanism (Koch et al., 2003). This striking morphological appearance of 
division-arrested peroxisomes facilitated the discovery of a novel lethal disorder affecting the 
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fission of both mitochondria and peroxisomes, the DLP1 deficiency (Waterham et al., 2007). 
The patient died shortly after birth and suffered from microcephaly, abnormal brain 
development, optic atrophy and hypoplasia, while enzyme measurements indicated a 
persistent lactic acidemia and mildly elevated VLCFAs, pointing to mitochondrial and/or 
peroxisomal dysfunctions. Altered mitochondrial and peroxisomal morphology in patient skin 
fibroblasts suggested a defect in organelle fission and indeed, a point mutation in the middle 
domain of DLP1 was identified (A395D). A recent biochemical study linked this point 
mutation (and other mutations in the middle domain of DLP1) to a failure in the generation of 
higher order structures of DLP1 (Chang et al., 2010). Studies in DLP1 KO mice have 
demonstrated that the complete absence of DLP1 is embryonically lethal (Ishihara et al., 
2009; Wakabayashi et al., 2009). Mice suffered from developmental abnormalities, 
particularly in the forebrain, heart and liver and impaired placenta development. Moreover, 
defects in neurite and synapse formation as well as a defect in neural tube formation were 
observed. Another mutation in the middle domain of DLP1 (C425F) has been linked to 
dilated cardiomyopathy in mice (Ashrafian et al., 2010). DLP1 action is furthermore 
extensively regulated by protein phosphorylation, sumoylation, ubiquitination and S-
nitrosylation (Chang & Blackstone, 2010). Notably, starvation-induced phosphorylation of 
DLP1 by protein kinase A was demonstrated to decrease its recruitment to mitochondria and 
thus result in the formation of elongated mitochondrial networks that resist autophagic 
degradation (Gomes et al., 2011). However, studies on the effects of post-translational 
modifications of DLP1 are so far restricted to mitochondria.  
The mechanistic basis of peroxisomal membrane constriction prior to fission remains to be 
elucidated. In Y. lipolytica, intra-peroxisomal lipid remodelling, and thus membrane 
constriction, was linked to the AOX-dependent modulation of YlPex16p activity (Guo et al., 
2003). In mammalian cells, the concerted action of non-muscle myosin A, Rho kinase II and 
the actin cytoskeleton was recently suggested to mediate membrane constriction 
(Schollenberger et al., 2010). 
1.2.2.3 Recruiting DLP1 to peroxisomal membranes – Fis1, Mff 
As DLP1 lacks the PH domain necessary for direct lipid binding, it is recruited to 
mitochondrial and peroxisomal membranes by membrane adaptor proteins. Initially, the tail-
anchored protein Fission 1 (Fis1) was implied to recruit DLP1 to mitochondria and 
peroxisomes, and thus mediate organelle division (Yoon et al., 2003; Koch et al., 2005; 
Kobayashi et al., 2007). The majority of Fis1 faces the cytosol (Mozdy et al., 2000) and TPR 
repeats in its N-terminus were suggested to facilitate protein-protein interactions (Suzuki et 
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al., 2003; Dohm et al., 2004; Suzuki et al., 2005). It is targeted to peroxisomes in a Pex19p-
dependent manner where it acts in a complex with Pex11pβ (Kobayashi et al., 2007; Delille & 
Schrader, 2008). 
 
Fig. 1.7: Key fission proteins on 
peroxisomes and mitochondria in 
mammals.  
Peroxisomes and mitochondria share key 
components of their fission machineries. 
DLP1 is a GTPase performing the final 
scission of constricted membranes and is 
recruited to the organelle from the cytosol 
by the tail-anchored membrane receptors 
Mff and Fis1. Whereas Mff appears to be 
the essential DLP1 receptor for organelle 
fission, Fis1 might fulfil regulatory 
functions. On peroxisomes, the peroxin 
Pex11pβ that is known to regulate 
peroxisome abundance and to elongate 
membranes prior to fission, is supposed to 
interact with Fis1, which might result in 
the assembly and/or recruitment of other 
components of the fission machinery. On 
mitochondria, the N-terminally anchored 
proteins MiD51 and MiD49 may 
sequester DLP1 thus inhibiting its 
function. Fis1 can potentially regulate the 
inhibitory effect of MiD51 on DLP1 
function and mitochondrial fission 




Another tail-anchored protein, the mitochondrial fission factor (Mff), was identified in a large 
scale siRNA screen in D. melanogaster and suggested to regulate fission of mitochondria and 
peroxisomes (Gandre-Babbe & van der Bliek, 2008). Detailed analysis of Mff recently 
revealed it to be the actual membrane receptor for DLP1, challenging the aforementioned role 
of Fis1 (Otera et al., 2010) (Fig. 1.7). Thus, the function of Fis1 at mitochondria and 
peroxisomes has to be reconsidered. Interestingly, Mff was only identified in metazoans 
(Gandre-Babbe & van der Bliek, 2008), thus the recruitment of the yeast DLP1 homologue 
dnm1 to mitochondria and peroxisomes still depends on the action of yeast Fis1. However, 
yeast Fis1 requires the additional action of the soluble molecular linkers Caf4 and Mdv1 
(Motley & Hettema, 2007; Motley et al., 2008), two WD40 proteins that bind to yeast dnm1 
as well as Fis1. Caf4 proteins have so far been only identified in Saccharomyces species and 
C. glabrata, but not in other yeast and fungi such as H. polymorpha (Delille et al., 2009). 
Additional factors involved in the recruitment and regulation of DLP1 action continue to 
emerge: MiD49 and MiD51/MieF, two novel N-terminally anchored mitochondrial membrane 
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proteins, have been found to recruit DLP1, at least to mitochondria (Palmer et al., 2011; Zhao 
et al., 2011). Similar to Mff, they are not found in yeast.  
1.2.3 Peroxisome motility and inheritance  
The intracellular distribution of peroxisomes in mammalian cells is achieved by a 
combination of microtubule-independent and dependent movement (Rapp et al., 1996; 
Schrader et al., 1996a; Schrader et al., 1996b; Wiemer et al., 1997; Huber et al., 1999; 
Thiemann et al., 2000; Schrader et al., 2003). Around 90 % of peroxisomes display short 
range, oscillating, microtubule-independent movements which enable contacts between 
neighbouring organelles (Rapp et al., 1996; Wiemer et al., 1997; Schrader et al., 2000). Those 
occur randomly, without any preferential direction. An involvement of the actin cytoskeleton 
was recently suggested to facilitate short-range movements and RhoA activity was implied to 
provide a switch between travelling on actin or microtubules, depending on its activation state 
(Schollenberger et al., 2010). For long range movements, peroxisomes utilize the microtubule 
cytoskeleton, covering mean distances of 10 µm with a velocity of 0.6 µm/second (Rapp et 
al., 1996; Wiemer et al., 1997; Schrader et al., 2000). This microtubule-dependent movement 
involves the action of dynein, kinesin, and dynactin (Schrader et al., 1996a; Schrader et al., 
2003; Kural et al., 2005). Recently, anchoring of peroxisomal membranes to microtubules 
was demonstrated to be mediated by Pex14p, an essential component of the importomer 
(1.1.5.1). Tubulin was shown to associate with Pex14p and long-range microtubule-dependent 
movements were diminished in Pex14p-deficient fibroblasts, but were restored upon its re-
introduction (Bharti et al., 2011). Whereas the formation of tubular peroxisomes is 
microtubule-independent (and is even induced upon microtubule depolymerisation) (Schrader 
et al., 1996a), intact microtubules are required for the proper distribution of the organelles 
(Schrader et al., 2003). Furthermore, microtubules are involved in Pex16p-dependent 
biogenesis of peroxisomes (Brocard et al., 2005).  
In yeast and plant cells, the actin cytoskeleton and type V myosins are required for 
peroxisome movement and inheritance (Hoepfner et al., 2001; Jedd & Chua, 2002; Mano et 
al., 2002; Mathur et al., 2002; Muench & Mullen, 2003). It is important to note that regulated 
peroxisome transport is crucial for peroxisome inheritance in yeast species, as non-induced 
yeast cells contain just one or only a few peroxisomes. Thus, coordination of cell cycle-
dependent division and transport to the daughter organelle is essential. The faithful 
partitioning of peroxisomes in yeasts is mediated by the proteins Inp1p and Inp2p in concert 
with Myo2p and Pex3p (Fagarasanu et al., 2005; Fagarasanu et al., 2006; Chang et al., 2009; 
Munck et al., 2009; Fagarasanu et al., 2010; Saraya et al., 2010). Within the mother cell, 
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peroxisomes are anchored at the cell cortex by the action of Inp1p and Pex3p, while some are 
actively transported into the bud due to the interaction of the motor Myo2p with the integral 
membrane protein Inp2. In contrast, mammalian cells contain hundreds of peroxisomes that 
are inherited in a rather random fashion.  
 
1.2.4 Regulation of peroxisome abundance 
Peroxisomes are known to be remarkably plastic organelles across species. In the following 
section, an overview will be given of the variety of stimuli influencing peroxisome abundance 
in mammals, yeast and plants. Moreover, the signal transduction mechanisms mediating 
peroxisome proliferation in the different kingdoms will be introduced.  
The inherent capacity of mammalian peroxisomes to adjust their morphology and proliferate 
after application of external stimuli has been known for decades (Hess et al., 1965). Classical 
models of peroxisome proliferation in mammals include the peroxisomal response to 
peroxisome proliferators (Fahimi et al., 1982) and the regenerating rat liver after partial 
hepatectomy (Yamamoto & Fahimi, 1987). Ultrastructural studies revealed that  peroxisomes 
in the regenerating rat liver display a very heterogeneous morphology, exhibiting tail-like 
membrane extensions and elongated forms, but also forming interconnections (Fahimi, 1969). 
In mammals, peroxisome proliferation is induced by the application of a high-fat diet, cold 
exposure, hypolipidemic drugs (such as fibrates), industrial compounds and environmental 
pollutants such as phtalates and plasticizers (Hess et al., 1965; Svoboda & Azarnoff, 1966; 
Lazarow & De Duve, 1976; Reddy et al., 1980; Fahimi et al., 1982; Bentley et al., 1993). 
However, it is important to note that different species respond with different intensities to 
peroxisome proliferators (PP), e.g. a massive peroxisome proliferation upon PP treatment is 
only observed in rodents, but not in humans (Islinger et al., 2010). Similarly, prolonged PP 
exposure gives rise to hepatocellular tumours in rodents, but not humans (Reddy et al., 1980; 
Kluwe et al., 1982; Reddy et al., 1982; Gariot et al., 1983; Moody et al., 1991). In addition to 
an increase of peroxisome number, PP treatment in rodents also leads to the induction of 
peroxisomal enzymes e.g. associated with fatty acid β-oxidation. Induction of proliferation 
and peroxisomal enzymes is dose-dependent and occurs at the protein and mRNA level (Beier 
et al., 1988; Schad et al., 1996). However, some chemicals may induce proliferation without 
simultaneous induction of β-oxidation enzymes (Baumgart et al., 1990) and vice versa 
(Lazarow et al., 1982). In mammalian cell culture models, a profound tubulation of 
peroxisomes was further observed upon addition of growth factors and unsaturated fatty 
acids, microtubule depolymerisation  or after UV irradiation and H2O2 exposure (Schrader et 
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al., 1998a; Schrader et al., 1999). A similar increase in peroxisome number and size is 
induced in yeast species and fungi after shifting cells to growth media that contain e.g. 
alkanes, oleic acid, methanol, D-amino acids, and purines, and thus substrates that require 
peroxisomal metabolic functions (Veenhuis et al., 1987; Schrader & Fahimi, 2006; van der 
Klei et al., 2006). For instance, 80 % of the cytoplasmic volume of the methylotrophic yeast 
H. polymorpha may be occupied by peroxisomes when shifting to methanol-containing 
cultures (Veenhuis et al., 2003). As peroxisomes are the only site of β-oxidation in yeast, 
fungi and plant cells (Kunau et al., 1988), the regulation of their numbers is essential for 
utilization of fats.  Plant peroxisomes respond to seed germination, herbicides, clofibrate as 
well as stress signals like ROS and ozone with peroxisome proliferation (Castillo et al., 2008). 
Interestingly, mussel peroxisomes proliferate extensively after exposure to crude petroleum, 
thus peroxisome proliferation may serve a valuable indicator of  marine pollution (Fahimi & 






















Fig. 1.8: Transcriptional regulation of peroxisome proliferation in different species. 
In most organisms, peroxisome proliferation is preceded by the induction of genes associated with fatty acid β-
oxidation and membrane elongation (e.g. Pex11). Activation of these pathways depends on several 
environmental and developmental conditions. In yeast, growth in the presence of oleic acid induces the 
dimerization of the transcription factors Oaf1p and Pip2p that, together with Adr1p, bind the oleate response 
element (ORE) and upstream activation sequence 1 (UAS1). In plants, light induces the expression of 
peroxisomal genes by the action of phyA and the binding of the transcription factor HYH to the PEX11b 
promoter. In mammals, peroxisome proliferator-activated receptor alpha (PPARα) and retinoid X receptor 
(RXR) co-ordinately bind to the PPAR response element (PPRE) to upregulate gene expression. Recently, other 
mechanisms independent of PPARα have also been described (e.g. PGC-1α dependent) (adapted from Ribeiro et 
al., 2011). 
 
Peroxisome proliferation in mammals is regulated by the activation of the peroxisome 
proliferator activating receptor (PPAR)α. PPARs are nuclear encoded transcription factors 
which belong to the family of steroid/retinoid/thyroid receptors of which three subtypes were 
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identified: alpha, beta (delta) and gamma (Issemann & Green, 1990). PPARs form hetero-
dimers with the retinoid X receptors (RXRs) and bind to specific DNA sequences known as 
peroxisome proliferator response elements (PPREs) (Fig. 1.8). PPREs not only regulate all 
peroxisomal lipid β-oxidation enzymes, but also other proteins (Schoonjans et al., 1996). 
Various peroxisome proliferators such as fibrates, hypolipidemic drugs and PUFAs activate 
PPARα which then regulates processes linked to lipid metabolism, lipoprotein synthesis and 
inflammatory response (Feige et al., 2006). PPARα is highly expressed in rodents, but only 
moderately in humans (Klaunig et al., 2003). Upon deletion of PPARα, KO animals are viable 
and maintain basic peroxisome functions (Lee et al., 1995), indicating that PPARα is not 
required for constitutive expression of peroxisomal genes. In rodents, PPARα-mediated 
peroxisome proliferation was linked to carcinogenesis in liver, pancreas and testis (Reddy et 
al., 1980; Reddy & Lalwani, 1983; Rabu & High, 2007), but the proliferators as such do not 
elicit a genotoxic response. Thus, tumour formation was linked to increased ROS damage (Qi 
et al., 2000), as the induction of various peroxisomal β-oxidation enzymes without 
concomitant induction of antioxidant enzymes (e.g. catalase) generates an intra-peroxisomal 
ROS imbalance, initiating ROS-related protein damage throughout the whole cell. PP induced 
peroxisome proliferation in mammals is linked to the induction of Pex11α as it is the only 
Pex11 isoform carrying a PPRE (Shimizu et al., 2004). However, Pex11α was shown to be 
only essential for peroxisome proliferation induced by non-classical proliferators, but was 
neglectable for proliferation stimulated by PPARα-dependent PPs (Li et al., 2002a). Thus, 
other PPARα-independent mechanisms of peroxisome proliferation might contribute 
profoundly to peroxisome homeostasis. In line with this, the transcriptional co-activator 
PGC1α was shown contribute to combined peroxisome and mitochondrial proliferation in 
brown adipose tissue after thermogenic stimuli in a PPAR-independent mechanism (Bagattin 
et al., 2010). Notably, these observations were made in rodent and human cells. As AOX or 
MFE2-deficient cell lines display a reduction in peroxisome number (Chang et al., 1999), a 
contribution of an intra-peroxisomal metabolic stimulus controlling peroxisomal abundance is 
discussed (Purdue & Lazarow, 2001), but was proposed to act independent of Pex11p (Li & 
Gould, 2002). Similar to the mammalian system, upon shift to oleate-containing growth 
media, the transcription factor Pip2-Oaf1 is activated in yeast that binds to oleate response 
elements (ORE) in the promoters of fatty acid response genes (Einerhand et al., 1993; Filipits 
et al., 1993; Rottensteiner et al., 1996; Karpichev & Small, 1998; Baumgartner et al., 1999; 
Rottensteiner et al., 2003b) (Fig. 1.8). Besides the OREs, several fatty acid response genes 
also contain an upstream activation sequence (UAS1) that is targeted by the transcription 
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factor Adr1 (Simon et al., 1992). These transcription factors induce the expression of Pex11p 
and the peroxisomal acyl-CoA oxidase Fox1p, while Pip2 additionally induces Pex25p 
(Gurvitz et al., 2001; Gurvitz & Rottensteiner, 2006). In methylotrophic yeasts, peroxisomal 
alcohol oxidase, the key enzyme for methanol oxidation (Ozimek et al., 2005), is regulated by 
the Adr1 homologue Mxrp1 in P. pastoris (Lin-Cereghino et al., 2006) and by Mpp1 in H. 
polymorpha (Leao-Helder et al., 2003). In plants, a light-induced signal transduction 
mechanism activating peroxisome proliferation has been identified (Hu & Desai, 2008). Far-
red light is perceived by the receptor phyA which in turn facilitates binding of the 
transcription factor HyH to the promoter region of the Pex11B gene (Fig. 1.8). Although plant 
peroxisomes respond to fibrate addition with proliferation, no orthologues for PPARα or Pip2 
have so far been identified in plants (Castillo et al., 2008; Kaur & Hu, 2009).  
Upon withdrawal of stimuli, excess peroxisomes are degraded (Yokota, 1993; Tuttle & Dunn, 
1995; Kiel et al., 2003). This is achieved by a combination of autophagy and membrane 
disruption by 15-lipoxygenase (Iwata et al., 2006). Around 70 % of peroxisomes are removed 
by autophagy in mammalian cells (Iwata et al., 2006). For autophagic removal, excess 
peroxisomes are first surrounded by ER membranes to create an autophagosome that fuses 
with lysosomal compartments. Upon fusion of double membranes, digestion of peroxisomes 
occurs. Peroxisome degradation is characterized in more detail in the yeast system and there 
termed pexophagy (Klionsky & Ohsumi, 1999; Kim & Klionsky, 2000; Dammai & 
Subramani, 2001; Farre & Subramani, 2004; Dunn et al., 2005; Monastyrska & Klionsky, 
2006). Another mechanism of peroxisome degradation requires the action of 15-lipoxygenase 
which binds to organelles and disrupts their membrane, resulting in a release of contents into 
the cytoplasm (van Leyen et al., 1998). The mechanism of 15-lipoxygenase recruitment to 
peroxisomes remains to be elucidated, but leaking peroxisomal proteins are then degraded by 
the proteasome.  
 
1.3 THE PEROXISOME-MITOCHONDRIA CONNECTION 
Mitochondria and peroxisomes are both ubiquitous subcellular organelles that fulfil essential 
metabolic functions. While mitochondria have often been reduced to the powerhouse of the 
cell, they are essential for a variety of other processes such as controlling cellular redox-state, 
calcium homeostasis, apoptosis and the biosynthesis of iron-sulphur clusters (Rizzuto et al., 
2000; Lill & Muhlenhoff, 2005; McBride et al., 2006). Although mitochondria and 
peroxisomes vary in some essential aspects, as  e.g. mitochondria contain their own DNA, 
possess a double membrane and are of different evolutionary origin, several findings indicate 
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that they share an intricate relationship on a metabolic, dynamic and pathological level 
(Schrader & Yoon, 2007; Camoes et al., 2009).  
On a metabolic level, peroxisomes and mitochondria obviously co-operate in the in the β-
oxidation of fatty acids in animals (1.1.2): Shortened acyl-CoA esters generated by the 
peroxisomal β-oxidation machinery may be shuttled to mitochondria to be fully oxidized for 
energy generation (Wanders, 2004; Schrader & Yoon, 2007). Furthermore, both organelles 
co-operate in thermogenesis in brown adipose tissue (BAT) (Nedergaard et al., 1980; Binns et 
al., 2006). Mitochondria in BAT possess the ability to uncouple oxidation from ATP 
production, thus generating heat, whereas peroxisomal β-oxidation is an inherently uncoupled 
process (1.1.2) (Nicholls & Locke, 1984; Sell et al., 2004). Moreover, co-operation in the 
glyoxylate cycle in yeast, the glycolate cycle and photorespiration of plants as well as biotin 
synthesis of fungi was demonstrated (Veenhuis et al., 1989; Reumann & Weber, 2006; 
Fujimura et al., 2007; Tanabe et al., 2011). Additionally, both organelles are essential for 
ROS detoxification (Antonenkov et al., 2009; Bonekamp et al., 2009; Bonekamp et al., 
2011a; Fransen et al., 2011). In line with a co-ordinated metabolic cooperation, the 
transcriptional co-activator PGC1α, a essential regulator of mitochondrial biogenesis 
(Puigserver et al., 1998; Puigserver et al., 1999), was recently shown to modulate peroxisome 
proliferation after thermogenic stimuli in BAT (Bagattin et al., 2010). Moreover, peroxisomes 
and mitochondria were shown to co-operate in antiviral defence (Dixit et al., 2010): the RIG-
I-like receptor adaptor protein MAVS, curiously another tail-anchored protein like Fis1 and 
Mff, was localized to mitochondria and peroxisomes. Upon viral infection, peroxisomal 
MAVS mediates short-term defence by induction of interferon-independent response genes, 
while mitochondrial MAVS stimulates interferon-dependent genes in order to stabilize the 
antiviral response.  
In addition to their metabolic co-operation, mitochondria and peroxisomes are both very 
dynamic organelles that can drastically change their morphology and number. Interestingly, 
both were shown to share key components of their fission machinery, the GTPase DLP1 as 
well as its membrane adaptors Fis1 and Mff (1.2.2) (Schrader & Fahimi, 2006; Camoes et al., 
2009; Schrader et al., 2011). As a result, the first combined disorder of mitochondrial and 
peroxisomal fission was described (Waterham et al., 2007). Sharing of fission machinery 
components appears to an evolutionary conserved concept in plants, yeast and mammals 
(Mano et al., 2004; Lingard et al., 2008; Zhang & Hu, 2008; Delille et al., 2009; Nagotu et al., 
2010). This mechanism might have been initiated when mitochondria lost their originally 
bacterial division components and thus adapted the peroxisomal ones (Osteryoung & Nunnari, 
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2003; Michels et al., 2005; Schrader & Fahimi, 2006). Unlike peroxisomes, however, 
mitochondria are further known to regulate their dynamics by complete fusion of mature 
organelles (Okamoto & Shaw, 2005). Peroxisomal fusion processes have only been implied in 
peroxisome biogenesis of Y. lipolytica (Titorenko & Rachubinski, 2000; Titorenko & 
Rachubinski, 2001a).  
Aforementioned findings raise the question of how inter-organellar cross-talk is achieved. 
Indeed, a vesicular transport pathway from mitochondria to peroxisomes was identified 
(Neuspiel et al., 2008). Those mitochondria-derived-vesicles (MDVs) were shown to bud off 
the mitochondrial membrane in a DLP1 independent manner and a subpopulation of MDVs 
was observed to fuse with a small subpopulation of peroxisomes (Neuspiel et al., 2008). 
Vps35, a component of the retromer complex, was shown to regulate the formation of  
transport vesicles between mitochondria and peroxisomes (Braschi et al., 2010).  Although 
the exact function of this vesicular pathway requires further analysis, it might contribute to 
the transport of metabolites, lipids, or proteins to peroxisomes. Alternatively, it might 
constitute a retrieval mechanism of peroxisomal proteins which have been mistargeted to 
mitochondria. Additionally, intra-organellar redox balance was indicated to facilitate inter-
organellar communication (Ivashchenko et al., 2011). It was demonstrated that mitochondrial 
redox balance is very sensitive to perturbations of peroxisomal redox state and a mechanism 
of direct cross-talk between the organelles was proposed. In line with this, damage or 
disturbances of one organelle may have deleterious effects on the other. For instance, 
inhibition of catalase not only leads to a decline in catalase levels and a subsequent 
peroxisomal H2O2 elevation, but also contributes to age-related mitochondrial dysfunction 
(Koepke et al., 2008).  As a consequence, the inner mitochondrial membrane potential and 
mitochondrial ROS production were increased. Additionally, certain peroxisomal disorders 
result in an accumulation of peroxisomal substrates such as VLCFA and bile acid 
intermediates that directly affect mitochondria and their redox balance by inhibiting the 
electron transfer chain (Fourcade et al., 2008; Ferdinandusse et al., 2009). In line with this, 
Pex5-/- mice show an extremely altered mitochondrial morphology with marked 
abnormalities in various tissues (Baumgart et al., 2001). Vice versa, in microvesicular hepatic 
steatosis, mitochondrial β-oxidation is impaired, leading to an accumulation of triglycerides 
and the formation of lipid droplets. Pre-treatment of steatotic rats with clofibrate, a 
peroxisome proliferator, which also enhanced catalase activity, partly reversed this phenotype 
(Natarajan et al., 2006). Thus, impairment of mitochondrial β-oxidation leads to a shift to 
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peroxisomal β-oxidation which results in an increase in ROS production due to higher activity 
of peroxisomal oxidases, inducing oxidative lesions in hepatic tissue.  
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1.4 OBJECTIVES  
Peroxisomes are ubiquitous subcellular organelles that catalyze numerous metabolic 
processes, some of which are carried out in co-operation with other cell organelles such as the 
ER, lipid droplets and mitochondria in particular. The crucial role of peroxisomes for human 
health is exemplified by the severe phenotype of peroxisomal disorders. However, 
peroxisomes are not merely static organelles, but display a remarkable degree of plasticity in 
regard to their number and morphology. Peroxisome dynamics have been shown to be 
regulated by a combination of peroxisomal membrane elongation, subsequent fission and 
intracellular distribution via the microtubule cytoskeleton. Moreover, a multitude of external 
stimuli was identified to induce peroxisome elongation and/or proliferation; however, there is 
only limited knowledge on their intracellular signal transduction onto the peroxisomal level.  
In mammals, peroxisomal growth and division is initialized by an elongation of the 
peroxisomal membrane which is mediated by the action of Pex11pβ, a constitutively 
expressed member of the Pex11 family of proteins. After subsequent constriction of the 
membrane tubule by a yet unidentified mechanism, final fission is carried out by the 
dynamin-like GTPases DLP1 that is recruited to the peroxisomal membrane by the membrane 
adaptor proteins Fis1 and Mff. Interestingly, the latter components are shared with 
mitochondria.  
In the recent years, evidence has been provided that organelle dynamics and their proper 
regulation are intricately linked to organelle function and/or distribution. In line with this, a 
patient with a lethal defect of mitochondrial and peroxisomal fission was identified. Thus, the 
aim of this thesis was to gain further insight into the processes contributing to and regulating 
peroxisome dynamics in mammalian cells. This thesis is comprised of three parts: in the first 
section, the contribution of a potential fusion between mature peroxisomes to peroxisome 
dynamics, analogous to mitochondria, was investigated. Moreover, it was addressed if 
components of the mitochondrial fusion machinery are also shared by peroxisomes. In the 
second part, the regulation of peroxisome dynamics at the organelle itself was investigated by 
characterizing Pex11pβ, the key mediator of peroxisome elongation/proliferation in 
mammalian cells, biochemically. Furthermore, modulations of Pex11pβ activity by post-
translational mechanisms were addressed.  In the final part, different groups of external 
stimuli were characterized in regard to their capacity to alter peroxisome dynamics in order to 
study the regulation of peroxisome dynamics on a transcriptional level in mammalian cell 
culture. The results obtained in this study will help to clarify the following basic cell 
biological questions: 
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• Peroxisome dynamics: Do mammalian peroxisomes fuse? Does the fusion of mature 
peroxisomes contribute to the regulation or organelle dynamics in a manner analogous 
to mitochondria? If not, are there other yet uncharacterized processes involved in 
peroxisome dynamics? Are mitochondrial fusion proteins also shared between 
mitochondria and peroxisomes as are components of the fission machinery?  
• Modulation of peroxisome dynamics by Pex11pβ action: What is the exact topology of 
human Pex11pβ? Is the protein targeted to the ER in peroxisome-deficient patient 
fibroblasts? Is human Pex11pβ regulated by phosphorylation and/or oligomerization? 
• Alterations of peroxisome dynamics: Do peroxisomes respond to distinct classes of 
external stimuli (apoptotic insults, oxidative stress, metabolic stimuli) with a change in 
peroxisome dynamics? Can the observed phenotype be correlated to a specific 
metabolic state/function? Can pancreatic rodent AR42J cells usually utilized to study 
zymogen granule biogenesis serve as physiological model system for peroxisome 
dynamics? Does external stimulation affect the expression of the three mammalian 
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2 MATERIALS AND METHODS 
 
2.1 EQUIPMENT  
Centrifuges 
 
• Centrifuge 5810R (Eppendorf, Hamburg, Germany) 
• Heraeus Fresco 17 Centrifuge (Thermo Scientific, Waltham, MA, USA) 
• Heraeus Pico 17 Centrifuge (Thermo Scientific, Waltham, MA, USA) 
• Minispin plus (Eppendorf, Hamburg, Germany)  
• Avanti Centrifuge J-251, Rotors JA-25.50 and JA-14 (Beckman Coulter, Fullerton, 
USA) 
• Optima LE-80K Ultracentrifuge, Rotor Ti80 (Beckman Coulter, Fullerton, USA) 
 
Incubators and shakers 
 
• Incubator for bacterial cultures (Binder, Tuttlingen, Germany) 
• Incubator shaker for bacterial cultures Innova 4400 (New Brunswick Scientific, 
Edison, USA) 
• Magnetic stirrer Agimatic-N (JP Selecta, Barcelona, Spain) 
• Mini Rocker MR-1 (Biosan, Riga, Latvia) 
• Shaker REAX 2 (Heidolph Instruments, Heidelberg, Germany) 
• Shaker, horizontal Unimac 1010 (Heidolph Instruments, Heidelberg, Germany) 
• Thermomixer comfort (Eppendorf, Hamburg, Germany) 
• Ultra Low -80°C freezer (Sanyo, Sakata, Japan) 
• Vortex Genius 3 (IKA, Staufen, Germany) 




• CO2 incubator (Sanyo, Sakata, Japan) 
• CO2 incubator HeraCell (Heraeus/Kendro Laboratory Products, Hanau, Germany)  
• Safety cabinet HeraSafe (Heraeus/Kendro Laboratory Products, Hanau, Germany) 
• Peristaltic pump Masterflex 701572 (Cole-Parmer, Vernon Hills, USA) 
• Pump Laboport (KNF Neuberger, Freiburg, Germany)  
• Electro Cell Manipulator (ECM) 630 (BTX Harvard Apparatus, Holliston, MA, USA) 
 
Optical equipment and microscopes 
 
• Leica DMIL microscope (Leica, Heidelberg, Germany; cell culture) 
• Olympus IX81 microscope; PlanApo 100x/1.40 oil objective (Olympus Optical, 
Hamburg, Germany)  
• Camera F-View II CCD and Soft Imaging software (Soft Imaging Systems, Münster, 
Germany) 
• Zeiss LSM 510 confocal microscope; Plan-Apochromat 63x and 100x/1.4 oil 
objectives (Carl Zeiss, Oberkochen, Germany) 
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• Zeiss LSM 510 live cell equipment: Heating insert P, CTI controller 3700 digital, 
Tempcontrol 37-2 (PeCon GmbH, Erbach, Germany) 
• Leica TCS SP2 AOBS confocal microscope; PlanApo 100x/1.40 oil objective (Leica, 
Wetzlar, Germany) 
• Andor Revolution XD spinning disk confocal microscope (Andor technology, Belfast, 
Northern Ireland) 
• AlphaImager HP (Alpha Innotech, San Leandro, USA)  
• BioRad Molecular Imager FX (BioRad, Munich, Germany) 
• Phospho-Imager FLA-3000 (Fujifilm Europe GmbH, Düsseldorf, Germany) 
• Calibrated Imaging Densitometer GS-710 (Bio-Rad, Munich, Germany) 
• Photometer Ultrospec 100 pro (Amersham Biosciences, Uppsala, Sweden) 
• Qubit fluorometer (Invitrogen, Carlsbad, CA, USA) 
• NanoDrop nanospectrophotometer 2000 (Fisher Scientific – NanoDrop products, 
Wilmington, DE, USA) 
• Tecan M200 infinite plate reader (Tecan Group Ltd., Männedorf, Switzerland) 
 
Electrophoretic and blotting equipment 
 
• Horizontal PerfectBlue Gel System Mini (Peqlab Biotechnology, Erlangen, Germany) 
• Electrophoresis power supply EPS 2A200 (Amersham Biosciences, Uppsala, Sweden) 
• Electrophoresis power supply EPS 601 (Amersham Biosciences, Uppsala, Sweden) 
• Slap mini gel chamber (Keutz, Reiskirchen, Germany) 




• Autoclave Uniclave 88 (AJC, Lisbon, Portugal) 
• Bag Sealer Folio (Severin, Sundern, Germany) 
• Balance Vicon (Acculab/Sartorius, Göttingen, Germany) 
• Balance, analytical BP 221S (Sartorius, Göttingen, Germany) 
• Centrifuge beakers, 250 ml (Beckman, Munich, Germany) 
• Centrifuge tubes, 50 ml (Nalgene, Rochester, USA) 
• Cryomed N2 storage (Forma Scientific, Waltham, USA) 
• Drying Oven (Sanyo, Sakata, Japan) 
• Easypet (Eppendorf, Hamburg, Germany) 
• Microwave KOR-63A5 (Daewoo, Butzbach, Germany) 
• pH meter PB-11 (Sartorius, Göttingen, Germany) 
• Research pipettes, 2.5 µl, 10 µl, 100 µl, 1000 µl (Eppendorf, Hamburg, Germany) 
• Thermal Cycler MyCycler (Bio-Rad, Munich, Germany) 
• X-Ray cassette (Roth, Karlsruhe, Germany) 
• Autoradiography cassette BAS Cassette 2040 (Fujifilm Europe GmbH, Düsseldorf, 
Germany) 
• Fujifilm Imaging Plate BAS-MP 2040S (Fujifilm Europe GmbH, Düsseldorf, 
Germany) 
• Ultracentrifuge adapters for reaction tubes (Rotor: 70Ti; Beckman Coulter) (Beranek 
Laborgeräte, Heidelberg, Germany)  
• BioRad GelAir gel dying system (BioRad, Munich, Germany) 
• Haemocytometer Neubauer counting chamber improved (Roth, Karlsruhe, Germany) 
• Metal rings for clone selection (inner diameter: 10 mm), self-made 
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2.2 CONSUMABLES  
Product Source 
Centrifuge tubes, 250 mL Nalgene, Rochester, NY, USA 
Centrifuge tubes, 50 mL Nalgene, Rochester, NY, USA 
Cover slips, round, 12 and 18 mm diameter Menzel, Braunschweig, Germany 
Cryovials, 2 mL Greiner Bio-One, Frickenhausen, Germany 
Cuvettes, semimicro Plastibrand/Brand, Wertheim, Germany  
Dishes for agar plates Greiner Bio-One, Frickenhausen, Germany 
Dishes for tissue culture, 35, 60, 100 mm Greiner Bio-One, Frickenhausen, Germany 
Dishes for tissue culture, 6, 12 and 24 well Greiner Bio-One, Frickenhausen, Germany 
Dishes for tissue culture, 96 well, black well, 
flat, microclear bottom  
Greiner Bio-One, Frickenhausen, Germany 
Electroporation cuvettes, 4 mm gap Molecular BioProducts, San Diego, USA 
Filter for medium, Sartolab P20, 0.2 µm Sartorius, Goettingen, Germany 
Folded filters Macherey-Nagel, Düren, Germany 
Glass bottom dishes, 35 mm MatTek, Ashland, USA 
Hyperfilm ECL Amersham Biosciences, Uppsala, Sweden 
Microcentrifuge tubes, 0.2 mL Axygen, Union City, CA, USA 
Microcentrifuge tubes, 0.5 mL for Qubit Axygen, Union City, CA, USA 
Microcentrifuge tubes, 0.5, 2 mL Sarstedt, Nürnbrecht, Germany 
Microcentrifuge tubes, 1.5 mL Greiner Bio-One, Frickenhausen, Germany 
Microcentrifuge tubes, 1.5mL, SafeLock Eppendorf, Hamburg, Germany 
Microscope slides, frosted end Menzel, Braunschweig, Germany 
Needle, Sterican 20 G x 1”, 0.45 x 25 mm B. Braun, Melsungen, Germany 
Needle, Sterican 26 G x 1”, 0.45 x 25 mm B. Braun, Melsungen, Germany 
Pipette tips, 20, 200, 1000 µL Sarstedt, Nümbrecht, Germany 
Protran Nitrocellulose Transfer Membrane Whatman, Dassel, Germany 
Reaction tubes, 15, 50 mL Greiner Bio-One, Frickenhausen, Germany 
Rubber policeman Roth, Karlsruhe, Germany 
Serological pipettes, 5, 10 mL Greiner Bio-One, Frickenhausen, Germany 
Silica Gel Orange Roth, Karlsruhe, Germany 
Syringe Inject, 10 mL B. Braun, Melsungen, Germany 
Syringe Omnifix-F, 1 mL B. Braun, Melsungen, Germany 
Tubes for bacterial cultures, 14 mL Greiner Bio-One, Frickenhausen, Germany 
Whatman filter paper, 3 mm Whatman, Dassel, Germany 
Table 2.1: Consumables 
2.3 CHEMICALS AND REAGENTS 
2.3.1 Chemicals 
Chemical Source 
[P32] orthophosphoric acid PerkinElmer, Waltham, MA, USA 




Invitrogen, Carlsbad, CA, USA 
2-Mercaptoethanol Sigma, Steinheim, Germany 
6-hydroxydopamine Sigma, Steinheim, Germany 
Acetic acid Merck, Darmstadt, Germany 
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Chemical Source 
Acrylamide – RotiphoreseGel 30 Roth, Karlsruhe, Germany 
Agar Formedium, Hunstanton, England 
Agarose NEEO Roth, Karlsruhe, Germany 
Albumin Fraction V (BSA) Roth, Karlsruhe, Germany 
Ammonium persulphate (APS) Sigma, Steinheim, Germany 
Ampicillin Sigma, Steinheim, Germany 
Arachidonic acid MP Biochemicals, Illkirch, France  
Bezafibrate Boehringer-Mannheim, Mannheim, Germany 
Bromophenol blue Sigma, Steinheim, Germany 
Calcium chloride Sigma, Steinheim, Germany 
CHAPS Roth, Karlsruhe, Germany 
Chloroform Merck, Darmstadt, Germany 
Copper Sigma, Steinheim, Germany 
Cycloheximide Sigma, Steinheim, Germany 
D(+)glucose monohydrate Fluka/Sigma, Steinheim, Germany 
Dexamethasone Sigma, Steinheim, Germany 
Digitonin Sigma, Steinheim, Germany 
Dimethyl sulphoxide (DMSO) Sigma, Steinheim, Germany 
Dithiothreitol (DTT) Sigma, Steinheim, Germany 
ECL advanced western blot detection kit Amersham Biosciences, Uppsala, Sweden 
Eicosatetraynoic acid (ETYA) Alexis/Axxora, Grünberg, Germany 
Ethanol Merck, Darmstadt, Germany 
Ethidium bromide solution Fluka/Sigma, Steinheim, Germany 
Ethylenediaminetetraacetic acid salt 
dehydrate (EDTA) 
Sigma, Steinheim, Germany 
FOY-305 protease inhibitor  Sanol-Schwarz, Monheim, Germany 
G418 (Geneticin) Sigma, Steinheim, Germany 
Glycerol Roth, Karlsruhe, Germany 
Glycine Sigma, Steinheim, Germany 
HEPES sodium salt Sigma, Steinheim, Germany 
Hoechst 33528 Polysciences, Warrington, USA 
Hydrochloric acid Merck, Darmstadt, Germany 
Hydrogen peroxide (30%) Merck, Darmstadt, Germany 
Isopropanol Merck, Darmstadt, Germany 
Kanamycin disulphate salt Sigma, Steinheim, Germany 
LB-Broth Miller Formedium, Hunstanton, England 
Malonate Sigma, Steinheim, Germany 
Menadione Sigma, Steinheim, Germany 
Methanol Merck, Darmstadt, Germany 
Milk, powder, low fat (Molico) Nestlé, Linda-a-Velha, Portugal 
MOPS sodium salt Sigma, Steinheim, Germany 
Mowiol 4-88 reagent Calbiochem/Merck, Darmstadt, Germany 
Nickel Sigma, Steinheim, Germany 
n-propylgallate Fluka/Sigma, Steinheim, Germany 
Oleic acid Merck, Darmstadt, Germany 
Palmitic acid MP Biochemicals, Illkirch, France  
Paraformaldehyde (powder) Sigma, Steinheim, Germany 
Paraquat (Methylviologen hydrate) Sigma, Steinheim, Germany 
PeqGold TriFast reagent PeqLab, Erlangen, Germany 
Phenylmethylsulphonyl fluoride (PMSF) Sigma, Steinheim, Germany 
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Chemical Source 
Polyethyleneglycol (PEG) 6000 Fluka/Sigma, Steinheim, Germany 
Ponceau S Roth, Karlsruhe, Germany 
Potassium chloride Sigma, Steinheim, Germany 
Potassium phosphate dibasic Sigma, Steinheim, Germany 
Protein A-Sepharose, 1 mg/ml Sigma, Steinheim, Germany 
Protein assay (Bradford) Bio-Rad, Munich, Germany 
Proteinase K Sigma, Steinheim, Germany 
Sodium azide Sigma, Steinheim, Germany 
Sodium bicarbonate Sigma, Steinheim, Germany 
Sodium carbonate Sigma, Steinheim, Germany 
Sodium chloride Sigma, Steinheim, Germany 
Sodium deoxycholate monohydrate Sigma, Steinheim, Germany 
Sodium dodecyl sulphate (SDS) Sigma, Steinheim, Germany 
Sodium fluoride Sigma, Steinheim, Germany 
Sodium hydroxide Merck, Darmstadt, Germany 
Sodium orthovanadate Sigma, Steinheim, Germany 
Sodium phosphate dibasic Sigma, Steinheim, Germany 
Sucrose Sigma, Steinheim, Germany 
Sudan Black Merck, Darmstadt, Germany 
Tetramethylethelenediamine (TEMED) Fluka/Sigma, Steinheim, Germany 
Trasylol (protease inhibitor) Bayer, Leverkusen, Germany 
Trichloroacetic acid (TCA) Merck, Darmstadt, Germany 
Tris Roth, Karlsruhe, Germany 
Triton X-100 Sigma, Steinheim, Germany 
Water, treated with DEPC Roth, Karlsruhe, Germany 
Table 2.2: Frequently used chemicals 
 
Further chemicals not listed in Table 2.2 were purchased from Sigma (Steinheim, Germany), 
Merck (Darmstadt, Germany), or Roth (Karlsruhe, Germany).   
2.3.2 Loading dyes and markers 
Product Source 
6x Orange Loading Dye Fermentas, Burlington, Canada 
Gene Ruler DNA Ladder Mix Fermentas, Burlington, Canada 
Kaleidoscope Precision Plus Protein 
Standard 
BioRad, Munich, Germany 
Precision Plus Proteins Standard BioRad, Munich, Germany 
Table 2.3: Loading dyes and markers 
2.3.3 Kits 
Product Source 
Nucleobond Xtra Midi Kit Macherey-Nagel, Düren, Germany 
Qiaprep Spin Miniprep Kit Qiagen, Hilden, Germany 
Qiaquick Gel Extraction Kit Qiagen, Hilden, Germany 
Quant-iT dsDNA BR Assay Kit Invitrogen, Carlsbad, CA, USA 
Quant-iT RNA Assay Kit Invitrogen, Carlsbad, CA, USA 
RNeasy Protect Mini Kit Qiagen, Hilden, Germany 
Table 2.4: Kits 
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2.3.4 Cell culture reagents 
Product Source 
Chloroquine diphosphate Fluka/Sigma, Steinheim, Germany 
Collagen R solution (4mg/mL) Serva, Heidelberg, Germany 
DEAE-Dextran hydrochloride Sigma, Steinheim, Germany 
DMEM high glucose with L-glutamine PAA Laboratories, Pasching, Austria 
DMEM with L-glutamine, without sodium 
bicarbonate and phenol red, powder 
(supplemented with 3.7 g/l sodium 
bicarbonate and filtered upon use) 
Sigma, Steinheim, Germany 
Fetal Bovine Serum “Gold” (FBS) PAA Laboratories, Pasching, Austria 
Ham’s F-12 with L-glutamine, powder 
(supplemented with 1.18 g/L sodium 
bicarbonate and filtered upon use) 
Sigma, Steinheim, Germany 
L-glutamine (100x) Sigma, Steinheim, Germany 
Lipofectamine reagent  Invitrogen, Karlsruhe, Germany 
MEM essential medium (MEM) without L-
glutamine, without L-methionine 
Biowest S.A.S., Nuaille, France 
N1 medium supplement for serum-free 
culture (100x) 
Sigma, Steinheim, Germany 
Penicillin/Streptomycin, 100x concentrate PAA Laboratories, Pasching, Austria 
Polyethylenimine (PEI) 25 kD Sigma, Steinheim, Germany 
Poly-L-Lysine Sigma, Steinheim, Germany 
Trypsin/EDTA PAA Laboratories, Pasching, Austria 
Turbofect transfection reagent Fermentas, Burlington, Canada 
Table 2.5: Frequently used cell culture reagents 
2.4 IMMUNOLOGICAL REAGENTS 
2.4.1 Primary antibodies 
Antibody Source Dilution 
Mouse mc anti-Actin 2G2 B. Jokusch, University of Braunschweig, 
Germany 
WB 1:1000 
Mouse mc anti-Myc 
epitope 9E10 




Mouse mc anti-Pex19 BD Biosciences, San Jose, USA WB 1:250 
Mouse mc anti-Tom20  BD Transduction Laboratories, San 
Diego, USA 
IF 1:200 
Mouse mc anti-α-Tubulin Synaptic Systems, Göttingen, Germany IF 1:100; WB 1:1000 




Rabbit pc anti-ATP 
synthase α/β 








Rabbit pc anti-GFP  Invitrogen, Carlsbad, CA, USA IF 1:100;  
WB 1:1000; IP 1:333 
Rabbit pc anti-OPA1 P. Belenguer, University of Toulouse, 
France 
IF 1:100, WB 1:1000 
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Rabbit pc anti-Pex11β Abcam, Inc, Cambridge, UK IF 1:200, WB 1:500 
Rabbit pc anti-Pex14 D. Crane, Griffith University, Brisbane, 
Australia 
IF 1:1000 
Rabbit pc anti-PMP70 A. Völkl, University of Heidelberg, 
Germany  
IF 1:200, WB 1:1000 
Sheep pc anti-
Chymotrypsinogen 
H. F. Kern, University of Marburg, 
Germany 
IF 1:400 
Table 2.6: Primary antibodies 
Abbreviations: IF, immunofluorescence; IP, immunoprecipitation; mc, monoclonal; pc, polyclonal; WB, western 
blotting. 
2.4.2 Secondary antibodies 
Antibody Source Dilution 
Donkey pc anti-mouse IgG conjugated 
to Alexa Fluor 488 
Invitrogen, Karlsruhe, Germany IF 1:400 
Donkey pc anti-mouse IgG conjugated 
to tetramethylrhodamine 5 
isothiocyanate (TRITC) 
Jackson ImmunoResearch, West 
Grove, USA 
IF 1:100 
Donkey pc anti-rabbit IgG conjugated 
to Alexa Fluor 488 
Invitrogen, Karlsruhe, Germany IF 1:500 
Donkey pc anti-rabbit IgG conjugated 
to TRITC 
Jackson ImmunoResearch, West 
Grove, USA 
IF 1:100 
Donkey pc anti-sheep IgG conjugated 
to TRITC 
Jackson ImmunoResearch, West 
Grove, USA 
IF 1:100 
Goat anti-mouse IgG conjugated to 
horseradish peroxidase (HRP) 
BioRad, Munich, Germany WB 1:2000 
Goat anti-rabbit IgG conjugated to HRP BioRad, Munich, Germany WB 1:2000 
Table 2.7: Secondary antibodies 
IF, immunofluorescence; WB, western blotting. 
2.5 MOLECULAR BIOLOGY REAGENTS 
2.5.1 Enzymes and other reagents 
Reagent Source 
Antarctic phosphatase New England Biolabs, Ipswich, USA 
dNTP’s New England Biolabs, Ipswich, USA 
KOD Hot Start DNA polymerase Novagen/Merck, Darmstadt, Germany 
M-MuLV reverse transcriptase New England Biolabs, Ipswich, USA 
Oligo-dT(15) primer Roche, Basel, Switzerland; Eurofins MWG Operon, 
Ebersberg, Germany 
Restriction enzymes:  
BamHI, BglII, EcoRI, HindIII, KpnI, 
MluI,  XhoI 
New England Biolabs, Ipswich, USA; Fermentas, 
Burlington, Canada; Invitrogen, Karlsruhe, Germany 
RNAse block  Stratagene, LaJolla, USA; New England Biolabs, 
Ipswich, USA 
T4 DNA ligase New England Biolabs, Ipswich, USA 
Taq DNA polymerase New England Biolabs, Ipswich, USA 
Table 2.8: Molecular biology reagents 
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2.5.2 Plasmids 
Name  Source/Reference 
APP-GFP O. da Cruz e Silva, University of Aveiro, Portugal 
EGFP-HsPex26(275-305)-
HsALDP(87-164) (pAH26) 
R. Erdmann, University of Bochum, Germany 
GFP-SKL S. Gould, Johns Hopkins University School of Medicine, 
Baltimore, USA 
Mfn 1-myc A. Niemann, ETH, Zurich, Switzerland 
Mfn 2-myc A. Niemann, ETH, Zurich, Switzerland 
Mfn1(K88T)-Myc A. Niemann, ETH, Zurich, Switzerland 
Mfn2(K109A)-Myc A. Niemann, ETH, Zurich, Switzerland 
Mfn2-IYFFT-Myc M. Rojo, Paris, France 
Mfn2-RRD-Myc M. Rojo, Paris, France 
Mito-DsRed Clontech, Saint-Germain-en-Laye, France 
Mito-GFP R. Lill, University of Marburg, Germany 
Myc-Pex11α (Delille et al., 2010) 
Myc-Pex11β (Schrader et al., 1998b) 
Myc-Pex11γ (Delille et al., 2010) 
pDsRed-C1-monomer Clontech, Saint-Germain-en-Laye, France 
pDsRed-Peroxi Clontech, Saint-Germain-en-Laye, France 
Pex11β-GFP G. Dodt, University of Tübingen, Germany 
Pex11β-Myc  (Schrader et al., 1998b) 
Pex11β-mYFP (Delille et al., 2010) 
pKillerRed-C Evrogen, Moscow, Russia 
pKillerRed-Mito Evrogen, Moscow, Russia 
pmEYFP-C1 Clontech, Saint-Germain-en-Laye, France 
PMP70-YFP J. Gärtner, University of Göttingen, Germany 
YFP-Pex11β (Delille et al., 2010) 
Table 2.9: Plasmids used for protein expression in this study 
Mfn, mitofusin.  
 
2.5.3 Constructs 
Name  Template Primer Enzymes Vector 







Table 2.10: Constructs generated in this study 
 
In frame insertion of all constructs was verified by sequencing (Eurofins MWG Operon, 
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2.5.4 Primers 
2.5.4.1 Mycoplasm PCR & Cloning 
 
Name Sequence (5’ to 3’) 
GPO1 ACT CCT ACG GGA GGC AGC AGT A 
MGSO TGA ACC ATC TGT CAC TCT GTT AAC CTC 
KR-PO_fw TTGAATTCCATTCAAGCTGTCTTAAGGAGTTTATGTCTGCTG 
KR-PO_rev TTGGATCCTCAGAGCTTGGACTGCAGTGACTTCAGG 
Table 2.11: Primers used for mycoplasm detection and cloning in this study 
Fw, forward; rev, reverse.  
2.5.4.2 Internal primers  
 




Pex11α, fw CAGGCAACTGAGCAGAGCAT 
Pex11α, rev GCCAGAGGCCTAGTTTGTCC 55°C 35 431bp 
Pex11β, fw CCTCTGGCGTTGTGGCCCTG 
Pex11β, rev CGCAGAGGTGCGCTGGAGTC 60°C 31 296bp 
Pex11γ, fw ATGACCTGGCCATGTTTGTC 
Pex11γ, rev GGAGATGGTGCCCATGAGG 52°C 40 464bp 
Pex3, fw CCTGGGCACGGTCCTTGGAGG 
Pex3, rev TCTGTCAGGCCATCTCCAAGTAGG 59°C 31 480bp 
Acox1, tv1, fw GCGCATCCAGCCACAGCAGG 
Acox1, tv1, rev AGCGGCCAAGCACAGAGCCA 59°C 25 488bp 
GAPDH, fw ACG ACC CCT TCA TTG ACC 
GAPDH, rev CCA GTG AGC TTC CCG TTC AGC 50°C 25 589bp 
Table 2.12: Primers used for semi-quantitative PCR in this study 
Fw, forward; rev, reverse; Tm, melting temperature used; tv, transcription variant.  
 
All primers were purchased at Eurofins MWG Operon (Ebersberg, Germany).  
 
2.6 FREQUENTLY USED BUFFERS AND SOLUTIONS 
All solutions were prepared with distilled water (ROpure infinity reverse osmosis water 
system; Barnstead, Dubuque, USA) if not indicated otherwise.  
 
 
Blocking solution for immunofluorescence 
• 1 % (w/v) BSA in PBS 
 
Blocking solution for western blots 
• 5 % (w/v) Milk powder in PBS 
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Fixative for immunofluorescence 
• 4 % (w/v) para-Formaldehyde in PBS, pH 7.4 
 
Cell culture medium for COS-7 and HepG2 cells 
• DMEM, high glucose (4.5 g/l) with L-glutamine 
• 10 % (v/v) FBS 
• 100 U/mL Penicillin 
• 100 µg/mL Streptomycin 
 
Cell culture medium for CHO cells 
• Ham’s F-12 with L-glutamine 
• 1.18 g/L Sodium bicarbonate 
• 10 % (v/v) FBS 
• 100 U/mL Penicillin 
• 100 µg/mL Streptomycin 
 
Cell culture medium for SH-S5Y5 cells 
• DMEM, high glucose (4.5 g/L) with L-glutamine 
• Ham’s F-12 with L-glutamine  
• Mix 1:1 
• 15 % (v/v) FBS 
• 100 U/mL Penicillin 
• 100 µg/mL Streptomycin 
 
Cell culture medium for serum-free growth of HepG2 cells 
• DMEM, high glucose (4.5 g/L) with L-glutamine 
• N1 serum supplement (1:100) 
• 100 U/mL Penicillin 
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HBS – HEPES buffered saline, pH 7.15, for electroporation 
• 5 g/L HEPES 
• 8 g/L Sodium chloride 
• 0.37 g/L Potassium chloride 
•  0.01g/L Sodium phosphate dibasic 
• 1.08 g/L D(+)Glucose 
 
LB medium 
• 2.5 % (w/v) LB-Broth Miller 
 
LB plates 
• 2.5 % (w/v) LB-Broth Miller 
• 1 % (w/v) Agar 
 
Lysisbuffer, pH 8.0 (radio-immunoprecipitation buffer) 
• 25 mM Tris 
• 50 mM Sodium chloride 
• 0.5 % (w/v) Sodium deoxycholate 
• 0.5 % (w/v) Triton X-100 
 
Mounting medium for immunofluorescence 
• 3 volumes Mowiol stock 
• 1 volume n-propylgallat stock 
 
Mowiol stock  
• 12 g Mowiol 4-88  
• 40 mL PBS, stir over night 
• 20 mL Glycerol, stir over night 
• Centrifuge 1 hour, 15.000 rpm, 4° C 
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PBS – phosphate buffered saline, pH 7.35 
• 140 mM Sodium chloride 
• 2.5 mM Potassium chloride 
• 6.5 mM Sodium phosphate dibasic 
• 1.5 mM Potassium phosphate dibasic 
 
Permeabilization for immunofluorescence 
• 0.2 % (v/v) Triton X-100 in PBS 
  
Permeabilization for immunofluorescence  
• 1 mg/mL Digitonin stock solution 
• 1:400 diluted in PBS 
 
Peroxisome homogenization buffer, pH 7.4 (standard) 
• 5 mM MOPS 
• 250 mM Sucrose 
• 1 mM EDTA  
• (0.1 % (v/v) Ethanol) 
 
n-propylgallate stock (anti-fading reagent) 
• PBS 
• 2.5 % (w/v) n-propylgallate 
• 50 % (v/v) Glycerol 
 
Protease inhibitor mix (final concentrations) 
• 0.1 mM PMSF 
• 0.01 mM FOY 305 
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SDS loading buffer (Laemmli, 1970) 
• 60 mM Tris, pH 6.8 
• 2 % (w/v) SDS 
• 10 % (v/v) Glycerol 
• 0.005 % (w/v) Bromophenol blue 
• 20 mM DTT 
• 5 % (v/v) β-mercaptoethanol (fresh) 
 
SDS running buffer 
• 25 mM Tris 
• 190 mM Glycine 
• 0.1 % (w/v) SDS 
 
Semidry blotting buffer 
• 48 mM Tris 
• 39 mM Glycine 
• 0.4 % (w/v) SDS 
• 20 % (v/v) Methanol 
 
Sudan Black solution 
• 0.1 g in 100 mL 70 % Ethanol (0.1 %) 
• Boil 
• Cool to room temperature 
• Filter 
 
50x TAE – Tris-Acetate-EDTA, pH 8.0 
• 40 mM Tris 
• 20 mM Acetic acid 
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TBS – Tris buffered saline 
• 50 mM Tris, pH 7.5 
• 150 mM Sodium chloride 
• 1 mM EDTA 
 
Tris buffer separation gel (pH 8.8) 
• 2 M Tris (60.56 g in 250 mL water) 
 
Tris buffer stacking gel (pH 6.8) 
• 1 M Tris (30.28 g in 250 mL water) 
 
Wash buffer I for immunoprecipitation 
• PBS, pH 7.35 
• 0.5 % (w/v) Sodium deoxycholate 
• 0.5 % (w/v) Triton X-100 
 
Wash buffer II for immunoprecipitation, pH 8.0 
• 500 mM Sodium chloride 
• 125 mM Tris 
• 10 mM EDTA 
• 0.5 % (w/v) Triton X-100 
 
2.7 MAMMALIAN CELL LINES 
2.7.1 Cell lines 
 
Unless indicated otherwise, all cell lines were obtained from the American Type Culture 
Collection (ATCC, Rockville, MD, USA).  
 
COS-7 
• ATCC number: CRL-1651 
• Organism: Cercopithecus aethiops (african green monkey) 
• Tissue: kidney 
• Morphology: adherent, fibroblast-like  
• Medium: DMEM, high glucose 
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CHO-K1 
• ATCC number: CCL-61 
• Organism: Cricetulus griseus (Chinese hamster) 
• Tissue: ovary 
• Morphology: adherent, epithelial 
• Medium: Ham’s F-12 with L-glutamine 
 
HepG2 
• ATCC number: HB-8065 
• Organism: Homo sapiens (human) 
• Tissue: hepatocellular carcinoma  
• Morphology: adherent, epithelial 
• Medium: DMEM, high glucose 
 
AR42J 
• ATCC number: CRL-1492 
• Organism: Rattus norwegicus (rat)  
• Tissue: exocrine pancreatic tumour  
• Morphology: adherent, epithelial 
• Medium: DMEM, high glucose 
 
SH-SY5Y cells 
• ATCC number: CRL-2266 
• Organism: Homo sapiens (human)  
• Tissue: brain neuroblastoma cell line (derived from bone marrow metastasis) 
• Morphology: mixed adherent and suspension, epithelial 
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Pex19-deficient patient fibroblasts (∆Pex19) 
• Source: G. Dodt (University of Tübingen, Germany); R. Wanders (AMC, Amsterdam, 
The Netherlands) 
• Organism: Homo sapiens (human) 
• Tissue: skin fibroblasts 
• Morphology: adherent fibroblasts 
• Medium: DMEM, high glucose 
2.7.2 Stable cell lines  
 
Name Parent cell line Construct Reference 
CHO-GFP-PTS1 CHO-K1 GFP-PTS1 (Islinger et al., 2007) 
CHO-DsRed-PTS1 CHO-K1 DsRed-PTS1 This study 
CHO-PMP70-YFP CHO-K1 PMP70-YFP This study 
CHO-DsRed-∆Pex26 CHO-K1 DsRed-∆Pex26 This study 
COS7-GFP-PTS1 COS-7 GFP-PTS1 (Koch et al., 2004) 
Table 2.13: Overview of the stable cell lines used/generated in this study 
 
2.8 CELL CULTURE  
Mammalian cell lines were routinely cultured under sterile conditions using a laminar flow 
safety cabinet and kept at 37°C under a 5 % CO2 atmosphere. All cell culture materials and 
solutions were sterilized by either filtration, heat inactivation (baking) or autoclaving prior to 
use. Unless indicated otherwise (2.8.9), culture media were supplemented with 10 % fetal 
bovine serum (FBS) to supply hormones, carrier proteins, attachment factors, amino acids, 
salts and trace elements essential for cell growth. To further avoid contamination of media 
and cell lines with bacteria, antibiotics were routinely added (100 U/mL penicillin, 100 
µg/mL streptomycin). For continuation of cultures and biochemical experiments, cells were 
seeded in 100 mm cell culture dishes; to seed cells for immunofluorescence, 60 mm cell 
culture dishes containing 18 mm coverslips were used. A Neubauer counting chamber was 
used to determine the number of cells prior to seeding.  
2.8.1 Cell passage 
In order to guarantee optimal growth and provide cells for subsequent experiments, cells were 
routinely passaged twice a week. In between cell passages, cell culture medium was 
exchanged every 2 days to provide fresh nutrients and remove cellular waste products. 
Protocol: After aspiration of cell culture medium, cells were washed once in PBS to remove 
any residual traces of culture medium. Next, 2mL of trypsin/EDTA solution (0.05 % 
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trypsin/0.02 % EDTA) were added and the cells were incubated at 37°C and 5 % CO2 for 5-10 
minutes to detach the adherent cells from the culture dish surface. At 37°C trypsin reaches its 
optimal activity, cleaving extracellular adhesion molecules (integrins) and cell-cell adhesions 
(cadherins). Furthermore, the chelator EDTA binds calcium – a necessary cofactor for both 
integrin and cadherin adhesions - which further impairs their integrity. The reaction was 
stopped by the addition of 10 mL of complete cell culture medium, as the included serum 
contains protease inhibitors. The detached cells were thoroughly resuspended, transferred to a 
15 mL reaction tube and pelleted by centrifugation at 500g for 5 minutes. The cells were then 
resuspended and seeded in a ratio of 1:10 into a fresh cell culture dish containing 10 mL of 
complete cell culture medium.  
For certain cell lines such as AR42J, SH-S5Y5 or HepG2 cells, an additional coating step of 
cell culture dishes and/or coverslips was routinely performed.  
AR42J cells were seeded onto materials coated with the so-called matrigel to facilitate general 
attachment of the cells. Matrigel is an extracellular matrix extract of the murine Engelbreth-
Holm-Swarm (EHS) tumour and was prepared according to Kleinmann (Kleinmann et al., 
1981). For cell culture use, matrigel was sterilized by irradiation with 100 Gray and stocks 
were aliquoted into 2 mL fractions and stored at -20°C. Prior to use, the stock was diluted 1:5 
in PBS. Coating with matrigel was performed for 5-10 minutes at room temperature and the 
surplus was collected again to be re-used.  
HepG2 and SH-S5Y5 cells were routinely seeded onto coated glass coverslips for 
immunofluorescence experiments to enhance attachment and spreading of cells in order to 
improve morphology. In the case of HepG2 cells, coating of glass coverslips was performed 
using Collagen R solution (1:10 in dH2O) for 5-10 minutes at room temperature while SH-
S5Y5 cells were seeded onto Poly-L-lysine coated coverslips (5-10 minutes Poly-L-lysine, 3 
times washed in dH2O). 
2.8.2 Generation of cell stocks 
In order to generate back-up stocks of cell lines, early cell passages were regularly collected 
and stored in liquid nitrogen. The freezing medium was created by supplementing the 
appropriate complete cell culture medium (2.7.1) with FBS and DMSO to minimize the 
formation of water crystals upon freezing and thus cell rupture.  
Protocol: Cells of a confluent 100 mm cell culture dish were trypsinized and pelleted by 
centrifugation (2.8.1). The cell pellet was then resuspended in freezing medium and the cell 
suspension was equally distributed over several 2mL cryo tubes. Aliquots were quickly frozen 
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at -80°C in a freezing unit to guarantee slow, gradual freezing to avoid a high mortality rate. 
After 24 hours, cells were transferred into liquid nitrogen for long time storage.  
 
Freezing medium 
• Cell culture medium 
• 20 % (v/v) FBS 
• 10 % (v/v) DMSO 
 
To defreeze said cell stocks, cell aliquots were carefully de-frozen by gradually applying a 
small volume of pre-warmed, sterile complete cell culture medium on top of the frozen cell 
suspension. Thawed cells were transferred to a 15 mL reaction tube, pelleted by 
centrifugation and resuspended in fresh complete medium to remove any traces of DMSO. 
The cells were seeded into 100 mm cell culture dishes and cultivated at 37°C under a 5 % 
CO2 atmosphere.  
2.8.3 Stimulation of AR42J cells with dexamethasone 
Stimulation of AR42J cells with the synthetic glucocorticoid dexamethasone leads to a 
profound rearrangement of cellular gene expression, cell morphology and cellular 
differentiation. As a result, all compartments of the secretory pathway are enlarged and the 
number of electron dense granule as well as the concentration and secretion of digestive 
enzymes increases (Logsdon et al., 1985; Swarovsky et al., 1988).  
Protocol: To stimulate AR42J cells with dexamethasone, the cell culture medium was 
removed and fresh complete medium containing 10 nM (or 1 µM where indicated) of 
dexamethasone was added to the cells. Stimulated cells were incubated for 24–72 hours at 
37°C and 5 % CO2.   
2.8.4 Mycoplasma detection 
To guarantee optimal cell growth of cultured cells, contaminations with intracellular 
pathogens such as mycoplasms have to be avoided. Potential contamination was determined 
by either Hoechst staining or Mycoplasm PCR.  
2.8.4.1 Hoechst staining 
Hoechst 33528 is a DNA intercalating reagent. Upon mycoplasma contamination, not only 
cell nuclei, but also the rod-shaped bacteria will appear upon UV irradiation (excitation: 359 
nm; emission: 461 nm). 
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Protocol: After cell passage (2.8.1), cells were seeded in 60 mm cell culture dishes containing 
18 mm coverslips. After 24 hours, the cell culture medium was aspirated and the cells were 
washed twice in PBS to remove any residual traces of medium. Then, cells were fixed for 20 
minutes at room temperature using 4 % para-Formaladehyde (pFA). Afterwards, cells were 
washed in PBS and stained with Hoechst 33258 (1:2000 in PBS) for 2 minutes at room 
temperature. Residual Hoechst solution was removed by extensive washing. Coverslips were 
shortly dipped in dH2O before mounting onto microscopy slides using Mowiol solution. 
Mycoplasma contamination was examined by fluorescence microscopy.  
 
2.8.4.2 Mycoplasm detection by polymerase chain reaction (PCR) 
Mycoplasm detection by PCR (2.12.3) is facilitated by the usage of primer pairs that comprise 
DNA sequences present in the majority of mycoplasm species.  
Protocol:  
Reagents Quantity 
Template  1.0 µL 
ThermoPol reaction buffer (10x) 5.0 µL 
Primer GPO (50 pmol) 0.5 µL 
Primer MGSO (50 pmol) 0.5 µL 
dNTP’s 2.5 µL 
Taq DNA polymerase 1.0 µL 
dH2O    37.5 µL 
Final volume       50 µL 
Table 2.14: Mycoplasm PCR reaction mix 
 
100 µL culture supernatant of cells grown for at least 2 days were collected and boiled at 
95°C for 5 minutes to lyse cells and possible mycoplasms. After a quick centrifugation step to 
pellet debris, the supernatant was transferred into a new reaction tube to be used as the PCR 
template. PCR was performed according to the program indicated below. Routinely, 
contaminated cell culture supernatants and dH2O were included as positive and negative 
controls, respectively.  
 
PCR program  
Initial denaturation    5 minutes, 95°C  
Denaturation 30 seconds, 95°C 
Annealing 30 seconds, 55°C 
Elongation     1 minute, 72°C 
35 × 
Final elongation   5 minutes, 72°C  
Table 2.15: PCR program 
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PCR samples were then subjected to 1 % agarose gel electrophoresis (2.12.5). Contaminated 
samples showed a band at 720 bp.  
 
2.8.5 Transient transfection of mammalian cells 
The term transfection describes the introduction of foreign DNA into a mammalian cell. A 
transient – i.e. temporary – transfection has to be discriminated from a stable (permanent) 
transfection. Depending on the cell line used and/or the desired quantity of transfected cells 
(transfection efficiency), several methods can be applied with different underlying 
mechanisms of DNA uptake and delivery.  
 
One can distinguish between DNA uptake 
• by endo- or phagocytosis (DEAE-Dextran, PEI, Turbofect) 
• by fusion with the cell (Lipofection) 
• by diffusion (electroporation) 
• by microinjection 
• by viral infection 
 
In general, the transfection efficiency depends on the cell lines used and the respective 
reaction conditions (such as e.g. the concentration of transfection reagent and cell density).  
2.8.5.1 Dietheylaminoethyl-(DEAE)-Dextran transfection  
The polycation DEAE-Dextran adsorbs to the negatively charged DNA which is thus 
associated with the high molecular weight structure of dextran. This high molecular weight 
particle is then endocytosed by the target cells. To avoid subsequent degradation of the DNA 
within lysosomes, chloroquine is added to the cells which buffers acidic compartments and 
prevents the activation of acidic hydrolases. DEAE-Dextran was used to transfect plasmid 
DNA derived from Mini-Preps (2.12.13) to check for correct targeting of positive clones.  
Protocol: One day prior to transfection, COS-7 cells were seeded onto glass 18 mm coverslips 
in a 12 well cell culture dish (1 coverslip per well). For transfection, 2 µL of plasmid DNA 
were mixed with 500 µL of serum-free DMEM and 3 µL of DEAE-Dextran polymer (50 
mg/mL). Cells were washed twice in PBS, as residual serum traces could adsorb to DEAE-
Dextran and mediate intracellular toxic effects. The mixture was added to one well of the cell 
culture plate and incubated for 1.5 hours at 37°C and 5 % CO2. The DEAE-Dextran mixture 
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was then replaced by 2 mL of complete medium supplemented with 2 µL of chloroquine (60 
mg/mL). The medium was changed again after 3-4 hours. Cells were fixed after 48 hours.   
 
2.8.5.2 Electroporation 
In the course of electroporation, the cell membrane is shortly permeabilized due to the electric 
current applied, thus allowing DNA to diffuse into the cell.  
Protocol: Cells of a confluent 100 mm cell culture dish were trypsinized (2.8.1) and pelleted 
by centrifugation for 5 minutes at 500g. The cell pellet was washed once in 5 mL HEPES-
buffered saline (HBS) buffer. Finally, the cell pellet was taken up in 1 mL of HBS before 500 
µL cell suspension were mixed with 10 µg of plasmid DNA in a 4 mm electroporation 
cuvette. Electroporation was carried out at the parameters indicated below. Immediately after 
the electric pulse, 1 mL of complete cell culture medium was added to the cells to relieve 
electroporation stress. Cells were resuspended and seeded into cell culture dishes containing 
pre-warmed culture medium. Cells were fixed 24-48 hours after electroporation. Note that 
electroporation of AR42J cells was carried out in complete cell culture medium. 
 
Cell line Voltage  Capacitance  Resistance 
AR42J 250V 1500µF 125Ω 
CHO 230V 1500µF 125Ω 
COS-7 230V 1500µF 125Ω 
∆Pex19 fibroblasts 260V 1050µF 100Ω 
Table 2.16: Electroporation conditions used 
2.8.5.3 Lipofectamine 
Lipofectamine transfection is mediated by the use of cationic lipids that contain a positively 
charged head group combined with up to two hydrocarbon chains. In a hydrophilic 
environment, a liposomal structure with a positive surface charge is formed. The negatively 
charged DNA adsorbs to the liposome and forms a complex that adheres to the cell membrane 
and can be endocytosed.  
Protocol: One day prior to transfection, cells were seeded on 18 mm coverslips in 60 mm cell 
culture dishes. To perform Lipofectamine transfection, 3.2 µg of DNA were mixed with 200 
µL of serum-free medium in one reaction tube, while 12 µL of Lipofectamine Transfection 
reagent were diluted in 200 µL of serum-free medium. Samples from both reaction tubes were 
pooled and incubated for 30 minutes at room temperature. Cells were washed with PBS and 2 
mL of serum- and antibiotic-free medium were added. Finally, the transfection mixture was 
applied to the cells which were subsequently incubated for 5 hours at 37°C and 5 % CO2. The 
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medium was then changed to complete medium and cells were incubated for 24-48 hours 
before further use.  
2.8.5.4 Polyethyleneimine-(PEI)-transfection 
The electron-dense PEI - an ethylene-imine-polymer - is a heavily branched, basic molecule 
whose amino groups are protonated in a hydrophilic environment. The negatively charged 
DNA backbone binds to the protonated amino groups and is taken up by cellular endocytosis. 
The high transfection efficiency of PEI transfection is mediated by the “proton sponge effect”, 
as the amino groups of the PEI molecule possess a high buffer capacity in the physiological 
range. This results in an increased uptake of counter anions (e.g. chloride ions) into the acidic 
compartments (lysosomes, endosomes) which in turn leads to osmotic swelling and organelle 
rupture. Thus, DNA is released into the cytoplasm (Akinc et al., 2005).  
Protocol: Prior to transfection, cells were seeded on coverslips in a 60 mm cell culture dish. 
For transfection, 15 µg of plasmid DNA were mixed with 750 µL of sterile 150 mM NaCl 
solution. In parallel, 100 µl of PEI working solution (0.9 mg/mL) were combined with 650 µL 
of NaCl solution. Both mixtures were incubated separately for 20 minutes at room 
temperature, before the PEI solution was added to the DNA mixture in a drop-wise fashion. 
The combined mixture was incubated for another 20 minutes at room temperature to allow the 
formation of DNA-PEI complexes. In the meanwhile, the cell culture medium was changed to 
2.5 mL of complete medium and ultimately 500 µL of the PEI-DNA mixture was added to the 
cells. After 3-6 hours of incubation at 37°C and 5 % CO2, cells were washed once with PBS 
and medium was exchanged to fresh complete medium. 24- 48 hours after transfection, cells 
were processed for further experiments.  
 
2.8.5.5 Turbofect 
The so-called TurboFect Transfection Reagent is a sterile solution of a cationic polymer in 
water. This polymer forms compact, stable, positively charged complexes with DNA that are 
taken up by the cell via endocytosis.  
Protocol: One day prior to transfection, cells were seeded on 18 mm coverslips in 60 mm cell 
culture dishes. For transfection with Turbofect, 4 µg of plasmid DNA were diluted in 400 µL 
of serum-free medium before 6 µL of Turbofect Transfection Reagent were added. The 
solution was mixed by pipetting and incubated for 20 minutes at room temperature to allow 
the formation of DNA-Turbofect complexes. Meanwhile, cells were washed twice in PBS and 
covered in 3 mL of serum-free medium. At last, the Turbofect transfection mixture was added 
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drop-wise to the cells and the cells were incubated for 5 hours at 37°C and 5 % CO2 before 
the medium was changed to regular complete medium. After 24-48 hours, cells were 
processed for further experiments.  
2.8.6 Generation of stable cell lines 
The stable, permanent insertion of a foreign DNA sequence into the cellular genome is 
referred to as a stable transfection. This procedure occurs naturally in only one of 104 cells 
and can be induced by selective pressure, such as the addition of the antibiotic G418 after 
transient transfection of a construct carrying the corresponding neomycin resistance marker.  
As the exact position of insertion into the cell genome occurs spontaneous and unselective, 
DNA sequences are inserted at different, differentially active sites, resulting in the generation 
of heterogeneously expressing cell lines. These need to be further subcloned to generate more 
homogenous cell lines. In line with this, instead of using high copy expression plasmids under 
the control of a viral CMV promoter, it is advantageous to use more moderate, mammalian 
expression vectors under the control of e.g. the murine ROSA26 promoter. Upon successful 
generation of stable cell lines, these can be cultured without the continuous application of 
selective pressure; however, cells then tend to lose the construct over time. Thus, the 
generation of early passage cell stocks is recommended. The stable CHO cell lines used in 
this study (2.7.2) were generated in co-operation with Prof. Dr. Georg Lüers 
(Universitätsklinikum Eppendorf, Hamburg, Germany).  
Protocol: The process of successfully generating stable mammalian cell lines can be 
subdivided into 4 steps: 
 
• transfection of mammalian cells 
• selection in G418 
• Selection/subcloning of cell clones 
• Validation of plasmid expression 
 
In order to introduce the desired plasmid into the cells, CHO cells were transfected by either 
lipofection (2.8.5.3) with 1-2 µg of DNA (in a 35 mm cell culture dish) or by electroporation 
of a 100 mm cell culture dish (2.8.5.2) with 5 µg of plasmid DNA. CHO cells transfected by 
lipofection were passaged into 100 mm cell culture dishes 24 hours after transfection (2.8.1). 
Depending on the transfection method used, the selection process was initiated 24 hours after 
electroporation or 48 hours after lipofection: the cell culture medium was exchanged for 10 
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mL of complete cell culture medium supplemented with G418 (1:100; Stock: 40 mg/mL). 
Selection occurred for 10 days in selection medium which was renewed every 2-3 days. After 
10 days, surviving cell clones – appearing as visible, round, small cell agglomerates on the 
cell culture dish – were isolated: the cell culture medium was aspirated and the position of cell 
clones was marked by labelling with a pen on the cell culture dishes exterior. Selection rings 
– small metal rings dipped in silicone (ca. 10 mm interior diameter) – were adhered to 
encircle cell clones. Afterwards cells were covered in PBS and 20 µL of trypsin solution were 
added to the interior of the selection rings to detach the cell clones. After a short incubation 
period, 20 µL of cell culture medium were added into the selection ring to resuspend the cell 
clones. The various selected cell clones were then transferred to the wells of a 24 well cell 
culture plate in duplicate (1 clone distributed over 2 wells). The cells of one well served to 
subculture the clone, the other well contained a coverslip to assess the expression of the 
plasmid by microscopy. Cell clones were then cultured for 2-3 days at 37°C and 5 % CO2. 
After 3 days, cell clones on coverslips were fixed for 20 minutes in 4 % pFA at room 
temperature and mounted on microscope slides. Plasmid expression was assessed by 
fluorescence microscopy. Several clones were screened for expression regarding the ratio of 
transfected cells, expression rate and heterogeneity. Cell clones displaying a homogenous, 
good expression rate of the fluorescent marker were further subcloned. Hence, the clones of 
the corresponding culture dish were trypsinized, seeded in a low cell density and subjected to 
another round of G418 selection.  
2.8.7 Generation of hybridoma cells/ in vivo fusion assay 
In order to study the potential fusion of peroxisomes in mammalian cells, an in vivo fusion 
assay was established based on mitochondrial fusion assays (Mattenberger et al., 2003; 
Niemann et al., 2005). The assay is based on the polytethyleneglykol-(PEG)-based fusion of 
differentially labelled stably transfected CHO cell lines (2.7.2) after co-cultivation of cells. 
Upon generation of hybridoma cells, further incubation at 37°C and 5 % CO2 ensures 
intermixing of organelles and potential fusion of peroxisomes, resulting in the generation of 
“yellow” peroxisomes upon fluorescent marker mixing.  
Protocol: In order to generate CHO hybridoma cells, differentially labelled CHO cell lines 
were co-cultured on 18 mm coverslips at a defined density of 1.6 x 106 cells/mL in 12 well 
cell culture dishes and cultivated overnight. After 24 hours, cycloheximide (10 mg/mL stock 
in dH2O), an inhibitor of eukaryotic protein translation, was added to fresh complete medium 
in a final concentration of 50 µg/mL. After 30 minutes of incubation at 37°C, cells were fused 
on a drop of pre-warmed 50 % (w/v) PEG-6000 in PBS/glucose solution (1 g/L) for 2 
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minutes. PEG is a chemical inert, water soluble, non-toxic polymer. Highly hydrated, it 
extracts water out of the contact zone between biological membranes, thus forcing them into a 
close apposition which in turn generates elastic stress. The stress is subsequently released by 
hemifusion of the outer bilayers and the formation of fusion pores (Chernomordik et al., 
2006). As protein diffusion is hampered by PEG, cells were washed extensively in 
PBS/glucose and kept in complete cell culture medium with cycloheximide until fixation or 
imaging.  
 
PEG-6000 solution (50 % w/v) 
• 10 g PEG-6000, autoclaved 
• 10 mL PBS/glucose solution 
 
2.8.8 Stimulation of peroxisomal fusion with peroxisomal metabolites 
To assess if the percentage of interacting peroxisomes could be increased upon stimulating 
heterogeneity between interacting peroxisomes, CHO-GFP-PTS1 cells were stimulated with 
peroxisomal metabolites prior to the in vivo peroxisomal fusion assay. 
Protocol: CHO-GFP-PTS1 cells were stimulated with either 10 µM arachidonic acid (AA) or 
400 µM oleic acid (OA) 24 hours prior to the in vivo peroxisomal fusion assay (Schrader et 
al., 1998a; Listenberger et al., 2007). In another set, cells were pre-stimulated with 100 µM 
H2O2 (Schrader et al., 1999). After application of the in vivo peroxisomal fusion assay, cells 
were fixed at the indicated time points and processed for epifluorescence microscopy.  
2.8.9 Screen for inducers of peroxisome tubulation and/or proliferation 
One objective of this study was to characterize the effects of certain classes of 
stresses/compounds on peroxisome dynamics.  
HepG2 and COS-7 cells were used as a model system to assess peroxisomal (oxidative) stress 
responses. As previously shown, the well-differentiated human hepatoblastoma cell line 
HepG2 has a very plastic peroxisome compartment, displaying small spherical (0.1-0.3 µm) 
and rod-shaped (0.3 µm) peroxisomes as well as elongated-tubular ones (up to 5 µm and 
more) (Schrader et al., 1994; Schrader et al., 1996a). Usually, 24 hours after seeding the 
majority of HepG2 cells grown under routine cell culture conditions (2.7.1) contain tubular 
peroxisomes (around 50 %), complicating the identification of external stimuli leading to 
peroxisome tubulation. However, the inherent formation of tubular peroxisomes can be 
almost completely inhibited by culturing under serum-free conditions (DMEM/N1), with 
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HepG2 cells still demonstrating healthy peroxisome morphology and numerical density. 
Induction of tubular peroxisomes is restored upon addition of 10 % FBS and growth factors, 
but also other inducers of tubulation were identified such as arachidonic acid, UV-C 
irradiation and H2O2 (Schrader et al., 1998a; Schrader et al., 1999). The serum-free HepG2 
cell culture model was employed in this study to characterize a peroxisomal response to 
several ROS inducers which generate oxidative stress at different intracellular sites:  
• The mitochondrial complex II inhibitor malonate: often used to induce striatal lesions 
to study ischemic stroke or Huntington’s disease, malonate was shown to induce cell 
death via mitochondrial potential collapse in a ROS-dependent fashion (Fernandez-
Gomez et al., 2005).  
• the neurotoxin 6-hydroxydopamine (6-OHDA): 6-OHDA is a toxin, widely used to 
induce lesions in dopaminergic neurons due to generation of ROS (Blum et al., 2001; 
Bove et al., 2005b; Gomez-Lazaro et al., 2008).  
• Heavy metals: ROS have been linked to the toxicity of transition metals by either 
involving Fenton-like chemistry (e.g. iron, copper) or depletion of glutathione and 
protein-bound sulfhydryls (nickel, cadmium) (Stohs & Bagchi, 1995). 
• Others: the widely-used herbicide paraquat generates superoxide radical upon redox 
cycling in vivo (Bus & Gibson, 1982; Franco et al., 2010). Moreover, direct 
application of H2O2 was chosen to increase cellular oxidative stress (Schrader et al., 
1999). 
As a control to test reactivity of HepG2 cells, 10 % FCS or AA were added to the cells to 
induce peroxisome tubulation (Schrader et al., 1998a). Some ROS inducers were further 
tested in COS-7 cells under regular culture conditions.  
In addition to an oxidative stress response, the effect of glucocorticoids on peroxisome 
dynamics was investigated by employing the rat AR42J model system using dexamethasone 
at physiological and pathophysiological conditions (2.8.3).   
Protocol:  Routinely cultured HepG2 cells were trypsinized (2.8.1) and seeded on coverslips 
in a 60 mm cell culture dish in serum-free DMEM/N1 at a defined density of 2 x 105 cells/mL 
as described previously (Schrader et al., 1998a; Schrader et al., 1999). After 4 hours of 
incubation at 37°C and 5 % CO2 to allow attachment and recovery of the cells, different 
stimuli were applied (see Table 2.17 and 2.18). After application of stimuli, HepG2 cells were 
incubated overnight in DMEM/N1, until peroxisome elongation reached its maximum after 24 
hours. COS-7 cells were seeded as described above (2.8.1).  
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Cells were fixed in 4 % pFA and processed for immunofluorescence (2.9.1) against 
peroxisomal markers (Bonekamp et al., 2011b). Induction of peroxisomal tubulation was 
examined by fluorescence microscopy (2.9.3); upon successful induction replication and 
statistical analysis was performed (2.9.8). Non-successful inducers were excluded from 
further studies.  
 
Compound Concentration Time 
Serum (FBS) 10 % 24 hours 
Arachidonic acid (AA) 10 µM 24 hours 
Palmitic acid (PA) 10 µM 24 hours 
Table 2.17: Tubulation controls employed for the HepG2 assay. 
 
Compound Concentration Time Cell line 
6-Hydroxydopamine     50 µM 3, 6, 12, 24 hours SH-SY5Y 
Copper  100 µM 24 hours HepG2 
Dexamethasone    10 nM, 
     1 µM 6, 24, 48, 72 hours 
AR42J 
 
Hydrogen peroxide  100 µM 24 hours HepG2 
Malonate 
   10 mM 
   50 mM 
 100 mM 
1, 6, 12, 24 hours HepG2 COS-7 
Menadione    10 µM 
   30 µM 
10, 30 minutes 
6, 24 hours  
HepG2 
COS-7 
Nickel  100 µM 24 hours HepG2 
Paraquat 
     5 µM 
   10 µM 
   25 µM 
   50 µM 
6, 12, 24, 48 hours HepG2 COS-7 
Table 2.18: Stresses/compounds screened in this study.   
2.8.10  Induction of peroxisome proliferation 
Peroxisomes react to the application of certain extracellular stimuli with an increase in the 
number and size of peroxisomes as well as with the induction of peroxisomal enzymes, a term 
referred to as peroxisome proliferation (1.2.4). In mammals, peroxisome proliferators 
encompass fibrates, polyunsaturated fatty acids and hypolipidimic drugs that activate PPARα, 
especially in rodents (1.2.4) (Pyper et al., 2010). One objective of this study was to screen for 
stresses/compounds that affect peroxisome morphology (tubulation) and thus potentially 
induce peroxisome proliferation events. To compare the mechanisms of peroxisome 
tubulation to action of well-described proliferators, rodent AR42J cells (2.7.1) were treated 
with described peroxisomes proliferators such as bezafibrate and eicosatetraynoic acid.  
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2.8.10.1 Bezafibrate 
Bezafibrate – like clofibrate and ciprofibrate – is an amphiphatic carboxylic acid that activates 
PPARα which regulates lipid metabolism and peroxisome proliferation.  
Protocol: 7.24 mg of bezafibrate were dissolved in 50 µL of DMSO. Medium was then added 
to a final volume of 2 mL. The pH was adjusted to pH 7 if necessary. This 0.01 M stock was 
added to the cells in a 1:1000 dilution. Cells were incubated at 37°C and 5 % CO2 for 4 days 
and fresh medium supplemented with bezafibrate was renewed daily.   
2.8.10.2 Eicosatetraynoic acid (ETYA) 
Polyunsaturated fatty acids (PUFAs) lead to a prominent peroxisome proliferation at 
physiological levels. ETYA is a non-metabolizable analogue of arachidonic acid that also 
activates PPARα. 
Protocol: 5 mg of ETYA were dissolved in 1 mL DMSO, creating a 16.8 mM stock solution.  
To induce peroxisome proliferation, a dilution of 1:1000 was prepared in complete cell 
culture medium. The medium was renewed every day and new ETYA was added over a 
course of 3-4 days.  
2.8.11  Detection of ROS generation using 2′,7′-dichlorodihydrofluorescein 
diacetate (2′,7′-dichlorofluorescein diacetate; H2DCFDA)   
2′,7′-dichlorofluorescein (DCF) and its derivatives are commonly used to fluorescently detect 
ROS generation. The different forms of DCF are non-fluorescent until the acetate groups are 
removed by intracellular esterases and oxidation by ROS occurs within the cell. Upon esterase 
cleavage of the lipophilic blocking groups, a charged form of the dye is generated that is 
retained within the cells. Oxidation of these probes and concomitant increase in fluorescence 
can be detected with a flow cytometer, a microplate reader or a fluorescence microscope, 
using excitation sources and filters appropriate for fluorescein. In this study, an assay using 
H2DCFDA and a TECAN microplate reader was established according to Wang (Wang & 
Joseph, 1999).  
Protocol:  A stock of H2DCFDA (10 mM) was prepared in DMSO and frozen at -20°C. One 
day prior to the experiment, cells were seeded in a black 96 well cell culture plate with 
transparent bottom at a density of 104 cells/well. Cell stressors (2.8.9) were added for the 
indicated time points. After incubation, the medium was carefully removed by decanting of 
the plate and the cells were washed once with PBS. 100 µL of DCF working solution (10 µM 
in PBS) were added to each well and the cells were incubated for 10 minutes at 37°C and 5 % 
CO2 to allow cellular uptake of DCF. The DCF was removed carefully and cells were washed 
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again once with PBS to remove traces of extracellular DCF. The fluorescence measurement 
was performed in PBS using a TECAN M200 infinite plate reader (excitation: 485 nm; 
emission: 530 nm; 37°C). To assess the level of background fluorescence, unlabelled cells 
and DCF only controls were routinely included in the procedure. In order to ensure that only a 
few cells were lost during the decanting procedure, centrifugation steps can be added during 
the labelling procedure (2 minutes, 1300 rpm, table top centrifuge).  
2.9 MICROSCOPIC TECHNIQUES 
2.9.1 Immunofluorescence 
The selective labelling of specific cellular structures using fluorescently-labelled antibodies is 
referred to as immunofluorescence. Sample preparation for immunofluorescence requires 
several careful steps: to preserve the cellular structures of interest, cells need to be quickly 
fixed. Commonly, formaldehydes (e.g. para-formaldehyde or glutaraldehyde) are used to fix 
cells by reversibly cross-linking primary amino groups in proteins with other nearby nitrogen 
atoms in other proteins or DNA. However, due to its strong autofluorescence, glutaraldehyde 
is more often used as a fixative in electron microscopy applications. Alternatively, alcohols 
and organic solvents can be used which basically dehydrate cells and precipitate proteins 
while removing lipids (thus simultaneously permeabilizing cell membranes). To enable 
antibody binding, cell membranes need to be permeabilized by the use of detergents such as 
Triton-X-100 or digitonin, however, the latter permeabilizes primarily the cell membrane 
while the peroxisomal membrane remains intact. As there is a high concentration of free 
aldehyde groups as well as potential epitopes within the cell’s protein environment, unspecific 
antibody binding needs to be avoided by a blocking step (e.g. in bovine serum albumin). 
Finally, specific antibodies are used to detect the structures of interest. The antibody can be 
directly coupled to a fluorophore or be labelled in an additional incubation step with a 
fluorophore-coupled secondary antibody that is directed against the IgG species of the 
primary antibody (indirect immunofluorescence). For most applications, immunofluorescence 
against peroxisomal or mitochondrial markers was performed (Bonekamp et al., 2011b). 
Protocol: Cells were washed twice in PBS to remove any traces of medium and were fixed for 
20 minutes at room temperature in 4 % para-formaldehyde (pFA). Routinely, cells were 
permeabilized using 0.2 % Triton-X-100 (Tx100) for 10 minutes at room temperature; 
however, some applications required permeabilization by digitonin (1:400, 1 mg/mL stock) 
for 5 minutes at room temperature. Unspecific reactions were then blocked using 1 % BSA 
for 10 minutes at room temperature, followed by incubation with primary and secondary 
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antibodies for one hour each. Antibody dilutions (2.4) were routinely prepared in PBS and 30 
µL were applied on top of the coverslip. Moreover, to avoid antibody evaporation and 
photobleaching, cells were kept in a humid, dark chamber during incubation. Between the 
different incubation steps, cells were thoroughly washed with PBS. At the end of the 
incubation period, cells were washed again in PBS, then carefully dipped in dH2O to remove 
salt traces and mounted onto a microscope slide using Mowiol 4-88 as mounting medium. 
The mounting medium was supplemented with the anti-fading reagent n-propylgallate. Slides 
were dried and evaluated by fluorescence microscopy.  
Note that for experiments requiring differential permeabilization pFA-fixed sets of cells were 
permeabilized using 0.2 % Tx100, digitonin and methanol (absolute, 5 minutes, room 
temperature).  
2.9.2 Lipid droplet staining 
The so-called lipid droplets are the main cellular organelles for the storage of neutral lipids. 
Previously thought to be inert, their dynamic formation and association with other subcellular 
organelles such as peroxisomes and the ER has gained considerable interest over the years 
(Guo et al., 2009). Upon increasing intracellular concentrations of neutral lipid, lipid droplets 
grow in size and number. The fat-soluble Sudan dyes are frequently employed to stain lipid 
droplets due their high affinity for fats.  
Protocol:  For Sudan Black staining of lipid droplets, cells were washed twice in PBS prior to 
fixation with 4 % pFA (30 minutes at room temperature). After removal of pFA, cells were 
washed shortly in dH2O, followed by a short incubation in 50 % ethanol. The Sudan Black 
staining solution was applied (0.1 % in 70 % ethanol) and lipid droplet staining was 
performed for 30 minutes at room temperature. After removal of the staining solution, cells 
were washed in dH2O and mounted for phase contrast microscopy.  
2.9.3 Epifluorescence microscopy 
Fluorescence microscopy is based on the principle that fluorophores absorb light of a specific 
wavelength and emit a fraction of the absorbed light as light of a higher wavelength. Using a 
combination of different filter sets, co-localization of proteins can be visualized. In 
epifluorescence microscopy the specimen is illuminated through the objective, using a high 
energy mercury lamp as a light source. Light of a specific wavelength is then applied onto the 
specimen by specific filter sets using a dichroic filter and excitation of the fluorophore 
ultimately leads to fluorescence. The thus emitted light is then collected by the objective and 
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reflected onto a dichroic mirror where it is focussed through an emission filter onto the ocular 
to be detected by the eye or a CCD camera.  
Protocol: For morphological studies an inverted Olympus IX-81 microscope was used 
equipped with the appropriate filter combinations and a 100x objective (Plan-Neofluar, 
100x/1.40 oil objective). Digital images were acquired with the F-View CCD camera and 
optimized for brightness and contrast using the Soft Imaging Software and Adobe Photoshop 
CS2.  
2.9.4 Confocal microscopy 
Using epifluorescence, the resolution within the z-plane is limited, resulting in the 
combination/intermixing of signals from different planes within the specimen. Confocal 
microscopy allows the collection of emission light from only one confocal plane. The Laser 
generated excitation light is focused onto one point of the specimen by the objective and the 
emitted light is focussed on a pinhole and detected by a series of photomultipliers. As the 
focal point and pinhole are in conjugated, so-called confocal, planes, scattered light of other 
areas/planes is repressed from detection. As only light of a specific point is detected, the 
specimen needs to be rastered line by line, creating a computer-generated image. By 
sequential scanning throughout the z-plane, 3 dimensional pictures can be obtained.  
Protocol: Confocal images were obtained using a Zeiss LSM 510 Meta confocal setup (Carl 
Zeiss, Oberkochen, Germany) equipped with Plan-Apochromat 63x and 100x/1.4 oil 
objectives using the 488 and 561 laser lines, respectively. Images were selected and optimized 
for brightness and contrast using LSM Image Browser and Adobe Photoshop CS2 software.  
2.9.5 Image deconvolution 
In imaging, the term deconvolution refers to the process of removing optical distortion (e.g. 
blurring of signals) from microscopic images using a software algorithm, thus sharpening 
images. Image stacks of different focal planes are generated and an image is then sharpened 
by calculating the distortion of the optical system (described by the point spread function, 
PSF) and the subsequent removal of the equivalent blur from each image. To generate high 
resolution images of peroxisomal interactions, confocal microscopy in combination with 
image deconvolution was performed.  
Protocol: After application of the in vivo peroxisomal fusion assay, cells were fixed and 
mounted for confocal microscopy using a Leica TCS SP2 AOBS confocal microscope (Leica, 
Wetzlar, Germany) equipped with a 100x oil objective (PlanApo 100x/1.40 oil objective). 
Using the 488 and 543 nm laser lines, z-stacks of hybridoma cells were generated with high 
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zoom setting (8x zoom) using the optimal number of slices suggested by the program (Leica 
Confocal Software). Oversaturation of signals was avoided by adjusting of respective 
photomultipliers. Image deconvolution was performed using Huygens Professional Software 
(Scientific Volume Imaging, Hilversum, The Netherlands). Using the 3D images generated by 
the program, interacting peroxisomes were assessed for co-localization of signals and mean 
distance between objects using the tools “co-localization parameters” and “distance to 
reference objects”, respectively. For data analysis, the relative co-localization between green 
and red peroxisomes was determined to identify true interaction events (co-localization 
parameters). Subsequently, the distance from the centre of a mass to the nearest surface point 
(in µm) was determined of those events by using the tool “distance to reference object”. 83 
different interaction events from 15 different hybridoma cells were evaluated. For calculation 
of a mean distance between interacting peroxisomes, those events were selected that displayed 
at least a mutual signal co-localization of 20 % (relColocS: % of intersecting intensity relative 
to object intensity) and the resulting mean distance was evaluated using Microsoft Excel. 
2.9.6 Live cell imaging 
In addition to the static, structural characterisation of e.g. protein localization within cells and 
tissues, the investigation of dynamic cellular processes has become more and more essential 
in the last two decades, especially due to the high utilization of the green fluorescent protein 
(GFP) and its analogues. GFP vectors are powerful tools for live cell imaging, as they allow 
the easy genetic addition of a stable tag with inherent fluorescent properties to any protein of 
interest. The autofluorescent properties of GFP – isolated from the jellyfish Aequoria victoria 
– are a result of the spontaneous formation of the chromophoric group that is comprised of the 
side chains of three adjacent amino acids (Ser65 – Tyr66 – Gly67). Live cell imaging 
applications include the characterization of cell migration, cell growth, mitosis, metabolic 
transport or even signal transduction events, however, the various processes differ 
dramatically in their kinetics, ranging from seconds to days. Thus, when e.g. investigating 
long time series, the imaging setup demands for maintenance of constant culture conditions 
(temperature, CO2, humidity) and the correct focal point. Compromises have to be found 
regarding detector sensitivity, velocity of image acquisition, signal stability, z-resolution and 
sample protection.  
Protocol:  For live cell time-lapse imaging studies, the Zeiss LSM 510 Meta confocal 
microscope was equipped with a closed chamber (heating insert P) aerated with 5 % CO2 that 
allowed the generation of stable culture conditions over the course of the experiment. Cells 
were seeded into 35 mm glass bottom dishes in complete culture medium without phenol red 
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to avoid quenching of fluorescent signals. In order to study the effect of ROS generation in 
shorter time frames in living cells, the genetically encoded photosensitizer KillerRed (Bulina 
et al., 2006a; Bulina et al., 2006b) was used. Variants of KillerRed targeted either to the 
cytoplasm, mitochondria or peroxisomes were transfected into COS-GFP cells one day prior 
to the experiment. To induce generation of free radicals, selected cells were illuminated with 
green fluorescent light using the mercury lamp and filter sets of the associated microscope. 
KillerRed bleaches were quickly upon activation and illumination was carried out for twice 
the duration of photobleaching, following the recommendation of Bulina et al (Bulina et al., 
2006b). Time series were subsequently acquired using the 488 laser line and collecting 
images every minute for 30-60 minutes.  
 
2.9.7 Spinning disk confocal microscopy 
Most commonly, confocal high speed spinning disk systems are used to investigate fast 
processes within the cell such as calcium imaging in real-time, as they allow for a very high 
rate of image acquisition (up to 400 pictures/second) upon use of one laser line. The so-called 
Nipkow-systems contain two spinning disks: the first one is equipped with a large number of 
tiny lenses and located directly behind the laser (source of light) where it simultaneously – 
due to the high number of lenses – focuses the laser light onto many focal points of the 
specimen. The other, synchronized spinning disc – which contains thousands of 
simultaneously rotating pinholes – generates the confocal behaviour, as it collects the 
emission signal of the many focal points of the specimen in parallel. Basically, the spinning 
disk system is a confocal microscope acting on many focal points in parallel. In contrast to 
conventional confocal setups, the emitted light is not detected by a photomultiplier, but by a 
CCD camera which quickly and simultaneously detects the light of the many pinholes, 
reducing phototoxicity and photobleaching. However, due to the multiple image acquisition, 
photobleaching experiments cannot be carried out with a Nipkow system.  
Protocol: To investigate peroxisomal fusion events, live cell imaging was performed using a 
spinning disk confocal system Andor Revolution XD (Advanced light microscope facility, 
IBMC, Porto under the supervision of Dr. Paula Sampaio) using the 488 and 561 laser lines, 
respectively. CHO cells were seeded into 35 mm glass bottom dishes in complete culture 
medium (Ham’s F-12) and images were taken after hybridoma generation (2.8.7). Images 
were acquired from 5 different z-planes (0.5µm thickness) every 5 seconds for 200 frames.  
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2.9.8 Quantitative evaluation of peroxisome and mitochondrial dynamics 
2.9.8.1 Evaluation of peroxisome and mitochondrial fusion in fixed cells 
For studies on peroxisomal fusion, the degree of matrix and membrane marker exchange was 
determined by fluorescence microscopy. Therefore, either matrix or membrane labelled CHO 
cell lines (2.7.2) were subjected to the in vivo fusion assay (2.8.7), cultivated for 2, 4 and 6 
hours, fixed and processed for fluorescence microscopy. Images of hybridoma cells were 
acquired and the total number of peroxisomes per hybridoma cell as well as the number of 
“yellow” (co-localization of signals) peroxisomes was determined using analySIS software, 
and the measuring tool “touch count”. Fusion of mitochondria was determined under the same 
experimental conditions using Mito-GFP and Mito-DsRed. As mitochondrial fusion within a 
cell was already almost complete, the percentage of hybridoma cells with “yellow” 
mitochondria over the whole coverslip was determined.  
2.9.8.2 Analysis of peroxisomal interactions 
For quantitative image analysis after spinning disk confocal microscopy, the ImageJ software 
(v1.45a, NIH, MD, USA) was used. The number of either green or red peroxisomes per cell 
was determined using the PlugIn Particle counter. For analysis of peroxisomal interactions, 
Image5D stacks of time lapse images were generated and frame-by-frame analysis was 
performed for every z stack. Interactions – defined as the close apposition of two 
differentially labelled peroxisomes -  and their dynamic behaviour were followed over the 
course of the experiment. The duration of the interactions, the number of peroxisomes 
involved and the number of re-engagements of the peroxisomes involved was assessed. In 
total, 425 interaction events from image stacks of 15 different hybridoma cells (n = 3) were 
analyzed. To analyze the kinetics of peroxisomal interactions, the duration of the interactions 
between individual peroxisomes and the duration of complete signal overlay was determined 
for every peroxisomal interaction evaluated (n = 903). The frequency of contacts lasting 
longer or equal than a certain duration was evaluated as a cumulative frequency plot against 
time using Microsoft Excel. Detailed mathematical analysis of the observed peroxisome 
interactions was performed by Dr. Fernão Vistelo de Abreu (University of Aveiro, Portugal) 
(8.1.1.1). Moreover, a simple computational model was developed to address the question 
whether the fraction of peroxisomes engaging in ATP driven motility has been optimized to 
promptly homogenize the peroxisomal population within a cell at a minimal energy expense.  
To analyze the number of peroxisomal interactions after fatty acid or ROS stimulation (2.8.8), 
images of hybridoma cells were evaluated using ImageJ (tool: cell counter) and the number of 
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green and red peroxisomes was determined as well as the number of interacting/attaching 
peroxisomes (defined as “yellow” ones and those attached to each other). Data is taken from 
3-4 independent experiments (10-15 cells/condition) and data analysis and presentation was 
performed using Microsoft Excel software. Data is presented as means +/- standard deviation 
(SD). An unpaired t-test was used to determine statistical differences between experimental 
groups. P-values < 0.05 are considered significant and P-values < 0.01 are considered highly 
significant.  
2.9.8.3 Quantification of peroxisome morphology 
For quantification of peroxisome morphology, peroxisomes were categorized as displaying 
either a spherical or rod-shaped or tubular morphology (Schrader et al., 1994; Schrader et al., 
1996a). 100 cells per coverslip (2-4 coverslips per condition) were categorized accordingly 
and experiments were performed 2-3 times. Data analysis and presentation was performed 
using Microsoft Excel software. Data is presented as means +/- standard deviation (SD). An 
unpaired t-test was used to determine statistical differences between experimental groups. P-
values < 0.05 are considered significant and P-values < 0.01 are considered highly significant.  
2.10   BIOINFORMATIC SCREENING TOOLS 
2.10.1  In silico determination of transmembrane domains 
In the course of this study, the membrane topology of the peroxisomal biogenesis factor 
Pex11pβ was investigated. For initial determination of potential transmembrane domains the 
following databases/tools/servers were used to screen the protein sequence (UniProtKB: 
O96011, PX11B_HUMAN):  
• UniProt: http://www.uniprot.org/ 
• SOSUI: http://bp.nuap.nagoya-u.ac.jp/sosui/ 
• Toppred tool, Mobyle@Pasteur: http://mobyle.pasteur.fr/cgi-bin/portal.py#welcome 
• HMMTOP: http://www.enzim.hu/hmmtop/ 
• TMPred: http://www.ch.embnet.org/software/TMPRED_form.html 
• TMHMM Server, v 2.0: http://www.cbs.dtu.dk/services/TMHMM/ 
• PredictProtein: http://www.predictprotein.org/ 
• Split 4.0 server: http://split.pmfst.hr/split/4/ 
 
For calculation of protein fragment size after proteinase K digest, peptide mass was calculated 
using PeptideMass (http://web.expasy.org/peptide_mass/).  
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2.10.2   In silico determination of potential phosphorylation sites 
Up until now, only little is known about the potential phosphorylation of the mammalian 
peroxisomal biogenesis factor Pex11pβ. Strongest evidence was obtained for the Pex11 
protein of the yeast S. cerevisiae (Knoblach & Rachubinski, 2010), however, the yeast and 
human proteins differ considerably. The following databases were used to screen for either 
phospho-sites within the human Pex11pβ sequence (UniProtKB: O96011, PX11B_HUMAN) 
or potential binding sites for kinases:  
 
• KinasePhos 2.0: http://kinasephos2.mbc.nctu.edu.tw/index.html 
• NetPhos 2.0: http://www.cbs.dtu.dk/services/NetPhos/ 
• DISPHOS: http://core.ist.temple.edu/pred/pred.html 
• NetPhosK: http://www.cbs.dtu.dk/services/NetPhosK/ 
• Scansite MotifScan: http://scansite.mit.edu/motifscan_seq.phtml 
• ScanProsite: http://expasy.org/tools/scanprosite/ 
• ELM: http://elm.eu.org/ 
 
Alignment of Pex11pβ protein sequences from different species was performed using the 
ClustalW2 tool (http://www.ebi.ac.uk/Tools/msa/clustalw2/).  
 
2.11  BIOCHEMICAL METHODS  
2.11.1  Preparation of peroxisome-enriched fractions 
In order to isolate organelles from intact cells, they have to be released by homogenisation 
procedures. To guarantee the extraction of intact organelles, adequate buffer conditions and 
the use of protease inhibitors have to be ensured. The heterogeneous homogenate can be 
further separated by differential centrifugation which is based on the principle that particles in 
liquid medium migrate according to their density and sedimentation coefficient. Hence, cell 
nuclei and debris sediment relatively fast, while mitochondria, peroxisomes and microsomes 
only follow at higher velocities. The resulting fractions can be further purified using density 
gradient centrifugation.  
Protocol: To prepare peroxisome-enriched fractions, cells of 4 confluent 100 mm cell culture 
dishes were washed twice with PBS before cells were scraped carefully from the dish surface 
in 1 mL of PBS using a rubber policeman. The combined cell suspensions of 4 cell culture 
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dishes were collected in a 15 mL reaction tube and pelleted by centrifugation using a table top 
centrifuge (500g; 5 minutes; room temperature). The supernatant was discarded, the cell pellet 
was resuspended in 1 mL of peroxisome homogenisation buffer supplemented with protease 
inhibitors and then transferred to a 2 mL reaction tube. Cells were subsequently homogenized 
using a 1 mL syringe equipped with a 26G needle. The resulting homogenate was centrifuged 
again at 500g for 5 minutes at 4°C. The supernatant was collected and the pellet was 
homogenized again in another 500 µL of peroxisome homogenisation buffer. Both 
supernatants were pooled and the resulting 500g pellet – containing cell debris and nuclei – 
was discarded. The 500g supernatant that contains cytosol and intact cell organelles was then 
centrifuged for 10 minutes at 2.000g at 4°C to pellet heavy mitochondria. Next, the resulting 
2.000g supernatant fraction was transferred to a 50 mL Beckman centrifugation tube and 
centrifuged for 25 minutes at 4°C and 25.000g (Beckmann Avanti-J251). The final pellet 
contained mitochondria, peroxisomes and microsomes. The supernatant was discarded and the 
pellet was resuspended in 100 µL of peroxisome homogenisation buffer for further 
experiments.  
Highly purified peroxisomal fractions were prepared as described previously and kindly 
provided by PD Dr. Markus Islinger (University of Aveiro, Portugal) (Völkl et al., 1996).  
2.11.2  Preparation of cell lysates 
In order to analyze the cellular protein content biochemically, cell lysates of various 
mammalian cell lines were routinely generated (e.g. to determine expression of a protein of 
interest).  
Protocol: Cells of one confluent 100 mm cell culture dish were washed twice with PBS to 
remove any traces of medium. Next, 500 µL of lysis buffer (2.6) supplemented with protease 
inhibitors were added to the cells and the cells were scraped off the culture dish using a 
rubber policeman. Lysates were transferred to a 1.5 mL reaction tube and incubated for 20 
minutes at 4°C with overhead rotation to guarantee complete rupture and lysis of cells and 
organelles. Subsequently, lysates were further homogenized using a 1 mL syringe equipped 
with a 26G needle to shred the liberated, denatured DNA. Finally, cell lysates were 
centrifuged for 15 minutes, at 4°C at 13.000rpm in a table-top centrifuge to pellet cell debris 
and DNA. The resulting supernatant was transferred into a new 1.5mL reaction tube.  
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2.11.3  Triton-X-100 (Tx100) extraction assay  
To assess the Tx100-mediated removal of the peroxisomal membrane protein Pex11pβ from 
the peroxisomal membrane biochemically, a Tx100-based extraction assay was designed. 
Protocol: COS-7 cells were transfected with myc-tagged variants of Pex11pβ prior to the 
experiment and seeded in 100 mm cell culture dishes. After the indicated time points, the cell 
culture medium was aspirated and cells were fixed using 4 % pFA for 20 minutes. 
Subsequently, cells were washed and 1.5-2 mL of 0.2 % Tx100 was added to the cells. After 
10 minutes, the Tx100 supernatant was collected in a reaction tube and centrifuged for 15 
minutes at 13.000 rpm and 4°C to remove cell debris. In parallel, the corresponding fixed 
COS-7 cells were lysed (2.11.2). The protein concentration of both Tx100 supernatant and 
cell lysate was determined (2.11.5) and sufficient amounts of protein were precipitated for 
downstream applications (2.11.4).  
 
2.11.4  Protein precipitation 
To remove traces of detergent and/or to concentrate the sample, protein precipitation was 
performed.  
2.11.4.1 Methanol-Chloroform precipitation (Wessel & Flugge, 1984) 
Protocol: 4 volumes of methanol p.a. were added to 1 volume of sample. The mixture was 
vortexed and 1 volume of chloroform was added. The sample was mixed again by vortexing, 
3 volumes of dH2O were added and centrifuged at 13.000 rpm for 3 minutes at room 
temperature in a table-top centrifuge. After centrifugation, two phases can be distinguished; 
the proteins accumulate as a white interphase between those. The upper watery phase was 
discarded, 3 volumes of methanol were added and the sample was centrifuged as indicated 
above after thorough mixing. A white protein pellet was formed which was dried at room 
temperature, taken up in Lämmli sample buffer after drying and boiled at 95°C for 5 minutes.  
2.11.4.2 Trichloroacetic acid (TCA)  precipitation 
Protocol: 1 volume of 20 % TCA solution was added to 1 volume of protein and incubated for 
30 minutes on ice. The mixture was then centrifuged for 15 minutes at 13.000 rpm and 4°C in 
a table-top centrifuge upon which a white protein pellet was formed. The supernatant was 
discarded and the pellet was washed twice with 1 mL of acetone, incubated for 5 minutes on 
ice and centrifuged again. Finally, the acetone supernatant was removed, the pellet was dried 
at room temperature and taken up in Lämmli sample buffer. To facilitate dissolution of the 
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protein pellet, the sample was incubated with shaking for 20 minutes at room temperature and 
then boiled at 95°C for 5 minutes.  
2.11.5  Determination of protein concentration according to Bradford 
The colorimetric determination of the protein concentration according to Bradford (Bradford, 
1976) is based on the reaction of functional groups of proteins with a colour-forming reagent, 
in this case the blue acidic dye Coomassie Brilliant Blue, which binds unspecifically to 
cationic and unpolar, hydrophobic amino acid side chains. In an acidic protein environment, 
the absorption maximum of the dye shifts from 465 nm to 595 nm as the unprotonated, 
sulphated form of the dye is complexed and stabilized. The intensity of the resulting colour 
switch is proportional to the protein concentration and can thus be quantified by 
spectrophotometry.  
Protocol: To generate a standard curve, defined amounts of standard (BSA, 1 mg/mL) were 
filled up to a final volume of 100 µL with 0.1 M NaOH in a 1.5 mL reaction tube. 2 µL of the 
sample were treated equally and standards as well as sample were supplemented with 1 mL 
Bradford reagent (1:5 in dH2O). Samples were incubated for 15 minutes at room temperature 
and measured in a table top spectral photometer at 595 nm against a blank. Measurement was 
performed in duplicate. 
2.11.6  One dimensional polyacrylamide gelelectrophoresis (SDS-PAGE) 
The term electrophoresis is defined as the migration of charged particles in an electric field. 
Different charges and sizes of particles result in a different electrophoretic mobility. Using 
SDS-PAGE, proteins within a matrix of polyacrylamide are separated according to their size. 
The gel matrix is formed by chemical co-polymerisation of acrylamide monomers with a 
cross-linker (N, -N,-Methylenebisacrylamide, BIS). The polymerisation reaction is started due 
to a chain reaction initiated by the disintegration of peroxide sulphate ions. The generated 
radicals activate TEMED which initiates the cross link of the monomers. As oxygen leads to 
termination of the chain reaction, a vertical gel stand is used, excluding as much oxygen as 
possible. Due to slow ongoing polymerization, the gels are cast one day prior to use. The 
anionic detergent SDS is usually added to gel mixture, as it covers the auto-charge of proteins 
so that particles with a constant negative charge are formed which are solely separated 
according to their size. Upon sample preparation in Lämmli sample buffer tertiary and 
quarternary structures of proteins are dissolved by boiling. Reducing thiol compounds (e.g. 
DTT or 2-mercaptoethanol) break inter-protein disulfide bonds. Routinely, a standard 
discontinuous electrophoresis system according to Lämmli (Laemmli, 1970) was used that 
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combines a tightly meshed resolving and a loosely meshed stacking gel. The use of a stacking 
gel avoids protein aggregation, resulting in better band separation. A Tris-Cl/Tris-glycine 
buffer system was used: the pH of the stacking gel is close to the isoelectric point of the 
amino acid glycine, thus glycine migrates more slowly within the gel. The chloride ions on 
the other hand migrate very fast (“leading ion”). The applied proteins migrate between those. 
If an electric field is applied, all ions within this discontinuous system migrate with the same 
velocity. Consequently, as migration velocity is proportional to electrical field strength and 
mobility, an area of lower field strength is formed around the ions with higher mobility and 
vice versa. Due to the subsequent formation of an electrical field gradient along the protein 
ions, those form a stack of protein ions according to their mobility (the protein ions with the 
highest mobility directly follow the leading ion and so forth). Upon entering the more tightly 
meshed resolving gel, migration of proteins, but not glycine is hindered, leading to the 
formation of a homogenous buffer and a migration according to protein sizes.  
Protocol:  
Stacking gel Separation gel  
 5 % 7.5 % 12.5 % 15 % 
30 % Polyacrylamide  1.66 mL   4.0 mL  6.67 mL     8.0 mL  
2 M Tris pH 8.8  - 2.89 mL  2.89 mL   2.89 mL  
1 M Tris pH 6.8   1.25 mL  - - - 
20 % SDS   50.0 µL   80.0 µL  80.0 µL   80.0 µL  
dH2O  6.95 mL  8.89 mL 6.22 mL  4.89 mL 
TEMED   10.0 µL     8.0 µL   8.0 µL      8.0 µL  
10 % APS    80.0 µL  48.0 µL  48.0 µL    48.0 µL  
Total volume  10.0 mL 16.0 mL 16.0 mL   16.0 mL 
Table 2.19: Gel solutions for SDS-PAGE 
 
Routinely, 12.5 % or 15 % polyacrylamide gels were cast. The various parts of the gel 
apparatus were cleaned with water and 70 % ethanol and assembled. The resolving gel was 
cast between the glass plates and covered with isopropanol to exclude oxygen during the 
polymerization reaction. When polymerization was complete, isopropanol was removed by 
decanting and the stacking gel was cast onto the resolving gel. Quickly, a comb was inserted 
to allow sample pocket formation. The fully polymerized gel was kept in a wet chamber at 
4°C until use. Samples were taken up in Lämmli sample buffer, boiled for 5 minutes at 95°C 
or 20 minutes at 65°C, quickly centrifuged and loaded onto the gel. To determine protein size, 
a protein marker standard was included. Electrophoresis was performed in SDS Running 
Buffer at an initial voltage of   80 V and then at 120 V (400 mA, 100 W).  
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2.11.7  Immunoblotting 
The term immuno- or western blotting refers to a transfer of proteins onto a carrier membrane 
followed by immnunodetection. Thus, proteins separated by SDS-PAGE are fixed. In 
electroblotting, the process is assisted by an electric field (Towbin et al., 1992). Routinely, a 
semi-dry blotting procedure according to Kyhse-Andersen (Kyhse-Andersen, 1984) was used. 
The blotting system is comprised of two plate electrodes in between which the blot sandwich 
- consisting of Whatman filters soaked in buffer, the polyacrylamide gel and the nitrocellulose 
membrane - is placed. Upon initiation of blotting, an electrical field is formed perpendicular 
to the gel layer and proteins migrate in the direction of the positively charged anode onto the 
membrane. SDS migrates faster than the proteins and is thus separated from those. 
Hydrophobic interactions between the proteins and the nitrocellulose membrane then lead to 
membrane adhesion of the proteins. This interaction is facilitated by the methanol-containing 
blotting buffer.  
Protocol: Whatman filter papers and nitrocellulose membranes were cut to gel size and 
soaked in blotting buffer. The blot sandwich consisting of filters, gel and membrane was 
assembled onto the plate electrodes of the semi-dry blotting machine. Protein transfer 
occurred at 12 V (400 mA, 100 W) for 45 minutes.  
2.11.8  Ponceau S staining  
In order to control successful transfer of proteins after western blotting, a Ponceau S staining 
was performed. Ponceau S is a red diazo dye that binds reversibly to the positively charged 
amino groups of proteins that can be easily washed off the nitrocellulose membrane after 
detection.  
Protocol: After western blotting, the nitrocellulose membrane was transferred into a plastic 
dish and covered in some millilitres of Ponceau S solution (0.1 % in 5 % acetic acid). After 
careful shaking, the protein pattern could be distinguished as pinkish-red bands on the 
nitrocellulose. If necessary, the membrane was cut into pieces along the band margins. The 
excess Ponceau S solution was recollected again for further use and the nitrocellulose 
membrane was washed with dH2O to remove the stain.  
2.11.9  Enhanced chemiluminescence (ECL) for detection of proteins 
The transferred proteins of interest are selectively detected by an antibody-based immune 
reaction with a peroxidase-linked secondary antibody. Quantification of proteins occurs by 
the ECL reaction: the indirectly coupled peroxidase catalyses the oxidation of luminol which 
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is excited to a higher energy level (excited state). Upon return to the stationary state, photons 
are emitted (chemiluminescence) that blacken the light-sensitive ECL film. The reaction is 
enhanced by phenols in one of the two solutions.  
Protocol: After transfer upon nitrocellulose and Ponceau staining, the membrane was 
incubated in a solution of 5 % skimmed milk (in PBS) for 1 hour at room temperature to 
block unspecific binding of the antibody. Primary antibody incubation was either performed 
for 3 hours at room temperature or over night at 4°C with overhead rotation. Residual traces 
of primary antibody were removed by washing with PBS. Next, the blot membrane was 
incubated with a peroxidase-coupled secondary antibody for 45 minutes at room temperature. 
After several more washing steps, the ECL solutions 1 and 2 were mixed (1:1) and incubated 
for 3 minutes with the blot membrane. Detection of signals was performed in a dark room on 
light sensitive films. Exposure times were adjusted depending on the strength of the signal.  
2.11.10  Removal of antibodies from western blots (Stripping) 
Stripping is the colloquial term used to describe the removal of primary and secondary 
antibodies from a western blot membrane which is necessary, if, for instance, one wants to 
investigate another protein of similar size on the same blot. The bound primary and secondary 
antibodies are denatured by the use of detergents and thiol compounds and subsequently 
removed by extensive washing.  
Protocol:  
 
Stripping buffer (final concentrations) 
• 2 % SDS 
• 62.5 mM Tris-HCl, pH 6.8 
• 100 mM 2-mercaptoethanol 
 
The nitrocellulose membrane was incubated in an excess of stripping buffer for 30 minutes at 
60°C with shaking. Next, the stripped blot was washed twice in TBS-T for 10 minutes at 
room temperature and then re-blocked in skimmed milk (5 % in TBS-T).  
2.11.11  Immunoprecipitation (IP) 
Using a so-called immunoprecipitation, proteins can be isolated – de facto precipitated – from 
a complex protein mixture using specific antibodies against the protein itself or an epitope 
tag. In order to accelerate pelleting of the antibody-antigen complex which would normally 
require the optimal ratio between antigen and antibody to allow maximum complex 
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formation, a sepharose matrix covered with protein A (PAS) from Staphylococcus aureus is 
commonly used. Protein A binds specifically to the constant chains of IgG antibodies and in 
combination with heavy sepharose serves to pellet the protein of interest more easily. To 
reduce unspecific binding of PAS within the protein environment of a cell lysate, a so-called 
pre-clearing is performed in which PAS is added to the lysate and pelleted by centrifugation 
before the addition of the specific antibody. After immunoprecipation and pelleting of the 
sepharose beads, several washing steps are carried to remove unspecific contaminants.  
2.11.11.1 Radio-immunoprecipitation to validate cycloheximide efficiency 
To determine the validity of the cycloheximide mediated import block within our peroxisomal 
in vivo fusion assay, a pulse-chase assay was established. The term “pulse-chase” refers to 
experiments in which the transport/fate of proteins is investigated over time. First, protein 
synthesis is arrested by depriving cells of the essential amino acid methionine in methionine-
free medium. After addition of the radioactively labelled methionine, translation is allowed to 
resume and a pool of newly synthesized, radio-labelled protein is generated. However, upon 
addition of cycloheximide, translation should still be terminated, thus no new, radioactive 
pool of protein is generated. The stable cell line CHO-GFP-PTS1 was used in this study and 
the IP was performed against GFP to assess efficient translation arrest.  
Protocol: CHO-GFP-PTS1 cells were pre-incubated for 1 hour in methionine-free DMEM 
supplemented with 10 % FBS and were afterwards pulse-labelled for 2 and 4 hours in fresh 
medium containing [S35]methionine (35 µCi) in the presence or absence of 50 µg/mL 
cycloheximide. Afterwards, cells were lysed in radio-immunoprecipitation buffer containing 
protease inhibitor mix and a pre-clearing with PAS was performed (3-6 hours) to minimize 
unspecific binding. Immunoprecipitation was performed with polyclonal anti-GFP antibody 
(1:666). To precipitate antigen-antibody complexes 20 µl of a 50% slurry of PAS was added 
to 500 µL of lysate and incubated with mixing overnight at 4°C. The beads were then 
pelleted, washed extensively with 3 x 1mL wash buffer 1 and 3 x 1 mL high salt wash buffer 
2 (2.6). The immunoprecipitates were solubilized in Lämmli sample buffer, and subjected to 
12.5 % SDS-PAGE. Phospho-images of dried gels were analyzed using a FLA-3000 
phosphoimager and GelProAnalyzer 4.0 software. 
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2.11.11.2 Radio-immunoprecipitation to determine protein phosphorylation (In vivo 
phospholabelling) 
To determine the phosphorylation status of the peroxisomal biogenesis factor Pex11pβ, in 
vivo phospholabelling against a YFP-tagged version of the protein was performed. APP-GFP 
and empty YFP-C1 vector served as positive and negative controls, respectively. The basic 
principle of the assay is as follows: cells expressing the above mentioned constructs are 
starved in phosphate-free Krebs-Ringer buffer and then pulse-labelled with an excess of the 
highly radioactive P32 orthophosphate that is subsequently equilibrated into cellular ATP/GTP 
pools and incorporated into proteins upon phosphorylation. Upon immunoprecipitation 
against the epitope tag, here GFP, the proteins of interest are pulled down and can be 
investigated for incorporation of radioactive phosphate after SDS-PAGE.  
Protocol: 48 hours prior to the phospholabelling, COS-7 cells (2 × 100 mm cell culture dishes 
per condition) were transfected with the proteins of interest (APP-GFP, YFP-C1, YFP-
Pex11β) by electroporation (2.8.5.2). In order to deplete intracellular phosphate pools, the cell 
culture medium was aspirated and the cells were washed 3 times in phosphate-free Krebs-
Ringer buffer before 5 mL of Krebs-Ringer buffer were added to each dish. Cells were 
incubated at 37°C and 5 % CO2 for 2 hours. Afterwards, cells were washed once and 2-3 mL 
of phosphate-free Krebs-Ringer buffer were added. Cells were then pulsed by the addition of 
50 µCi/mL of P32 orthophosphate and incubated for 4 hours at 37°C with shaking. 
Subsequently, the radioactive buffer was removed and cells were washed once in washing 
buffer (20 mM HEPES, pH 7.4, 150 mM NaCl) before 500 µL of radio-immunoprecipitation 
buffer supplemented with protease inhibitor mix and phosphatase inhibitors (2 mM sodium 
orthovanadate, 50 mM sodium fluoride) was added to the cells. Cells were scraped off the 
culture dish and lysates of the 2 corresponding 100 mm cell culture dishes were pooled in a 2 
mL reaction tube. Lysates were rotated 20 minutes at 4°C to guarantee complete cell and 
organelle lysis and then centrifuged for 15 minutes at maximum speed in a table top 
centrifuge. The supernatant was transferred into a new 1.5 mL reaction tube. For pre-clearing, 
30 µL of PAS were added to the lysates and rotated at 4°C for at least 2 hours. To pellet the 
PAS beads, lysates were centrifuged for 2 minutes at 5.000 rpm in a table top centrifuge and 
the supernatant was transferred to a new reaction tube. 1.5 µL of polyclonal anti-GFP 
antibody were added to each of the samples, followed by further incubation with rotation at 
4°C for more 30 minutes before 50 µL of PAS were added to the mixture. Incubation 
occurred overnight at 4°C with rotation. The next day, immunoprecipitates were pelleted by 
centrifugation at 5.000 rpm and 4°C in a table top centrifuge. PAS beads were washed twice 
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in IP washing buffers 1 and 2 to reduce unspecific binding and after a final spin at 5.000 rpm 
for 5 minutes, PAS beads were taken up in 30 µL of 3 x Lämmli sample buffer. The denatured 
proteins and antibodies are thus removed from the sepharose beads. Samples were boiled for 
5 minutes at 95°C, shortly centrifuged to pellet beads and loaded onto a 12.5 % SDS gel. 
After SDS-PAGE, the gel was fixed and dried for 2-3 hours using a BioRad gel drying unit. 
The radioactive gel was exposed on a phospho-imaging screen for 2-3 days. Phospho-imaging 
was performed using a BioRad Molecular FX scanner.  
 
Krebs-Ringer Buffer (phosphate-free) 
• 118 mM sodium chloride 
• 4.75 mM potassium chloride 
• 1.2 mM magnesium chloride 
• 0.26 mM calcium chloride 
• 25 mM sodium bicarbonate 
 
2.11.12  Proteinase K digest 
Proteinase K (or endopeptidase K) is a highly reactive serine protease that was isolated from 
the fungus Tritirachium album. Interestingly, it is stable over a broad range of pH and 
temperature and various concentrations of buffer salts and detergents. Even in the presence of 
0.1-0.5 % SDS it retains its activity, rendering it a useful tool for the inactivation of nucleases 
in DNA preparations and the determination of protein topology on (intra)cellular membranes. 
To determine membrane protein topology, protein samples and untreated controls are 
incubated with proteinase K. The parts of the protein that are accessible to the protease will be 
cleaved into fragments, while membrane protected parts will remain intact. The resulting 
changes in the size of detectable protein bands yield a certain pattern from which the protein 
topology can be concluded. As a control, samples will also be digested in the presence of 
detergents (or otherwise permeabilized membranes) which results in the complete digest of 
the protein.  
Protocol: In this study, proteinase K digest was carried out on overexpressed peroxisomal 
membrane proteins, therefore two days prior to the experiment, cells were transfected to yield 
4 confluent 100 mm cell culture dishes at the day of the experiment. Routinely, untransfected 
cells were included as controls to rule out any antibody artefacts. On the day of the 
experiment, peroxisome-enriched fractions were prepared out of the cells of 4 confluent 100 
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mm cell culture dishes to increase the concentration of the protein of interest (2.11.1). The 
crude peroxisome pellet was taken up in 100 µL of peroxisome homogenization buffer 
(Azevedo protocol) without the addition of protease inhibitors which would compromise 
further digest. A Bradford assay was performed to determine protein concentration (2.11.5) 
and for each condition, 3 samples were prepared: 60 µg of protein was transferred into a 
reaction tube, for the untreated control the sample was filled up to a volume of 50 µL with 
homogenisation buffer. Proteinase K was added to the other samples (25 µL of a 2 mg/mL 
stock) in the presence or absence of 1 % Tx100. Additionally, as an alternative to Tx100 
permeabilization, peroxisomal membranes were ruptured by sonication (3 × 10 seconds, 100 
W, on ice). The proteinase K digest was carried out for 30-45 minutes on ice and then stopped 
by the addition of PMSF (5 mM final concentration). All samples were brought to a volume 
of 100 µL with homogenisation buffer and a TCA precipitation was performed (2.11.4.2). 
Protein pellets were dissolved in 3x Lämmli sample buffer and run on 12.5-15 % 
polyacrylamide gels.  
 
Peroxisome homogenisation buffer (Azevedo protocol) 
• 20 mM MOPS-KOH pH 7.4 
• 250 mM  Sucrose 
• 1 mM EDTA-NaOH pH 7.4 
 
Proteinase K 
• Stock: 2 mg/mL in 20 mM MOPS-KOH, pH 7.4 
 
2.11.13  Carbonate treatment 
To weaken and disrupt the ionic bonds/interactions and thus extract peripheral membrane 
proteins, solutions of extreme ionic strength or pH can be incubated with cellular membranes. 
In this study, peripheral membrane proteins were removed by a solution of 500 mM Na2CO3, 
pH 11.5 (Fujiki et al., 1982).  
Protocol: To yield a sufficient amount of protein, cells were usually transfected to express the 
protein of interest and peroxisome-enriched fractions were prepared out of 8 confluent 100 
mm cell culture dishes per condition. Routinely, also untransfected cells were used as 
controls.  The crude peroxisome pellet was resuspended in 100 µL of peroxisome 
homogenization buffer (with protease inhibitor mix) and split into two samples (Control and 
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carbonate-treated fraction). The control sample was diluted 1:5 in peroxisome 
homogenisation buffer and the carbonate-treated fraction was diluted 1:5 in ice-cold sodium 
carbonate solution (500 mM Na2CO3, pH 11.5). Both fractions were incubated for 30 minutes 
on ice with gentle shaking every 5 minutes. The samples were centrifuged in an Optima LE-
80K Ultracentrifuge (Ti 80 rotor; Beckman Coulter) at 50.000 rpm (223 000g) for 1 hour at 
4ºC. The resulting pellet fractions correspond to the membrane fraction (containing integral 
membrane proteins) and – in the case of the carbonate-fraction – the supernatant contains the 
extracted peripheral membrane proteins. The pellet was resuspended in peroxisome 
homogenization buffer and protein concentrations of all fractions were determined (2.11.5) 
prior to SDS-PAGE (2.11.6) and immunoblotting (2.11.7).  
 
2.12  MOLECULAR BIOLOGY TECHNIQUES 
2.12.1  Extraction of total RNA from mammalian cell lines 
Isolation of total RNA from mammalian cell lines was routinely performed to generate cDNA 
template for subsequent cloning purposes or to assess differences in the expression pattern of 
key peroxisomal biogenesis factors after stimulation.  
2.12.1.1 RNA-extraction using RNeasy Mini Kit (Qiagen) 
A commercially available RNA extraction kit (RNeasy Mini Kit, Qiagen) was regularly used 
to extract total RNA from human HepG2 cells for cloning purposes.  The collected HepG2 
cell pellets were resuspended in buffer containing guanidinium isothiocyanate and 2-
mercaptoethanol that leads to a complete denaturation of the cell and organelle membranes, 
including the nucleus. 2-mercaptoethanol serves as an RNAse inhibitor. Subsequent 
homogenisation of the viscous solution with a 20G syringe needle guarantees shredding of 
genomic DNA and other cellular components, yielding a more homogenous solution to be 
applied to the extraction columns. The addition of ethanol improves the selective binding of 
the negatively charged RNA molecules to the positively charged silica matrix of the 
extraction column. Contaminants are removed in consecutive washing steps and the total 
RNA can be eluted.  
Protocol: The cell pellet of 1.5 confluent 100 mm cell culture dishes was carefully 
resuspended in the supplied buffer (supplemented with 2-mercaptoethanol, according to the 
manufacturer’s instructions) and homogenized using a syringe and a 20G needle. RNA 
extraction was carried out according to the manufacturer’s instructions. RNA was eluted in 30 
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µL of the supplied RNAse-free water. After determination of RNA concentration (2.12.14), 
RNA was aliquoted and frozen at -80°C.  
 
2.12.1.2 RNA extraction using TriFast (PeqLab, (Chomczynski & Sacchi, 1987)) 
The so-called TriFast reagent from PeqLab (or the analogous TriZol from Invitrogen) allows 
the simultaneous isolation of RNA, DNA and protein from cells and tissues of various origins 
(animal, plant, bacterial, yeast). The supplied TriFast solution contains the organic solvent 
phenol and guanidinium thiocyanate to lyse cellular membranes. Upon lysis, chloroform is 
added and after subsequent centrifugation the homogenate separates into three phases – the 
upper aqueous phase contains RNA, the white interphase DNA and the organic phase 
proteins. The upper RNA phase is then carefully transferred into a new reaction tube and 
RNA is precipitated using isopropanol. After washing and drying, the RNA pellet is 
resuspended in RNAse-free water. TriFast extraction was routinely used to extract RNA from 
AR42J cells to determine regulation of key peroxisomal biogenesis factors in subsequent 
semi-quantitative PCR (2.12.4).  
Protocol:  Cells of a confluent 60 mm cell culture dish were harvested by trypsinization 
(2.8.1) and pelleted by centrifugation in a 1.5 mL reaction tube. For homogenization, 500 µL 
of TriFast were added and the lysate was passed several times through the pipette tip before 
incubation for 5 minutes at room temperature to guarantee complete lysis. For phase 
separation, 100 µL of chloroform were added and the tube was shaken vigorously by hand for 
15 seconds. After a further incubation step for 5 minutes at room temperature, homogenates 
were centrifuged for 15 minutes at 12.000g and 4°C in a table top centrifuge.  The upper RNA 
phase was carefully transferred into a fresh 1.5 mL reaction tube. To facilitate RNA 
precipitation, 3 M sodium acetate, pH 4.5 was added to the RNA solution (1:10 of final 
volume) before 3 volumes of 100 % ethanol p.a. were added to one volume of the solution to 
precipitate RNA. The mixture was incubated at -20°C for at least 30 minutes and centrifuged 
for 15 minutes at 12.000g and 4°C upon which a faint RNA pellet is formed at the bottom of 
the tube. The pellet was washed twice in 500 µL of 75 % ethanol (in RNAse-free water) and 
then air-dried at room temperature. Usually, the RNA pellet was then resuspended in 30 µL of 
RNAse-free water and stored at -80°C until further use.  
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2.12.2  Reverse Transcription (cDNA synthesis) 
To be used as template DNA for PCR applications, the extracted total RNA has to be 
transcribed into cDNA – i.e. DNA that is complementary to the mRNA sequence. In this 
study, a reverse transcriptase originating from the moloney-mouse-leukemia virus (MuLV 
RTase) was used. To initiate polymerization and to isolate the desired mRNA, a so-called 
OligodT primer – consisting of 15 thymidine nucleotides, hence the name - was employed 
which binds complementary to the poly-A-tail characteristic for the 3’ end of mRNA.  
Protocol:  
Reagent Volume 
Total RNA 3.0 µg 
OligodT primer (100 µM) 2.8 µL 
dNTP’s (10 mM each) 0.5 µL 
10 × M-MuLV reverse transcription buffer   3.0 µL 
RNAse Inhibitor (40 U/µL) 0.5 µL 
M-MuLV reverse transcriptase (200 U/µL) 0.5 µL 
RNAse-free water    x   µL 
Final volume  30 µL 
Table 2.20: Reverse transcription 
 
The reaction mixture was carefully pipetted on ice and well mixed. Next, an initial incubation 
at room temperature for 10 minutes was performed, followed by incubation at 42°C – the 
enzymes temperature optimum – for 90 minutes with shaking. Inactivation of the reverse 
transcriptase was carried out at 65°C for 20 minutes. The cDNA mixture was aliquoted on ice 
and stored at -20°C until further use.  
2.12.3  Polymerase chain reaction (PCR) 
Polymerase chain reaction (PCR) is a method to selectively amplify specific stretches of 
DNA. It is based on the intrinsic ability of DNA polymerases to duplicate DNA in the 
presence of short stretches of double-stranded (ds) DNA that contain a free OH group at their 
3’end (primer). For PCR applications, sequence specific primers of 20-30 base pair length are 
used to amplify the desired region between the so-called forward and reverse primers. In 
addition to template DNA and primers, the reaction usually includes an adequate buffer 
solution, free nucleotides and MgSO4 as an essential polymerase co-factor. The PCR reaction 
itself is comprised of several specific steps: the initial denaturation step at 94°C leads to 
dissolution of the DNA double helix into its single strands, the following annealing step 
allows forward and reverse primers to bind to the specific sequences in the corresponding 
DNA template strands. The annealing temperature is dependent on the melting temperature of 
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both primers and is usually chosen to lie 5-10 degrees below the aforementioned. Within the 
subsequent elongation phase, the thermostable DNA polymerase generates the PCR product 
from the primer pairs in 5’-3’ direction. Elongation temperature is dependent on the 
temperature optimum of the polymerase used. Moreover, for cloning purposes in which the 
correct amplification of the DNA sequence is essential, it is beneficial to use a DNA 
polymerase that displays 3’-‘5 exonuclease  activity (proofreading). Each PCR cycle leads to 
a doubling of the desired sequence, by repetition of the three basic steps, a specific DNA 
fragment is further amplified.  
Protocol: For cloning purposes, a proofreading polymerase of Thermococcus kodakaraensi 
was used, supplied as the so-called “KOD Hot Start Polymerase Kit” (Novagen). The 
polymerase action is initially inhibited by complexing with two monoclonal antibodies that 
block polymerase and exonuclease activity to minimize unspecific amplification. In the initial 
denaturation, the antibodies are inactivated and polymerase action can begin.  
 
Reagent Volume 
Template cDNA 5.0 µL 
Forward primer (100 pmol/µL) 0.5 µL 
Reverse primer (100 pmol/µL) 0.5 µL 
10 × KOD Hot Start DNA polymerase PCR buffer 5.0 µL 
dNTP’s (2 mM each) 5.0 µL 
MgSO4 (25 mM) 2.0 µL 
KOD Hot Start DNA polymerase (1 U/µL) 1.0 µL 
ddH2O  x    µL 
Final volume 50 µL 
Table 2.21: Standard PCR 
 
The PCR reaction was pipetted on ice according to the protocol listed above before PCR was 
carried out under the following conditions: 
 
PCR program   
Initial denaturation/activation of polymerase 94°C,   3 min  
denaturation 94°C, 30 sec 
annealing 55°C, 30 sec 
elongation 72°C, 60 sec 
 
34 × 
Final elongation 72°C,   3 min 
cooling   4°C,    ∞ 
 
Table 2.22: Standard PCR program 
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2.12.4  Semi-quantitative PCR (SQ-PCR) 
The classical PCR (2.12.3) is a highly qualitative method to strongly amplify even the 
smallest amount of template. The course of the PCR reaction can be roughly divided into 
three phases: the initial lag phase that is characterized by low template concentrations and 
suboptimal conditions regarding the ratio between template, primer and polymerase, the 
exponential phase in which there is a correlation between the concentrations of PCR product 
and template and the plateau phase in which the ratio between template, primer and enzyme 
is again suboptimal due to the high amount of amplified product, limited amount of primer 
and nucleotides and a possible instability of the enzyme. Thus, a correlation between 
expression level of the target mRNA – and hence the targets abundance as cDNA - and the 
PCR product can only be concluded from the exponential phase. The so-called semi-
quantitative PCR aims at determining the relative expression levels of the mRNA of interest 
(e.g. after extracellular stimulation) in relation to appropriate controls within the exponential 
phase of the standard PCR reaction. In order to determine the exponential phase itself, 
samples of the PCR mix are manually collected after several cycles to be checked on an 
agarose gel. If a continuous increase in the amount of PCR product can be seen, it is possible 
to conclude cycles within the exponential phase. The manual approach is similar to the more 
sophisticated real-time quantitative PCR in which the amount of PCR product is measured by 
fluorescence after each cycle.  
Protocol: In order to assess the expression level of key peroxisomal biogenesis factors after 
dexamethasone stimulation, specific internal primer sets were chosen by consulting the NCBI 
Primer Blast tool (http://www.ncbi.nlm.nih.gov/tools/primer-blast) and selected according to 
the following parameters: primer length between 18-25 bases (optimal: 21); the melting 
temperature (Tm) should fall between 57-65°C (optimal 60-62°C); the length of the 
amplification product between 200 and 500 bp (Marone et al., 2001). RNA isolation (2.12.1) 
and cDNA synthesis (2.12.2) were carried out as indicated above. It was extremely important 
to transcribe equal amounts of RNA and use equal amounts of cDNA to detect changes in 
expression. To first determine the exponential phase of the PCR, 10 µL of the various PCR 
reactions were collected within the standard PCR run (2.12.3) at the end of the elongation 
phase – for peroxisomal biogenesis factors sample collection was carried out starting at 24 
cycles, for housekeeping genes such as GAPDH after 15 cycles. After determination of the 
optimal cycles for each template, the SQ-PCR was performed using the optimized annealing 
temperatures for each of the primer sets investigated. The PCR run was terminated after the 
determined cycle number (2.5.4.2) (within the exponential phase). Routinely, as controls 
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housekeeping genes were included. 10 µL of the samples were run on 1 % agarose gels and 
checked for changes in expression.  
Reagent Volume 
cDNA 2.0 µL 
Forward primer (10 µM) 1.0 µL 
Reverse primer (10 µM) 1.0 µL 
ThermoPol Taq reaction buffer (10 ×) 5.0 µL 
dNTP’s (10 mM each) 1.0 µL 
Taq polymerase (5 U/µL) 0.5 µL 
ddH2O x   µL 
Final volume 50 µL 
Table 2.23: Semi-quantitative PCR 
 
PCR program   
Initial denaturation 94°C,   5 min  
denaturation 94°C, 30 sec 
annealing  x °C, 30 sec 
elongation 72°C, 90 sec 
 
40 × 
Final elongation 72°C,   5 min 
cooling   4°C,    ∞ 
 
Table 2.24: Semi-quantitative PCR program 
2.12.5  Agarose gel electrophoresis 
DNA can be electrophoretically separated, as the negatively charged sugar phosphate 
backbone migrates to the positive charged anode upon application of an electric field. 
Depending on their size, DNA fragments collide with the agarose gel matrix and are thus 
retained and slowed in their migration. Velocity of migration is therefore dependent on DNA 
fragment size, applied voltage, running buffer, agarose concentration and intercalating 
reagents. Routinely, horizontal midi gels were cast using Tris-acetate buffer to separate DNA 
fragments according to their size. Sample buffer included glycerol to increase density and the 
dyes bromphenol blue and xylenecyanol that enable visual verification of the migration 
progress. Ethidium bromide was routinely used to stain DNA; the organic dye intercalates 
with the heteroaromatic rings of the DNA due to its planar structure and can be excited by UV 
light to emit orange-yellow range fluorescence.  
Protocol: Agarose concentration was chosen depending on fragment size and the adequate 
amount of agarose was dissolved in TAE buffer upon boiling in a microwave. The solution 
was allowed to cool down and ethidium bromide (0.5 µg/mL) was added. The gel was cast 
into a horizontal midi gel chamber prepared with combs to allow pocket formation. Sample 
buffer (6 times concentrated) was added to the DNA mixture and gels (midi) were run at 75 V 
and 400 mA for 30-60 minutes.  
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2.12.6  Restriction digest 
Restriction enzymes (RE) are endonucleasese of bacterial origin that hydrolytically cleave the 
phospho-diester bond of the DNA backbone. The many restriction enzymes differ in their 
recognition sequence, their cleavage sequence and their organism of origin. For molecular 
biological applications, type II restriction enzymes are used that cleave within their 
recognition sequences which generates defined fragments that can be separated on an agarose 
gel. In most cases, the often palindromic recognition sequence spans 4-8 base pairs and 
cleavage can generate blunt or ends with an overhang (sticky ends). After incubation of the 
fragment to be cloned and the target vector under appropriate buffer conditions, 
complementary ends are generated which are used to ligate the sequences (preparative digest). 
To ensure correct orientation of the insert within a vector, most commonly fragments and 
vector are digested with two different restriction enzymes (double digest) either 
simultaneously or in consecutive reactions. In this study, consecutive restriction digest was 
performed and DNA was precipitated in between (2.12.7).  Moreover, successful insertion of 
fragment into the vector can be verified by restriction digest in a smaller scale (analytical 
digest).  
Protocol: For preparative digest, both insert and vector DNA were mixed with restriction 
enzyme under appropriate buffer conditions according to the protocol below. The digestion 
mix was incubated for at least 2 hours at 37°C and DNA was precipitated and dissolved in 
dH2O before restriction digest with another enzyme. 
 
Reagent Volume 
DNA  1-2 µg 
Restriction enzyme I (10 U) 1.0 µL 
Buffer (10 ×) 5.0 µL 
dH2O   x  µL 
Final volume  50 µL 
Table 2.25: Preparative restriction enzyme digest 
 
Reagent Volume 
DNA (Mini-prep)   2  µL 
Restriction enzyme I (10 U) 0.2 µL 
Buffer (10 ×) 2.0 µL 
dH2O   x  µL 
Final volume  20 µL 
Table 2.26: Analytical restriction digest 
2.12.7  DNA precipitation 
DNA can be easily precipitated in the presence of ethanol or isopropanol.  
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Protocol: 2 volumes of 100 % ethanol were mixed with 1 volume of DNA mixture and 
incubated at –80°C at 30 minutes. To pellet DNA, centrifugation for 30 minutes at 17.000g 
and 4°C was performed. The supernatant was removed and the pellet was washed once in 50 
µL 70 % ethanol. The DNA pellet was then dried and resuspended in an adequate amount of 
dH2O.  
2.12.8  Gel Extraction 
PCR products and similar samples were extracted from the agarose gel for furter applications 
using commercially available gel extraction kits (Macherey-Nagel).  
Protocol:  The desired fragment was quickly cut out of the agarose gel using UV illumination 
and then boiled in buffer containing chaotropic salts to solubilise the gel matrix. 
Simultaneously, the buffer conditions created optimal conditions for DNA binding to the 
silica membrane of the columns. Upon application of the sample, agarose residues run 
through the column, while salts were washed away with ethanol-containing buffers. Finally, 
the DNA was eluted from the column. Gel extraction was carried out according to the 
manufacturer’s instructions.  
2.12.9  Dephosphorylation of vector DNA 
To avoid false-positive clones after, dephosphorylation of the vector backbone was routinely 
performed using a so-called Antarctic Phosphatase. The phosphatase removes the free 
5’phosphate from the vector backbone; therefore relegation of the vector is suppressed. The 
presence of 5’phosphates on the insert is sufficient for subsequent ligation.  
Protocol: The eluted vector sample was mixed with Antarctic Phosphatase buffer (1:10 of 
volume) and 1 µL of Antarctic Phosphatase and incubated for 30 minutes at 37°C. 
Inactivation of the phosphatase occurred for 20 minutes at 65°C.  
2.12.10  Ligation 
To insert the desired DNA sequence into the target vector after restriction digest, the 
complementary ends are connected by the reaction of the enzyme ligase that creates a 
phosphodiester bond upon annealing of the sequences 
Protocol:  To increase the possibility of successful insertion, the insert is usually added in 
excess to the vector. As a guideline to determine the amount of fragment, the following 
formula can be used:  
(10 ng vector × bp fragment) ⁄ bp vector  =  ng fragment (× 3, for 3:1 ratio insert-vector) 
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The ligation reaction was prepared according to the table below and either incubated for 1 




Insert DNA   x  µg 
Vector DNA  30 µg 
T4 ligase buffer (10 ×) 3.0 µL 
T4 ligase 1.0 µL 
dH2O   x  µL 
Final volume  30 µL 
Table 2.27: Ligation reaction 
2.12.11 Generation of chemically competent bacteria 
To amplify DNA plasmids, bacterial strains that are competent for transformation are used. 
They have previously been modified by chemical or electrical procedures to allow easier 
uptake of plasmids.  
Protocol: In order to generate chemically competent bacteria, 5 mL of an overnight culture of 
DH5α E-coli were added to 500 mL of LB medium and incubated at 37°C with shaking until 
an optical density of OD600nm = 0.4 was achieved. Then the bacterial culture was incubated for 
15 minutes on ice before pelleting at 3.000 rpm at 4°C in a Beckman Avanti centrifuge. The 
pellet was resuspended in 40 mL of ice-cold 0.1 M CaCl2 and incubated for another 30 
minutes on ice. After another centrifugation step, bacteria were resuspended in 20 mL of ice-
cold 0.1 M CaCl2 and 20 % (v/v) of glycerol were added. After 2 hour incubation on ice, 
competent bacteria were aliquoted, frozen in liquid nitrogen and transferred to -80°C for long-
term storage.  
2.12.12  Chemical transformation into competent bacteria 
In order to transform bacteria, the DNA plasmid is incubated together with the competent 
bacteria. A subsequent heat shock at 42°C shortly permeabilizes the bacterial cell membrane 
and the plasmid can be taken up by diffusion. As the plasmid carries a bacterial origin of 
replication, it can be promoted and amplified in E. coli.  
Protocol: 100 µL of competent E.coli (DH5α strain) were mixed with DNA (1 µL of plasmid 
DNA or total ligation mixture) and incubated on ice for 30 minutes. After a heat shock at 
42°C for 90 seconds, 700 µL of LB medium were added to the cells and they were incubated 
for 1 hour at 37°C. Afterwards, cells were pelleted by centrifugation at 5.000 rpm for 3 
minutes on a table top centrifuge and resuspended in 100 µL of LB medium before the 
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bacteria solution was plated on LB agar plates carrying the appropriate selection antibiotic. 
The plates were incubated overnight at 37°C.  
2.12.13  Plasmid preparation in a small (mini prep) and large scale (maxi 
prep)  
Plasmid DNA routinely needs to be amplified to e.g. check for the correct insertion of cloned 
inserts or for the transfection of mammalian cell lines. Plasmid preparation is initiated by 
overnight culture of bacteria that were transformed with the desired plasmid. Bacteria are 
pelleted and then resuspended in an EDTA containing buffer which destabilizes the bacterial 
cell walls upon chelating of Ca2+. Subsequently, alkaline lysis of bacteria is performed buffer 
containing SDS and NaOH, as the anionic detergent removes phospholipids and protein 
components while the NaOH denatures genomic and plasmid DNA as well as protein. The 
following neutralization step in acidic potassium acetate buffer results in the formation of 
acetate containing complexes of proteins, DNA and cell debris. As potassium dodecylsulfate 
is less soluble than its sodium counterpart, it precipitates. In contrast to genomic DNA, the 
smaller plasmid DNA is not denatured as dramatically, thus renaturing upon neutralisation 
and staying in solution. In commercially available plasmid preparation kits, the supernatant is 
applied to an anion exchange matrix in which the negatively charged DNA interacts with the 
protonated DEAE-Dextran groups under low salt conditions. After washing steps in a high 
salt buffer to remove unspecific contaminants, plasmid DNA can be eluted. After elution, 
plasmid DNA is precipitated by the addition of isopropanol (and monovalent cations). The 
DNA can then be pelleted by high speed centrifugation. To remove salts and traces of 
isopropanol, the DNA pellet is washed with ethanol.  
Protocol: Plasmid preparations in a large scale were carried out according to the 
manufacturer’s instructions (Macherey-Nagel Kit). One day prior to the experiment, 200 mL 
of LB medium supplemented with the appropriate selection marker were inoculated with 
bacterial cultures (e.g. a 3 mL pre-culture or from glycerol stocks) and cultured at 37°C 
overnight.  
Analogously, a Macherey-Nagel Mini Kit was used to perform pure mini-preps from 3-5 mL 
of bacterial cultures inoculated 1 day prior to use. Alternatively, a “dirty” mini-prep using 
self-made solutions was performed. After overnight incubation at 37°C in selection medium, 
most of the culture was transferred into a 1.5 mL reaction tube and bacteria were pelleted at 
13.000 rpm for 30 seconds in a table top centrifuge. To increase DNA concentration, several 
more millilitres of culture can be pelleted again. The supernatant was discarded and the 
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bacterial pellets were resuspended in 300 µL of Solution I. Next, 300µL of Solution II were 
added and mixed by gently inverting the tube prior to a 5 minute incubation at room 
temperature. Neutralization was initiated by the addition of Solution III (ice cold) and the tube 
was gently turned again and incubated for another 5 minutes at room temperature. To pellet 
cell debris, centrifugation was carried out at 13.000 rpm at room temperature for 10 minutes 
in a table top centrifuge. To precipitate DNA, 600 µL of isopropanol were added to 800 µL of 
plasmid solution and vortexed well. DNA was pelleted by centrifugation at 13.000 rpm for 5 
minutes at 4°C. Pellets were washed once in 500 µL of 70 % ethanol and final DNA pellets 
were dried at room temperature. Finally, DNA was dissolved in 50 µL of TE or dH2O.  
 
Solution I, pH 8.0, autoclave 
• 50 mM Glucose 
• 10 mM Tris 
• 10 mM EDTA 
• 100 µg/mL RNAse 
 
Solution II 
• 0.2 M Sodium hydroxide 
• 1 % (w/v) SDS 
 
Solution III 
• 3 M Potassium acetate 
• pH 4.8 with glacial acetic acid 
2.12.14  Determination of nucleic acid concentration 
For most applications, the exact amount of DNA or RNA needs to be determined. 
Photometric determination of nucleic acid concentration is carried out by measurement at 260 
nm against a blank, as nucleic acids are capable to absorb UV light due to their aromatic 
rings. The absorption maxima of single-stranded nucleic acids are higher than those of 
double-stranded nucleic acids (hyperchromia). By approximation, 1 OD260nm corresponds to 
50 µg/mL of dsDNA, 40 µg/mL of ssDNA and 33 µg/mL of ssRNA. By determining the ratio 
OD260nm/OD280nm the purity of a preparation can be determined; a pure DNA preparation is 
supposed to have a ratio of 1.8 and a clean RNA preparation a ratio of 2.0. The advantage of 
the NanoDrop photometer is that it allows the usage of tiny quantities of 0.5-2 µL samples 
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without a cuvette. The sample is directly pipetted on a sample pedestal and as the apparatus is 
closed, a sample column is formed that is automatically adjusted for optimal path length and 
then measured photometrically.  
Protocol: Using the Qubit fluorometer, samples were prepared according to the 
manufacturer’s instructions using the kit “BR DNA assay” and “BR RNA assay”, 
respectively.  
For determination of nucleic acid concentration using NanoDrop, 1 µL of sample was loaded 
onto the sample pedestal and measured at 260 nm against a blank. 
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3 RESULTS 
3.1 PEROXISOMAL DYNAMICS: DO MAMMALIAN PEROXISOMES 
FUSE? 
Peroxisomes and mitochondria are both essential cellular organelles that fulfil a variety of 
metabolic functions, however, in recent years it became more and more obvious that they 
share an intricate relationship (Schrader & Yoon, 2007; Camoes et al., 2009; Ivashchenko et 
al., 2011). They cooperate on a metabolic level, e.g. in the β-oxidation of fatty acids, 
thermogenesis in brown adipose tissue and the scavenging of ROS, but also in antiviral 
defence (Binns et al., 2006; Schrader & Yoon, 2007; Bonekamp et al., 2009; Dixit et al., 
2010; Bonekamp et al., 2011a). Moreover, both organelles were shown to be highly dynamic 
and thus prone to frequent changes in size and morphology. Interestingly, the organellar 
fission processes are mediated by key proteins shared between the organelles, such as the 
membrane receptors Mff, Fis1 and the large GTPase DLP1 (Delille et al., 2009; Schrader et 
al., 2011) (1.2.2). However, mitochondria are known to regulate their dynamics by frequent 
fusion events (for review, see Okamoto & Shaw, 2005; Hoppins et al., 2007)), while the 
existence of a peroxisomal fusion mechanism has only been indicated as part of peroxisome 
maturation in the yeast Y. lipolytica (Titorenko & Rachubinski, 2001a).  The occurrence of 
fusion events between mature peroxisomes in mammalian cells, in a mechanism analogous to 
mitochondrial fusion, has been a matter of debate. Along the same line, it remains to be 
elucidated if proteins of the mitochondrial fusion machinery, like the ones of the fission 
machinery, are also shared with peroxisomes.  
In the first part of this thesis, the contribution of peroxisome fusion to peroxisome dynamics 
in mammalian cells was investigated. Moreover, a dual localization of mitochondrial fusion 
proteins was addressed. The work presented in this section is the continuation of a diploma 
thesis (Bonekamp, 2007).  
3.1.1 Establishing an in vivo fusion assay to study peroxisomal fusion 
To examine peroxisomal fusion in mammalian cells, an in vivo cell fusion assay using 
Chinese Hamster Ovary (CHO) cells as a model system was established (Fig. 3.1 A, 
alternative figures adjusted to for colour-blind people can be found in the appendix (8.1.2)). 
CHO cells are frequently used for peroxisomal studies (Tsukamoto et al., 1990; Nashiro et al., 
2011), as they contain a dynamic peroxisomal compartment. First, CHO cells were generated 
that stably express either a red (DsRed-PTS1) or a green (GFP-PTS1) fluorescent marker 
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protein targeted to the peroxisomal matrix which greatly facilitated the subsequent analysis of 
potential fusion events in comparison to transient transfection. In order to generate hybridoma 
cells, CHO-DsRed-PTS1 and CHO-GFP-PTS1 cells were mixed, co-cultivated at optimized 
cell densities, and cell fusion was initiated by the addition of PEG-6000 according to 
established assays for mitochondrial fusion (Mattenberger et al., 2003; Niemann et al., 2005). 
Hybridoma cells were then further incubated at 37°C to guarantee proper intermixing of 
organelles as well as potential fusion and mixing of peroxisomal matrix components. If 
mammalian peroxisomes are engaged in fusion events, similar to mitochondria, intermixing 
of red and green matrix markers would result in a co-localization of signals and thus, in 
“yellow” peroxisomes as illustrated in Fig. 3.1 A. 
 
Fig. 3.1: Establishing a peroxisomal in vivo fusion assay.  
(A) Principle of the peroxisomal in vivo fusion assay 
established in this study. CHO cell lines either stably 
expressing a matrix-targeted peroxisomal GFP (CHO-GFP-
PTS1) or DsRed construct (CHO-DsRed-PTS1) were 
generated. To assess peroxisomal fusion, the cell lines were 
mixed and fused using PEG-6000. Hybridoma cells were 
incubated at 37° C in the presence of cycloheximide to avoid 
false positive events by peroxisomal protein import. The 
appearance of yellow peroxisomes (marker for co-localization) 
and peroxisomal dynamics were investigated by fluorescence 
microscopy and live cell imaging.  
(B) Protein translation is efficiently blocked over the course of 
the observation period. Control (-) and cycloheximide (Cy, +)-
blocked CHO-GFP-PTS1 cells were pulse labeled with S35-
methionine for 2 and 4 hours, respectively. Cell lysates were 
split and subjected to immunoprecipitation with anti-GFP. One 
set of samples was subjected to SDS-PAGE and 
autoradiographs were developed by PhosphoImaging (upper 
panel). As a loading control, the other set of samples was 
separated by SDS-PAGE, immunoblotted and incubated with 
anti-GFP (lower panel).  
(C - E) Mitochondrial fusion in CHO cells. As a positive 
control, CHO-K1 cells were transiently transfected with Mito-
GFP (C) and Mito-DsRed (D), respectively. Differentially 
labeled cells were subjected to the in vivo fusion assay. After 4 
hours, cells were fixed and processed for fluorescence 
microscopy. Overlay of fluorescent signals from (C) and (D) is 








To exclude false positive co-localization of GFP-PTS1 and DsRed-PTS1 signals due to 
peroxisomal import of the corresponding matrix marker, protein biosynthesis was inhibited 
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for the duration of the experiment by the addition of cycloheximide, a widely used inhibitor of 
eukaryotic protein translation. To validate the efficiency of the cycloheximide block, radio-
immunoprecipitation of intracellular GFP-PTS1 was performed. The cells were pulse-labelled 
with S35-methionine either in the presence or absence of cycloheximide and incubated at 
37°C. Afterwards, cells were lysed and an immunoprecipitation with anti-GFP antibodies was 
performed. In the presence of cycloheximide no signal for radio-labelled – and thus newly 
synthesized – GFP-PTS1 was detected (Fig. 3.1 B, upper panel) indicating that protein 
biosynthesis (translation) was efficiently blocked. To ensure that the lack of GFP signal was 
not due to loading artefacts, fractions of the immunoprecpitation were immunoblotted using 
anti-GFP antibodies. Equal amounts of GFP were precipitated corresponding to the pre-
existing GFP-PTS1 pool in the cycloheximide-containing fractions (Fig. 3.1 B, lower panel). 
Thus, de novo protein synthesis and consecutive peroxisomal import of fluorescent proteins 
was excluded under the chosen experimental conditions. 
Finally, to verify the applicability of the in vivo fusion assay, mitochondrial fusion 
served as a positive control. CHO-K1 cells were transiently transfected with either matrix-
targeted Mito-GFP or Mito-DsRED and subsequently fused with PEG-6000. After 4 hours, 
cells were fixed and analyzed by fluorescence microscopy (Fig. 3.1 C-E). Hybridoma cells 
displayed fusion of differentially labelled mitochondria and subsequent intermixing of 
mitochondrial matrix markers as reported in other studies (Mattenberger et al., 2003; 
Niemann et al., 2005), thus the in vivo fusion assay was successfully established.  
 
3.1.2 The occurrence of yellow peroxisomes points to peroxisomal fusion 
events in CHO cells 
Next, the potential fusion of mature peroxisomes in CHO cells was examined using the 
peroxisomal in vivo fusion assay. After generation of hybridomas, cells were fixed after 2-6 
hours and analyzed for the occurrence of yellow peroxisomes and hence peroxisomal fusion 
by epifluorescence microscopy (Fig. 3.2 A-E).   
A clear co-localization of GFP and DsRed fluorescence was observed in several areas 
of the hybridoma cells (Fig. 3.2 A-E, arrowheads). Depending on the ratio of green to red 
fluorescence, more orange to greenish overlays of peroxisomal signals were as well observed, 
but were more difficult to detect. Furthermore, several red and green peroxisomes in close 
vicinity to each other were also observed, apparently caught in some type of interaction (Fig. 
3.2, asterisks).  
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To exclude the possibility that co-localization of fluorescence resulted from overlay of 
peroxisomal signals from different focal planes in epifluorescence, confocal microscopy was 
performed (Fig. 3.2 F-H). As mature, spherical peroxisomes are known to have a diameter of 
around 0.3-0.5 µm, a plane thickness of ≤ 0.37 µm was selected to ensure co-localization of 
signals from one confocal plane. Confocal microscopy confirmed a clear co-localization of 
the peroxisomal matrix marker proteins GFP-PTS1 and DsRed-PTS1 in a subset of 
peroxisomes of the CHO hybridoma cells (Fig. 3.2 H). These observations point to the 
existence of peroxisomal fusion in CHO hybridoma cells. 
 
Fig. 3.2: Peroxisomal matrix signals co-
localize in fixed cells.  
CHO-GFP-PTS1 (A, F) and CHO-
DsRed-PTS1 cells (B, G) were mixed and 
subjected to the peroxisomal in vivo 
fusion assay. Hybridoma cells were 
incubated for 4 hours, fixed and 
processed for epifluorescence (A – E) or 
confocal microscopy (F – H). Higher 
magnification images of the boxed 
regions in (C) are shown in (D) and (E). 
Arrowheads point to yellow peroxisomes. 
Asterisks highlight red and green 
peroxisomes engaged in intimate 
contacts.  
(I) Quantitative analysis of mitochondrial 
and putative peroxisomal matrix 
intermixing (yellow organelles). CHO 
cell lines either transfected with 
differential mitochondrial or peroxisomal 
markers were subjected to the in vivo 
fusion assay. After the indicated time 
points, cells were fixed and processed for 
fluorescence microscopy. The percentage 
of yellow peroxisomes (% of total 
organelle number per hybridoma cell) at 
different time points of a representative 
experiment is shown. To assess 
mitochondrial fusion, the overall number 
of hybridoma cells with yellow 
mitochondria (full fusion) was 





Mitochondrial fusion has been shown to result in a thorough mixing of about 50 % of matrix 
signals after approx. 4 hours in in vivo fusion assays (Niemann et al., 2005). To similarly 
assess the extent of peroxisomal matrix interchange, statistical analysis of fusion events was 
performed (Fig. 3.2 I). The number of co-localizing peroxisomes (“yellow” peroxisomes) in 
regard to the total number of peroxisomes in a hybridoma cell at different time points (2-6 
hours) after cell fusion was determined. An increase in co-localization of peroxisomal 
markers was not observed after extended time points (data not shown). Furthermore, omitting 
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cycloheximide in the assay did not alter co-localization events (data not shown). Fusion of 
mitochondria was determined under the same experimental conditions (Fig. 3.2 I). As 
mitochondrial fusion (Mito-GFP and Mito-DsRed overlap) was almost complete within 
hybridoma cells, the overall percentage of hybridoma cells with “yellow” mitochondria was 
determined. For peroxisomes, the degree of peroxisomal marker protein “intermixing” was 
around 2 % after 2 hours, and remained similar over time. In contrast to that, a constant 
increase of matrix intermixing (hybridoma cells with “yellow” mitochondria) was observed 
over time (Fig. 3.2 I).  
In summary, contrary to previous indications in mammalian cells (Huybrechts et al., 2009), 
co-localization events between peroxisomes were detected under the chosen experimental 
conditions, pointing to the occurrence of peroxisomal fusion. However, though mitochondrial 
fusion appeared to be fast, time dependent and almost complete as expected, peroxisomal 
fusion was slow, time independent, less frequent and only visible in a subpopulation of 
peroxisomes. This questioned the exchange of matrix marker proteins between individual 
peroxisomes, at least by a complete mechanism analogous to mitochondria; therefore, fusion 
events were investigated using live cell imaging.  
 
3.1.3 Live cell imaging reveals close peroxisomal contacts and vivid 
peroxisomal interactions without an exchange of matrix proteins 
To clarify the question if peroxisomes fuse with each other and exchange matrix marker 
proteins, live cell imaging was performed 1-6 hours after hybridoma generation. The 
peroxisomal in vivo fusion assay was conducted and peroxisome interactions in hybridoma 
cells were observed using time-lapse spinning disk confocal microscopy. Images were 
captured every 5 seconds in 5 different confocal planes (0.5 µm) using the 488 and 561 laser 
lines, respectively. When monitoring the dynamic behaviour of differentially labelled 
peroxisomes (Fig. 3.3), it was observed that previously separated, single peroxisomes 
interacted with each other (Fig. 3.3, 0-50s arrowheads) and were engaged in transient and 
long term contacts. Moreover, the same peroxisomes were often observed to interact multiple 
times. This “re-engaging” behaviour remained restricted to the initially interacting 
peroxisomes, although other candidate peroxisomes for interaction were in close vicinity and 
abundant (Fig. 3.3). During these contacts the red and green fluorescent signals were observed 
to completely co-localize (Fig. 3.3, 60-65s), accounting for the observations made in fixed 
cells (Fig. 3.2). However, with proceeding observation time, the closely interacting 
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peroxisomes separated again into the initial, individual (red and green) peroxisomes without 
any detectable exchange of matrix markers (Fig. 3.3, 80s; see also Movies S1 and S2). Even 
with increased sensitivity (higher gain settings and exposure times), no exchange of matrix 
fluorescence was detected and the fluorescence signals of the separated organelles remained 
similar to the individual peroxisomes before interaction.  
These findings indicate that while peroxisomes do not fully fuse to allow exchange of matrix 
marker proteins, differential peroxisomes are engaged in close, long-term interactions.  
 
Fig. 3.3: Time-lapse confocal microscopy reveals that peroxisomes interact extensively, but do not exchange matrix 
proteins.  
CHO-GFP-PTS1 and CHO-DsRed-PTS1 cells were subjected to the peroxisomal in vivo fusion assay. Hybridoma cells were 
allowed to recover for 30 minutes and were then analyzed by time-lapse confocal microscopy. Images were taken every 5 
seconds using 488 and 561 laser lines, respectively (see also Movies S1 and S2). Arrows indicate interaction events. Note the 
close (60 – 65s), but transient (80s) overlap of differentially labelled peroxisomes. Bar, 5µm. 
 
In order to confirm the observation of close, intimate contacts between individual 
peroxisomes at a higher resolution, image deconvolution was performed. After application of 
the in vivo peroxisomal fusion assay, cells were fixed and mounted for confocal microscopy 
using a Leica TCS SP2 AOBS confocal microscope equipped with a 100x objective. Using 
the 488 and 543 nm laser lines, z-stacks were generated of hybridoma cells (settings: 8x 
zoom) using the optimal number of slices suggested by the program (Leica Confocal 
Software). Oversaturation of signals was avoided by adjusting of respective PMTs. Image 
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deconvolution was performed using Huygens Professional Software, generating high 





















Fig. 3.4: High resolution images of peroxisomal interactions. 
Differentially labelled CHO cell lines were subjected to the in vivo peroxisomal fusion assay and processed for 
confocal microscopy. Image deconvolution was performed using Huygens Professional software. A selection of 
peroxisomal interaction events is shown (A-E). Arrows highlight overlap of markers; a potential fission event is 
labelled by an asterisk. Note the close, intimate contacts between interacting peroxisomes. In (E, peroxisomes on 
the right) one peroxisome appears to embrace another (estimated co-localization of signals: approx. 50% (green) 
and 24% (red)). Data analysis revealed a mean distance between interacting peroxisomes of about 0.07 µm +/- 
0.029 µm. As data evaluation only allowed for the calculation of distances between the centre of one mass to the 
nearest surface point (but not for the surface-to-surface distance), the actual distance is most probably even 
smaller. Bars, 1µm (A); 0.25µm (B); 0.5µm (C-E). 
 
High resolution 3D images obtained by image deconvolution confirmed intimate contacts 
between interacting peroxisomes (Fig. 3.4). In some cases, the differentially labelled 
peroxisomes appeared to embrace each other (Fig. 3.4 E); this frequent appearance of lengthy 
and intimate contacts points to a physiological relevance of the observed peroxisomal 
interactions.  
 
3.1.4 Transient peroxisomal interactions can potentially contribute to the 
homogenization of the peroxisomal compartment 
In search for a physiological function of close peroxisome interactions, we used a simple 
computational model to address if peroxisome contacts could principally contribute to the 
distribution of e.g. metabolites, signals, or other “molecular information” and thus, to the 
homogenization of the peroxisomal compartment on a feasible timescale.  
The majority of peroxisomes in mammalian cells was shown to perform Brownian like 
movements, reaching distances of L<0.5 µm after ∆t=2 min (Rapp et al., 1996; Wiemer et al., 
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1997; Schrader et al., 2000). For Brownian movements L varies with time as L~(D ∆t)1/2. 
Given a typical cell size of 50 µm, it can be concluded that the time required for these 
peroxisomes to travel from one side of the cell to the other would be of the order of ∆t ~ 
2x104 minutes, i.e. almost two weeks. For smaller cells of e.g. 15 µm widths, the time 
required would be of the order of one day. Thus, it can be concluded that the slow diffusion of 
peroxisomes may be irrelevant for physiological functions requiring peroxisome contacts. 
However, a small fraction of peroxisomes has been shown to use ATP driven, microtubule-
dependent motility to move faster and more persistently (Rapp et al., 1996; Wiemer et al., 
1997; Schrader et al., 2000). The existence of the aforementioned numerous and lengthy 
contacts suggests that, even with energy expenditure, peroxisomal interactions may confer a 
physiological advantage. Indeed, for mean velocities of around 0.2 µm/s, peroxisomes could 
cross the whole extent of the cell in 50/0.2 = 4 min.  
One may wonder whether the fraction of peroxisomes engaging in ATP driven motility has 
been optimized to promptly homogenize the peroxisomal population within a cell at a 
minimal energy expense. In order to address this issue a simple computational model was 
developed (co-operation Dr. F. Vistelo de Abreu, University of Aveiro). In this model 
peroxisomes are viewed as small spheres with a diameter of d = 0.3µm, displaying two types 
of movements. One class of peroxisomes performs slow Brownian movements, with the 
velocity sµmvslow 024.0=  and changing onto another randomly chosen velocity direction 
every ∆t=20s. The other class performs faster sµmv fast 24.0=  and more persistent 
movements (change direction every ∆t=100s). These values agree with previous observations 
(Rapp et al., 1996; Wiemer et al., 1997; Schrader et al., 2000). For simplicity the intracellular 
space was modelled to correspond to two fused flat cells as a bidimensional square with a side 
length equal to 70µm. Reflecting boundary conditions were considered on the ends, keeping 
peroxisomal movements within the cell. Whenever peroxisomes collide, they bind and move 
together with the same averaged velocity. Then they unbind at a rate p=0.05s-1. At the 
beginning of the simulation it was assumed that two disjoint peroxisomal subpopulations (red 
and green peroxisomes, on different sides as in Fig. 3.1 A) were present. Peroxisomes were 
then allowed to move and mix. The number of peroxisomes that contacted peroxisomes from 
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Fig. 3.5: Relation between energy consumption, fast moving peroxisomes and peroxisome interactions. 
(A) The average energy consumed (arbitrary units) measured by the number of moves by fast moving 
peroxisomes for time intervals ∆t=0.1s. (B) The time required for 75% of the peroxisomes to have interacted 
with at least one peroxisome of the other fused cell, as a function of the percentage of fast moving (ATP driven) 
peroxisomes. Each point corresponds to results obtained from simulations on 100 different populations. Note the 
marked decrease in the energy spent between 10% and 15% of fast moving peroxisomes. Simultaneously, the 
time required for proper mixing of the populations is increasing. 
 
Fitting these curves, τ, the characteristic mixing time, was measured. The number of moves 
required by fast moving (ATP driven) peroxisomes was also measured, until 75 % of the 
population contacted a peroxisome from the other peroxisomal population. This quantity is 
proportional to the energy cost involved to mix the population to that extent. Simulations 
were performed 100 times for each fraction of fast moving peroxisomes in the population. 
Characteristic mixing times and energy costs were averaged and standard errors calculated 
(Fig. 3.5). Results are consistent with the expectation that fast peroxisomes can efficiently 
mix the populations. Indeed, characteristic mixing times can be well below one hour with 
only a small fraction of fast peroxisomes participating actively in the diffusion. While the 
amount of time required for mixing diverges for small fractions of fast peroxisomes, a sharp 
decrease in the energy expenditure appears for small fractions (Fig. 3.5 A). This confirms the 
initial assumption that no prominent advantage for mixing would be achieved if all 
peroxisomes participated in fast and yet costly motility. Thus, it appears that an optimization 
may have occurred to quickly homogenize peroxisomal populations with the lowest energy 
costs. Interestingly, results are consistent with previous observations of ~15 % fast moving 
peroxisomes (Rapp et al., 1996; Wiemer et al., 1997; Schrader et al., 2000).  
In conclusion, a combination of fast, ATP-driven movement of peroxisomes and subsequent 
formation of close contacts between individual peroxisomes might well contribute to a 
homogenization of the peroxisomal compartment in mammalian cells in the timescale of one 
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to several hours. The simple model obtained here is consistent with the degree of peroxisomal 
mixing in the cell fusion assay.  
 
3.1.5 Transient peroxisomal interactions display a complex behaviour 
Next, the interactions between differentially labelled peroxisomes were analyzed to determine 
their characteristics with focus on frequency, duration and number of peroxisomes involved. 
Determining the number of interacting (red and green) peroxisomes in each frame revealed 
that about 5-6 differentially labelled peroxisomes interact within a hybridoma cell, accounting 
for 1.5-2% of the total number of peroxisomes (up to 4 % when a similar interaction rate 
between peroxisomes labelled in the same colour is assumed). These observations are 
consistent with our findings in fixed cells (Fig. 3.2 I). For most of the time, the initial two 
peroxisomes only interact with each other, but other peroxisomes can join to take part in the 
interactions (mostly 2-3, but even up to 4 and more peroxisomes, Fig. 3.6 E). Within the 
course of the interaction, the individual peroxisomes interacting also separate again, only to 
re-engage in interactions; most frequently the same two peroxisomes come together again 1-3 
times, but can also re-engage up to 8 times (Fig. 3.6 F). The majority of the peroxisomes, 
which are engaged in close contacts, stay attached to each other for a time span of about 5-40 
seconds (Fig. 3.6 A), but some even up to 300 or 500 seconds. Thirty-five percent of those 
interactions result at some time point in an interaction that is tight enough for apparent co-
localization of matrix signals (“overlay”, see Fig. 3.6 C); the majority of those marker 
“overlay” events has a duration of about 5-15 seconds, but again single events last up to 100, 
300 and even 500 seconds (Fig. 3.6 C).  
For both cases, the frequency of events with a duration larger than a given value (the 
cumulative frequency distribution of contact duration) was analysed in more detail (Fig. 3.6 
B, D) (co-operation Dr. F. Vistelo de Abreu, University of Aveiro). A marked difference can 
be observed on both distributions. The distribution of close contacts shows an exponential 
behaviour (Fig. 3.6 B), while the distribution of “overlay” contacts displays power law decay 
(Rhodes & Anderson, 1996; Viswanathan et al., 2002; Newman, 2005; Sornette, 2006; 
Clauset et al., 2009; James et al., 2011). 
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Fig. 3.6: Characteristics of peroxisomal interactions.  
Image 5D stacks of time lapse images were generated and frame-by-frame analysis was performed for every z-
stack. To analyze the kinetics of peroxisomal interactions, the duration of the interactions (A) (i.e. the time frame 
of intimate attachment between peroxisomes, see Fig. 3.3, 0s) and the duration of complete signal overlay (C) 
(Ovl, see Fig. 3.3, 60s) was determined for every peroxisomal interaction evaluated (n = 903). The frequency of 
contacts lasting longer or equal than a certain duration is represented as a cumulative frequency plot against time 
(in seconds) in (B) and (D). Data in (B) is expressed on a semi-logarithmic scale to highlight approximate 
exponential behaviour, while data in (D) is presented on a logarithmic scale to highlight power law behaviour. 
The mean number of peroxisomes involved in an interaction as well as the mean number of re-engagement 
between individual peroxisomes is presented in (E) and (F), respectively and expressed as relative frequency 
plot.  
 
Power law behaviour has been extensively investigated in many biological areas (Rhodes & 
Anderson, 1996; Viswanathan et al., 2002; Newman, 2005; Sornette, 2006; Clauset et al., 
2009; James et al., 2011), because it indicates the existence of intricate dynamics originating 
from diverse, and yet specific mechanisms. It has also been hypothesized that power laws 
could emerge from optimality principles e.g. in foraging (Viswanathan et al., 2002), although 
this remains controversial (James et al., 2011). Power law distributions have heavy tails, i.e. 
the number of events with lower frequencies – in our case, the number of long term contacts – 
is substantially larger than it could be expected from an exponential distribution, 
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corresponding to random events. We used the statistical methods described in (Clauset et al., 
2009) and performed a goodness-of-fit test calculating a p-value of 0.89, which is greater than 
0.1 and hence supports the hypothesis that the frequency distribution has power law decay 
(8.1.1.1). An estimate for the power law exponent 2.08.1 ±−=α  on the cumulative 
frequency distribution of contact duration was obtained. In the Appendix, a simple model is 
provided that could explain the origin of this power law behaviour 2−=α . This model 
indicates that to account for this type of frequency dependency, it is necessary to assume that 
interactions between peroxisomes can span over a wide range of contact lifetimes, and it 
crucially depends on the contact interaction process. This is also consistent with the 
observation of an exponentially decaying distribution for the duration of close contacts (Fig. 
3.6 B). In this case, in some events peroxisomes may not be interacting and consequently their 
consideration “smears” the power law decay behaviour. This also supports the idea that the 
power law behaviour observed indeed originates from intricate peroxisome interactions. 
Hence, this analysis strongly suggests that peroxisome interactions appear to be more diverse 
and complex than assumed.  
 
3.1.6 Peroxisomal interactions: not be mistaken for fission 
In some cases, where peroxisomes are engaged in close contacts of longer duration, their 
separation may easily be misinterpreted as peroxisomal fission, especially in live cell 
observations, where only one fluorescent peroxisomal marker is used. Peroxisomes multiply 
by processes of elongation, constriction and subsequent fission (Schrader & Fahimi, 2006; 
Schrader et al., 2011). However, true peroxisomal fission events have been rarely documented 
in live cells. Thus, the occurrence of peroxisomal fission was screened for in COS-7 cells 
overexpressing YFP-Pex11pβ by time-lapse spinning disk confocal microscopy (Fig. 3.7). 
Pex11pβ promotes an elongation of peroxisomes and subsequent DLP1-dependent fission into 
numerous small peroxisomes (Schrader et al., 1998b; Delille et al., 2010; Schrader et al., 
2011) (1.2.2.1). During live cell imaging, peroxisomes in YFP-Pex11pβ expressing cells were 
observed to form tubular extensions and become elongated prior to fission. A daughter 
peroxisome often “pinches off” at the end of the tubule (Fig. 3.7, Movie S3). Elongated or 
tubular peroxisomes are also observed in mammalian cells under normal culture conditions 
(the degree of elongation may vary depending on cell type and growth conditions) (Schrader 
& Fahimi, 2006). Thus, it is likely that fission events in mammalian cells (in contrast to 
peroxisome interactions and separation) are accompanied by some degree of membrane 
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elongation prior to division. These findings have to be considered when analyzing 






















3.1.7 Peroxisomes do not exchange membrane proteins during peroxisome 
interaction 
As there was no evidence for an exchange of matrix marker proteins during peroxisome 
interactions, it was subsequently investigated whether peroxisomal membrane marker proteins 
can redistribute upon interaction. To address this possibility, CHO cell lines stably transfected 
with peroxisomal membrane markers (PMP70-YFP and dPex26-mDsRed, respectively) were 
generated. The peroxisomal in vivo fusion assay was conducted with these cell lines and a 
possible exchange of membrane markers was determined by confocal microscopy (Fig. 3.8 A-
C, higher magnifications shown in G). Peroxisomes in the hybridoma cells were thoroughly 
Fig. 3.7: Peroxisomal fission in time-lapse confocal 
microscopy.  
COS-7 cells were transfected with YFP-Pex11β to stimulate 
peroxisome elongation and subsequent DLP1-dependent fission 
and analyzed by time-lapse confocal microscopy. Note the 
membrane extension/elongation of a spherical peroxisome and the 
subsequent division into two spherical organelles (arrowheads) 
(see Movie S3). Higher magnification view of the selected 
peroxisome is shown in the upper left corners. Bar, 10µm. 
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mixed, with PMP70-YFP occasionally inducing the formation of peroxisomal aggregates, an 






















Fig. 3.8: Peroxisomes do not exchange membrane components.  
CHO-K1 cells stably expressing the peroxisomal membrane markers PMP70-YFP (A) or DsRed-dPex26 (B) 
were subjected to the peroxisomal in vivo fusion assay and assayed for the exchange of membrane components 
(C). In a second set of experiments, CHO-PMP70-YFP (D) and CHO-DsRed-PTS1 cells (E) were fused. 
Overlay of signals is shown in (F). Higher magnification images of (C) and (F) are shown in (G) and (H), 
respectively. Arrowheads point to intimate interactions. (I) Quantitative analysis of putative peroxisomal 
membrane intermixing. The percentage of yellow organelles (% of total organelle number per hybridoma cell) at 
different time points of a representative experiment is shown. N, nucleus. Bars, 20µm.  
 
Similar to the observations made with matrix marker proteins, a close interaction between 
differentially labelled peroxisomes and subsequent co-localization of membrane marker 
fluorescence was detected (Fig. 3.8, arrowheads). However, no constant increase in “yellow” 
peroxisomes was observed by statistical analysis (approx. 2 % at 4 and 6 hours after fusion, 
Fig. 3.8 I), indicating that there was no intermixing of membrane markers between 
peroxisomes over time. Furthermore, no exchange of membrane markers or membrane fusion 
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was observed, when peroxisomes were artificially clustered (Fig. 3.8 G) (Delille et al., 2010). 
Additionally, fusion experiments with PMP70-YFP were also conducted using the more 
homogenous matrix-labelled DsRed-PTS1 cell line (Fig. 3.8 D-F, higher magnifications 
shown in H). It was assumed that if membrane components would be exchanged, there would 
be an increase of YFP-signal on the red peroxisomes, but not vice versa. However, this 
experimental setup was consistent with our previous results. Thus, we conclude that despite 
vivid and complex interactions, mammalian peroxisomes do not fuse completely or exchange 
the matrix or membrane marker proteins tested in our experimental setup.  
 
3.1.8 Peroxisomal interactions do not increase after fatty acid or H2O2 
treatment 
Peroxisomal interactions may facilitate the exchange of metabolites between different 
peroxisomal pools. To investigate, whether an increase in the heterogeneity between 
peroxisomal subpopulations would result in an enhanced frequency of peroxisomal 
interactions, CHO-GFP-PTS1 cells were pre-trated with different peroxisomal metabolites 
(oleic acid (OA), arachidonic acid (AA), H2O2) prior to fusion with non-stimulated CHO-
DsRed-PTS1 cells. Successful application of fatty acids was monitored by an increase in the 
number and size of lipid droplets (Fig. 3.9 A, B). After the indicated time points, cells were 
fixed, processed for epifluorescence microscopy and assessed for the percentage of 
interacting peroxisomes (Fig. 3.9 C). Unlike before when determining the number of “fusing” 
peroxisomes (Fig. 3.2), for this experiment interacting, non-“yellow” peroxisomes were also 
included in the calculations, thus the number of interacting peroxisomes in control cells is 
higher than reported before and increased with time due to complete intermixing (Fig. 3.2 I). 
The slight increase in the number of interactions after AA treatment (after 1 hour) was not 
found for OA. H2O2 treatment resulted in an overall decrease of interactions, probably due to 
cellular oxidative stress. In general, no prominent increase in the percentage of interacting 
peroxisomes was detected between control and treated cells (Fig. 3.9 C). In addition, pre-
treatment of the cells with peroxisome proliferators (bezafibrate, ETYA) did not alter the 






































Fig. 3.9: Stimulation with peroxisomal metabolites does not result in an increase of peroxisomal 
interactions.  
(A, B) Oleic acid (OA) leads to an increase in the size of lipid droplets in CHO cells. To verify successful 
stimulation of CHO cells, lipid droplet staining using Sudan Black was performed in control (A) and treated 
cells (B). Bars, 20µm. 
(C) Statistical evaluation of peroxisomal interactions after stimulation. 24 hours prior to the in vivo fusion assay, 
CHO-GFP-PTS1 cells were stimulated with either OA, AA or H2O2 to increase heterogeneity between 
populations. After application of the in vivo peroxisomal fusion assay, cells were fixed at the indicated time 
points and processed for epifluorescence microscopy. Images of hybridoma cells were evaluated using ImageJ. 
The number of green and red peroxisomes as well as the number of interacting/attaching peroxisomes (defined 
as “yellow” ones and those attached to each other) was determined. Data evaluation was performed using 
Microsoft Excel and data is taken from 3-4 independent experiments (10-15 cells/condition each) and expressed 
as means +/- standard deviation (* p< 0.05; ** p<0.01, compared to control).  
 
3.1.9 Mitochondrial fusion proteins do not localize to peroxisomes 
Although above findings exclude the existence of a peroxisomal fusion in a manner similar to 
mitochondrial fusion, a dual localization of mitochondrial fusion proteins was still 
investigated. First of all, both organelles have been shown to share their key division 
components, such as the large GTPase DLP1 that mediates fission of both organelles after 
recruitment by the tail-anchored adaptor proteins Fis1 and Mff (Schrader et al., 2011). 
Moreover, though primarily described as mitochondrial, the outer membrane protein 
Mitofusin (Mfn) 2 was also localized to the ER where it controls ER morphology and its 
tethering to mitochondria (de Brito & Scorrano, 2008b; de Brito & Scorrano, 2009), while 
OPA1 was localized to lipid droplets (Pidoux et al., 2011). Thus, a potential peroxisomal 
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localization of the mitochondrial fusion proteins Mfn 1 and 2 – large GTPases that coordinate 
outer membrane fusion – and OPA1, a GTPase mediating inner membrane fusion was 
investigated.  
3.1.9.1 The outer membrane fusion proteins Mfn 1 and 2 do not localize to peroxisomes 
Myc-tagged variants of wild-type Mitofusin 1 and 2 were expressed in COS-7 cells stably 
expressing a GFP-PTS1 fusion protein, which is exclusively targeted to peroxisomes (Koch et 
al., 2004). As a positive control, GFP-Fis1 was expressed, a tail-anchored protein which is 
known to be targeted to both peroxisomes and mitochondria (Koch et al., 2005) (Fig. 3.10 B). 
Co-localization with peroxisomes was assessed by epifluorescence microscopy. While GFP-
Fis1 showed a dual localization to both peroxisomes and mitochondria (Fig. 3.10 C), Myc-



































Fig. 3.10: The mitochondrial fusion protein Mfn1 does not localize to peroxisomes.  
(A–C) Fis1 is dually targeted to peroxisomes and mitochondria. As a positive control, COS-7 cells were transfected with 
GFP-hFis1 (B) and processed for immunofluorescence with anti-PMP70 (A). (C) Overlay of (A, B). Note the localization of 
GFP-Fis1 at peroxisomes (asterisks) and clustering of mitochondria.  
(D–G) Mfn1 does not localize to peroxisomes. COS-7 cells stably expressing GFP-PTS1 (D) were transfected with Mfn1-
myc (E) and processed for immunofluorescence using anti-myc. Higher magnification image of the boxed area in (E) is 
shown in (F–H). Overlay (Merge) of (F, G) is shown in (H). Note that although small punctuate Mfn1 positive structures can 
be seen, there is no co-localization with peroxisomal markers (arrowheads). 
N, nucleus. Bars, 20µm. 
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Similar observations were made upon overexpression of Mfn2 (data not shown). Alterations 
of mitochondrial morphology were observed upon overexpression of the mitofusins which are 
consistent with previous findings, as e.g. overexpression of Mfn 1 is known to cause 
perinuclear aggregation of mitochondria (Santel et al., 2003) (Fig. 3.10 E). Furthermore, 
activity-deficient variants of the mitofusins (Fig. 3.11) were expressed that are known to alter 
mitochondrial morphology resulting in their fragmentation and perinuclear clustering. 
However, peroxisomal morphology remained unaffected, indicating that mitofusins are not 
functionally relevant to maintain peroxisome morphology (Fig. 3.11). 
 
 
Fig. 3.11: Expression of activity-deficient mitofusin variants does not affect peroxisome morphology.  
COS-7 cells stably expressing GFP-PTS1 (A, D) were transfected with activity-deficient variants of Mfn1 (K38T) (B) and 
Mfn2 (K109A) (E). After 24 hours, cells were processed for immunofluorescence using anti-myc antibodies. Overlays 
(Merge) of (A, B) and (D, E) are shown in (C) and (F). Higher magnification images of boxed areas in (C) and (F) are shown 
in (G) and (H). Asterisks highlight mitofusin-positive punctuate structures that do not co-localize with peroxisomal markers. 
Note that although mitochondria are prone to fragmentation upon overexpression of Mfn mutants, peroxisomal morphology 
remains unaffected. N, nucleus. Bars, 20µm.  
 
Taken together, upon overexpression of wild-type and activity-deficient variants of both 
mammalian outer membrane fusion proteins no peroxisomal localization was detected. 
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Moreover, the mutant variants did not affect peroxisome morphology, thus neither Mfn1 nor 
Mfn2 are targeted to peroxisomes.  
3.1.9.2 The inner mitochondrial membrane protein OPA1 is not targeted to peroxisomes 
To study the localization of the inner mitochondrial membrane GTPase OPA1 in COS-7 cells, 
immunofluorescence microscopy using OPA1-specific antibodies was performed. Similar to 
above observations for Mfn1 and 2, no OPA1 signal was detected on peroxisomes, even when 
OPA1 signals appeared to be concentrated as spherical structures reminiscent of peroxisomes  
(Fig. 3.12 E, arrowheads). Using a specific OPA1 antibody, these findings were substantiated 
by immunoblotting, using highly purified peroxisomal and mitochondrial fractions (Fig. 3.12 
F). While OPA1 was detected in the mitochondrial fractions, it appeared to be absent from 
highly purified peroxisomes (Fig. 3.12 F, PO).  
 
Fig. 3.12: The mitochondrial inner 
membrane fusion protein OPA1 
does not localize to peroxisomes.  
OPA1 is not a peroxisomal protein. 
(A–E) COS-7 cells stably expressing 
GFP-PTS1 (A) processed for 
immunofluorescence using anti-
OPA1 (B). Higher magnification 
images of the boxed area in (B) are 
shown in (C–E). (E) Overlay 
(Merge) of (C, D). Note that some 
punctuate structures are positive for 
OPA1, but do not co-localize with 
the peroxisomal marker. N, nucleus. 
Bar, 20µm.  
(F) Highly purified peroxisomes 
(PO) and mitochondria (Mito) were 
separated by 12.5% SDS-PAGE and 
immunoblotted using anti-OPA1, 
anti-PMP70 and anti-ATP synthase 
antibodies. Equal amounts of protein 
(50µg) were applied. Multiple OPA1 








As a conclusion, this study could clearly show for the first time that mitochondrial fusion 
proteins are not shared by mitochondria and peroxisomes, unlike their key fission machinery.  
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3.1.10  Summary 
In the first part of this thesis, the contribution of peroxisomal fusion to organelles dynamics, 
analogous to mitochondrial fusion, was addressed systematically. An in vivo fusion assay was 
established based on hybridoma formation by cell fusion and, unlike what was observed in 
other studies (Huybrechts et al., 2009), a clear co-localization of matrix markers was detected 
in fixed cells. Although subsequent live cell studies excluded an exchange of matrix or 
membrane markers between individual peroxisomes, the existence of transient, vivid contacts 
between peroxisomes was demonstrated for the first time. Using computational modelling and 
mathematical analysis, transient peroxisome interactions were shown to follow a complex, 
non-random behaviour that might facilitate homegenization of the compartment. However, 
they do not appear to contribute to the exchange of fatty acids or H2O2. Furthermore, 
computational analysis indicated for the first time that the contribution of microtubule-
dependent peroxisome movement has evolved to represent the optimum between energy cost 
and organelle distribution. Finally, it was conclusively shown that mitochondria and 
peroxisomes do not share components of the fusion machinery, although the key fission 
proteins are shared by the two organelles.  
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3.2 REGULATION OF PEROXISOME DYNAMICS: 
CHARACTERIZATION OF THE PEROXISOMAL MEMBRANE 
PROTEIN PEX11Β AND ITS N-TERMINAL DOMAIN 
 
Peroxisomes are remarkably dynamic organelles which modulate their morphology and 
dynamics by a combination of membrane elongation and fission processes. Moreover, they 
travel long distances along microtubules and engage in vivid interaction as shown in the 
previous section (3.1). The key proteins mediating the dynamic growth and division of 
peroxisomes in mammals have been identified in recent years: prior to fission, the peroxisome 
membrane is elongated by the action of the Pex11 proteins (for review, see Schrader et al., 
2011). Subsequently, the elongated tubule is constricted and divided by the large GTPase 
DLP1 that is recruited to the membrane by the tail-anchored proteins Mff and Fis1 (Delille et 
al., 2009; Otera et al., 2010; Schrader et al., 2011). While the latter components are shared 
with mitochondria, the mammalian membrane protein Pex11pβ is a constitutively expressed, 
uniquely peroxisomal protein that is placed in the centre of initiating and regulating 
peroxisomal growth and division in mammals (Schrader et al., 1998b; Schrader & Fahimi, 
2006; Delille et al., 2010; Schrader et al., 2011). Only recently, Pex11pβ-mediated 
peroxisome proliferation was shown to follow a multi-step maturation process (Delille et al., 
2010).  Furthermore, the underlying mechanistic basis of the Pex11p-based membrane 
elongation was linked to the existence/action of a conserved amphipathic helix in the N-
terminal domain of various Pex11 proteins from different species (Opalinski et al., 2011). 
Although the presence of this amphipathic helix is conserved from yeast to mammals, and its 
presence was confirmed in mammalian Pex11pβ, further characterization of the mammalian 
Pex11 family of proteins is required. For instance, it remains to be elucidate if the mere 
presence of Pex11pβ, and its amphipathic helix, is sufficient to promote and regulate 
peroxisome elongation. Furthermore, the regulation of Pex11p by phosphorylation or 
oligomerization has only been addressed in the yeast S. cerevisiae (Marshall et al., 1996; 
Knoblach & Rachubinski, 2010).  
In the following part of this thesis, the regulation of peroxisome dynamics on the organelle 
level was investigated by characterizing the properties of human Pex11pβ, the key protein 
facilitating peroxisomal growth and division. Due to conflicting information in silico data, the 
topology of human Pex11pβ was determined in order to also conclusively define its crucial N-
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terminal domain. Moreover, its regulation by phosphorylation and oligomerization was 
addressed.  
3.2.1 Predicted positions of transmembrane domains within human Pex11pβ  
Insight into the regulation of Pex11p proteins has been obtained from their domain structure, 
however, the mode of membrane association and the topology of the Pex11 proteins varies 
immensely across species, but also remained controversial in a single organism: ScPex11p 
was initially assumed to be an integral membrane protein, but re-defined as a peripheral 
protein (Erdmann & Blobel, 1995; Marshall et al., 1996; Schrader et al., 2011). Similarly, the 
topology and especially the position of the first transmembrane domain of human Pex11pβ 
remains elusive: using a variety of commonly used, online screening tools (Fig. 3.13, in silico 
screening), the position of the predicted transmembrane domains of human Pex11pβ was 
determined (Fig. 3.13). Notably, although generally assumed to carry two transmembrane 
domains (Abe & Fujiki, 1998; Schrader et al., 1998b), the majority of the algorithms used 
only detected a single transmembrane domain within human Pex11pβ. This information was 
also incorporated into widely used protein databases such as UniProtKB. As most algorithms 
only  calculate the transmembrane domain at the extreme C-terminus, Pex11pβ was even 
identified as a tail-anchored protein in a large scale screen (Kalbfleisch et al., 2007). As 
indicated, the predicted position of the first transmembrane domain, if detected, also 
depended on the algorithm used (Fig. 3.13, TM1). As Pex11pβ plays a crucial role in the 
regulation of peroxisome dynamics, it extremely important to clarify its topology and the 
position of its transmembrane domains, also in order to conclusively define its essential N-
terminal domain.   
 
Fig. 3.13: Overview of the 
predicted positions of the 
transmembrane domains of 
human Pex11pβ.  
Using the human sequence of 
Pex11pβ, a variety of in silico 
screening tools were applied to 
determine the position of the 
transmembrane domains. 
Based on the results, the 
expected size of the protein 
fragment between the two 
transmembrane domains was 
calculated using the tool 
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3.2.2 Pex11pβ is removed from the peroxisomal membrane by Triton-X-100 
treatment after formaldehyde fixation 
To examine the characteristics of Pex11pβ in comparison to the other human isoforms, COS-7 
cells were transfected with plasmids encoding myc-tagged version of Pex11pα, β and γ and 
differential permeabilization using either digitonin or Triton-X-100 (Tx100) was performed. 
In contrast to Tx100 which permeabilizes all cellular membranes, digitonin does not 
permeabilize peroxisomal membranes (Motley et al., 1994; Schrader et al., 1998b; Bonekamp 
et al., 2011b). To guarantee peroxisomal membrane integrity after digitonin permeabilization, 
untransfected COS-7 cells were either stained with an antibody against the cytosolic domain 
of the peroxisomal membrane protein PMP70 or the matrix protein acyl-CoA-oxidase (AOX) 
after differential permeabilization (Fig. 3.14 A-D). While PMP70 was readily detected under 
both conditions (Fig. 3.14 A, B), the peroxisomal matrix protein AOX only became 
accessible after membrane rupture with Tx100 (Fig. 3.14 C, D), verifying the efficiency of 
our differential permeabilization protocol. Interestingly, although one would assume the 
integral membrane protein Pex11pβ to be unaffected by Tx100 application after preceding 
fixation with 4 % pFA, the myc signal corresponding to Pex11pβ was lost upon Tx100 
incubation and subsequent immunofluorescence (Fig. 3.14 H). In contrast to that, Tx100 
incubation did not affect the localization of the other two Pex11 isoforms to this degree (Fig. 
3.14 E-F, I-J). The observed Tx100 sensitivity might be indicative of incomplete cross-
linking and subsequent removal of the protein (Goldenthal et al., 1985), however, fixation of 
proteins using pFA is catalyzed by chemical cross-linking of their lysine residues whose 
number is comparable between the three mammalian Pex11 isoforms. To address the removal 
of Pex11pβ from the peroxisomal membrane into the supernatant biochemically, COS-7 cells 
overexpressing myc-Pex11pβ were fixed in 4 % pFA and incubated with Tx100. As a control, 
PBS instead of the detergent was used after fixation. Tx100 and PBS supernatants were 
collected (Fig. 3.14 K, S) and the corresponding cells were lysed (Fig. 3.14 K, P). Equal 
amounts of protein of the supernatant and pellet fractions of PBS controls and Tx100-treated 
cells were subjected to SDS-PAGE and immunoblotting gainst the myc epitope (Fig. 3.14 K). 
In PBS-treated controls, a signal corresponding to Pex11pβ was observed in the pellet 
fraction, but not in the supernatant. Upon Tx100 incubation, however, only a small fraction of 
the protein still associated with the pellet and it was clearly extracted into the supernatant 
(Fig. 3.14 K). Nonetheless, signals corresponding to the pellet fractions remained weak under 
both conditions, which might indicate that epitope recognition is hampared by previous cross-
linking of proteins with pFA. Interestingly, another band was clearly detected by the myc 
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antibody of around 55 kD size, corresponding to a dimeric form of myc-Pex11pβ 
(approximate molecular weight 28kD) (Fig. 3.14 K).  
 
In summary, these findings demonstrate that, unlike the other mammalian isoforms, Pex11pβ 
was removed from the peroxisomal membrane after Tx100 addition, even after fixation. This 
intrinsic characteristic of the protein enabled its simple simultaneous extraction and 
enrichment by a straightforward biochemical approach that allows for a side-by-side detection 
of monomeric and dimeric variants of the Pex11pβ. The established Tx100 extraction assay 
Fig. 3.14.: Pex11pβ is removed from the 
peroxisomal membrane after Tx100 
treatment. 
(A-D) Controls for differential permeabilisation. 
COS-7 cells were fixed and permeabilized with 
either Tx100 (B, D) or digitonin (A,C). Then 
immunofluorescence was performed against the 
peroxisomal membrane protein PMP70 (A, B) 
or the matrix marker (C, D).  
(E-J) In contrast to the other mammalian 
isoforms, Pex11pβ is profoundly removed from 
the peroxisomal membrane after Tx100 
treatment. COS-7 cells were transfected with 
myc-tagged variants of Pex11pα (E-F), Pex11pβ 
(G-H) and Pex1pγ (I-J). 24 hours after 
transfection, cells were processed fro differential 
permeabilzation and immunofluorescence 
against the myc epitope. Bars, 20µm.  
(K) Pex11β is extracted by Tx100 into the 
supernatant. COS-7 cells were transfected by 
electroporation with myc-Pex11β and 24 hours 
later, were fixed using 4% pFA. After fixation, 
they were either permeabilized using Tx100 or 
PBS as a control. The supernatants were 
collected amd cells were lysed. After 
determination of protein concentration, samples 
of the supernatant and pellet fractions were run 
on an SDS-PAGE and subjected to 
immunoblotting against the myc epitope. Note 
that the myc signal in the control pellet appears 
weak.  
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was subsequently employed to investigate regulation of human Pex11pβ by oligomerization 
(3.2.11).  
3.2.3 All human Pex11 isoforms behave like integral membrane proteins 
Searching for an indication of why Pex11pβ is more Tx100-sensitive than the other 
mammalian isoforms, we compared the membrane association of the three mammalian Pex11 
isoforms using carbonate extraction. COS-7 cells were transfected with myc-tagged variants 
of the human Pex11 isoforms and subjected to carbonate extraction at pH 11.5 (Fujiki et al., 
1982). Equal amounts of pellet and supernatant samples from control and carbonate-treated 
peroxisome-enriched fractions were subjected to SDS-PAGE and immunoblotting against the 
myc-epitope. Detection of PMP70, a multi-membrane spanning protein of the peroxisomal 
membrane, was used as a control for integral association, while Pex19p served as a control for 
peripheral association. Although Pex19p is a PMP-binding chaperone shuttling between the 
cytosol and the peroxisomal membrane, it tightly associates with the peroxisomal membrane 
in the course of the PMP-import process by binding to the membrane receptor Pex3p, 
mimicking a transient peripheral association (1.1.5.2).  
  
Fig. 3.15: All Pex11 isoforms behave like integral membrane 
proteins.  
COS-7 cells were transfected with myc-tagged variants of the 
human Pex11 isoforms and subjected to carbonate extraction at 
pH 11.5.  Protein concentration was determined and supernatant as 
well as pellet samples from control and carbonate treated fractions 
(60µg) were run on 12.5 % SDS-PAGE and subjected to 
immunoblotting against the myc epitope. To serve as a control for 











As expected for a multi-membrane spanning ABC transporter, PMP70 remained tightly 
associated with peroxisomal membrane in controls and carbonate-treated samples (Fig. 3.15, 
Con, Carb.). In the case of Pex19p, a faint, but clear signal was detected in the pellet fractions 
of controls, but not in the respective supernatant (Fig. 3.15). After carbonate treatment, a 
significant portion of Pex19p shifted into the supernatant, indicating that it was removed from 
the peroxisomal membrane and, at least transiently, behaved like a peripheral membrane 
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protein. However, none of the human Pex11 isoforms were removed from the peroxisomal 
membrane after carbonate treatment, indicating that all of them clearly behave like integral 
membrane proteins. Thus, membrane association as such does not provide an explanation for 
the Tx100-sensitivity of human Pex11pβ.  
3.2.4 Characterization of a newly available Pex11pβ antibody  
Up until now, conclusive determination of Pex11pβ topology was limited by the availability 
of adequate antibodies; however, a recently available antibody directed against a non-
specified internal site of the human Pex11pβ protein now enabled further biochemical 
characterization.  
Initially, detection of endogenous Pex11pβ was investigated in COS-7 and human HepG2 
cells by indirect immunofluorescence with the Pex11pβ antibody after combined 
formaldehyde and methanol fixation.  Pex11pβ immuno-staining revealed a very faint, spot-
like intracellular signal, indicating that either epitope recognition was low or that steady-state 
Pex11pβ expression was below the detection threshold (data not shown). Thus, for further 
experiments characterizing Pex11pβ topology, overexpression of Pex11pβ was performed. 
For differential permeabilization, COS-7 cells were transfected with a myc-tagged variant of 
Pex11pβ prior to fixation and permeabilization with either Tx100, digitonin or methanol (Fig. 
3.16). Cells were then processed for immunofluorescence against the myc epitope and 
Pex11pβ itself. To ensure peroxisomal membrane integrity upon digitonin application, 
immuno-staining against PMP70 and AOX was routinely included (see Fig. 3.14). After 
overexpression of Pex11pβ-myc and Tx100 incubation (Fig. 3.16 A-I), no clear signal 
corresponding to myc-Pex11pβ was observed using either antibody (Fig. 3.16 A-C), 
consistent with our previous observations regarding Pex11pβ Tx100 sensitivity (Fig. 3.14). 
Using digitonin, the C-terminal myc tag was readily recognized by the myc antibody, 
however, no signal corresponding to the Pex11pβ antibody was observed (Fig. 3.16 D-F) 
which indicates that the antibody epitope resided within the peroxisomal membrane and 
matrix and was thus not accessible to the antibody. Using combined fixation and membrane 
permeabilization by methanol, a Pex11pβ antibody signal readily co-localized with the myc 
signal (Fig. 3.16, G-I). Similar observations were made upon overexpression of YFP-
Pex11pβ, a variant carrying a larger protein tag (Fig. 3.16, J-R). Interestingly, unlike the myc-
tagged variant, YFP-Pex11pβ was not extracted from the peroxisomal membrane by Tx100, 
presumably due to its large protein tag (of equal size as Pex11pβ itself). The fusion tag 
introduces further lysine residues into the protein and might thus facilitate a more profound 
cross-linking to other proteins. Consequently, an overlay of YFP and Pex11pβ signals was 
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only observed upon peroxisomal membrane permeabilization by Tx100 and methanol (Fig. 
3.16, L, R), but not after digitonin application (Fig. 3.16, O).  
 
 
Fig. 3.16: The Pex11pβ 
antibody only recognizes its 
epitope after peroxisomal 
membrane permeabilization.  
COS-7 cells were transfected 
with either Pex11β-myc (A-I) 
or YFP-Pex11β (J – R) and 
fixed after 24h. Membrane (and 
organelle membrane) 
permeabilization was achieved 
by incubating fixed cells with 
either 0.2 % Tx100 (A – C; J – 
L), 25µg/ml digitonin (D – F; 
M – O) or methanol (MetOH; G 
– I; P – R), before 
immunostaining against the 
myc epitope and an internal 
part of Pex11β (A – I) or 
Pex11β alone (J – R) was 
performed.  
Note that Pex11β-myc is 
reomved from the peroxisomal 
membrane after Tx100 
permeabilisation (A – C), while 
YFP-Pex11pβ is retained after 






















The observed recognition pattern after differential permeabilization indicates that the novel 
Pex11pβ antibody detects an epitope within the peroxisomal membrane or matrix; upon 
inquiry, the company confirmed that it was raised against a peptide sequence of the human 
protein comprised of amino acids 110 and 140 which rendered the antibody suitable for 
subsequent protease-protection assays.  
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3.2.5 Proteinase K digest of human Pex11pβ results in the formation of a 17 
kD protease-protected fragment 
The information on the position of the antibody epitope provided us with the opportunity to 
conclusively determine the position of the first transmembrane domain of human Pex11pβ. 
The localization of the epitope suggests the following scenarios: if Pex11pβ contains only one 
transmembrane domain at its very C-terminus (Fig. 3.17 A, upper panel), digest with the 
versatile serine protease proteinase K would result in an almost complete degradation of the 
protein (and the epitope), therefore no Pex11pβ signal would be detected upon 
immunoblotting. If a first transmembrane domain between amino acid positions 170 and 200 
would be assumed (Fig. 3.13), the epitope would similarly be digested. On the other hand, if 
the first transmembrane domain lies approximately in the centre of the protein (positions aa 
85-105), the antibody epitope would be rendered protected between the two transmembrane 
domains, resulting in the formation of a protein fragment of approximately 17kD upon 
proteinase K digest (Fig. 3.17 A, lower panel).  
 
Fig. 3.17.: Protease protection assay of 
YFP-Pex11pβ.  
(A) Scheme of assay, see text for details.  
(B) COS-7 cells were transfected with YFP-
Pex11β or mock transfected as a control 
(UT). 48 hours after transfection, 
peroxisome-enriched fractions were prepared 
and protein concentrations were determined. 
For protease K digest, 60 µg of protein were 
digested with protease K in the presence or 
absence of Tx100. Undigested controls were 
included. After 40 minutes, the reaction was 
stopped by the addition of PMSF and 
samples were precipitated by TCA. Samples 
were run on 12.5 % SDS-PAGE and 
immunoblotting was performed against 
Pex11pβ. As a loading control, the membrane 
was re-incubated with anti-GFP after 
membrane stripping. Asterisks indicate YFP-




For protease-protection assays, COS-7 cells were transfected with YFP-Pex11pβ and 
peroxisome-enriched fractions were generated. Untransfected cells were routinely included. 
Equal amounts of protein of were subjected to proteinase K digest for 40 minutes on ice 
(untreated controls, proteinase K addition in the presence and absence of Tx100), before the 
reaction was stopped with PMSF and protein was precipitated by TCA. Subsequently, protein 
samples subjected to SDS-PAGE and immunoblotting using the Pex11pβ antibody (Fig. 3.17, 
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B). Untransfected cells were routinely included as a control (Fig. 3.17, UT). After 
immunoblotting, the Pex11pβ antibody recognized an unspecific band in untransfected and 
transfected samples of around 60 kD, as indicated by the supplier. It also failed to detect a 
band corresponding to endogenous Pex11pβ (Fig. 3.17 B, UT), consistent with our previous 
observations. Upon overexpression of YFP-Pex11pβ, the expected band of around 56 kD size 
was observed in undigested, intact fractions, albeit weakly (Fig. 3.17 B, asterisk). After 
proteinase K addition to intact peroxisomes, a band shift occurred, yielding a detectable 
protein fragment of 16-18 kD size which was lost upon incubation with Tx100 (asterisks in 
Fig. 3.17 B). Interestingly, the YFP-fusion protein of YFP-Pex11pβ has proven to be resistent 
to proteinase K action, most probably due to the compact β-barrel structure of GFP and its 
analogues (Fig. 3.17 B, αGFP). Thus, it served as an excellent loading control upon re-
incubation with anti-GFP antibody to ensure equal loading of lanes (Fig. 3.17 B, αGFP). In 
undigested controls, the YFP signal correlated with the previously observed Pex11pβ signal, 
while the YFP fusion tag was cleaved from Pex11pβ after proteinase K addition and remained 
resistent to its action (Fig. 3.17 B, #). Similar band intensities of YFP were detected with and 
without the addition of Tx100, verifying equal loading of lanes. Further incubation of 
nitrocellulose membranes with an AOX antibody routinely ensured integrity of the 
peroxisomal membrane before Tx100 addition (data not shown). Furthermore, similar results 
were obtained upon overexpression of the wild-type protein. The concentration of proteinase 
K used in this study was in line with experimental protocols employed in other peroxisomal 
studies (Pinto et al., 2009), but further protease-protection assays were performed using 
increasing concentrations of proteinase K (10µg/ml to 500µg/ml). The 17 kD fragment was 
already generated using lower concentrations of proteinase K (20µg/ml) (data not shown).    
The results obtained by proteinase K digest are consistent with a predicted first 
transmembrane domain of Pex11pβ located approximately between amino acid positions 90 
and 110 (Fig. 3.13) (PredictProtein; TM predict) (Schrader et al., 1998b).  
In above experiments, specificity of the assay was ensured by addition of the detergent Tx100 
and subsequent digest of the now accessible protein fragment, however, Pex11pβ was shown 
to be Tx100 sensitive. Thus, to address the question if the region between the two 
transmembrane domains extends into the peroxisomal matrix, protease-protection assays were 








Fig. 3.18: The remaining Pex11pβ fragment is digested 
upon sonication.  
COS-7 cells were transfected with YFP-Pex11β. 48 hours 
after transfection, peroxisome-enriched fractions were 
prepared and protein concentrations were determined. For 
proteinase K digest, 60 µg of protein were digested with 
proteinase K in the presence or absence of Tx100. 
Alternatively, fractions were sonicated (3 x 10 seconds, 
100 W). Undigested controls were included. After 40 
minutes, the reaction was stopped by the addition of 
PMSF and samples were precipitated by TCA. Samples 
were run on 12.5 % SDS-PAGE and immunoblotting was 
performed against Pex11pβ. As a loading control, the 
membrane was re-incubated with anti-GFP antibody. 
Successful membrane rupture was verified by incubation 
with an antibody against AOX, a peroxisomal matrix 
marker. Note that due to protein processing 3 bands 
corresponding to AOX are detected after 






Disruption of peroxisomal membrane integrity by sonication and Tx100 addition was 
validated by monitoring AOX reactivity. After sonication or Tx100 treatment and subsequent 
proteinase K digest, a prominent decline in corresponding AOX signals was observed (Fig. 
3.18, AOX), indicating successful membrane permeabilization. In line with our previous 
observations, proteinase K digest of intact peroxisomal membranes resulted in the generation 
of a 17kD protein fragment of YFP-Pex11pβ which disappeared upon sonication (Fig. 3.18, 
Pex11β). Detection of YFP again served as a loading control (Fig.  3.18, GFP) 
These findings indicate that the regio between the two transmembrane domains of Pex11pβ 
extends into the peroxisomal matrix and becomes susceptible to protease digest upon 
sonication. Thus, finally, human Pex11pβ was conclusively shown to possess two 
transmembrane domains, the first of which is localized between amino acids 90 and 110; 
consequently its crucial N-terminal domain is defined to reach from amino acids 1-90.  
3.2.6 In peroxisome-deficient cells, Pex11pβ is mistargeted to mitochondria 
Mutations in the peroxins Pex3p, Pex16p and/or Pex19p which are essential for peroxisomal 
membrane biogenesis result in a complete absence of peroxisomal structures (1.1.5.2), 
resulting in severe pathophysiological conditions (1.1.4). Under those conditions, the ER was 
suggested to serve a default membrane for peroxisomal membrane proteins (1.2.1), thus the 
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targeting of human Pex11pβ was investigated in peroxisome-deficient ∆Pex19 patient 
fibroblasts.  
Pex11pβ-myc was co-transfected with a mitochondrial GFP construct (Mito-GFP) into 
∆Pex19 fibroblasts. After 24 hours, cells were fixed and processed for immunofluorescence 
against the myc epitope (Fig. 3.19) 
 
Fig. 3.19.: In ∆PEX19 cells, Pex11pβ 
mistargets to mitochondria and leads to 
their fragmentation.  
(A, B) ∆PEX19 fibroblasts were transfected 
with either the mitochondrial matrix marker 
Mito-GFP (A) or myc-Fis1, a tail-anchored 
protein known to fragment mitochondria (B). 
Cells were fixed and in the case of (B) 
processed for immunofluorescence against 
the myc epitope.  
(C-E) ∆Pex19 fibroblasts were co-transfected 
with Mito-GFP and Pex11β-myc and 
processed for immunofluorescence against 
the myc epitope. Merge of signals is seen in 
(E). Bars, 20µm.  
(F) For statistical analysis, ∆Pex19 fibroblasts 
were either transfected with Mito-GFP alone 
or  co-transfected with Mito-GFP and 
Pex11β-myc and processed for 
immunofluorescence. Mitochondrial 
morphology was assessed to be either tubular 
(A) or fragmented (B) and 100 cells/coverslip 
(2 coverslips/condition) were grouped 
accordingly. Data is shown as means +/- SD 





Interestingly, in the absence of peroxisomal membranes, Pex11β-myc was mislocalized to 
mitochondria, but not to the ER (Fig. 3.19 C-E). Moreover, contrary to its default role as 
membrane tubulator, mitochondrial mistargeting of Pex11pβ led to a prominent fragmentation 
of mitochondria reminiscent of e.g. overexpression of Fis1, a tail-anchored protein that is 
involved in recruiting DLP1 to mitochondria and peroxisomes (Fig. 3.19 B) (1.2.2.3). 
Mitochondrial morphology was assessed to be either tubular (A) or fragmented (B) and 
statistical analysis was performed. Statistical evaluation clearly revealed a highly significant 
increase in the number of fragmented mitochondria after Pex11pβ-myc overexpression and 
mistargeting.  
 
  3. RESULTS  
 125 
3.2.7 Upon mistargeting to mitochondria Pex11pβ retains its Tx100 
sensitivity and orientation 
Contrary to its membrane elongating effects on peroxisomes, targeting of Pex11pβ to 
mitochondria led to their severe fragmentation; to address if its native characteristics and 
orientation were perturbed, Tx100 sensitivity and protein topology at the mitochondrial 
membrane were investigated.  
N-terminally and C-terminally myc-tagged variants of Pex11pβ were transfected into ∆Pex19 
fibroblasts and processed for differential permeabilization using either digitonin or Tx100. 
Subsequently, cells were processed for indirect immunofluorescence against the myc epitope 
and evaluated by epifluorescence microscopy.  
 
Fig. 3.20: Upon  mistargeting to mitochondria, 
Pex11β retains its Tx100 sensitivity and both 
termini remain exposed to the cytosol. 
(A-D) Permeabilization controls. ∆Pex19 fibroblasts 
were fixed and processed for differential 
permeabilization using either digitonin (A, C) or Tx100 
(B, D). Subsequently, they were stained either with 
antibodies against the outer membrane marker TOM20 
(A, B) or the matrix localized portion of ATP-Synthase 
(αβ subunit) (C, D).  
Bars, 20µm. 
(E-H) Both termini of Pex11pβ are exposed to the 
cytosol. ∆Pex19 fibroblasts were transfected with either 
N-terminally or C-terminally tagged Pex11β and 
processed for differential permeabilization and 
immunofluorescence 24 hours later.  











To control differential permeabilization of mitochondrial membranes, immunofluorescence 
against the outer membrane protein TOM20 as well as the matrix-localized portion of ATP-
Synthase (subunit αβ) was performed. As expected, TOM20 was readily detected under both 
conditions (Fig. 3.20 A,B), while ATP-Synthase reactivity was only provided upon 
mitochondrial membrane permeabilization with Tx100 (Fig. 3.20 D). Both, N-terminally and 
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C-terminally tagged variants of Pex11pβ were localized at the mitochondrial membrane after 
digitonin permeabilization, indicating that both termini extend to the cytosol (Fig. 3.20 E,G). 
Upon Tx100 addition, however, the Pex11pβ signal was reduced to the appearance of small 
spot-like structures throughout the cytosol (Fig. 3.20 F,H) that were not associated with 
mitochondria anymore. Hence, Pex11pβ retained its Tx100 sensitivity, although it was 
embedded in a different lipid environment. To address if Pex11pβ is inserted into the 
mitochondrial membrane in its native topology, Pex11pβ-myc was overexpressed in ∆Pex19 
fibroblasts and differential permeabilization and co-staining with the Pex11pβ antibody was 
performed.  
 
Fig. 3.21:  Pex11pβ retains its topology upon 
mistargeting to mitochondria.  
(A-I) ∆Pex19 fibroblasts were transfected with 
Pex11pβ-myc, fixed after 24 hours and 
permeabilized using either Tx100 (A-C), 
digitonin (D-F) or methanol (G-I). Subsequently, 
they were co-stained with antibodies against the 
myc epitope (A, D, G) and Pex11pβ (B, E, H).  
(J-R) In a similar approach, ∆Pex19 fibroblasts 
were transfected with Pex11β-GFP before 
permeabilization using either Tx100 (J-L), 
digitonin (M-O) or methanol (P-R).  
Subsequently, staining against Pex11pβ was 
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Similar to the observations made in COS-7 (Fig. 3.16), upon mistargeting to mitochondria in 
∆Pex19 cells, the Tx100-sensitive Pex11pβ-myc was only recognized by the Pex11pβ 
antibody upon permeabilization of the mitochondrial membrane with methanol (Fig. 3.21 A-
I). Overexpression of Pex11pβ-GFP which was not removed from (peroxisomal and) 
mitochondrial membranes by Tx100, and subsequent co-staining with the Pex11pβ antibody 
in ∆Pex19 cells similarly revealed that antibody detection was only guaranteed after 
membrane rupture with either Tx100 or methanol (Fig. 3.21 J-R). As the Pex11pβ antibody 
recognition pattern after differential permeabilization mirrored the observations at the 
peroxisomal membrane, Pex11pβ was inserted in its proper orientation into the mitochondrial 
membrane in ∆Pex19 cells. It has to be noted, however, that upon overexpression a fraction of 
the protein was detected in the cytosol, but never at the ER.  
 
3.2.8 Pex11pβ targeting to mitochondria depends on its  N-terminal domain 
Upon overexpression of YFP-Pex11pβ in peroxisome-deficient ∆Pex19 cells, hardly any 
mitochondrial localization of the fusion protein was observed, while Pex11pβ-GFP 
mistargeted efficiently to mitochondria, indicating that the N-terminal domain is important for 
mitochondrial targeting. To investigate this question, side-by-side overexpression of YFP-
Pex11pβ, Pex11pβ-YFP and Pex11pβ-GFP in ∆Pex19 fibroblasts and subsequent analysis by 
epifluorescence microscopy was performed. Overexpression of YFP-Pex11pβ led to a 
predominantly cytosolic localization of the protein (Fig. 3.22 B), while C-terminal tagging of 
Pex11pβ resulted in a clearly detectable mitochondrial localization (Fig. 3.22 C, D). 
Moreover, mitochondrial targeting of Pex11pβ was impaired upon deletion of the first 40 
amino acids of the protein (∆N40-Pex11pβ-myc) (Fig. 3.22 A).  
 
Fig. 3.22: The N-terminal domain 
of Pex11pβ mediates its 
mitochondrial targeting.  
∆Pex19 fibroblasts were either 
transfected with a deletion mutant of 
Pex11β-myc lacking the first 40 aa 
(A), YFP-Pex11pβ (B), Pex11pβ-
YFP (C) or Pex11pβ-GFP (D) and 
after 24 hours were fixed and 
processed for immunofluorescence. 
Note that although the protein is 
targeted to mitochondria in (C) and 
(D), there is some cytosolic signal. 
Bars, 20µm 
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These findings indicate that mitochondrial mistargeting of Pex11pβ is mediated by its N-
terminal domain.  
3.2.9 Post-translational regulation of human Pex11pβ: In silico phospho 
screening of mammalian Pex11β 
In the previous section of this study, the often evoked N-terminal domain of Pex11pβ was 
defined to be comprised of amino acids 1-90. Although the membrane deforming capacity of 
Pex11 proteins was recently linked to the presence of an amphipathic helix within the N-
terminus, only little is known about how the action of Pex11 proteins is further regulated by 
other post-translational mechanisms. For instance, phosphorylation of ScPex11p was only 
demonstrated in the yeast S. cerevisiae and shown to be crucial for its action (Knoblach & 
Rachubinski, 2010), therefore, the potential regulation of human Pex11pβ by phosphorylation 
was examined.  
An initial in silico screen of Pex11pβ was performed using various databases that either 
calculate potential phosphorylation sites within the protein or screen for potential kinase 
binding sites (2.10.2). To gain insight into the selection of appropriate residues, screening 
results obtained with the validated S165/167 phospho-site of ScPex11p were used as a 
guideline where applicable. To further narrow down the number of potential phospho-sites, 
only multiple hits obtained by several screening tool were selected for further characterization 
(Fig. 3.23 A). Furthermore, a homology screen of various Pex11pβ protein sequences was 
performed and examined for conservation of phosphosites (Fig. 3.23 C). The positions of 
potential phospho-sites are indicated by red brackets in Fig. 3.23 C. Combining in silico 
screening results and protein homology of Pex11pβ, several conserved sites were identified at 
positions S11, S38, S70, S154, S160, S168 and T178 within the human protein. Their position 
within the protein overall architecture is depicted in Fig. 3.23 B (probable sites). However, 
due to the fact that no intra-peroxisomal kinases have been identified so far and our study was 
focused on the regulation of the protein’s N-terminal domain, intra-peroxisomal phospho-sites 
were excluded for further analysis for the time being (Fig. 3.23 B, extraperoxisomal sites). 
Furthermore, the potential S70 site was excluded from further studies due to preliminary data 
indicating that deletion of the first 70 amino acid of Pex11pβ did not exercabate the effect of 
deletion of the first 40 amino acids (personal communication MJ. Cardoso). Thus, for a 
parallel approach, the potential N-terminal phospho-sites S11 and S38 were selected for the 
generation of phospho-mimicking “on” and “off” mutants (Fig. 3.23 B, selected sites).  
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Fig. 3.23: Determination of potential phospho-sites within human Pex11pβ.  
(A) Overview of multiple hits for different positions. Several online screening tools were used to determine potential 
phospho-sites in the sequence of human Pex11pβ. The various tools are plotted against the positions given.  
(B) Scheme depicting phospho-sites chosen for subsequent studies. Based on the screening, several potential phosphosites 
were selected whose approx. location is indicated in the upper scheme (potential sites). Based on our findings regarding the 
topology of Pex11pβ, intraperoxisomal sites were excluded (Extraperoxisomal sites). Furthermore, based on studies 
regarding deletions of N-terminus, the sites listed on the bottom were chosen.  
(C) Overview of conserved amino acids in Pex11pβ protein sequences across species. The potential phospho-sites are 
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3.2.10  Human Pex11pβ is not phosphorylated in COS-7 cells 
To determine phosphorylation of human Pex11pβ, in vivo phospho-labelling of Pex11pβ was 
performed while phospho-mimicking “on” and “off” mutants of the S11 and S38 residues 
were generated in parallel (co-operation MJ. Cardoso).  
For in vivo phospho-labelling, COS-7 cells overexpressing human YFP-Pex11pβ were starved 
in phosphate-free buffer and then incubated with P32-orthophosphate for several hours, before 
the cells were lysed in the presence of protease and phosphatase inhibitors. Subsequently, 
immunoprecipitation against YFP was performed. Overexpression of YFP-Pex11pβ was 
chosen due to high transfection and precipitation rates. As negative and positive controls, 
YFP-C1 (empty vector) and human APP-GFP were included. APP, the amyloid precursor 
protein, is an integral membrane protein that functions as a cell surface receptor and performs 
physiological functions on the surface of neurons relevant to neurite growth, neuronal 
adhesion and axonogenesis. In the last decades, studies of APP and its proteolytic products 
have been mostly focused on its role as a producer of the toxic amyloid beta peptide 
associated with Alzheimer’s disease. However, especially the C-terminal domain of APP has 
been shown to be extensively regulated by phosphorylation essential for its physiological 
function (Lee et al., 2003; Schettini et al., 2010).   
 
Fig. 3.24: YFP-Pex11pβ is not 
phosphorylated in COS-7 cells.  
COS-7 cells were transfected with 
either APP-GFP (100kD), YFP-C1 
(28kD) or YFP-Pex11β (56kD). 24 
hours later, in vivo phospholabelling 
was performed for 4 hours at 37°C 
before cells were lysed and  
immunoprecipitation against GFP was 
performed. Precipitated samples were 
run on 12.5 % SDS-PAGE , fixed and 
dried. The dried gel was exposed for 3 
days on a phosphoimaging screen and 
evaluated using a BioRad Molecular 





Phosphorylated APP-GFP was successfully precipitated with the GFP antibody, resulting in 
the detection of a radio-labelled protein band of the expected size (Fig. 3.24). Furthermore, no 
signal corresponding to empty YFP vector was observed. Concerning YFP-Pex11pβ, no 
radio-labelled fraction of the protein was detected upon in vivo phospho-labelling, similar to 
the negative control, indicating that human Pex11pβ is not phosphorylated in COS-7 cells. 
Furthermore, no effect on peroxisome dynamics was observed upon expression of the selected 
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phospho-mimicking mutants of Pex11pβ when compared to wild-type, thus, phosphorylation 
does not appear to contribute to the regulation of Pex11pβ activity in mammals.  
3.2.11  Pex11pβ-mediated peroxisome membrane elongation is regulated by 
homo-dimerization 
Concerning the regulation of Pex11 protein activity, the action of Pex11p in S. cerevisiae was 
suggested to be regulated by homo-dimerization in a redox-dependent manner: a model was 
proposed in which ScPex11p actively acts as a monomer at the inner surface of the 
peroxisomal membrane and is oxidized upon maturation of peroxisomes to form inactive 
dimers in mature peroxisomes (Marshall et al., 1996). Human Pex11pβ was also shown to 
form homo-dimers, depending on its N-terminal domain (Li & Gould, 2003; Kobayashi et al., 
2007; Koch et al., 2010). Deletion of the N-terminal domain abolishes membrane elongation 
(Kobayashi et al., 2007) (our unpublished results}, but it not clear if monomeric or dimeric 
Pex11pβ represents the active form in higher organisms. For instance, while the decline in 
Pex11pβ-based membrane elongation upon N-terminal deletion might only be linked to the 
deletion of the amphipathic helix (Kobayashi et al., 2007), our unpublished results indicated 
that deletion of the first 40 amino acids already diminished membrane elongation, although 
the amphipathic helix remained intact. As phosphorylation of Pex11pβ was excluded to 
contribute to regulate peroxisome dynamics at the organelle level, the dimerization of 
Pex11pβ was addressed.  
Overexpression of Pex11pβ in mammalian cells was shown to profoundly induce the 
formation of elongated peroxisomal structures: already 5 hours after transfection, 
approximately 90 % of the transfected cells contained predominantly tubular peroxisomes. 
Subsequently, the number of elongated peroxisomes decreased to 60 % after 24 hours and 25 
– 30 % after 72 hours, respectively (Schrader et al., 1998b) (Fig. 3.25 A). In order to correlate 
the described morphologies with the stochiometry of human Pex11pβ, we took advantage of 
the Tx100 extraction protocol established in this study (3.2.2) that allowed simultaneous 
cross-linking and enrichment of Pex11pβ. COS-7 cells were transfected with myc-Pex11pβ 
and the Tx100 extraction assay (2.11.3) was performed 5, 24 and 72 hours after transfection. 
Equal amounts of supernatant and pellet fractions of fixed COS-7 cells as well as unfixed 
lysates were subjected to SDS-PAGE and subsequent immunoblotting against the myc 
epitope (Fig. 3.25). While overall expression of myc-Pex11pβ remained low at early time 
points (L, 5h, 24h), detectable levels of Pex11pβ were successfully extracted into the 
supernatant. Interestingly, mostly dimeric forms of myc-Pex11pβ (approx. 56kD) were 
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detected 5 and 24 hours after transfection, coinciding with a predominantly tubular 
morphology of peroxisomes at these time points (Fig. 3.25 A). Note that, like before (3.2.2) 
monomeric Pex11pβ was also detected upon longer exposure, albeit at lower concentrations. 
72 hours after transfection, monomeric Pex11pβ was primarily detected. Notably, upon 
overexpression of an N-terminally truncated version of Pex11pβ-myc lacking the first 40 
amino acids (∆N40-Pex11pβ-myc), peroxisomes maintained a predominantly spherical 
morphology 5 – 72 hours after transfection. After application of the Tx100 extraction assay 
and subsequent immunoblotting at the corresponding time points, dimer formation of 
Pex11pβ was impaired (personal communication S. Grille).  
These findings indicate that, contrary to to ScPex11p, human Pex11pβ acts as a dimer to 
induce membrane tubulation, while monomeric might mirror an inactive state.  
 
Fig. 3.25: Human Pex11pβ acts predominantly as a 
dimer at early time points.  
(A) Induction of tubular peroxisomes after Pex11pβ 
expression. COS-7 cells were transfected by 
electroporation with myc-Pex11pβ and were fixed after 
5, 24 and 72 hours, resp, and processed for 
immunofluorescence against peroxisomal markers. 
(adapted from (Schrader et al., 1998b). 
(B) COS-7 cells were transfected by electroporation 
with myc-Pex11pβ and were fixed after 5, 24 and 72 
hours, resp, using 4 % pFA. After fixation, they were 
permeabilized using 0.2% Tx100. The supernatants (S) 
were collected and cells (P) were lysed. 
Simultaneously, lysates (L) of non-fixed cells were 
prepared to verify expression of myc-Pex11pβ. After 
determination of protein concentration, samples of the 
supernatant and pellet fractions were run on an SDS-
PAGE and subjected to immunoblotting against the 
myc epitope. Note that the myc signal in the control 
pellet is very difficult to detect. Similarly, myc-
Pex11pβ detection in control lysates (L) is very faint at 
early time points, indicating expression of the protein is 
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3.2.12  Summary 
In the second part of this thesis, human Pex11pβ, a crucial protein regulating peroxisomal 
growth and division, was characterized biochemically in order to gain insight into the 
regulation of peroxisome dynamics on the organellar level. Using a newly available antibody 
directed against an internal part of the protein in combination with differential 
permeabilization and protease-protection assays, the first transmembrane domain of human 
Pex11pβ was conclusively localized to amino acid positions 90-110 for the first time. 
Consequently, the N-terminal domain of the protein was investigated in regard to its 
contribution to Pex11pβ regulation. In vivo phospho-labelling did not reveal phosphorylation 
of human Pex11pβ, but biochemical cross-linking and enrichment of Pex11pβ in time-course 
experiments linked its membrane-deforming activity to homo-dimerization. Deletion of the 
first 40 amino acids abolished the formation of elongated peroxisomal structures, concomitant 
with an impairment in dimer formation, although the amphipathic helix remained intact. Thus, 
human Pex11pβ is regulated in a different manner than its yeast counterpart. Moreover, 
human Pex11pβ was shown to mistarget to mitochondria in patient fibroblasts lacking any 
peroxisomal structures, an observation that might have further, underappreciated 
consequences for the severity of peroxisomal disorders.   
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3.3 IDENTIFICATION OF NOVEL STIMULI ALTERING PEROXISOME 
DYNAMICS 
Peroxisomes have been known to be highly dynamic in regard to their morphology: in 
addition to spherical structures (the common textbook image), elongated, tubular peroxisomes 
as well as tubulo-reticular networks have been observed in electron and light microscopy 
(Gorgas, 1985; Gorgas, 1987; Yamamoto & Fahimi, 1987; Schrader et al., 2000; Schrader, 
2001; Schrader & Fahimi, 2006). In mammalian cell culture models, peroxisome elongation 
was strongly induced upon direct manipulation of components of the peroxisomal growth and 
division machinery (e.g. by Pex11p overexpression or inhibition of DLP1, Fis1 or Mff) 
(Schrader et al., 1998b; Koch et al., 2003; Lingard & Trelease, 2006; Tanaka et al., 2006), but 
also stimulated under conditions of cellular growth and after the addition of growth factors 
and polyunsaturated fatty acids (PUFAs, e.g. arachidonic acid) (Schrader et al., 1996a; 
Schrader et al., 1998a). Moreover, a higher frequency of elongated peroxisomes was observed 
upon depolymerisation of microtubules and exposure of cells to UV irradiation and ROS 
(Schrader et al., 1996a; Schrader et al., 1996b; Schrader et al., 1999). However, the reception 
of those signals as well as their transduction onto the peroxisomal level mediating the 
stimulated formation of peroxisomal tubules remains unknown. Morphologically distinct 
types of peroxisomes have been described in different organs of mammalian organisms and 
cell types (Hicks & Fahimi, 1977; Gorgas, 1987; Yamamoto & Fahimi, 1987; Fahimi et al., 
1993; Schrader et al., 1994; Litwin & Bilinska, 1995; Schrader et al., 1996a; Schrader et al., 
2000), but mostly elongated structures have been linked to peroxisomal growth and division 
processes (1.2.2). Similarly, peroxisome elongation after UV irradiation was suggested to 
serve protective effect, as an increase in peroxisome numbers by growth and division might 
facilitate the scavenging of ROS and combat ROS-induced cell damage (Schrader et al., 
1999). However, distinct peroxisomal structures induced upon stimulation might also be 
indicative of other specific functions: the formation of tubulo-reticular networks observed in 
lipid synthesizing epithelia was indicated to facilitate metabolic functions, e.g. by increasing 
the surface to volume ratio and generating a uniform distribution of proteins within the 
network (Gorgas, 1987; Kollatakudy et al., 1987; Schrader et al., 2000; Ribeiro et al., 2011). 
It has become clear in recent years that organelle morphology and dynamics are intricately 
linked to its function and thus, cellular homeostasis. In line with this, a lethal defect affecting 
peroxisomal and mitochondrial fission has been identified (Waterham et al., 2007). Moreover, 
alterations in peroxisome dynamics and perturbations of  their number are linked to several 
  3. RESULTS  
 135 
pathophyiological conditions such obesity, AOX1 deficiency and cancer (Chang et al., 1999; 
Lauer et al., 1999; Funato et al., 2006; Frederiks et al., 2010; Diano et al., 2011). Thus, it is 
extremely important to decipher the relationship between peroxisome morphology and 
function as well as to gain insight into the signal transduction mechanisms regulating 
organelle dynamics to potentially compensate disease phenotypes. .  
The following section of this thesis aimed at characterizing a link between stimulated 
alterations of peroxisome dynamics and their potential function. Several different stimuli 
were grouped according to the nature of the stimulus and screened for a potential effect on 
peroxisome dynamics. Subsequent characterization of the response on the peroxisomal level 
enabled the characterization of a novel cell culture model to study the regulation of 
peroxisome dynamics.  
3.3.1 6-hydroxydopamine induces DLP1-dependent fragmentation of 
mitochondria and apoptosis in SH-SY5Y neuroblastoma cells but has 
no effect on peroxisome dynamics 
In the course of this study, the effects of 6-hydroxydopamine (6-OHDA) on mitochondrial 
morphology in neuronal SH-SY5Y cells were investigated (co-operation J. Jordan Bueso, 
University of Castilla-LaMancha, Spain). The neurotoxin 6-OHDA is an oxidative metabolite 
of dopamine that is widely used to generate experimental models of Parkinson’s disease 
(Blum et al., 2001; Bove et al., 2005b). Although its mechanism of action remains a matter of 
debate, the generation of reactive oxygen species has been implicated (Galindo et al., 2003). 
It was observed that 6-OHDA induced a profound fragmentation of mitochondria that 
represented an early event of neuronal apoptosis, preceding the collapse of mitochondrial 
membrane potential and cytochrome c release (Gomez-Lazaro et al., 2008). Interestingly, the 
mitochondrial fragmentation was shown to be dependent of DLP1, the large GTPase 
mediating fission of mitochondria and peroxisomes. Therefore, the effect of 6-OHDA on 
peroxisomal morphology was investigated. 
SH-SY5Y neuroblastoma cells transfected with a mitochondrial GFP construct were seeded 
on coverslips and treated with 50 µM 6-OHDA for 3 hours, a time point at which 
mitochondria were already profoundly fragmented. Cells were fixed and epifluorescence 
microscopy using antibodies against the peroxisomal membrane marker PMP70 was 
performed (Fig. 3.26 A-D). 
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Fig. 3.26: 6-OHDA does not affect 
peroxisome dynamics.  
(A-D) SH-SY5Y cells transfected with Mito-
GFP (A, C) were either mock treated (A,B) or 
treated with 50 µM 6-OHDA for 3 hours and 
fixed with 4 % pFA. Subsequently cells were 
processed for immunofluorescence against the 
peroxisomal membrane protein PMP70 (B, D).  
(E-F) To facilitate detection of peroxisome 
fragmentation, SH-SY5Y cells were 
transfected with Pex11pβ-myc before treatment 
with 50 µM 6-OHDA (G). Cells were fixed 
and processed for immunofluorescence against 









Whereas treatment with 50 µM 6-OHDA resulted in a clear fragmentation of mitochondria 
after 3 hours, no alterations of peroxisome dynamics were detected (Fig. 3.26 B, D). 
Peroxisomes retained their spherical morphology and no obvious increase in peroxisome 
number was observed. Even after prolonged incubation with 6-OHDA, no effect on 
peroxisome morphology was observed (data not shown). However, as detection of a potential 
fragmentation of already spherical peroxisomes proved difficult, SH-SY5Y cells were 
additionally transfected with the peroxisomal membrane tubulator Pex11pβ-myc prior to 6-
OHDA treatment to induce a profound elongation/proliferation of peroxisomes and 
potentially determine a difference in the kinetics of subsequent division with and without 6-
OHDA (Fig. 3. 26 E-F). Nonetheless, 6-OHDA treatment after Pex11pβ overexpression failed 
to induce any changes in peroxisomal morphology and number which would be expected if 
there was an induced fragmentation of peroxisome tubules (Fig. 3.26  F, G).  
Taken together, these findings indicate that although 6-OHDA induced mitochondrial 
fragmentation in a DLP1-dependent manner, there was no effect on peroxisome morphology 
and dynamics. This suggests that although DLP1 is a shared component of both organelle 
fission machineries, the recruitment and/or regulation of DLP1 in response to specific stimuli 
is co-ordinated in an organelle-specific manner. Additionally, DLP1-mediated fragmentation 
after 6-OHDA application was shown to represent an early event in the onset of cellular 
apoptosis that precedes the collapse of mitochondrial membrane potential and cytochrome c 
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release (Gomez-Lazaro et al., 2008). Upon onset of cell death, peroxisomes maintained a 
predominantly spherical morphology, in line with previous observations (our unpublished 
results). Hence, the absence of tubular or more complex peroxisomal structures which to 
growth and division or a potential protective function might indicate that a “costly” induction 
of peroxisome tubulation was rendered unnecessary under apoptotic conditions in which cell 
death is imminent.   
3.3.2 Alterations of peroxisome dynamics in response to oxidative stress 
3.3.2.1 Overview of the model system employed to study alterations of peroxisome 
dynamics in response to oxidative stress 
Peroxisomes in human HepG2 cells were shown to respond to UV irradiation and H2O2 
treatment with profound peroxisomal tubulation, displaying a morphology reminiscent of the 
“beads-on-string” appearance associated with growth and division (Schrader et al., 1999). The 
observed phenotype was linked to oxidative stress, as pre-treatment with antioxidants 
reversed the response. Similarly, a dual response of peroxisomes to oxidative stress was 
characterized in plants, where plant peroxisomes were shown to respond to short-term 
oxidative stress (up to 2 hours) with the formation of small membrane protrusions called 
peroxules, while maintained oxidative stress initiated an analogous peroxisomal “bead-on-a-
string” morphology (Sinclair et al., 2009). Peroxisomal tubulation after ROS exposure was 
suggested to represent a protective, morphological response, as an increase in the number 
and/or volume of peroxisomes might facilitate their ROS scavenging abilities. Interestingly, 
the formation of peroxules in plant cells was linked to the action of hydroxyl radicals and 
hydrogen peroxide (Sinclair et al., 2009), indicating that the nature of the stress signal is 
important. To analyze the importance of the nature, but also the intracellular source of 
oxidative stress leading to alterations of peroxisome dynamics, mammalian HepG2 and COS-
7 cells were used as a model system (Fig. 3.27). In order to quantify a peroxisomal stress 
response, the induction of peroxisomal tubules was used as a read-out. Examples for a 
spherical (B, D) and tubular morphology (C, E) of the peroxisomes in the respective cell lines 
are given in Fig. 3.27 (B-E). To investigate the question if a general increase in cytosolic 
oxidative stress stimulates peroxisome tubulation, cells were treated with H2O2, the heavy 
metals copper and nickel (whose toxicity has been linked to ROS induction by Fenton-like 
chemistry or depletion of GSH) (Stohs & Bagchi, 1995) as well as paraquat (2.8.9). The 
toxicity of paraquat, one of the most widely used herbicides in the world, has been attributed 
to an enzymatically catalyzed one-electron redox cycling of the parent molecule, resulting in 
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generation of superoxide anions (Bus & Gibson, 1982). Its neurotoxic capacities have been 
linked to the development of Parkinson’s disease (PD) which is further employed in toxin-
induced PD models (Bove et al., 2005a; Franco et al., 2010). Additionally, the question was 
addressed if impairment of mitochondrial function affects peroxisome morphology and 
dynamics (Fig. 3.27 A, compartment-specific response). Therefore, cells were treated with 
inhibitors of the mitochondrial respiratory chain such as rotenone (complex I), malonate 
(complex II) and sodium azide (complex IV) (Chance et al., 1963; Schulz et al., 1997; 
Yoshikawa et al., 1998; Fei et al., 2000; Fernandez-Gomez et al., 2005).  The existence of 
compartment-specific induction of tubular peroxisomes was further addressed by live cell 
imaging using variants of the photosensitizer KillerRed targeted to the cytosol, mitochondria 
and peroxisomes (Bulina et al., 2006a). The existence of peroxules in mammalian cells was 
additionally investigated in this set-up.  
 
Fig. 3.27: Induction of tubular peroxisomes in 
mammalian cell lines.  
(A) Scheme of the tubulation assay employed in this 
study. Peroxisomes (PO) have been shown to respond to 
oxidative stress with elongation, however, it is currently 
unclear if tubulation mirrors a global ROS response. 
Moreover, more factors leading to tubulation  need to be 
identified. Furthermore, the existence of small 
membrane tubules (peroxules) after short-term stress 
has not been investigated in mammalian cells. It is also 
unclear if tubulation is induced differently depending if 
ROS are generated in the cytosol, mitochondria (Mito) 
or peroxisomes.  
(B-E) Examples for peroxisome morphology in HepG2 
(B, C) and COS-7 cells (D, E). HepG2 and COS-7 cells 
were seeded on coverslips, fixed and subjected to 
immunofluorescence against the peroxisomal membrane 
marker Pex14. In both cells, peroxisomal morphology 
can range from a more spherical (B, D) to a tubular 
morphology (C, E).  
Bars, 20µm.  
 
 
3.3.2.2 Screening for alterations of peroxisomes in response to oxidative stress 
In order to screen for alterations of peroxisome dynamics after profound increase in cytosolic 
oxidative stress, HepG2 cells seeded on coverslips were treated with H2O2, the heavy metals 
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copper and nickel and paraquat. Stressors were applied in the indicated concentrations (Fig. 
3.28 A). After 24 hours, cells were fixed and prepared for indirect immunofluorescence 
against the peroxisomal marker Pex14p before peroxisome morphology was assessed by 
epifluorescence microscopy. Peroxisome morphology was either defined as being spherical or 
tubular as described above.  
 
Fig. 3.28.: Screening for stressors affecting 
peroxisome dynamics.  
(A) HepG2 were seeded on glass coverslips at a 
defined density of 2 x 105 cells/ml. 4 hours after 
seeding, the indicated stressors were applied at the 
indicated concentrations. After 24 hours, when 
peroxisome tubulation is described to reach its 
maximum (Schrader et al., 1998a; Schrader et al., 
1999), cells were fixed and processed for 
epifluorescence microscopy. Peroxisome 
morphology was determined to be either spherical 
or tubular and data of representative experiments 
is shown.  
(B) Paraquat induces a profound increase in 
oxidative stress in human HepG2 cells. HepG2 
cells were seeded at a defined density of 10.000 
cells/well in a black 96 well plate. The next day, 
cells were subjected to paraquat treatment at the 
indicated concentrations. After the indicated time 
points, cells were stained with 10 µM DCFDA 
and fluorescence intensity was measured using a 
TECAN fluorescence spectrometer. A minimum 
of 6 wells was measured per conditions. A 
representative experiment for paraquat treatment 
is shown.  
(C)  HepG2 cells respond to serum and fatty acid 
addition with elongation.  In order to control the 
plasticity of peroxisomes in HepG2 cells, 4 hours 
after seeding, cells grown in serum-free medium 
were treated with 10 % serum as well as 
arachidonic acid (AA) and palmitic acid (PA) as 
described before (Schrader et al., 1998a). The next 
day, cells were fixed and processed for 
epifluorescence microscopy. Peroxisome 
morphology was determined to be either spherical 
or tubular. Data is shown as means +/- SD and 





Although peroxisomes in HepG2 cells responded to the addition of H2O2 with a slight 
increase in the number of tubular peroxisomes (Fig. 3.28 A), treatment with nickel, copper or 
paraquat did not result in a significant elongation of the peroxisomal compartment.  Similar 
results were obtained in COS-7 cells (data not shown). To verify a successful induction of 
oxidative stress, an increase of DCF fluorescence intensity after application of stressors was 
measured (2.8.11); as a representative example, induction of oxidative stress after paraquat 
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application is shown in Fig. 3.28 B. In HepG2 cells, a profound increase of DCF fluorescence 
was measured after 6 hours of paraquat exposure (up to 3-5 fold of control, depending on the 
concentration of paraquat used) that was diminished after longer incubation (1.5-2 fold after 
12 hours). After prolonged time points (24 and 48 hours) the measured fluorescence intensity 
decreased to levels around control or even below control in the case of higher paraquat 
concentrations. This might be explained by the fact that cell metabolism and growth were 
already severely affected by paraquat treatment, resulting in a diminished growth rate when 
compared to control cells. Hence, the cell-density-dependent ratio of DCF fluorescence in 
regard to controls decreased below 1-fold. Similar observations were made with the other 
stressors. To rule out the possibility that the plasticity of peroxisomes as such was diminished 
or impaired in the HepG2 cells used, e.g. due to changing culture conditions, HepG2 cells 
(grown under serum-free conditions in this model system (2.8.9)) were stimulated with 10 % 
FCS and the fatty acids arachidonic acid (AA) and palmitic acid (PA) as described before 
(Schrader et al., 1998a). Although application of ROS stressors did not lead to any 
peroxisome tubulation, stimulation with serum and AA induced a profound tubulation when 
compared to controls (Fig. 3.28 C), indicating that the dynamics of the peroxisomal 
compartment were  not impaired as such.  
In a different set of experiments, the effect of mitochondrially-derived oxidative stress on 
peroxisome morphology was assessed. However, using different concentrations of malonate, 
an inhibitor of complex II of the mitochondrial electron transfer chain, no induction of 
peroxisome tubulation was observed in HepG2 cells (Fig. 3.28 A). In a parallel study, similar 
observations were made using rotenone and sodium azide (inhibitors of complex I and IV, 
respectively) in COS-7 cells (master thesis S. Pinho, co-supervisor N. Bonekamp): while both 
compounds led to a slight increase in oxidative stress (quantified by DCF measurement), 
sodium azide failed to induce profound peroxisome tubulation while rotenone treatment led to 
the formation of elongated peroxisomes. However, this observation was subsequently linked 
to its microtubule-depolymerising effects and not to oxidative stress or impairment of 
mitochondrial function. Interestingly, an induction of tubular peroxisomes was observed upon 
treatment with L-buthionine sulfoximine (BSO), a compound that changes cellular redox state 
by irreversibly inhibiting the rate-limiting enzyme of GSH synthesis (Griffith & Meister, 
1979).  
While HepG2 cells responded to external growth factor stimulation, but also to UV 
irradiation, with an elongation of the compartment, induction of cytosolic oxidative stress did 
not result in significant alterations of peroxisome dynamics. Furthermore, inhibition of the 
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mitochondrial electron transfer chain and subsequent ROS generation did not alter 
peroxisome morphology. Hence, these stimuli were excluded from further studies analyzing 
the molecular basis of peroxisome elongation. These findings indicate that mammalian 
peroxisomes do not respond to oxidative stress with a generalized, morphological ROS 
reponse, but that other factors contribute to modulate peroxisome morphology. For instance, 
while UV irradiation increases intracellular oxidative stress, it might trigger the activation of 
additional signalling cascades contributing to the observed peroxisome elongation. Moreover, 
the observations made after exposure to BSO suggest that alterations of peroxisome 
morphology might be more closely linked to changes in the cellular redox-state, but not a 
global increase in oxidative stress.  
3.3.2.3 Compartment-specific activation of KillerRed does not induce peroxules or 
peroxisomal tubules 
A possible compartment-specific effect of ROS increase on peroxisome dynamics was further 
investigated by live cell imaging using KillerRed. KillerRed is a phototoxic dimeric red 
fluorescent GFP-like protein that exceeds the phototoxic properties of any GFP protein by at 
least 1.000 fold (Bulina et al., 2006a; Bulina et al., 2006b). Being genetically encoded, it can 
either be fused to any protein or be targeted to any organelle of choice, where the fusion 
protein will produce primarily superoxide radicals upon green light activation. To examine an 
effect of compartment-specific ROS induction on peroxisome dynamics, KillerRed constructs 
targeted to either the cytosol (KillerRed-C) or mitochondria (KillerRed-Mito) were obtained. 
Additionally, the existence of small peroxisomal protrusions (peroxules) that are formed upon 
induction of short-term oxidative stress (up to 2 hours) in plant cells (Sinclair et al., 2009) 
was investigated in this set-up by determining alterations in peroxisome dynamics 30 – 90 
minutes after KillerRed activation. COS-7-GFP-PTS1 cells, chosen because of their plastic 
peroxisomal compartment and their easy manipulation, were transfected with either 
KillerRed-C or KillerRed-Mito and subjected to live cell imaging using a Zeiss LSM 510 
Meta confocal microscope equipped with a PECON chamber 24 hours later. According to the 
protocol (Bulina et al., 2006b), single cells expressing KillerRed were chosen and focused 
quickly in the centre of the image window. Exposure to green fluorescent light was kept to a 
minimum to avoid premature photobleaching. Using the 488 laser line, an image was taken of 
peroxisomal GFP-PTS1 prior to bleaching, then KillerRed activation was performed using the 
green fluorescent light of the mercury lamp. As expected, there was a profound 
photobleaching of KillerRed upon green light illumination and, in line with the 
manufacturer’s instructions, cells were irradiated for twice as along as required for 
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photobleaching to ensure a reliable phototoxic effect (Bulina et al., 2006b). After 
photobleaching, images were taken every 60 seconds for 30-90 minutes using the 488 and 561 
laser lines. Although KillerRed-C as well as KillerRed-Mito was clearly targeted to the 
respective compartments (Fig. 3.29, pre-bleach), and there was a successful photobleaching of 
KillerRed consistent with its activation and induction of oxidative stress, no changes in 
peroxisome morphology – including the formation of smaller tubules – were observed in live 
cell imaging. Even after longer time periods, there was no generation of tubular peroxisomes 
(Fig. 3.29), indicating that increased levels of both cytosolic and mitochondrial oxidative 
stress do not effect peroxisome dynamics.  
 
Fig. 3.29: Activation of KillerRed targeted to the cytosol or mitochondria does not alter  peroxisome dynamics. 
COS-7-GFP-PTS1 cells were transfected with either KillerRed-C (upper panel) or KillerRed-Mito (lower panel). 24 hours 
later, cells were subjected to live cell imaging using a LSM 510 Meta confocal microscope. Before activation of KillerRed 
images of single cells were taken (Pre-bleach). After photobleaching of KillerRed, images were collected every 60 seconds 
for 30-90 minutes.  
Bars, 20µm.  
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In another set of experiments, the effect of an increase in intra-peroxisomal oxidative stress 
on peroxisome dynamics was examined. Therefore, a peroxisomally-targeted variant of 
KillerRed was generated by fusion of a C-terminal fragment of AOX to the C-terminus of 
KillerRed (KR-PO, Fig. 3.30, A-C). To ensure proper targeting, KR-PO was transfected into 
COS-7-GFP-PTS1 cells and co-localization of signals was observed by epifluorescence 
microscopy (Fig. 3.30, C). Note that in some cells, a cytosolic signal of KR-PO was observed, 
indicating a slower targeting of the construct into peroxisomes which is consistent with 
findings made in a recent study (Ivashchenko et al., 2011). For live cell imaging and 
activation of KR-PO, the construct was transfected into COS-7-GFP-PTS1 cells and subjected 
to the imaging procedure described above. Single cells displaying a clearly peroxisomal 
morphology were chosen.  
 
Fig. 3.30: Activation of 
peroxisomal KillerRed 
does not affect 
peroxisome dynamics.  
(A-C) COS-7-GFP-
PTS1 (B) cells were 
transfected with 
KillerRed-PO (KR-PO, 
A). 24 hours later, cells 
were fixed and mounted 
for epifluorescence 
microscopy. Merge of 
signal is shown in C.  
(D) KR-PO was 
transfected into COS-7-
GFP-PTS1 cells.  24 
hours later, cells were 
subjected to live cell 
imaging using a LSM 
510 Meta confocal 
microscope. Before 
activation of KillerRed 




KillerRed, images were 
collected every 60 
seconds for 30-90 
minutes.  





Similar to the observation made with the cytosolic or mitochondrial variant, activation of the 
peroxisomally-targeted KillerRed variant did not result in any, not even short-term, changes 
in peroxisome morphology (Fig. 3.30, D) which maintained a primarily spherical appearance.  
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Thus, the observations made in live cell upon activation of the photosensitizer KillerRed 
targeted to the cytosol, mitochondria or peroxisomes support the aforementioned results 
obtained in fixed cells after treatment with oxidative stressors and inhibitors of the 
mitochondrial electron transfer chain. Moreover, small protrusions of peroxisomes, similar to 
the peroxules in the plant system, were never seen in this study.  
In summary, no peroxisomal oxidative stress response coinciding with a profound alteration 
in peroxisome dynamics occurred in the mammalian system; however, additional signals 
might contribute to mediate a morphological response. Furthermore, peroxisomal 
characteristics other than dynamics may be affected by oxidative stress.  
3.3.3 Dexamethasone treatment leads to an elongation of peroxisomes in 
AR42J cells 
While screening for external stimuli affecting peroxisome dynamics, the effect of the 
synthetic glucocorticoid dexamethasone on peroxisome morphology was tested in rodent 
AR42J cells. AR42J cells were originally derived from a rat pancreatic tumour following 
exposure to azaserine (Longnecker et al., 1979) and have been used as a model system for 
granule formation and pancreatic exocrine secretion (Swarovsky et al., 1988). Treatment with 
the synthetic glucocorticoid dexamethasone induces the differentiation of AR42J cells into 
exocrine, acinar-like cells and the de novo formation of electron-opaque secretory granules, 
which contain the major pancreatic zymogens (Logsdon et al., 1985; Logsdon et al., 1987; 
Swarovsky et al., 1988). For instance, secretory differentiation markers such as 
chymotrypsinogen and amylase show a profound induction in regard to their mRNA and 
synthesis rates (Scheele, 1993).   
To determine potential changes in peroxisome morphology, AR42J cells were seeded on 
coverslips and the next day, cells were induced using either 10 nM or 1 µM dexamethasone, a 
more pathophysiological concentration (Du et al., 2009). The cell culture medium was 
exchanged using fresh dexamethasone every day. Untreated controls and treated cells were 
fixed after 6, 24, 48 and 72 hours and processed for immunofluorescence against the 
peroxisomal membrane protein Pex14p. Routinely, co-staining with the secretory granule 
marker chymotrypsin was included as a positive control in order to verify successful 
induction of zymogen granules which are profoundly induced upon glucorticoid induced 
secretory differentiation (see above).  
Peroxisome morphology was examined by confocal microscopy. Peroxisomes in AR42J cells 
usually display a small, spherical appearance (Fig. 3.31, A), however, upon prolonged 
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treatment with dexamethasone more elongated structures became prominent within the cells 
(e.g. Fig. 3.31, E, F, K). Moreover, the overall number of cells with tubular peroxisomes 
increased. These observations were made after 24, 48 and 72 hours of treatment, but not after 
6 hours (Fig. 3.31. A-C). Furthermore, using a higher concentration of dexamethasone, the 
overall number of cells with tubular peroxisomes increased as well as the degree of tubulation 
within single cells, indicating a dose-dependent effect of dexamethasone. To substantiate 
























Fig. 3.31.: Dexamethasone induces peroxisome tubulation in AR42J cells.  
AR42J cells were seeded on glass coverslips and were subsequently induced with either 10nM (B, E, H, K) or 1µM 
dexamethasone (C, F, I, L) after 24 hours. Untreated controls (A, D, G, J) and treated cells were fixed after 6, 24, 48 and 72 
hours and processed for immunofluorescence against the peroxisomal marker protein Pex14. Changes in peroxisome 
morphology were assessed by confocal microscopy.  
Bars, 10µm, except for H and L, 5µm. 
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For statistical analysis, untreated controls and induced AR42J cells were processed for 
immunofluorescence and epifluorescence microscopy as described above and peroxisome 
morphology was either determined to be spherical (e.g. Fig. 3.31 A) or tubular (Fig. 3.31 E) 
and grouped accordingly.  
 
 
Fig. 3.32: Dexamethasone induces 
peroxisome elongation in a dose-
dependent manner.  
(A) For statistical analysis, untreated 
controls and dexamethasone-induced 
AR42J cells were processed 
immunofluorescence against Pex14p and 
chymotrypsin as described. Peroxisome 
morphology was either determined to be 
round/spherical or tubular and 100 cells per 
coverslip were counted. Per experimental 
condition, 2 coverslips were analyzed and 
data is presented from 4 independent 
experiments as means +/- SD (*, p<0.05; 
**, p<0.01 when compared to controls). 
(B) Distribution of tubular peroxisomes 
after dexamethasone treatment over time.  
The percentage of tubular peroxisomes 
determined above was plotted against the 
different time points.  
(C) Secretory granules are successfully 
induced upon dexamethasone treatment.  
As a control, untreated controls and 
dexamethasone-treated AR42J cells were 
processed for immunofluorescence against 
the granule marker chmyotrypsin after the 
indicated time points. For statistical 
analysis, 100 cells/coverslips were counted. 
Data is presented as means +/- S.D. and 









While 6 hour treatment of 
AR42J cells with both concentrations of dexamethasone did not result in a profound change 
in peroxisome morphology (Fig. 3.32 A, 6 hours), prolonged incubation with dexamethasone 
for 24, 48 and 72 hours clearly induced a significant increase in the number of tubular 
peroxisomes when compared to respective controls. The difference between controls and 
treated cells became more prominent over time, as peroxisomes in control cells were observed 
to acquire a smaller, more spherical morphology with increased culture time (and cell 
density). Application of the higher dexamethasone concentration (1 µM) further increased the 
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percentage of tubular peroxisomes, indicating a dose-dependent effect of dexamethasone on 
peroxisome dynamics.   
Plotting of the percentage of tubular peroxisomes over time (Fig. 3.32 B) revealed a clear 
trend for peroxisome tubulation: peroxisomes in untreated controls reached their peak tubular 
morphology 6 hours after induction (and 24 hours after seeding) after which the number of 
tubular structures steadily decreased to reach a minimum after 72 hours. Upon treatment with 
10 nM dexamethasone, however, the percentage of tubular peroxisomes increased after 24 
hours of induction and - after reaching a slight plateau after 48 hours – increased even further 
to reach a maximum at 72 hours after induction. A steady and even more dramatic continuous 
increase in the percentage of tubular peroxisomes was observed at the higher concentration of 
1 µM dexamethasone. Successful stimulation with dexamethasone was verified by examining 
the induction of zymogen granules in AR42J cells. Controls and treated cells were processed 
for immunofluorescence against the granule marker chymotrypsin and analyzed by 
epifluorescence microscopy (Fig. 3.32 C). Stimulation with dexamethasone led to a re-
arrangement of the secretory compartment in AR42J cells concomitant with an increase in 
chymotrypsin-positive granular structures after 24 – 72 hours. Still, it must be noted that not 
all cells displaying tubular peroxisomes also contained granular structures, indicating two 
uncoupled processes.  
These findings indicate that dexamethasone induces the formation of tubular peroxisomes in a 
dose-dependent manner that is uncoupled from granule induction. Moreover, continuous 
application of dexamethasone seems to provide a constant stimulus for peroxisome 
tubulation, most probably inhibiting subsequent fission, as no obvious increase in the number 
of spherical peroxisomes was observed.  
 
3.3.4 One-time stimulation with dexamethasone is sufficient to induce 
peroxisome elongation 
Above findings indicate that application of dexamethasone provided a continuous stimulus for 
peroxisome elongation that did not result in an apparent subsequent fission of the tubuli which 
would be reminiscent of peroxisome proliferation. Thus, it was interesting to analyze if 
removal of dexamethasone after initial stimulation would lead to a breakdown of the tubules 
by fission and thus, an increase in peroxisome numbers. AR42J cells were seeded on 
coverslips and treated with 10 nM dexamethasone as described. Dexamethasone was then 
removed either 24 or 48 hours after initial stimulation and cells were thoroughly washed 
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before regular culture medium was applied. Upon shift to normal medium, cells were 
incubated for another 48 or 24 hours, respectively. 72 hours after initial induction, cells were 
fixed and processed for epifluorescence microscopy. Untreated controls as well as 
continuously treated AR42J cells were included as negative or positive controls. For statistical 
analysis, peroxisome morphology was assessed to be either spherical or tubular and cells were 
















Fig. 3.33: Initial dexamethasone treatment is sufficient to maintain elongated peroxisomes.  
AR42J cells were seeded on coverslips and treated with 10nM dexamethasone. Dexamethasone was removed after either 24 
or 48 hours after stimulation and cells were thoroughly washed before they were shifted to regular culture medium. Then, 
cells were incubated for another 48 or 24 hours, respectively. 72 hours after initial induction cells were fixed and processed 
for epifluorescence microscopy. Untreated controls as well as continuously treated AR42J cells were included as negative or 
positive controls. For statistical analysis, peroxisome morphology was assessed to be either spherical or tubular and 100 
cells/coverslip (2 coverslips/condition) were analyzed accordingly. Data is shown as means +/- SD and derived from 3 
independent experiments. (*, p<0.05; when compared to untreated controls). 
 
Consistent with the observations made before, the large majority of untreated control cells 
contained spherical peroxisomes 72 hours after mock stimulation (Fig. 3.33, Con), whereas 
treatment with dexamethasone resulted in a significant increase in the number of tubular 
peroxisomes (Fig. 3.33, 10 nM Dexa, 72h). Surprisingly, removal of dexamethasone after 
either 24 or 48 hours and subsequent cultivation without further stimulation still led to a 
profound increase in the number of tubular peroxisomes after 72 hours, very similar to what 
was observed for continuous stimulation (Fig. 3.32).  
These findings indicate that even shorter application of dexamethasone treatment is sufficient 
to exert its downstream events on the peroxisomal level, most likely involving effects on the 
peroxisomal growth and division machinery.  
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3.3.5 The observed changes in peroxisome morphology after dexamethasone 
treatment are reminiscent of the phenotype of Pex11pβ overexpression 
The previous findings characterized a novel effect of dexamethasone on the formation of 
tubular peroxisomes in rodent AR42J cells. The formation of tubular peroxisomes displaying 
a “beads-on-a-string”-like morphology was shown to be indicative of the early steps of 
peroxisomal growth and division (Schrader & Fahimi, 2006), a process in which the Pex11 
family of proteins was shown to be key mediators of membrane elongation processes 
(Schrader et al., 2011). Thus, the overall morphology of peroxisomes after dexamethasone 
stimulation was compared to an overexpression phenotype of the three mammalian Pex11 
isoforms in AR42J cells. AR42J cells were transfected with myc-tagged variants of the 
human Pex11 isoforms, Pex11pα, Pex11pβ and Pex11pγ. After 24 hours cells were fixed and 
processed for immunofluorescence against the myc epitope and the peroxisomal membrane 
marker PMP70 to ensure proper targeting. Confocal images were acquired using a Zeiss LSM 
510 Meta confocal setup (Fig. 3.34). Upon overexpression, all three isoforms were 
successfully targeted to peroxisomes (Fig. 3.34, C, F and I). While overexpression of myc-
Pex11pα did not result in the formation of tubular peroxisomes (Fig. 3.34 A-C), expression of 
the ubiquitously expressed Pex11pβ isoform (Fig. 3.34 D-F) led to a prominent elongation of 
the peroxisome compartment, reminiscent of the phenotype observed after dexamethasone 
stimulation. Expression of the Pex11pγ variant resulted in some elongation of peroxisomes, 
albeit not as strong as the observed Pex11pβ phenotype (Fig. 3.34 G-I).  
As there was a striking similarity between the observed peroxisome morphology after 
dexamethasone treatment and overexpression of Pex11pβ, our results point to a relationship 
between dexamethasone-induced peroxisome elongation and the regulation of the mammalian 
Pex11 proteins. Therefore, they were selected as prime candidates to investigate the 
downstream effects of dexamethasone on a peroxisomal level.  
 
3.3.6 Pex11α and Pex11β are induced upon dexamethasone treatment 
To gain insight into the effects of dexamethasone on the regulation of the three mammalian 
Pex11 isoforms, uniquely peroxisomal regulators of peroxisomal growth and division, their 
expression pattern was assassed by semi-quantitative RT-PCR (SQ-PCR).  
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Fig. 3.34: Overexpression of the three human isoforms of Pex11 in AR42J cells.  
AR42J cells were transfected with myc-tagged variants of the 3 human isoforms of Pex11, Pex11pα (A-C), Pex11pβ (D-F) 
and Pex11pγ (G-I). After 24 hours, cells were fixed and processed for immunofluorescence against the myc epitope (A, D, 
G) and the peroxisomal membrane protein PMP70 (B, E, H). Images were taken using a LSM 510 Meta confocal 
microscope. Merge of signals is shown in C, F and I, respectively.  
Bars, 20µm.  
 
Rodent AR42J cells were treated with 10 nM (+) or 1 µM (++) dexamethasone for 24, 48 and 
72 hours. Untreated cells (-) as well as induced ones were harvested, total RNA was extracted 
and transcribed into cDNA. Semi-quantitative RT-PCR was subsequently performed using 
specific primer pairs for the three rat Pex11 isoforms, while AOX and GAPDH served as a 
internal controls (Fig. 3.35). The PCR reaction was stopped after pre-determined cycle 
numbers (2.5.4.2) to ensure that the reaction was still in its exponential phase and reliable 
conclusions in regard to initial copy numbers could be made.  
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Fig. 3.35: Pex11α and Pex11β 
are induced by 
dexamethasone treatment.  
Rodent AR42J cells were 
treated with 10 nM (+) or 1 
µM (++) dexamethasone for 
24, 48 and 72 hours. Untreated 
cells (-) as well as induced 
ones were harvested, total 
RNA was extracted and 
transcribed into cDNA. Semi-
quantitative RT-PCR was 
subsequently performed using 
specific primers for the 3 
Pex11 isoforms, AOX and 
GAPDH as a loading control. 






Detection of the housekeeping gene GAPDH revealed that its expression was not affected by 
stimulation with dexamethasone (Fig. 3.35), thus serving as an adequate normalization 
control. In regard to the Pex11 isoforms, there was a clear induction of Pex11α after 24, 48 
and 72 hours of treatment: in non-treated controls faint, barely visible bands appeared under 
the conditions chosen which became clearly detectable using both dexamethasone 
concentrations chosen. In untreated controls, a signal for Pex11β was observed, in line with 
its ubiquitous, consistent expression in all tissues. Interestingly, although Pex11β is usually 
regarded as a non-inducible Pex11 isoform, since it is not induced upon treatment with 
classical PPARα-dependent proliferators (1.2.4), Pex11β levels were increased after 
dexamethasone stimulation for 24 and 48 hours when compared to controls. After 72 hours, 
no significant difference between control and stimulated Pex11β expression levels was 
observed. The third Pex11 isoform, Pex11γ was barely detected at all under the conditions 
chosen, thus only contributing marginally to the regulation of peroxisome morphology in 
AR42J cells. The induction of the peroxisomal key enzyme AOX mirrored the expression 
pattern of Pex11α, as it was induced after all the time points investigated. Interestingly, both, 
AOX and Pex11α. are induced by the action of the nuclear transcription factor PPARα (1.2.4), 
thus their induction pattern was very much reminiscent of peroxisome proliferation induced 
by e.g. fibrates.  
To verify these findings on a protein level, peroxisome-enriched fractions of controls and 
dexamethasone treated samples (10 nM and 1 µM) were prepared and subjected to SDS-
PAGE and immunoblotting against AOX and Pex11pβ. Detection of actin levels was used as 
a loading control (Fig. 3.36).  
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Fig. 3.36: AOX induction is reflected 
on the protein level.  
AR42J cells were treated with no (-), 10 
nM (+) or 1 µM (++) dexamethasone for 
24, 48 and 72 hours. Cells were 
harvested and peroxisome-enriched 
fractions were generated before equal 
amounts of protein were subjected to 
SDS-PAGE and immunoblotting against 
the peroxisomal markers AOX and 
Pex11pβ as well as actin as a loading 
control.  
Asterisks in the upper panel indicated the 
respective AOX bands at around 50 and 








Whereas signals corresponding to AOX were only faintly detected under control conditions at 
all time points (Fig. 3.36, asterisks), there was a prominent increase in AOX protein levels 
after dexamethasone treatment, similar to the induction pattern observed by semi-quantitative 
PCR. Equal loading was ensured by detection of actin signals. In regard to Pex11pβ, several 
slight bands were observed at higher molecular weights; however, none of those corresponded 
to its approximate protein size of 28 kD. While this might also indicate that the overall 
expression levels of Pex11pβ remained below the detection threshold, it is more likely that the 
Pex11pβ antibody, which was raised against a peptide of the human protein, does not cross-
react with the rat protein as indicated on its datasheet. In line with this, no clear antibody 
signal corresponding to Pex11pβ was detected after indirect immunofluorescence of control 
and dexamethasone-treated AR42J cells.   
In conclusion, dexamethasone treatment induced PPARα-inducible peroxisomal enzymes like 
AOX, a pattern indicative of peroxisome proliferation. Notably, not only the inducible 
Pex11α isoform was up-regulated on a transcriptional level, but also Pex11β which is not 
induced by classical PPARα-dependent proliferators. Although both Pex11 isoforms were 
shown to be up-regulated and thus able to contribute to the observed alterations of peroxisome 
morphology, only Pex11pβ induced a profound tubulation of peroxisomes (1.2.2.1) (Fig. 
3.35), similar to what was observed after dexamethasone addition.  
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3.3.7 AR42J cells do not respond to bezafibrate with peroxisome 
proliferation  
Although several stimuli have been identified that lead to peroxisome proliferation and/or 
elongation, signal transduction events linked to changes in peroxisome dynamics are largely 
limited to the activation of PPARα in rodents. Upon binding of ligands – such as fatty acids 
and fibrates – PPARα forms heterodimers with RXR receptors, enabling them to bind to 
PPREs (1.2.4). As a result, there is a significant increase in peroxisome number as well as an 
induction in fatty acid β-oxidation enzymes such as AOX. The mechanism of transcriptional 
up-regulation via PPARα/PPRE is largely similar to induction by glucocorticoids. 
Furthermore, the response elements share large similarity, although Pex11β was never shown 
to be regulated by PPARα. In order to exclude that the observations made upon 
dexamethasone treatment represent merely an unspecific effect, AR42J cells were treated with 
bezafibrate, a well-known inducer of PPARα. Bezafibrate was renewed every day. For 
morphological and statistical analysis, untreated controls and treated cells were fixed after 24, 
48, 72 and 96 hours and processed for epifluorescence microscopy (Fig. 3.37 A-C). 
Peroxisome morphology was determined to either be spherical or tubular and statistical 
analysis was performed. In contrast to the observations made for dexamethasone, 
peroxisomes retained their primarily spherical morphology and tubular peroxisomes were 
seldom observed (Fig. 3.37 B). Statistical analysis further indicated that bezafibrate failed to 
induce peroxisome tubulation in contrast to dexamethasone. Moreover, no obvious increase in 
peroxisome number was noticed. To compare the peroxisomal induction profiles of 
bezafibrate and dexamethasone, semi-quantitative RT-PCR was performed. AR42J cells were 
treated with bezafibrate for 96 hours, total RNA was extracted and cDNA was transcribed. 
Semi-quantitative RT-PCR was performed using primers against the rat Pex11 isoforms as 
well as AOX and GAPDH as controls. Surprisingly, while detected levels of the loading 
control GAPDH or the constitutively expressed Pex11β largely remained the same, no 
induction of either Pex11α or AOX was determined, unlike what was consistently shown for 
bezafibrate treatment in rodent hepatocytes. Similar observations were made upon treatment 
with ETYA, a analogue of arachidonic acid shown to activate PPARα (data not shown). An 
induction of AOX was further not detected by immunoblotting (Fig. 3.37 C).  
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Fig. 3.37: Bezafibrate does not induce peroxisome 
proliferation in rodent AR42J cells.  
(A-C) AR42J cells were either mock treated (Con) or 
treated with bezafibrate for 24, 48, 72 or 96 hours. 
Cells were fixed and processed for 
immunofluorescence against the peroxisomal marker 
Pex14. For statistical analysis, peroxisome 
morphology was either assessed to be spherical or 
tubular. 100 cells/coverslip were counted accordingly 
(2 coverslips/condition) and data is shown as means 
+/- SD.  
Bars, 20µm. 
(D) Expression profiles of bezafibrate treated AR42J 
cells.  
AR42J cells were treated with bezafibrate for 96 
hours, total RNA was extracted and cDNA was 
transcribed. Semi-quantitative RT-PCR was 
performed using primers against the Pex11 isoforms 
as well as AOX and GAPDH as controls. To validate 
findings on a protein level, peroxisome-enriched 
fractions of controls and bezafibrate treated samples 
were prepared and subjected to SDS-PAGE and 





Thus, our findings indicate that rodent pancreatic AR42J cells do not respond to bezafibrate 
treatment in a manner similar to rat hepatocytes. However, they responded prominently to 




In the final part of this thesis, stimuli altering peroxisome dynamics were screened for to 
delineate the relationship between peroxisome morphology and function, but also to establish 
a mammalian cell culture model to investigate signal transduction regulating peroxisome 
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dynamics. Although the neurotoxin 6-OHDA led to the fragmentation of mitochondria in a 
DLP1-dependent manner, no effect on peroxisome dynamics was observed which maintained 
a primarily spherical morphology. Induction of cytosolic oxidative stress, inhibition of the 
mitochondrial respiratory chain as well as the compartment-specific generation of superoxide 
radical using the genetically-encoded photosensitizer KillerRed did not result in any short or 
long-term alterations of peroxisome dynamics. Thus, previously observed alterations of 
peroxisome morphology (e.g after UV irradiation) might not be exclusively linked to the 
induction of oxidative stress, but to other factors such as the intra- or extracellular origin of 
the signal, cellular redox-state or other signalling pathways. In contrast to that, addition of 
dexamethasone to rodent pancreatic AR42J cells significantly elongated peroxisomal 
membranes in a dose-dependent manner. Notably, peroxisomes maintained their tubulated 
morphology without subsequent peroxisome fission, even after removal of the external 
stimulus. Dexamethasone action was linked to an induction of Pex11α and the PPARα-
independent proliferator Pex11β by SQ-PCR by a potentially PPARα-independent 
mechanism. The classical peroxisome proliferator bezafibrate did not elicit any proliferative 
response in rodent pancreatic AR42J cells, contrary to rodent hepatocytes, which indicated the 
cell line to be a non-responder. The rodent AR42J cell line thus has high potential to serve as 
a highly reliable model system to study stimulus-induced alterations of peroxisome dynamics 
(without a large-scale manipulation of the peroxisomal growth and division machinery by e.g. 
overexpression of Pex11p).   
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4 DISCUSSION: TOWARDS AN UNDERSTANDING OF PEROXISOME 
DYNAMICS IN MAMMALIAN CELLS 
 
Peroxisomes are ubiquitous, dynamic cell organelles that play a key role in numerous 
metabolic processes such as the α- and β-oxidation of fatty acids, the biosynthesis of 
plasmalogens and bile acids as well as the metabolism of ROS (van den Bosch et al., 1992; 
Wanders & Waterham, 2006b; Bonekamp et al., 2009; Bonekamp et al., 2011a; Fransen et al., 
2011) (1.1.2). Moreover, novel biological functions continue to emerge, such their 
involvement in antiviral signalling (Dixit et al., 2010). Interestingly, many of the above 
mentioned functions are performed in co-operation with mitochondria (Schrader & Yoon, 
2007; Bonekamp et al., 2009; Camoes et al., 2009; Dixit et al., 2010; Ivashchenko et al., 
2011) (1.3). Peroxisomes and mitochondria also share components of their fission machinery 
and evidence has even been provided for a vesicular trafficking pathway between the two 
organelles (Neuspiel et al., 2008; Delille et al., 2009; Braschi et al., 2010; Schrader et al., 
2011), indicating that the organelles share a much closer interrelationship than previously 
appreciated (Schrader & Yoon, 2007; Camoes et al., 2009). As a result of the essential 
contribution of peroxisomes to cellular homeostasis, disturbances of their functions and 
biogenesis lead to severe disorders (Steinberg et al., 2006; Wanders & Waterham, 2006a) 
(1.1.4). Originally, peroxisomes were thought to be autonomous organelles like mitochondria 
that multiply solely by growth and division from pre-existing organelles (Lazarow & Fujiki, 
1985; Schrader & Fahimi, 2006), however, they were also observed to arise de novo from the 
ER under special conditions (Hoepfner et al., 2005; Kim et al., 2006; Hettema & Motley, 
2009; Nagotu et al., 2010).  The contribution of both processes under wild-type conditions in 
different species remains a matter of debate (Motley & Hettema, 2007; Hettema & Motley, 
2009; van der Zand et al., 2010). In mammalian cells, peroxisome growth and division was 
shown to follow a well-defined sequence of morphological alterations: initial membrane 
elongation of the compartment is carried out by the key peroxisomal membrane protein 
Pex11pβ, whereas the combined action of the tail-anchored proteins Mff and Fis1 as well as 
the large GTPase DLP1 mediates final fission into smaller, spherical organelles (Koch et al., 
2003; Li & Gould, 2003; Koch et al., 2005; Gandre-Babbe & van der Bliek, 2008; Otera et 
al., 2010; Schrader et al., 2011). While the key components of the fission machinery are 
shared with mitochondria (1.2.2), Pex11 proteins are uniquely peroxisomal and are, up until 
now, the only proteins identified to mediate peroxisome multiplication/proliferation in 
mammals which places them in the centre of regulating peroxisome dynamics. Proteins of the 
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Pex11 family have been identified across species for several years (Erdmann & Blobel, 1995; 
Marshall et al., 1995; Abe & Fujiki, 1998; Abe et al., 1998; Schrader et al., 1998b; Li et al., 
2002a; Thoms & Erdmann, 2005; Lingard & Trelease, 2006; Schrader et al., 2011), but only 
recently the contribution of Pex11pβ to a multi-step maturation process of peroxisomal 
growth and division has been characterized (Delille et al., 2010). Moreover, studies on P. 
chrysogenum Pex11p have defined the importance of an N-terminal amphipathic helix in 
mediating membrane tubulation (Opalinski et al., 2011). In order to fulfil their multiple 
functions, peroxisomes are known to adjust their enzyme content, but also their number and 
morphology. For instance, UV irradiation, ROS, fatty acids and growth factors were 
previously shown to induce peroxisome elongation in mammalian cell culture models 
(Schrader et al., 1998a; Schrader et al., 1999). Moreover, treatment of rodents with 
hypolipidemic compounds such as fibrates not only leads to an increase in peroxisome 
number, but also an induction of enzymes involved in fatty acid β-oxidation (Hess et al., 
1965; Lazarow & De Duve, 1976). The latter response was linked to the action of the nuclear 
receptor PPARα and the subsequent induction of its target genes (Issemann & Green, 1990; 
Pyper et al., 2010), such as the inducible Pex11 isoform Pex11pα (Abe et al., 1998). 
However, so far, regulation of peroxisome proliferation on a the molecular level remains 
largely limited to PPARα action, although several studies point to the existence of PPARα- 
and Pex11pα-independent mechanisms (Li et al., 2002a; Bagattin et al., 2010). (Gorgas, 1987; 
Kollatakudy et al., 1987; Schrader et al., 2000; Ribeiro et al., 2011). It has become clear in 
recent years that organelle morphology and dynamics are intricately linked to function and 
thus, human well-being. In line with this, a lethal defect affecting peroxisomal and 
mitochondrial fission has been identified (Waterham et al., 2007). Moreover, alterations in 
peroxisome dynamics and perturbations of  their number are linked to several 
pathophyiological conditions such obesity, AOX1 deficiency and cancer (Chang et al., 1999; 
Lauer et al., 1999; Funato et al., 2006; Frederiks et al., 2010; Diano et al., 2011), therefore 
controlled manipulation of peroxisome proliferation (and morphology) might provide an 
interesting therapeutic target counteracting pathophysiological defects. 
Thus, the aim of this thesis was to gain insight into the processes contributing to and 
regulating peroxisome dynamics in mammalian cells, both on a transcriptional and a post-
translational level. These issues will be the focus of future research.   
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4.1 PEROXISOMAL DYNAMICS: DO MAMMALIAN PEROXISOMES 
FUSE?  
4.1.1 Unlike mitochondria, mature mammalian peroxisomes do not exchange 
matrix or membrane components   
Both mitochondria and peroxisomes are known to co-operate extensively in regard to 
metabolic activity and have also been shown to share key components of their fission 
machinery (Schrader & Yoon, 2007; Camoes et al., 2009). Moreover, both are very dynamic 
organelles prone to frequent changes in number and size, however, mitochondria fuse with 
one another to exchange matrix and membrane components (for review, see Okamoto & 
Shaw, 2005; Bereiter-Hahn & Jendrach, 2010; Westermann, 2010). In addition to complete 
fusion of mitochondrial networks, a transient mitochondrial fusion was only recently 
described upon which mitochondria interact in shorter time intervals to exchange soluble IMS 
and matrix components (Liu et al., 2009). Mitochondrial fusion itself is a stepwise process 
involving the sequential fusion of the outer and inner mitochondrial membranes which is 
mediated by the concerted action of the GTPases Mitofusin 1 and 2 (Mfn) and OPA1 (optic 
atrophy protein) 1 (for review, see Okamoto & Shaw, 2005; Zorzano et al., 2010). Mfn1 and 
Mfn2 are outer mitochondrial membrane proteins that were identified to be homologues of the 
Drosophila fuzzy onions (Fzo) protein (Hales & Fuller, 1997; Santel & Fuller, 2001; Chen et 
al., 2003; Eura et al., 2003; Santel et al., 2003). Human Mfns share a 63 % sequence identity 
as well as the same functional domains and they can interact in a homotypic and heterotypic 
fashion (Griffin et al., 2006; Zorzano et al., 2010). Fusion of the mitochondrial outer 
membrane is thought to occur by tethering of individual mitochondria upon Mfn1 
dimerization that is followed by a GTP-dependent docking step. The inner mitochondrial 
membrane protein OPA1 (Mgm1p in yeast) controls mitochondrial inner membrane fusion as 
well as cristae remodelling (Cipolat et al., 2004; Chen et al., 2005; Song et al., 2007). It exists 
in eight splice variants in humans and is regulated by post-transcriptional and post-
translational mechanisms (Delettre et al., 2000; Delettre et al., 2001; Olichon et al., 2007). 
The question if peroxisomes engage in analogous fusion events, resulting in extensive 
intermixing of matrix and membrane components, remained a matter of debate. One of the 
aims of this study was to systematically investigate the existence of a potential peroxisomal 
fusion in mammalian cells and to determine if mitochondrial fusion proteins – similar to the 
fission machinery – are also shared by peroxisomes.  
  4. DISCUSSION  
 159 
In order to investigate the existence of fusion of mature peroxisomes in CHO cells 
systematically, an in vivo fusion assay was established that included the application of 
cycloheximide, a well-known inhibitor of eukaryotic protein translation, to avoid false-
positive signals due to peroxisomal import of the corresponding, newly synthesized marker 
proteins. Monitoring of mitochondrial fusion served as a positive control (Fig. 3.1). The assay 
is based on the co-cultivation of CHO cells stably expressing either a red or a green 
fluorescent protein targeted to peroxisomes and subsequent hybridoma formation by cell 
fusion. DsRed-PTS1 and GFP-PTS1 fusion proteins served as markers for the peroxisomal 
matrix (Fig. 3.2), whereas PMP70-YFP and dPex26-mDsRed represented peroxisomal 
membrane markers (Fig. 3.8). Successful shut-down of protein biosynthesis was verified by 
pulse-chase labelling with S35-methionine (Fig. 3.1). In contrast to previous findings in CHO 
cells (Huybrechts et al., 2009), yellow peroxisomes were clearly observed in time course 
experiments with fixed cells by epifluorescence and confocal microscopy (Fig. 3.2). In 
contrast to mitochondrial fusion, however, which was fast, time dependent and almost 
complete, intermixing of peroxisomal matrix and membrane markers appeared to be slow, 
independent of time, less frequent and only visible in a subpopulation of peroxisomes (Fig. 
3.2, Fig. 3.8). In depth-analyses of these observations by live cell imaging revealed that 
individual red and green peroxisomes were engaged in vivid interactions, but did not fuse. 
However, individual peroxisomes formed close contacts, which resulted in complete co-
localisation of signals, and thus the “yellow” colour which accounted for the observations 
made in fixed cells (Fig. 3.3.; Fig. 3.4). Nonetheless, the observed interaction was only 
transient and individual red and green peroxisomes remained their entities after separation. 
No exchange or mixing of labelled matrix marker proteins was detected (even after increasing 
gain settings and exposure times). The same was true for red and green peroxisomal 
membrane marker proteins. These observations strongly indicate that, unlike mitochondria, 
individual peroxisomes in mammalian CHO cells do not fuse in a way which allows an 
exchange or mixing of matrix or membrane proteins. Our observations are in line with other 
findings made for mature peroxisomes in yeasts, plants and mammals (Arimura et al., 2004; 
Motley & Hettema, 2007; Huybrechts et al., 2009). In the yeast S. cerevisiae no overlap or 
mixing between the peroxisomal matrix markers GFP-PTS1 and HcRed-PTS1 was detected in 
a mating assay (Motley & Hettema, 2007), challenging the idea that mature yeast 
peroxisomes fuse in vivo. Similar to our observations, the formation of some yellow 
peroxisomes indicated the occurrence of peroxisomal fusion in plants, which did not result in 
a transition to a uniform colour of peroxisomes, even 1 day after photoconversion of the 
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marker used (Kaede-PTS1) (Arimura et al., 2004).  Another study in mammalian CHO cells 
employed the HaloTag technology which enabled the differential labelling of peroxisomes 
and thus the generation of different peroxisome populations. Subsequent generation of 
hybridoma cells and epifluorescence microscopy revealed that peroxisomes containing newly 
imported matrix and membrane proteins do not mix their matrix content with pre-existing 
peroxisomes, as – in contrast to our observations - no spatial overlap of combined matrix 
signals was ever detected in this experimental setup (Huybrechts et al., 2009). Thus, “true” 
peroxisomal fusion processes remain limited to the multi-step peroxisome maturation process 
in the yeast Y. lipolytica (Titorenko & Rachubinski, 2000; Titorenko & Rachubinski, 2001a). 
However, none of the aforementioned studies ever addressed the formation of close contacts 
and vivid interactions between individual peroxisomes. Thus, a new dynamic behaviour 
contributing to peroxisome dynamics was characterized in the present study (see below). In 
terms of peroxisome dynamics, there are certain caveats that have to be considered. As 
peroxisomes are frequently observed to interact, but then come apart again as individual 
organelles, these observations could also be misinterpreted as peroxisomal fission events, 
especially when only one peroxisomal marker (e. g. GFP-PTS1) is used (Fig. 3.7).  
In parallel, a peroxisomal localization of the mitochondrial fusion proteins Mfn1 and 2 as well 
as OPA1 was investigated, some of which were recently shown to be targeted to multiple 
subcellular organelles: Mfn2, for example, was localized to the ER (de Brito & Scorrano, 
2008a) while OPA1 was recently identified at lipid droplets where it regulates adrenergic 
control of lipolysis (Pidoux et al., 2011). To determine the localization of mitofusins to 
peroxisomes, overexpression studies were performed in COS-7 cells stably transfected with a 
peroxisomal GFP-PTS1 and co-localization of markers was assessed by epifluorescence 
microscopy. However, wild type versions of Mfn1 and Mfn2 were not targeted to 
peroxisomes (Fig. 3.10). Moreover, expression of activity-deficient mutants of Mfn1 and 
Mfn2 did neither localize to peroxisomes nor resulted in any morphological changes of 
peroxisomes, whereas mitochondrial morphology shifted to a perinuclear aggregation as 
reported (Fig. 3.11) (Chen et al., 2003; Santel et al., 2003; Koshiba et al., 2004). Expression 
of Mfn2variants in which amino acid exchange in their C-terminal part leads to 
neutral/hydrophobic (Mfn2-IYFFT) or polar/basic (Mfn2-RRD) characteristics and thus, 
mistargeting to the ER (Rojo et al., 2002), still did not result in a peroxisomal localization. It 
was assumed that if mitofusins possess any peroxisomal targeting potential, they would be 
detectable at peroxisomes after experimental mistargeting. Moreover, OPA1 was also not 
observed at peroxisomes by immunofluorescence and immunoblotting of highly purified 
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peroxisomes (Fig. 3.12). Consequently, key mitochondrial fusion proteins (Mfn1, Mfn2 or 
OPA1) fail to localize to peroxisomes, unlike components of the fission machinery.  
 
4.1.2 Transient and complex peroxisomal interactions: a new dynamic 
behaviour of mammalian peroxisomes 
Despite the lack of evidence for an exchange or mixing of matrix content or membrane 
proteins between individual spherical peroxisomes, the organelles were observed to engage in 
vivid interactions (Fig. 3.3, Movie S1 and S2). In some cases, peroxisomes moved along 
linear tracks prior to their interaction as reported before (Schrader et al., 2000). By applying a 
simple computational model, evidence was provided that a combination of fast, ATP-driven 
movement of peroxisomes and subsequent formation of close contacts between individual 
peroxisomes can principally contribute to the homogenization (intermixing) of the 
peroxisomal compartment on a timescale of one to several hours (Fig. 3.5), e.g. to distribute 
metabolites, signals, or other “molecular information”. This model also offers an explanation 
for the previous observation that only ~15 % of peroxisomes in mammalian cells are engaged 
in fast, microtubule dependent, long range movements (Rapp et al., 1996; Wiemer et al., 
1997; Schrader et al., 2000). Apparently, no prominent advantage for homogenization or 
intermixing is achieved if all peroxisomes would participate in fast and yet energy consuming 
and costly motility. This may reflect an optimization process for rapid homogenization of 
peroxisome populations at the lowest energy costs.  
Frame by frame analysis revealed that individual peroxisomes were engaged in several 
transient and long term contacts (approximately 2 % of differentially labelled peroxisomes at 
all times), and remained in close association for about 5-40 seconds (Fig. 3.6). However, 
some peroxisomes also stayed attached to one another for extended periods of time (up to 500 
seconds). Moreover, individual peroxisomes also re-engaged in contacts, although there was a 
surplus of other potential peroxisomal interaction partners in the close vicinity. Thus, these 
interactions are not likely to be random events. Detailed analysis of the duration of interaction 
events indicated that the distribution of long term contacts displays power law behaviour 
(Rhodes & Anderson, 1996; Viswanathan et al., 2002; Newman, 2005; Sornette, 2006; 
Clauset et al., 2009; James et al., 2011) (Fig. 3.6). Power law distributions are defined to have 
heavy tails, as the number of events with higher values, in this case, the number of long term 
contacts, is substantially larger than could be expected from an exponential distribution 
(which would indicate random events). Power law distributions in biological processes are 
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indicative of the existence of intricate dynamics originating from diverse, and yet specific 
mechanisms. Hence, our analysis strongly suggests that peroxisome interactions appear to be 
more diverse and complex than assumed.  
Regarding a possible physiological function of the observed interactions, it was surmised that 
the close apposition of peroxisomes may favour an exchange of metabolites and metabolic 
cross-talk. The interactions could as well contribute to the degradation of ROS or H2O2. As 
peroxisomes are very heterogeneous in regard to density, protein composition and import 
competence between species as well as within the same cell (Heinemann & Just, 1992; Luers 
et al., 1993; Islinger et al., 2007; Wiese et al., 2007; Islinger et al., 2010), an exchange of 
metabolic information might be required. To prevent release and escape of components from 
individual peroxisomes, a close interaction might also be beneficial. In search for a 
physiological function of transient peroxisomal interactions, it was therefore investigated 
whether an increase in the heterogeneity between peroxisomal subpopulations would result in 
an enhanced frequency of peroxisomal interactions. However, pre-treatment of CHO-GFP-
PTS1 cells with peroxisomal metabolites such as fatty acids and H2O2 prior to fusion with 
non-stimulated CHO-DsRed-PTS1 cells did not result in a prominent increase of peroxisomal 
interactions (Fig. 3.9). Similar results were obtained after pre-treatment with peroxisome 
proliferators or after treatment of both cell lines prior to and after the formation of hybridoma 
cells. Thus, it is unlikely that the close apposition of peroxisomes favours an exchange of 
metabolites such as fatty acids or H2O2. However, peroxisomes contribute to a variety of 
metabolic processes (1.1.2); an exchange of other metabolites or lipids therefore cannot be 
rigorously excluded. Alternatively, the interactions might be part of a signalling system to 
sense the state and/or distribution of the peroxisomal population in the cell. This might be 
especially important in mammalian cells, where a large number of peroxisomes has to be co-
ordinately distributed in a relatively large cytoplasmic volume. It is striking that shortly after 
hybridoma formation, the red and green peroxisome populations acquire a uniform, 
intermixed distribution within the cell. Microtubule-driven fast movements of peroxisomes 
and transient contacts might thus contribute to equilibrate peroxisome pools throughout the 
cell. In line with this, the formation of small groups (or functional units) of peroxisomes has 
been observed, e.g. in conjunction with lipid droplets (Novikoff & Shin, 1964) or in HepG2 
cells after a phase of peroxisome multiplication when the cells become more confluent and 
differentiated (Stier et al., 1998). 
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4.1.3 Peroxisomal versus mitochondrial dynamics 
Despite the fact that mitochondria and peroxisomes utilize the same basic molecular 
machinery for organelle fission (Schrader et al., 2011), the findings presented here further 
stress the point that peroxisomal dynamics are regulated in manner different and distinct from 
mitochondria. In general, mitochondria engage in frequent fission and fusion processes that 
enable the repartitioning of lipids, proteins and mtDNA throughout the cells and are 
furthermore distributed throughout the cell by microtubule-dependent movements, thus 
ensuring mitochondrial homeostasis (Nakada et al., 2001; Ono et al., 2001; Li et al., 2004) 
(Fig. 4.1). Transient mitochondrial fusion events were suggested to serve as a quick re-
stocking mechanism for mitochondria in this regard (Liu et al., 2009). Moreover, the 
regulated formation of elongated structures/networks by shifting the balance to mitochondrial 
fusion was recently shown to prevent mitochondria from autophagosomal destruction upon 
nutrient starvation and represent a mitochondrial stress response (Tondera et al., 2009; Gomes 
et al., 2011; Rambold et al., 2011a; Rambold et al., 2011b). In terms of peroxisomal 
dynamics, an analogous balanced fusion/fission equilibrium regulating peroxisome dynamics 
can be excluded, but it should be noted that the observations presented here account for 
mature, spherical peroxisomes. Thus, the fusion of pre-peroxisomal structures or vesicles, e.g. 
during the formation or maturation of peroxisomes (Titorenko & Rachubinski, 2001a) cannot 
be excluded. Furthermore, in cultured cells and tissues, more complex reticular networks of 
peroxisomes have occasionally been described which appear to be engaged in vivid 
interactions (Schrader et al., 2000; Schrader & Fahimi, 2006). Hence, it cannot be rigorously 
excluded, that under more specific metabolic, environmental or developmental conditions 
peroxisomes fuse to form more complex reticular structures to fulfil special metabolic 
functions more efficiently. Nevertheless, the formation of reticular peroxisomes is unlikely to 
involve key components of mitochondrial fusion in contrast to what was recently shown for 
mitochondrial networks (Tondera et al., 2009; Gomes et al., 2011). Furthermore, in contrast to 
mitochondria, stress- or stimulus-induced elongation of mature peroxisomes (Schrader & 
Fahimi, 2006) is not mediated by a fusion of peroxisomes, but by processes of membrane 
deformation and elongation (Fig. 4.1). Additionally, our findings on the existence of transient 
and complex peroxisomal interactions add a new and interesting twist to peroxisomal 
dynamics, as they might contribute to an exchange a certain type of “molecular” information 
or as part of a signalling system to sense the state and/or distribution of the peroxisomal 
population in the cell (Fig. 4.1). Still, the physiological significance of the inter-peroxisomal 
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contacts requires further investigation. Furthermore, peroxisomes may arise de novo from the 
ER (Nagotu et al., 2010) which has not been observed for mitochondria.  
However, similar to mitochondria, peroxisomes move along microtubule tracks, share key 
fission components with mitochondria, and are engaged in transient and long term contacts 
(Fig. 4.1).  
Fig. 4.1: Comparison of mitochondrial 
and peroxisomal dynamics.  
Mitochondrial dynamics (upper panel) are 
regulated by a combination of frequent 
fusion and fission events that serve to 
homogenize the compartment. 
Mitochondrial fission is mediated by the 
action of Mff (yellow), Fis1 (red) and 
DLP1 (green), while fusion is concerted 
by the action of mitofusins (Mfn, purple) 
and OPA1 (violet). Note that fused 
mitochondria might further interact and 
fuse to form mitochondrial networks 
(lower right corner). Transport of 
mitochondria throughout the cell is 
facilitated by microtubule-dependent 
movements. Note that individual 
mitochondria continuously engage in 
cycles of fusion and fission. Peroxisomal 
dynamics (lower panel) are regulated by 
peroxisomal growth and division: unlike 
mitochondria, formation of tubular 
peroxisomal structures is facilitated by 
inherent membrane elongation mediated 
by Pex11pβ (blue). After constriction, 
fission into smaller organelles is carried 
out by the same machinery as 
mitochondrial fission. Long-range 
transport of peroxisomes is also mediated 
by the microtubule cytoskeleton. Unlike 
mitochondria, peroxisomes do not fuse 
and do not share the mitochondrial fusion 
proteins. However, they may engage in 
transient interactions that might, in 
combination with long-range transport, 
homogenize the compartment. 
Furthermore, peroxisomes arise de novo 
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4.2 REGULATION OF PEROXISOME DYNAMICS: 
CHARACTERIZATION OF MAMMALIAN PEX11Β AND ITS N-
TERMINAL DOMAIN 
The ubiquitously expressed Pex11pβ has been known to mediate elongation of the 
peroxisomal membrane prior to constriction and final fission into smaller, spherical 
peroxisomes in mammalian cells (Schrader et al., 1998b), placing this uniquely peroxisomal 
protein in the centre of regulating peroxisomal dynamics. Recently, Pex11pβ-mediated 
peroxisome proliferation was shown to follow a multistep-maturation process (Delille et al., 
2010). The mechanistic basis of the membrane elongating properties of Pex11 proteins across 
species have now been linked to the existence/action of a conserved amphipathic helix in the 
protein’s N-terminus (Opalinski et al., 2011). Although the presence of the amphipathic helix 
and thus the basic molecular mechanism of Pex11p-mediated peroxisomal membrane 
elongation appear to be conserved from yeast to mammals, it remains to be elucidated if the 
presence of the most conspicuous amphipathic helix within the human Pex11pβ isoforms is 
sufficient to induce peroxisomal membrane elongation. Furthermore, the regulation of 
Pex11pβ activity by post-translational mechanisms such as oligomerization or 
phosphorylation needs to be determined.   
 
4.2.1 Human Pex11pβ – one integral membrane protein modulating the 
morphology of  two organelles   
Insight into the regulation of Pex11pβ in mammals has been obtained from its basic domain 
structure: its very short C-terminal tail was implied to facilitate interaction with the tail-
anchored protein Fis1 which participates in the assembly of the final fission complex (1.2.2.3) 
(Kobayashi et al., 2007; Koch et al., 2010). Furthermore, Pex11pβ was shown to form homo-
oligomers  and hetero-oligomers with the mammalian gamma isoform (Li & Gould, 2003; 
Kobayashi et al., 2007; Koch et al., 2010). Its homo-oligomerization capacity is dependent on 
the presence of its N-terminal domain (aa 1-85) (Kobayashi et al., 2007), a region that also 
comprises the most conspicuous amphipathic helix (aa 45-75) within human Pex11pβ 
(Opalinski et al., 2011) (Fig. 4.2). The mode of membrane association and the topology of 
Pex11 proteins, however, may vary greatly across species (Schrader et al., 2011); for instance, 
S. cerevisiae Pex11p was initially characterized as a integral peroxisomal membrane protein 
(Erdmann & Blobel, 1995), but depending on the degree of peroxisome purification was then 
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re-defined as a peripherally associated protein of the peroxisomal membrane (Marshall et al., 
1995; Marshall et al., 1996). Similarly, although both termini of Pex11pβ were shown to 
protrude into the cytosol by in silico studies and differential permeabilization (Abe & Fujiki, 
1998; Schrader et al., 1998b), the exact position of the first transmembrane domain – and thus 
the definition of the crucial N-terminal domain – remained elusive due to the limited 
availability of suitable antibodies. In line with this, the predicted position of the first 
transmembrane domain within human Pex11pβ varies greatly, depending on the in silico 
search algorithm used (Fig. 3.13).  
In the present study, a newly available, commercial Pex11pβ antibody was characterized to 
determine the topology of the human protein. Endogenous Pex11pβ was only recognized 
weakly, thus further analyses on its topology were carried out after overexpression of either 
myc or YFP-tagged variants of Pex11pβ that were previously shown to be functional 
(Schrader et al., 1998b; Delille et al., 2010). Differential permeabilization (using Tx100, 
methanol or digitonin) and subsequent immunostaining against Pex11pβ indicated that the 
antibody epitope was located within the peroxisomal membrane or matrix (Fig. 3.16) Personal 
communication with the supplier revealed that the antibody recognizes a stretch of amino 
acids located between amino acid positions 110 and 140 which enabled us to determine 
protein topology as well as the position of the first transmembrane domain by a protease-
protection assay (Fig. 3.17). After proteinase K digest of YFP-Pex11pβ at intact peroxisomal 
membranes and subsequent immunoblotting with the Pex11pβ antibody, a protease-resistent 
fragment of approximately 17kD was detected. The molecular weight was consistent with the 
predicted fragment size obtained when the first transmembrane domain of Pex11pβ was 
located between amino acids 90 and 110 (Fig. 3.13) (PredictProtein: aa 86 – 103; TMPredict: 
aa 96 – 114) (Schrader et al., 1998b). The protease-resistant fragment was digested by 
proteinase K upon membrane permeabilization with either Tx100 or sonication (Fig. 3.17 B, 
Fig. 3.18), indicating an intra-peroxisomal localization of the region between the two 
transmembrane domains of Pex11pβ. Similar observations were made upon overexpression of 
the untagged wild-type Pex11pβ and lower concentrations of proteinase K (data not shown). 
Most of the protease-protection assays were carried out using YFP-Pex11pβ; as the YFP-
fusion protein tag itself was not digested by the action of proteinase K, most probably due to 
its very compact β-barrel structure, it served as an excellent loading control in our assay (Fig. 
3.17 B), while membrane integrity of peroxisomes was monitored by the detection of AOX 
signals (Fig. 3.18). Thus, the position of the first transmembrane domain of human Pex11pβ 
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was localized to amino acid positions 90 – 110. Consequently, the often evoked soluble N-
terminal domain of human Pex11pβ is comprised of amino acids 1-90.  
In another set of experiments, the targeting of human Pex11pβ was examined in patient 
fibroblasts devoid of Pex19p. Pex19p is a multifunctional protein, serving as a chaperone as 
well as an import-receptor for newly synthesized PMPs in the cytosol that directs PMPs to the 
peroxisomal membrane where it is tethered via interaction with Pex3p (Fransen et al., 2001; 
Fransen et al., 2004; Jones et al., 2004; Shibata et al., 2004) (1.1.5.2). In the ∆Pex19 patient 
fibroblasts, peroxisomal membrane biogenesis is impaired and peroxisomal structures are 
completely absent. Upon co-expression of myc-tagged Pex11pβ with a mitochondrial GFP in 
∆Pex19 patient fibroblasts, a clear mistargeting of Pex11pβ to mitochondria was observed 
where it significantly induced mitochondrial fragmentation (Fig. 3.19). The mitochondrial 
phenotype was reminiscent of Fis1 overexpression (which leads to mitochondrial 
fragmentation) (1.2.2.3) (Fig. 3.19 B), however, no ER localization of myc-Pex11pβ was ever 
observed. In order to address if the induced mitochondrial fragmentation was a result of 
improper/incorrect insertion of Pex11pβ into the mitochondrial membrane, the topology of 
mitochondrial Pex11pβ was assessed by using N- and C-terminally myc-tagged variants of the 
protein, differential permeabilization and subsequent immunostaining against the myc epitope 
(Fig. 3.20). Consistent with the observations made at the peroxisomal membrane, both termini 
of Pex11pβ were accessible after digitonin treatment, while the protein remained sensitive to 
Tx100. In parallel, protein topology at the mitochondrial membrane was further examined 
using the Pex11pβ antibody after differential permeabilization with Tx100, methanol or 
digitonin (Fig. 3.21). Similar to our previous findings at the peroxisomal membrane, Pex11pβ 
signals were only detected upon membrane rupture, indicating that Pex11pβ retained its 
proper topology (at least to some degree) despite its mistargeting to a different organelle 
membrane. Still, it has to be noted that in addition to its mitochondrial localization, a 
cytosolic Pex11pβ signal was detected after overexpression of GFP-tagged variants (Fig. 
3.22). Mitochondrial targeting of Pex11pβ itself was inhibited by either deletion of the first 40 
amino acids or N-terminal tagging of the protein with YFP (Fig. 3.22), i.e. that a potential 
mitochondrial targeting signal might reside within the protein’s N-terminus. However, no 
classical mitochondrial targeting signal was identified by common screening tools. Insertion 
of Pex11pβ into the mitochondrial membrane might also be facilitated by its potential default 
recognition by the mitochondrial tail-anchored protein import machinery: Pex11pβ was 
wrongly identified as a tail-anchored protein in a large scale screen due to its extreme C-
terminal transmembrane domain (Kalbfleisch et al., 2007), but the determination of its protein 
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topology at the mitochondrial membrane exclude the possibility that Pex11pβ behaves like a 
tail-anchored protein (Fig. 3.21). Furthermore, C-terminal tagging of tail-anchored proteins 
usually interferes with their proper targeting, but mitochondrial targeting of Pex11pβ was not 
affected in our case (Fig. 3.22). Thus, mitochondrial mistargeting of Pex11pβ in peroxisome-
deficient patient fibroblasts appears to be mediated by an unidentified or unspecific 
mechanism. Intriguingly, contrary to its default role as a tubulator of peroxisomal membranes, 
Pex11pβ led to a profound fragmentation of mitochondrial membranes in peroxisome-
deficient cells. As Pex11pβ was shown to interact with Fis1 (Kobayashi et al., 2007; Koch et 
al., 2010) which recruits the large GTPase DLP1 to peroxisomes and mitochondria, Pex11pβ-
induced fragmentation of mitochondria might be mediated by a DLP1-dependent mechanism. 
In line with this, mitochondrial morphology upon mistargeting of Pex11pβ resembled Fis1 
overexpression (Fig. 3.19). Alternatively, as Pex11pβ maintained its proper protein topology, 
differences in organellar lipid compositions might account for the observed phenotype. The 
action of P. chrysogenum Pex11p and its amphipathic helix was shown to depend on 
membrane lipid composition, since addition of a peptide comprising the most conspicuous 
amphipathic helix only led to liposome tubulation upon incubation with negatively charged 
small unilamellar vesicles (SUV) that had a lipid content similar to the peroxisome 
membrane. Neutral SUVs similar to the plasma membrane composition, however, remained 
spherical (Opalinski et al., 2011). Nonetheless, the lipid composition of peroxisomes in P. 
pastoris (used in above study) shares some similarity to the mitochondrial membrane 
(Wriessnegger et al., 2007): PC and PE are the major constituents of both membranes, with 
smaller but similar amounts of PS. The mitochondrial membrane naturally contains a higher 
amount of CL, which was also identified to be a true component of the peroxisomal 
membrane (Schneiter et al., 1999; Wriessnegger et al., 2007), whereas the peroxisomal 
membranes contain more PI (almost twice the amount). Nevertheless, it is interesting to note 
that targeting of Pex11pβ to a different lipid environment within the mitochondrial membrane 
did not only result in a “non-elongation” as observed for the artificial neutral SUVs 
(Opalinski et al., 2011), but to a severe fragmentation of mitochondria, a phenotype 
frequently associated with pathological conditions as e.g. apoptosis (Sheridan & Martin, 
2010).  
Interestingly, upon expression of Pex11pβ in peroxisome-deficient patient fibroblasts, no ER 
association was ever observed. Studies on the potential mistargeting of peroxisomal proteins 
in conditions where peroxisomal membrane biogenesis is impaired (PBDs; 1.1.4) often 
remain focused on the ER, as peroxisome-deficient cell lines lacking Pex3p, Pex16p or 
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Pex19p are capable of forming peroxisomes de novo from the ER upon re-introduction of the 
missing gene (Matsuzono et al., 1999; South & Gould, 1999; Muntau et al., 2000; Toro et al., 
2009). In addition to that, de novo formation of peroxisomes from the ER was also observed 
in yeast (Hoepfner et al., 2005; Kragt et al., 2005; Tam et al., 2005; Haan et al., 2006), while 
several peroxisomal proteins (such as plant ascorbate peroxidase, Pex16p or ScPex15p) travel 
to the ER in yeast, plants and mammals (Elgersma et al., 1997; Mullen et al., 1999; Kim et al., 
2006; van der Zand et al., 2010). Thus, the notion was established that the ER serves as a 
default membrane accommodating peroxisomal proteins in peroxisome-deficient cell lines. In 
contrast to that, our observations on the mitochondrial targeting of Pex11pβ in peroxisome-
deficient cells support the idea that mitochondria provide the preferred membrane 
environment for PMPs in mammals under peroxisome-deficient conditions. In line with this, 
the mammalian tail-anchored protein Pex26p was targeted to mitochondria after mutation of 
its peroxisomal targeting signal, while an ER association was hardly ever observed (Halbach 
et al., 2006). Furthermore, truncated versions of Pex3p, Pex14p and PMP70 were also shown 
to be mistargeted to mitochondria in human fibroblasts (Soukupova et al., 1999; Sacksteder et 
al., 2000). Interestingly, Pex3p targeted artificially to mitochondria also enabled de novo 
formation of peroxisomes from mitochondria instead of the ER (Rucktaschel et al., 2010). A 
preferential mistargeting of peroxisomal proteins to mitochondria in the absence of functional 
peroxisomes in mammalian cells might be an underappreciated factor when characterizing the 
pathophysiological implications of PBDs. While the characterization of PBD severity is 
naturally focused on peroxisome function or the lack thereof, endogenous peroxisomal 
proteins might be mistargeted to mitochondria and affect their morphology and function, a 
side effect observed in this study. Thus, mitochondrial mistargeting of peroxisomal proteins 
might contribute to the phenotypes and severity of peroxisomal disorders. Nonetheless, it has 
to be taken into account that the observations presented here were based on overexpression 
studies, i.e. that intracellular Pex11pβ concentrations clearly exceeded the endogenous levels 
of peroxisomal proteins in PBD patients several fold, however, its mitochondrial mistargeting 
potential has been clearly established.   
Our findings further strengthen the notion that in mammals, mitochondria serve a default 
membrane for peroxisomal membrane proteins in the absence of functional peroxisomes 
(Soukupova et al., 1999; Sacksteder et al., 2000; Halbach et al., 2006; Rucktaschel et al., 
2010) with potential consequences for patient pathology.  
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Fig. 4.2: Overview of the structure of 
human Pex11pβ and its N-terminal 
domain.  
Overview of the position of 
transmembrane domains within human 
Pex11pβ (dark blue) and the amino acid 
sequence of its N-terminal domain. The 
positions of potential amphipathic helices 
are highlighted in green (taken from 
Opalinski, 2011). An overview of the 
different deletion mutants of Pex11pβ 
generated in our lab and their effect on 
peroxisome membrane elongation is given 





4.2.2 Regulation of human Pex11pβ by oligomerization, but not 
phosphorylation 
 
The presence of the most conspicuous amphipathic helix within P. chrysogenum Pex11p was 
shown to be sufficient to induce membrane elongation in vitro and in vivo upon expression in 
H. polymorpha (Opalinski et al., 2011). However, deletion of the first 40 amino acids of 
human Pex11pβ already abolished its membrane elongating capacity, although the predicted 
amphipathic helix remains intact (our unpublished results, Fig. 4.2). In line with previous 
findings (Kobayashi et al., 2007), further deletion of the first 60 and 70 N-terminal amino 
acids of Pex11pβ, also spanning the amphipathic region, inhibited peroxisomal membrane 
elongation, but did not exacerbate the phenotype of the ∆40 mutant (our unpublished results). 
Thus, it can be concluded that the mere presence of an amphipathic helix within human 
Pex11pβ is not sufficient to induce peroxisomal membrane elongation, indicating that the 
action of the protein is regulated by additional mechanisms. This part of the thesis aimed at 
investigating the regulation of human Pex11pβ by phosphorylation and oligomerization.  
Up until now, evidence on a post-translational regulation of Pex11 proteins remained largely 
limited to studies in S. cerevisiae in which both phosphorylation and oligomerization of 
Pex11p was described: using in silico screening and subsequent in vivo phospho-labelling, 
ScPex11p was shown to be phosphorylated at a serine residue (S165/167) in the central part 
of the protein. Expression of phospho-mimicking mutants generated either a hyper-
proliferative phenotype (“On”, S165/167D) or resulted in the formation of only a few 
clustered peroxisomes (“Off”, S165/167A) (Knoblach & Rachubinski, 2010). The 
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phosphorylation of ScPex11p was further determined to be dependent on the action of the 
kinase Pho85p which was previously identified (in combination with the cofactor pcl1) to 
potentially phosphorylate ScPex11p in a global analysis of protein phosphorylation in baker’s 
yeast (Ptacek et al., 2005; Knoblach & Rachubinski, 2010). Only indirect evidence has been 
provided on a potential phosphorylation of Pex11pβ at a Y126 residue by a large scale screen 
using phospho-tyrosine antibodies in human tumour tissue (Rikova et al., 2007); however, 
this residue is positioned within the peroxisomal matrix and so far, no intra-peroxisomal 
regulation by kinases has been described. To determine a potential phosphorylation of human 
Pex11pβ, initially, in silico screening of human Pex11pβ was performed using databases that 
calculate potential phosphorylation sites (e.g. NetPhos 2.0, also used for the study on 
ScPex11p) and those that screen for potential kinase binding sites (e.g. KinasePhos 2.0) (Fig. 
3.23 A). To gain insight into the applicability of the screening tools, values obtained for the 
confirmed ScPex11p S165/167 residue were used as a reference (probability of 0.995 using 
NetPhos 2.0). To narrow down the number of potential phospho-sites, we selected those 
identified by multiple screening tools which were also conserved among species (Fig. 3.23 
A,C). Furthermore, as this study focused on the regulation of the N-terminal domain of 
Pex11pβ, intra-peroxisomal sites were excluded. Thus, the potential phosphorylation sites at 
positions S11, S38 and S70 were chosen for further studies. As deletion of the first 70 amino 
acids of Pex11pβ did not exacerbate the inhibition of elongation observed upon deletion of the 
first 40 amino acids (our unpublished results), phospho-mimicking mutants of the positions 
S11 and S38 were generated (co-operation with MJ Cardoso). In parallel, in vivo phospho-
labelling and subsequent immunoprecipitation was performed using the YFP-tagged variant 
of Pex11pβ (Fig. 3.24). Empty YFP vector and the phosphoprotein APP-GFP were included 
as negative and positive controls, respectively. Although a radioactive signal was readily 
detected for the APP variant, consistent with its native regulation by phosphorylation (Lee et 
al., 2003; Schettini et al., 2010), no signal corresponding to YFP-Pex11pβ was discernable, 
indicating that it is not phosphorylated in human cells. Prominent elongation of peroxisomal 
membranes was confirmed by epifluorescence, indicating that the protein readily mediated 
elongation at the time points investigated. As overexpression of APP-GFP itself was 
sufficient to detect protein phosphorylation, it was surmised that the same would be 
applicable for Pex11pβ. Nonetheless, it cannot be excluded that phosphorylation of human 
Pex11pβ might only occur after very specific stimuli or that phosphorylation in humans is not 
linked to its membrane elongation capacity.  
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In regard to the regulation of  Pex11p by oligomerization in S. cerevisiae, it is assumed to be 
regulated by dimerization in a redox-dependent manner (Marshall et al., 1996). After protein 
cross-linking and subsequent immunodetection, ScPex11p was shown to form monomers and 
dimers. Dimeric complexes of ScPex11p appeared to be more dominant in fractions 
representing mature peroxisomes. As protein dimerization was inhibited after mutation of a 
N-terminal cysteine residue, the authors proposed a model in which ScPex11p actively acts as 
a monomer at the inner surface of the peroxisomal membrane. Due to the increasing oxidative 
metabolism in mature peroxisomes, ScPex11p is then oxidized, leading to the formation of 
disulfide bridges and thus the formation of (inactive) dimeric forms of ScPex11p. (Marshall et 
al., 1996). As the human protein is also known to form homo-oligomers (Li & Gould, 2003; 
Kabeya et al., 2005; Kobayashi et al., 2007; Koch et al., 2010) which appear to be essential 
for peroxisomal membrane elongation (Kobayashi et al., 2007) (our unpublished results}, it 
remained unclear if monomeric Pex11pβ represents the active form in higher organisms. One 
of the aims of this study was to investigate the regulation of Pex11pβ by oligomerization. In 
order to do so, we took advantage of the fact that human myc-Pex11pβ, unlike the other 
mammalian Pex11 isoforms, was extracted from the peroxisomal membrane by Tx100 after 
protein-crosslinking with 4 % pFA (Fig. 3.14). Interestingly, the addition of a YFP-tag to the 
protein retained its localization at the peroxisomal membrane (Fig. 3.16 J-L). Although the 
Tx100 sensitivity of Pex11pβ was noticed before (Schrader et al., 1998b), this was the first 
time that its extraction into the supernatant was addressed by a biochemical approach. After 
immunoblotting of Tx100-treated fractions (Fig. 3.14), a prominent signal corresponding to 
myc-Pex11pβ was detected in the Tx100 supernatant fraction (Fig. 3.14 K). The respective 
pellet signal remained rather weak. The removal of membrane proteins after Tx100 addition 
was usually linked to incomplete protein-crosslinking by pFA (Goldenthal et al., 1985). 
Fixation of proteins by pFA is based on chemical crosslinking of their lysine residues, 
however, the overall number of lysine residues within the three mammalian Pex11 isoforms is 
similar. As Pex11pβ was the only isoforms removed from the peroxisomal membrane after 
Tx100 addition (Fig. 3.14), other factors must account for its behaviour. Alternatively, the 
non-ionic detergent Tx100 has long been indicated to interact with both amphiphilic proteins 
and unfixed lipids (Goldenthal et al., 1985). Furthermore, sequence similarities between 
ScPex11p and the ligand-binding domain of PPARs have been indicated, pointing to lipid-
binding capabilities of ScPex11p (Barnett et al., 2000) which might facilitate interactions with 
Tx100. Additionally, the peroxisomal import receptor Pex3p similarly was also shown to 
contain α-helical structures capable of binding membrane lipids (Pinto et al., 2009). Thus, it is 
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tempting to assume that due to its amphiphilic, lipid-binding properties, Pex11pβ is able to 
interact with the non-ionic detergent Tx100 and is therefore extracted from permeabilized 
membranes. As the protein was shown to form predominantly homo-oligomers (Li & Gould, 
2003; Kobayashi et al., 2007; Koch et al., 2010), protein cross-linking by pFA most probably 
led to the formation of Pex11pβ oligomers that share the same characteristic behaviour. The 
fact that the YFP variant of Pex11pβ remained situated at the peroxisomal membrane might 
be explained by the addition of the larger tag – of equal size as Pex11pβ itself – that led to the 
introduction of further lysine residues which facilitate a more potent cross-linking, also to 
other proteins. Using the Tx100 extraction assay, in addition to monomeric myc-Pex11pβ, 
another band was detected at the twofold molecular weight (Fig. 3.14), most probably 
representing a cross-linked, dimeric form of myc-Pex11pβ. As the Tx100 extraction assay 
established in this study provided a simple method of simultaneously cross-linking and 
enriching Pex11pβ, it was applied to determine the monomer/dimer ratio of human Pex11pβ 
at different time points: overexpression of myc-tagged variants of Pex11pβ was shown to 
initiate a prominent elongation of peroxisomes as soon as 5 hours after transfection (approx. 
90 % tubular peroxisomes). After 24 hours, the majority of peroxisomes remains tubular, but 
diminishes after 48-72 hours due to subsequent fission of the newly-formed organelles 
(Schrader et al., 1998b). The distribution of monomeric and dimeric forms of myc-Pex11pβ 
was determined 5, 24 and 72 hours after transfection using the Tx100 extraction protocol and 
immunoblotting against the myc epitope (Fig. 3.25). Interestingly, in contrast to the findings 
in the yeast S. cerevisiae, dimeric forms of Pex11pβ were more prominent at the early time 
points corresponding to ongoing and profound peroxisome elongation. Thus, dimerization of 
human Pex11pβ appears to modulate protein activity. The observation that deletion of the first 
40 amino acids of human Pex11pβ already diminished peroxisomal membrane elongation, 
although the predicted amphipathic helix of the protein remained intact, strongly indicated 
that those residues are necessary for the dimerization of the protein. Indeed, upon 
overexpression of the ∆N40 variant of Pex11β-myc, formation of Pex11pβ dimers was 
abolished (personal communication S. Grille).  
In summary, our findings indicate that in mammalian cells, peroxisome dynamics at the 
organelle level are not merely regulated by the presence of amphipathic helix within the N-
terminus of Pex11pβ, but that dimerization of the protein is required to exert its membrane 
deforming activity.   
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4.3 NOVEL STIMULI ALTERING PEROXISOME DYNAMICS 
It has been pointed out that peroxisomes are highly dynamic subcellular organelles displaying 
a large plasticity, as not only spherical but also tubular structures as well as tubulo-reticular 
structures have been observed in ultrastructural and light microscopy studies (Yamamoto & 
Fahimi, 1987; Schrader et al., 1994; Schrader et al., 2000). In cell culture models, elongated 
peroxisomes have further been shown to be induced by stimulation with defined growth 
factors, PUFAs, microtubule depolymerisation, UV irradiation and exposure to H2O2 
(Schrader et al., 1996a; Schrader et al., 1998a; Schrader et al., 1999). Similarly, peroxisome 
elongation/proliferation can be induced in plants after stress e.g. upon wounding, pathogen 
attack, osmotic stress or excess light (Lopez-Huertas et al., 2000; Desikan et al., 2001; del Rio 
et al., 2002; del Rio et al., 2006). In addition to that, the fast, transcription-independent 
formation  of small peroxisomal tubules after ROS exposure was suggested to serve as a 
quick response to oxidative stress (Sinclair et al., 2009); thus it became more and more clear 
in recent years that peroxisome morphology is very closely linked to organelle function. 
Modulations of mitochondrial shape were shown to influence cellular functions such as 
calcium signalling and apoptosis (Westermann, 2010; Otera & Mihara, 2011), similarly, 
alterations and adaptations of peroxisome morphology and dynamics are also essential for 
cellular homeostasis. Along the same line, a lethal defect in peroxisome and mitochondrial 
fission was identified (Waterham et al., 2007). Peroxisome elongation as such represents an 
early step of peroxisomal growth and division to proliferate peroxisomes according to cellular 
needs (Wiemer et al., 1997; Schrader & Fahimi, 2006; Schrader et al., 2011); however, more 
complex peroxisomal structures such as elongated tubules or tubulo-reticular networks may 
also contribute and/or facilitate other peroxisomal functions (e.g. in metabolism, membrane 
signalling or stress response). In line with this, the formation of elongated peroxisomes is 
induced after UV irradiation or viral stimulation (Schrader et al., 1999; Dixit et al., 2010).  
However, detailed characterization of the link between peroxisome morphology and dynamics 
and the corresponding cellular function is required. Moreover, insight into reception of 
extracellular stimuli and their transduction onto the peroxisomal level remains is still limited.  
 
4.3.1 Peroxisomes and neuronal apoptosis: no need for elongation at the 
point of no return? 
Using the SH-SY5Y neuroblastoma cell line, the effects of the neurotoxin 6-
hydroxydopamine (6-OHDA) on mitochondria and peroxisomes were investigated (co-
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operation J. Jordan Bueso, University of Castilla-LaMancha, Spain). 6-OHDA, an oxidative 
metabolite of dopamine, is commonly used to generate experimental models of Parkinson’s 
disease and its action has been linked to the increased generation of ROS (Blum et al., 2001; 
Bach et al., 2003; Galindo et al., 2003; Bove et al., 2005a). Exposure of SH-SY5Y cells to 6-
OHDA led to a profound fragmentation of mitochondria which was very similar to the 
morphology observed after overexpression of Fis1, a protein involved in DLP1 recruitment. 
Mitochondrial fragmentation occurred rapidly (within 15 minutes after treatment) and could 
be observed in the majority of treated cells after 3 hours (Gomez-Lazaro et al., 2008). The 
effect of 6-OHDA on mitochondria was linked to ROS generation, as the use of “aged” 6-
OHDA (from which ROS had been liberated by auto-oxidation) as well as the combined use 
of antioxidants prevented mitochondrial fragmentation. Interestingly, mitochondrial 
fragmentation seemed to be an early event in apoptosis, preceding the collapse of 
mitochondrial membrane potential and cytochrome c release, and was shown to be dependent 
on the action of DLP1 by silencing experiments. However, peroxisome morphology and 
dynamics remained unaffected by 6-OHDA treatment at time points when mitochondria were 
already drastically fragmented, but also after longer exposure (Fig. 3.26; Fig. 4.3). As an 
induction of a potential peroxisome fragmentation was difficult to detect, cells were 
additionally transfected with Pex11pβ-myc prior to 6-OHDA treatment to induce a profound 
tubulation of the peroxisomal membrane. Nevertheless, no effect of 6-OHDA on peroxisomes 
(fragmentation) was observed. (Fig. 3.26). Thus, the application of the ROS-inducing 6-
OHDA stress did not exert any alteration of peroxisome morphology, unlike what was 
previously reported after UV irradiation and H2O2 exposure in HepG2 cells (Schrader et al., 
1999). UV irradiation-induced peroxisome tubulation was linked to oxidative stress and 
suggested to mediate a protective response, e.g. by increasing the number of peroxisomes to 
counteract the effects of oxidative damage. As 6-OHDA action rapidly induced an apoptotic 
response, it might be concluded that a potential “rescue” mechanism corresponding to 
peroxisome elongation becomes obsolete under conditions where controlled cell death is 
already initiated. It is further interesting to note that while DLP1 is a shared component of 
both peroxisomes and mitochondria, DLP1-mediated effects of 6-OHDA are translated onto 
the organelle level in a differing manner. The proteins involved in the membrane recruitment 
of DLP1, the tail-anchored proteins Mff and Fis1, are also shared by both organelles, 
therefore differences in the regulation of the fission complex at mitochondria and 
peroxisomes are probably mediated by additional factors or mechanisms. In line with this, 
MiD49 and MiD51/MIEF have recently been identified as new components modulating DLP1 
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activity at mitochondria, but not peroxisomes (Palmer et al., 2011; Zhao et al., 2011) (our 
unpublished results). DLP1 was further shown to be influenced by post-translational 
modifications such as phosphorylation, sumoylation and ubiquitination (Chang & Blackstone, 
2010), however, studies on the effects of those modifications have been limited to 
mitochondria. Future research needs to aim at determining potential effects on peroxisome 
dynamics, but nonetheless our results already indicate that mitochondrial and peroxisome 
dynamics are regulated in a differing manner.   
 
4.3.2 Stress-induced peroxisomal elongation: the nature of the signal is the 
key 
To further address the existence of general response of peroxisomes to an increase in 
oxidative stress, alterations of peroxisome dynamics were assessed after application of 
various ROS inducing compounds for longer time points (24 hours) in mammalian cells (Fig. 
3.28). HepG2 and COS-7 cells were treated with various ROS-inducing components (leading 
to initiation of ROS production in the cytosol and mitochondria) and alterations of 
peroxisome morphology were determined by epifluorescence microscopy. While peroxisomes 
elongated profoundly after stimulation with fatty acids and serum in a control experiment 
(Schrader et al., 1998a) (Fig. 3.28 C), none of the applied oxidative stimuli induced a 
significant increase in the number of tubular peroxisomes (Fig. 3.28 A), in contrast to what 
was reported before after UV irradiation and H2O2 exposure (Schrader et al., 1999). 
Successful generation of oxidative stress after application of insults was confirmed by 
measuring an increase in DCF fluorescence (Fig. 3.28 B). Additionally, the existence of a 
short-term response to oxidative stress was examined. In plants, a dual response of 
peroxisomes to oxidative stress was observed, since short-term stress (up to 2 hours) initiated 
the formation of small membrane protrusions (“peroxules”), whereas longer stress periods led 
to the formation of the full peroxisomal “bead-on-a-string” morphology indicative of 
peroxisome proliferation that was also observed after UV irradiation (Schrader et al., 1999; 
Sinclair et al., 2009). A compartment-specific, short-term ROS response was investigated by 
the use of the genetically-encoded photosensitizer KillerRed (Bulina et al., 2006a; Bulina et 
al., 2006b). KillerRed is a phototoxic red fluorescent protein that is activated upon green light 
exposure, resulting in the generation of predominantly superoxide radical (Bulina et al., 
2006a; Bulina et al., 2006b). KillerRed variants targeted to the cytosol, mitochondria and 
peroxisomes were overexpressed in COS-GFP-PTS1 cells and effects of their activation on 
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peroxisome morphology were assessed by live cell imaging (Figs. 3.29; 3.30). This set-up 
served a two-fold purpose: first, live cell imaging after KillerRed activation as such enabled 
us to determine if small, peroxisomal extensions were also formed in mammalian cells after 
30-90 minutes, while the organelle-specific targeting of KillerRed variants served to validate 
a compartment-specific ROS response of peroxisomes, e.g. to determine if a sharp increase in 
mitochondrial stress leads to a rapid peroxisome elongation as a potential rescue or 
complementation mechanism. However, in this experimental setup, activation of none of the 
expressed variants led to any peroxisome elongation (Fig. 3.29; 3.30). This is in line with 
findings from our group on the effect of mitochondrial ROS generation (induced upon 
inhibition of the electron transfer chain) on peroxisome morphology in COS-7 cells in which 
no ROS-mediated elongation of peroxisomes was observed (Master thesis, S. Pinho; Co-
supervisor: N. Bonekamp). Interestingly, the complex I inhibitor rotenone was demonstrated 
to have a dramatic microtubule-depolymerizing effect which initiated peroxisome elongation, 
in line with previous findings on the contribution of the microtubule cytoskeleton to 
peroxisome dynamics (Schrader et al., 1996a; Schrader et al., 1996b). Notably, treatment with 
L-buthionine sulfoximine (BSO), a compound inhibiting GSH repletion and thus modulating 
intracellular redox-state (Griffith & Meister, 1979), stimulated a significant increase in the 
percentage of tubular peroxisomes. Interestingly, a recent study has investigated the intra-
peroxisomal redox balance in response to several stimuli using a reduction-oxidation sensitive 
GFP variant (roGFP) (Ivashchenko et al., 2011). Ratiometric measurements of its excitation 
maxima (representing reduced and oxidized states) allowed the determination of organellar 
redox-state after targeting of roGFP variants to either the cytosol, mitochondria and 
peroxisomes at steady-state conditions and after insults. Perturbations in peroxisomal 
function, e.g. in catalase-deficient fibroblasts, strongly affected mitochondrial redox-state. 
Additionally, KillerRed variants targeted to the cytosol, mitochondria and peroxisomes were 
used in combination with roGFP. Similar to our observations, KillerRed-PO displayed slower 
peroxisomal targeting kinetics (Fig. 3.30). In line with our findings, KillerRed activation in 
the three subcellular compartments did not modulate peroxisomal morphology, however, the 
peroxisomal redox state was shown to be affected, albeit only by upon intra-peroxisomal 
oxidative stress. Mitochondrial redox state on the other hand remained largely sensitive to 
changes within peroxisomes, suggesting an inter-organellar cross-talk mechanism 
(Ivashchenko et al., 2011). These findings indicate that a compartment-specific peroxisomal 
response to (oxidative) stress might rather be based on “detection” of organellar redox-state 
without a concomitant alteration of peroxisome morphology. Large scale alterations of 
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peroxisome morphology such as a prominent elongation might only be induced under very 
specific conditions. Interestingly, Ivashchenko et al also demonstrated that the peroxisomal 
redox state as such was largely influenced by cell culture conditions and passage number of 
the cells which strongly affected the experimental results and accounted for contradictory 
findings (Yano et al., 2010; Ivashchenko et al., 2011). Hence, this leaves us with the 
possibility that the steady-state intra-peroxisomal redox state differed between the present and 
previous studies (Schrader et al., 1999). Moreover, it is possible that the signal mediating a 
peroxisomal response to UV irradiation as such was not only linked to an increase in 
oxidative stress, but potentially also to the activation of other signalling pathways. For, 
instance the UV irradiation pulse applied (UV-C, 254 nm) (Schrader et al., 1999) affects 
DNA integrity, therefore the numerous cellular pathways activated as a DNA damage 
response might contribute to the observed phenotype (Lagerwerf et al., 2011). Interestingly, 
DNA damage has been shown to trigger autophagy (Rodriguez-Rocha et al., 2011), thus, an 
elongated peroxisome morphology might serve to protect peroxisomes from autophagosomal 
destruction as has been described for mitochondria (Gomes et al., 2011; Rambold et al., 
2011a). Peroxisomes might then be protected and capable of supplying metabolites and lipids 
to counteract cellular damage.   
The findings presented in this study indicate that the nature of stress signals is essential in 
modulating peroxisome dynamics. While a global increase in oxidative stress did not affect 
peroxisome morphology , changes in cellular redox state did (Fig. 4.3). Moreover, application 
of stressors might affect intra-peroxisomal redox-state without any visible change in 
peroxisome dynamics (Ivashchenko et al., 2011). Thus, the UV-induced tubulation of 
peroxisomes might not be linked as much to a large scale increase in oxidative stress as to 
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Fig. 4.3: Overview of the 
different extra- and 
intracellular stimuli and their 
effect on peroxisome 
dynamics.  
Note that induction of cytosolic 
or mitochondrial (Mito) 
oxidative stress does not affect 
peroxisome dynamics, while UV 
irradiation, low cell density, 
growth factor and PUFA 
stimulation leads to a tubulation 
of peroxisomes. To facilitate 
this, membrane receptors and 
intracellular (damage) signalling 
might contribute to exert a 
peroxisomal response. 
Dexamethasone (Dexa) 
treatment induces peroxisome 
elongation which is linked to the 
regulation of Pex11β while 6-
OHDA addition did not affect 
peroxisomal, but mitochondrial 
dynamics. Note that tubulation 
of peroxisomes might indicate 
peroxisomal growth and division to increase peroxisome numbers or mediate a metabolic function by e.g. 
increasing the surface-to-volume ratio.  
 
4.3.3 The effect of the glucocorticoid dexamethasone on peroxisome 
proliferation: a defined physiological cell culture model to study 
peroxisome dynamics 
 
Although several external stimuli leading to alterations of peroxisome dynamics and/or the 
induction of peroxisome proliferation have been characterized, knowledge regarding their 
molecular reception and subsequent signal transduction is still limited. In mammals, insight 
into the regulation of peroxisomal proliferation remains largely restricted to the activation of 
the nuclear receptor PPARα and its target genes in rodent animal models after feeding of 
peroxisome proliferators (1.2.4). Moreover, manipulation of peroxisome dynamics in cell 
culture is usually achieved by a “global” modulation of proteins involved in peroxisome 
growth and division processes, e.g. after overexpression of Pex11pβ. On a related note, for 
some of the signals inducing a profound tubulation of peroxisomes in mammalian cells, such 
as addition of serum or cell density (Schrader et al., 1994; Schrader et al., 1996a; Schrader et 
al., 1998a), an exact stimulus affecting peroxisome dynamics can hardly be defined, as 
numerous cellular pathways are affected. Hence, the characterization of a cell culture model is 
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desirable which allows to reliably monitor alterations of peroxisome dynamics after 
application of a defined, well-characterized stimulus.  
In this study, we took advantage of an AR42J cell culture model that is usually employed to 
study the differentiation of pancreatic acinar cells and the biogenesis of zymogen granules 
(Swarovsky et al., 1988; Faust et al., 2008; Borta et al., 2010). Stimulation of AR42J cells 
which are derived from rat exocrine pancreatic tumour cells, with glucocorticoids such as 
dexamethasone was shown to lead to the coupled induction of exocrine proteins and a 
profound remodelling of intracellular compartments involved in the secretory pathway 
(Logsdon et al., 1985; Logsdon et al., 1987; Swarovsky et al., 1988). For instance, secretory 
differentiation markers such as chymotrypsinogen and amylase show a profound induction in 
regard to their mRNA and synthesis rates and the formation of zymogen granules is induced 
(Scheele, 1993). The AR42J cell culture model has been established in our lab (Faust et al., 
2008; Borta et al., 2010) and was thus used here to study the effects of dexamethasone, a 
synthetic fluorinated glucocorticoid, on peroxisome dynamics. AR42J cells were treated with 
either 10 nM dexamethasone, a concentration used to stimulate differentiation of AR42J cells, 
or 1 µM of the compound, representing a more pathophysiological concentration (Du et al., 
2009).  Induction was carried out for 6-72 hours with fresh dexamethasone and peroxisome 
morphology as well as induction of chymotrypsinogen (a zymogen granule marker) was 
assessed by epifluorescence microscopy. As described before, a significant increase of 
zymogen granules/chymotrypsinogen was observed (Fig. 3.32 C), verifying successful 
dexamethasone action, but interestingly dexamethasone treatment also resulted in a 
significant, dose-dependent tubulation of peroxisomes (Fig. 3.31; 3.32; 4.3). Untreated 
controls displayed the pattern of peroxisome morphology after seeding as described for 
mammalian cells (Schrader et al., 1994; Schrader et al., 1996a), i.e. an increase in tubular 
forms 24 hours after seeding (and here 6 hours after induction) with a subsequent increase in 
spherical forms reminiscent of fission. In contrast to that application of dexamethasone 
provided a time- and dose-dependent stimulus for continuous peroxisome elongation (Fig. 
3.32 B). Although induction of tubular peroxisomes mirrored the kinetics of zymogen granule 
formation, it is important to note that not all cells with tubular peroxisomes also displayed 
granular structures, insinuating that both processes are not necessarily coupled. Interestingly, 
also singular addition of dexamethasone and subsequent removal of the stimulus was 
sufficient to induce peroxisome tubulation, even 48 hours after removal of dexamethasone 
(Fig. 3.33). As the observed peroxisome morphology after dexamethasone treatment largely 
mimicked the morphology of peroxisomes observed after overexpression of Pex11pβ (Fig. 
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3.34), further analysis aimed at investigating changes in the induction profile of the three rat 
Pex11 isoforms by a semi-quantitative PCR approach (SQ-PCR) (Fig. 3.35). AR42J cells 
were stimulated with dexamethasone (10 nM and 1 µM) for 24, 48 and 72 hours and the 
induction of Pex11α, Pex11β and Pex11γ was assessed in comparison to the housekeeping 
gene GAPDH by SQ-PCR. The peroxisomal key enzyme AOX was included as a control for 
peroxisome proliferation. Compared to the stable expression of GAPDH, AOX was clearly 
induced after dexamethasone treatment. This induction pattern was mirrored at the protein 
level (Fig. 3.31) and is indicative of peroxisome proliferation. Pex11α, the inducible isoform 
(Abe et al., 1998), was similarly expressed and was only clearly detected after dexamethasone 
induction, mirroring the pattern of AOX induction. In contrast to that, clear signals 
corresponding to Pex11β were seen in controls at every time point investigated, in line with 
its constitutive expression in all tissues. However, Pex11β was also induced 24 and 48 hours 
after treatment with dexamethasone when compared to controls (Fig. 3.31). The Pex11pβ 
antibody failed to recognize the rat protein upon immunoblotting, thus induction of Pex11pβ 
was not verified on the protein level. Nonetheless, as the induction of AOX on the protein 
level followed the pattern observed on the mRNA level (Fig. 3.31), the observations made by 
SQPCR were reliable. Comparison between Pex11β levels in control cells at different time 
points revealed it to be induced after 72 hours (96 hours after seeding) when compared to the 
24 and 48 hour expression levels. This might be due to a potential “normal” induction of 
Pex11β in the course of cell growth and differentiation. While Pex11α and Pex11β were 
clearly induced by dexamethasone addition, Pex11γ signals remained barely detectable 
throughout the experiment and were thus concluded to play a minor role in regulating 
dexamethasone-induced alterations of peroxisome morphology. Altogether, the rat AR42J cell 
line was established as a valuable cell culture model to study alterations of peroxisome 
dynamics and their regulation. In contrast to other stimuli, e.g. serum addition, the initial 
signal leading to peroxisome elongation was corresponded to one well-defined external 
stimulus, the glucocorticoid dexamethasone. The results obtained here were also highly 
reproducible. Moreover, dexamethasone addition was directly linked to the activation of key 
components of the peroxisomal growth and division machinery, Pex11α and Pex11β. 
However, as peroxisome tubulation is initiated upon expression of Pex11pβ and Pex11pγ, but 
not Pex11pα (Fig. 3.34), the peroxisomal phenotype of dexamethasone addition is most 
probably linked to Pex11β induction. Interestingly, although Pex11β is not induced by 
PPARα-mediated peroxisome proliferator acting on rat hepatocytes, its expression was 
stimulated by dexamethasone, thus a novel mechanism of PPARα-independent regulation of 
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peroxisome dynamics was identified in this study. Dexamethasone-induced peroxisomal 
elongation thus provides an easy, amenable and highly reproducible cell culture model to 
assess changes in the expression profile of peroxisomal genes involved in the regulation of 
peroxisome dynamics by e.g. large scale expression profiling. It might also contribute to the 
identification of novel components regulating peroxisome dynamics and offers a more 
straightforward approach to study regulation of peroxisome abundance when compared to 
fibrate-induced peroxisome proliferation in rodents. 
The molecular action of glucocorticoids has so far been linked to several mechanisms: 
glucocorticoid activities can be divided into genomic effects, mediated by the cytosolic 
glucocorticoid receptor alpha (cGCR) and other non-genomic effects (Pratt, 1998; Almawi & 
Melemedjian, 2002; Adcock & Lane, 2003; Wikstrom, 2003; Buttgereit et al., 2004; 
Buttgereit et al., 2005; Stahn et al., 2007). In the classical mode of action, the unligated 
cGCR, a member of the steroid hormone receptor family, resides in the cytoplasm as a 
multiprotein complex including heat shock proteins, immunophilins, chaperones (such as Src) 
and several kinases of the MAPK family (Pratt, 1998; Almawi & Melemedjian, 2002; 
Wikstrom, 2003). The cGCR itself contains 3 key domains, the N-terminal transactivation 
domain, a DNA-binding zinc finger domain and a ligand binding domain (Wikstrom, 2003). 
Glucocorticoids can pass the plasma membrane due to their lipophilic structure and are able to 
bind the receptor which in turn leads to dissociation of the cCGR complex, homo-
dimerization of the receptor and its translocation into the nucleus occurs where it binds 
specific DNA binding sites (glucocorticoid response elements, GREs) (Almawi & 
Melemedjian, 2002). In line with their use as anti-inflammatory drugs, GREs induce anti-
inflammatory proteins, but also genes for gluconeogenesis. In addition to this positive 
regulation of GREs (“transactivation”), there is also negative regulation (“transrepression”) of 
negative GREs, inhibiting e.g. transcription of interleukin-1 (Falkenstein et al., 2000). 
Moreover, apart from direct GRE binding, the activated GC/GCR complex can also interact 
with other transcription factors or compete with other nuclear co-activators, leading to a 
transrepression of genes (Reily et al., 2006; Stahn et al., 2007) In terms of the genomic effects 
of cGCR action, the activation, translocation and binding to GREs takes about 30 minutes, 
while changes on the cellular or tissue level become apparent after hours or days (Stahn et al., 
2007). Other non-genomic effects are thought to occur by a direct effect of the lipophilic GCs 
on biological membranes (e.g. by intercalation with the mitochondrial membrane) (Buttgereit 
& Scheffold, 2002; Buttgereit et al., 2004), downstream effects of the release of the cGCR 
complex via e.g. release of MAPK and activation of a potential membrane-bound GCR 
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(Gametchu et al., 1999; Croxtall et al., 2000; Buttgereit et al., 2004). Up until now, there is 
only limited information on the role of glucocorticoid action on peroxisome function and/or 
dynamics. However, dexamethasone was shown to regulate the expression of PPARα in rat 
hepatocytes (Rao & Subbarao, 1997; Plant et al., 1998; Lawrence et al., 2001). Most of these 
studies were carried out in rat hepatocytes to not only determine the contribution of 
glucocorticoids to peroxisome proliferation, but also to determine the basis of the cell 
proliferation and tumour growth observed in rodents upon feeding with peroxisome 
proliferators. It was also demonstrated that the addition of glucocorticoids during culturing of 
primary rat hepatocytes was necessary to maintain PPARα expression and thus 
responsiveness to peroxisome proliferators (Mitchell et al., 1984). Upon addition of 
peroxisome proliferators, electron microscopy and morphometric analysis then revealed in 
increase in the fractional volume of peroxisomes. However, dexamethasone application alone 
was not sufficient to induce the expression of the peroxisome marker PMP70 in mice 
(Lawrence et al., 2001). Our observations on the induction of Pex11α and Pex11β indicate a 
genomic effect of dexamethasone on peroxisome dynamics; however, the exact molecular 
regulation requires further analysis. The induction of AOX and Pex11α, both of which are 
regulated by PPARα, might indicate that dexamethasone induces PPARα which in turn 
activates transcription of its targets. To analyze a potential contribution of PPARα stimulation 
to the observed phenotype, AR42J cells were treated with bezafibrate, a potent inducer of 
PPARα-mediated peroxisome proliferation in rat hepatocytes. It was surmised that if 
dexamethasone effects stem from indirect consequences of PPARα activation, the observed 
morphology and induction pattern in AR42J cells would be similar. However, no effect on 
peroxisome elongation or proliferation was observed (Fig. 3.37 A-C). Furthermore, no 
induction of AOX or Pex11α – PPARα target genes – was detected (Fig. 3.37 D), indicating 
AR42J cells of rodent pancreatic origin only respond weakly to bezafibrate, unlike rat 
hepatocytes. Similar results were obtained using ETYA, another peroxisome proliferating 
drug (data not shown). This might be due to a low expression of PPARα in AR42J cells which 
actually contain features of both exocrine and endocrine pancreas. In line with this, though 
primarily endocrine pancreas was investigated, PPARα expression was indicated to be low in 
pancreatic tissue, while the glucocorticoid receptor was moderately expressed (Bookout et al., 
2006). As our findings indicate AR42J cells to be low responders to bezafibrate and thus the 
action of PPARα, we concluded dexamethasone-induced peroxisome elongation is regulated 
independently. Notably, peroxisomes maintained their tubular morphology, even after 
removal of the dexamethasone stimulus, indicating that initial stimulation was sufficient to 
4. DISCUSSION                                ___________________________________________________ 
184 
activate the downstream signal transduction onto the molecular and then peroxisomal level. 
The maintained peroxisome elongation after glucocorticoid stimulation was not indicative of 
growth and division processes upon which peroxisomal tubules subsequently would be 
divided. Interestingly, elongation of the peroxisomal membrane and formation of complex 
structures have been linked to metabolic processes such lipid synthesis or penicillin 
production (Kollatakudy et al., 1987; Kabeya et al., 2005; Kiel et al., 2005b) and were 
suggested to facilitate a metabolic function of peroxisomes by generating a uniform 
biochemical distribution of proteins, increasing the surface to volume ratio and exchanging 
metabolites (Schrader & Fahimi, 2006). Thus, continuous membrane elongation after 
dexamethasone stimulation might represent a specific peroxisome morphology indicative of a 
metabolic function instead of an growth and division process. As glucocorticoids have vast 
anti-inflammatory capacities (Buttgereit et al., 2004; Stahn et al., 2007), a shift of 
peroxisomal dynamics to a more tubulated structure might modulate the anti-inflammatory 
response, by e.g. a stimulation peroxisomal breakdown of the inflammatory mediators 
leukotriene or prostaglandin as well as arachidonic acid (AA). In line with this, application of 
AA also induced elongated peroxisomes (Schrader et al., 1998a).   
Thus, rat pancreatic AR42J cells have a high potential to serve as a model system for 
dexamethasone-induced peroxisomal elongation (Fig. 4.3). It provides an amenable system to 
easily assess changes in the expression profile of peroxisomal genes involved in the 
regulation of peroxisome dynamics after application of a well-defined stimulus. Future studies 
using large scale expression profiling in this system might contribute to the identification of 
novel components regulating peroxisome morphology and dynamics.  
4.4 FUTURE PERSPECTIVES 
In the present study, processes contributing to the modulations of peroxisome dynamics in 
mammalian cells were investigated. Although a complete fusion process of mature 
peroxisomes was ruled out to modulate peroxisome dynamics, peroxisomes were shown to 
engage in transient, but complex interactions. Future studies need to determine the 
physiological significance of the observed peroxisomal contacts. As peroxisomes are further 
known to interact extensively with other organelles such as the ER or mitochondria, the 
existence of complex interactions of peroxisomes with those organelles might also be 
addressed by live cell imaging studies and subsequent mathematical evaluation. Furthermore, 
membrane fusion processes might still be involved in the formation of more complex 
peroxisomal structures such as tubulo-reticular networks. Thus, it is desirable to establish a 
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model system to induce a higher frequency of reticular peroxisomes in order to characterize 
the generation of peroxisomal networks.   
The regulation of peroxisome dynamics on the organellar level was addressed by 
characterizing the central peroxisomal biogenesis factor Pex11pβ. Upon mistargeting of 
human Pex11pβ to mitochondria in peroxisome-deficient cells, mitochondria were 
fragmented; however, the molecular basis of the observed fragmentation remains to be 
elucidated. Although in vivo phospho-labelling experiments indicated that Pex11pβ was not 
phosphorylated in mammalian cells, it cannot be strictly excluded that the protein is 
phosphorylated at very specific time points and/or after very particular stimuli. Moreover, 
phosphorylation in mammalian cells might be required for other downstream purposes, such 
as initiation of fission. Time-course experiments and subsequent detection of phosphorylation 
using non-radioactive methods such as phospho-amino acid specific antibodies might help to 
elucidate this question. Dimerization of human Pex11pβ was shown to be crucial to mediate 
its membrane deforming activity. It might be interesting to address if human Pex11pβ can be 
regulated in a redox-dependent manner, similar to the yeast ScPex11p. In order to do so, 
conspicuous cysteine residues within Pex11pβ need to be identified. Site-directed 
mutagenesis and subsequent expression studies might facilitate screening for a potential 
impairment of Pex11pβ-membrane elongation. Furthermore, redox western blotting 
techniques might additionally provide insight into a potential redox-regulation of Pex11pβ, 
especially after stress conditions and also after manipulation of the cellular redox state.   
Finally, dexamethasone was identified as a novel stimulus inducing profound peroxisomal 
membrane tubulation. In this respect, the now established AR42J cell culture model provides 
a highly reproducible system in which peroxisome elongation can be induced upon 
application of a very defined stimulus. The cell model might form an elegant basis for large 
scale expression profiling to gain insight into peroxisome-related signal transduction of 
glucocorticoids, but also to screen for other yet unidentified regulators of peroxisome 
proliferation. The genomic effects of the glucocorticoid cascade in comparison to non-
genomic effects might also be characterized on the peroxisomal level. Reporter studies using 
Pex11 promoter regions will help to determine the mode of genomic activation. A potential 
non-genomic effect via MAPK activation or downstream signalling and its contribution to the 
glucocorticoid-induced membrane elongation can be addressed by pharmacological studies 
using specific inhibitors. The suggestions outlined here will help to gain further insight in the 
regulation of peroxisome proliferation and dynamics.  
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5 SUMMARY  
Peroxisomes are ubiquitous subcellular organelles involved in a variety of important 
metabolic processes. Recently, it became obvious that many of those functions are carried out 
in co-operation with mitochondria. The essential role of peroxisomes for human health is 
exemplified by the severe phenotype of peroxisomal disorders. Furthermore, peroxisomes are 
highly dynamic, adjusting their protein content, morphology and number in response to 
cellular needs. In recent years, peroxisome dynamics and their proper regulation were closely 
linked to organelle function and thus, human well-being. In line with this, a patient with a 
lethal defect in mitochondrial and peroxisomal fission was identified. Peroxisome dynamics 
are regulated by growth and division of the organelle, however, peroxisomes can also arise de 
novo from the ER under special conditions. In mammalian cells, peroxisomal growth and 
division follows a well-defined sequence of morphological alterations. Initial membrane 
elongation is carried out by the key peroxisomal membrane protein Pex11pβ, while final 
scission into smaller organelles is achieved by the combined action of the membrane adaptors 
Mff and Fis1 as well as the large GTPase DLP1. Interestingly, the key components of the 
peroxisomal fission machinery are shared with mitochondria; however the occurrence of 
peroxisomal fusion analogous to mitochondria remains a matter of debate. Although several 
external stimuli were identified to alter peroxisome dynamics, detailed information on their 
reception and transduction onto the peroxisomal level is limited.  Thus, the aim of this study 
was to gain a deeper understanding of the processes contributing to and regulating 
peroxisome dynamics in mammalian cells. This thesis contains three parts: in the first section, 
the contribution of peroxisomal fusion, analogous to mitochondria, to organelle dynamics was 
addressed. In the second part, the regulation of peroxisome dynamics at the organelle itself 
was investigated by characterizing post-translational mechanisms modulating the action of 
Pex11pβ, the key mediator of peroxisome elongation/proliferation in mammalian cells. In the 
final part, different groups of external stimuli were characterized in regard to their capacity to 
alter peroxisome dynamics in order to study the regulation of peroxisome dynamics on a 
transcriptional level in mammalian cell culture.  
To investigate fusion of mature peroxisomes in mammalian CHO cells, an in vivo fusion 
assay was established based on hybridoma formation by cell fusion using cell lines stably 
expressing GFP- or DsRed-derived peroxisomal matrix and membrane markers. Fluorescence 
microscopy in time course experiments of fixed cells revealed a merge of different 
peroxisomal markers in fused cells, pointing to a certain degree of peroxisomal fusion. 
Although subsequent live cell imaging indicated that peroxisomes did not exchange matrix or 
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membrane markers, the existence of transient, vivid interactions between individual 
peroxisomes was characterized for the first time. Interacting peroxisomes were shown to be 
tightly associated, accounting for the marker overlay observed in fixed cells. Using 
computational modelling and mathematical analysis, transient peroxisome interactions were 
shown to follow a complex, non-random behaviour that has the potential to facilitate the 
homogenization of the heterogeneous peroxisomal compartment. Pre-treatment with 
peroxisomal substrates indicated that transient, peroxisomal interactions do not contribute to 
the exchange of fatty acids or H2O2, but might facilitate the exchange of other peroxisomal 
metabolites or be part of a signaling system to sense the state and/or distribution of the 
peroxisomal population in the cell. Furthermore, for the first time, computational analysis 
provided an explanation why only 15 % of the peroxisome population is engaged in long-
range microtubule-dependent movement. Additionally, evidence was provided that 
mitochondrial fusion proteins do not localize to peroxisomes, indicating that peroxisome 
dynamics in mammalian cells are regulated in a distinct manner.   
To gain insight into the modulation of peroxisome dynamics at the organelle itself, Pex11pβ 
was characterized biochemically. Differential permeabilization and protease-protection assays 
in combination with a newly available commercial antibody localized the position of its first 
transmembrane domain to the amino acid positions 90 – 110.  Subsequently, the contribution 
of the N-terminal domain to the regulation of human Pex11pβ activity was addressed. 
Deletion of the first 40 amino acids abolished Pex11pβ-membrane elongation, although the 
essential amphipathic helix within the protein remained intact. Biochemical cross-linking and 
enrichment of Pex11pβ in time-course experiments linked its homo-dimerization to its 
activity which was diminished upon N-terminal deletion. In vivo phospho-labelling did not 
indicate phosphorylation of Pex11pβ in a manner similar to its S. cerevisiae orthologue. Thus, 
Pex11 proteins in yeast and mammals appear to be regulated in an opposite manner. 
Furthermore, overexpression of Pex11pβ in peroxisome-deficient patient fibroblasts resulted 
in its mistargeting to mitochondria where an excessive fragmentation was induced. This 
further emphasizes that mitochondria, but not the ER, serve a default membrane for 
peroxisomal membrane proteins in the absence of peroxisomes in mammals. Potential 
disturbances of mitochondrial function might thus contribute to the clinical severity of 
peroxisome disorders.   
In the final part of this thesis, external stimuli altering peroxisomal dynamics were 
characterized to establish a more physiological and amenable cell culture model to investigate 
the transcriptional regulation of peroxisome dynamics in mammalian cells.  Application of the 
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neurotoxin 6-OHDA in SH-S5Y5 neuroblastoma cells did not affect peroxisome dynamics, 
but led to a profound DLP1-dependent fragmentation of mitochondria. Though DLP1 is a 
shared component of both organelles, mitochondrial and peroxisomal dynamics further appear 
to be regulated in a distinct manner. Using a variety of compounds inducing cytosolic and 
mitochondrial oxidative stress, no morphological alterations of peroxisomes were observed. 
KillerRed-based induction of ROS in different compartments produced similar results in 
living cells. Thus, other factors besides the induction of oxidative stress, such as e.g. the 
intracellular or extracellular origin of the signal, alterations of cellular redox-state or yet 
unidentified signalling pathways might contribute to induce the alterations of peroxisome 
dynamics observed before.  Addition of the glucocorticoid dexamethasone to rat pancreatic 
AR42J cells resulted in a profound, continuous elongation of peroxisomes. Notably, 
peroxisomes maintained their tubular morphology even after removal of the stimulus. 
Continuous peroxisome tubulation might be linked to cell differentiation or a metabolic 
function. Dexamethasone application induced Pex11β (and Pex11α) on a transcriptional level 
by a potentially PPARα-independent mechanism. Thus, dexamethasone-induced peroxisome 
elongation in AR42J cells has a high potential to serve as a more physiological model to study 
the regulation of peroxisome dynamics in mammalian cells. Future studies using expression 
profiling after dexamethasone stimulation in order to identify novel components and/or 
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6 ZUSAMMENFASSUNG 
Peroxisomen sind ubiquitäre Zellorganellen, die an einer Vielzahl wichtiger metabolischer 
Prozesse beteiligt sind. Viele dieser Funktionen werden in enger Kooperation mit 
Mitochondrien ausgeführt. Da Peroxisomen für die Gesundheit und Entwicklung des 
Menschen essentiell sind, führen peroxisomale Dysfunktionen zu schwerwiegenden 
Erkrankungen. Des Weiteren sind Peroxisomen sehr dynamische Zellorganellen, die ihre 
Proteinkomposition, Morphologie und Anzahl an die zellulären Anforderungen anpassen. 
Kürzlich wurde ein Patient mit einem letalen Defekt der mitochondrialen und peroxisomalen 
Teilung identifiziert; daraus wird ersichtlich, dass der korrekte Ablauf dynamischer 
peroxisomaler Prozesse eng mit der Funktion der Organelle verknüpft ist und somit ebenfalls 
essentiell für die menschliche Gesundheit ist. Die Dynamik der Peroxisomen als solche wird 
durch Wachstums- und Teilungsprozesse reguliert, jedoch können Peroxisomen unter 
bestimmten Bedingungen auch de novo aus dem ER gebildet werden. In Säugerzellen geht der 
peroxisomale Wachstums- und Teilungsprozess mit einer Reihe klarer morphologischer 
Veränderungen der Organelle einher: eine initiale Elongation der peroxisomalen Membran 
wird durch das peroxisomale Membranprotein Pex11pβ vermittelt, während die 
Durchschnürung der peroxisomalen Tubuli in kleinere Organellen durch die 
Membranadaptoren Mff, Fis1 sowie die GTPase DLP1 erfolgt. Interessanterweise sind 
letztere Proteine auch an der Teilung von Mitochondrien beteiligt. Die Frage, ob ausgereifte 
Peroxisomen, ähnlich wie Mitochondrien, miteinander fusionieren, blieb umstritten. Es 
wurden außerdem diverse externe Stimuli identifiziert, die die peroxisomale Dynamik 
verändern, jedoch sind die Mechanismen ihrer Rezeption und der Signaltransduktion auf die 
Ebene der Organelle weithin unbekannt. Die vorliegende Studie zielte daher darauf ab, 
Einblicke in Prozesse zu gewinnen, die an der Dynamik der Peroxisomen beteiligt sind und zu 
ihrer Regulation beitragen. Diese Dissertation besteht aus drei Teilen: im ersten Teil wurde 
die Existenz einer Fusion ausgereifter Peroxisomen, analog zur mitochondrialen Fusion, 
untersucht. Im zweiten Teil dieser Arbeit wurde die Regulation von Pex11pβ, des 
Schlüsselproteins der peroxisomalen Biogenese in Säugerzellen, durch post-translationale 
Mechanismen untersucht, um Einblicke in die Regulation der peroxisomalen Dynamik auf der 
Ebene der Organelle selbst zu gewinnen. Im dritten Teil dieser Studie wurden verschiedene 
Gruppen von Stimuli im Hinblick auf ihren Effekt auf das peroxisomale Kompartiment 
charakterisiert, um die Regulation der peroxisomalen Dynamik auf transkriptioneller Ebene in 
Säugerzellkulturmodellen zu untersuchen.  
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Um die Fusion ausgereifter Peroxisomen in Säugerzellen zu untersuchen, wurde ein in vivo 
Fusionsassay in CHO-Säugerzellen etabliert. Dieser beruhte auf der Kokultivierung stabiler 
Zelllinien, die GFP- oder DsRed-basierte peroxisomale Matrix- oder Membranmarker 
exprimierten, und der anschließenden Generierung von Hybridomzellen durch Zellfusion. 
Eine Überlappung der unterschiedlichen peroxisomalen Marker wurde 
fluoreszenzmikroskopisch in zu verschiedenen Zeitpunkten fixierten Zellen festgestellt, was 
zunächst auf einen gewissen Grad peroxisomaler Fusionen hinwies. Weitere Studien in 
lebenden Zellen zeigten jedoch, dass kein Austausch peroxisomaler Marker stattfand. 
Allerdings wurde erstmals die Existenz transienter peroxisomaler Interaktionen 
charakterisiert. Interagierende Peroxisomen gingen dabei enge Kontakte ein, die für die 
beobachtete Überlappung von peroxisomalen Markern in fixierten Zellen verantwortlich 
waren. Computer-basiertes Modelling und mathematische Analyse ergaben, dass transiente 
peroxisomale Interaktionen einem komplexen, nicht-zufälligen Verhaltensmuster folgten, 
welches potentiell zu einer Homogenisierung des peroxisomalen Kompartiments beitragen 
könnte. Vorstimulation der Zellen mit peroxisomalen Substraten wies darauf hin, dass 
Fettsäuren und H2O2 nicht ausgetauscht wurden, jedoch könnten transiente peroxisomale 
Interaktionen dem Austausch anderer peroxisomaler Metabolite dienen oder Teil eines 
Signalsystems z. B. zur Feststellung der Verteilung der Peroxisomenpopulation sein. Erstmals 
konnte außerdem erklärt werden, warum nur ein bestimmter Anteil von Peroxisomen (15 %) 
mikrotubuliabhängig bewegt wird. Zusätzlich wurde erstmals nachgewiesen, dass 
mitochondriale Fusionsproteine nicht peroxisomal lokalisiert sind, welches daraufhin weist, 
dass die Dynamik der Peroxisomen durch eigene, charakteristische Prozesse reguliert wird.  
Um die Regulationsmechanismen der peroxisomalen Dynamik an der Organelle selbst zu 
untersuchen, wurde das zentrale Membranprotein Pex11pβ biochemisch charakterisiert.  
Differentielle Permeabilisierung und protease-protection assays ermöglichten in Kombination 
mit einem seit kurzem erhältlichen Antikörper die Lokalisation der ersten 
Transmembrandomäne von Pex11pβ zwischen den Aminosäurepositionen 90 und 110. Im 
Anschluss wurde die Bedeutung der N-terminalen Domäne von Pex11pβ für die Regulation 
der Proteinaktivität untersucht: die Deletion der ersten 40 Aminosäuren des Proteins 
inhibierte bereits die Pex11pβ-induzierte Elongation peroxisomaler Membranen, obwohl die 
für die Membrandeformation essentielle amphipathische Helix intakt blieb. Durch chemisches 
Cross-linking und eine Anreicherung von Pex11pβ nach unterschiedlichen 
Expressionszeitpunkten konnte festgestellt werden, dass eine Homodimerisierung des 
Proteins mit seiner membrandeformierenden Aktivität einhergeht. Diese wiederum war 
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abhängig von der N-terminalen Domäne von Pex11pβ. Im Gegensatz zum orthologen Protein 
in S. cerevisiae, wiesen in vivo phospho-labelling-Experimente nicht auf eine 
Phosphorylierung von Pex11pβ in Säugerzellen hin. Daher scheinen die Pex11-Proteine in 
Säuger- und Hefezellen gegensätzlich reguliert zu werden. Eine Überexpresssion von 
Pex11pβ in peroxisomendefizienten Patientenfibroblasten führte außerdem zu einer 
Fehllokalisation des Proteins an Mitochondrien, wo es eine exzessive mitochondriale 
Fragmentierung verursachte. Diese Beobachtung unterstreicht, dass in Säugerzellen 
Mitochondrien anstatt des ER als alternatives Membrankompartiment für peroxisomale 
Proteine dienen, wenn keine Peroxisomen vorhanden sind. Daraus resultierende Effekte auf  
die Dynamik und Funktion der Mitochondrien könnten zum klinischen Phänotyp 
peroxisomaler Erkrankungen beitragen.    
Im letzten Teil dieser Arbeit wurden externe Stimuli charakterisiert, die die peroxisomale 
Dynamik beeinflussen, um ein eher physiologisches Säugerzellkulturmodel zu etablieren, 
welches die Untersuchung der Regulation dynamischer peroxisomaler Prozesse ermöglicht. 
Die Behandlung von SH-S5Y5 Neuroblastomzellen mit dem Neurotoxin 6-OHDA hatte 
keinen Einfluss auf die peroxisomale Dynamik, resultierte allerdings in einer prominenten 
DLP1-abhängigen Fragmentierung der Mitochondrien. Obwohl DLP1 eine Komponente 
beider Organellen ist, werden demnach die mitochondriale und peroxisomale Dynamik 
unterschiedlich reguliert. Des weiteren wurde eine Reihe verschiedener Komponenten, die 
zytosolischen und mitochondrialen oxidativen Stress auslösen, appliziert, diese führten 
allerdings nicht zu einer Veränderung des peroxisomalen Kompartiments in Säugerzellen. 
KillerRed-basierte Induktion von oxidativem Stress in verschiedenen Kompartimenten führte 
zu ähnlichen Resultaten in lebenden Zellen. Dies weist darauf hin, dass andere Faktoren als 
oxidativer Stress allein, wie z. B. der extra- oder intrazelluläre Ursprung des Signals, eine 
Veränderung des zellulären Redox-Gleichgewichts oder andere, bisher unidentifizierte 
Signaltransduktionsmechanismen, dazu beitragen, eine Veränderung der peroxisomalen 
Dynamik, wie in früheren Studien beobachtet, auszulösen. Die Behandlung von AR42J 
Zellen, einer Rattenzelllinie pankreatischen Ursprungs, mit dem synthetischen Glukokortikoid 
Dexamethason führte zu einer prominenten, kontinuierlichen Elongation von Peroxisomen. 
Interessanterweise wurde die tubuläre Morphologie der Peroxisomen auch aufrechterhalten, 
wenn der externe Stimulus entfernt wurde. Die kontinuierliche peroxisomale Tubulation 
könnte mit der Differenzierung der Zellen verknüpft sein oder auf eine bestimmte 
metabolische Funktion hinweisen. Dexamethasonbehandlung führte außerdem zu einer 
transkriptionellen Induktion von Pex11β (and Pex11α) durch einen potentiell PPARα-
6. ZUSAMMENFASSUNG               ___________________________________________________ 
192 
unabhängigen Mechanismus. Daher hat das hier etablierte Modell der Dexamethason-
induzierten peroxisomalen Elongation großes Potenzial, als eher physiologisches 
Säugerzellkulturmodell zur Untersuchung der Regulation peroxisomaler Dynamik zu dienen. 
Weitere Studien wurden bereits initiiert, um Veränderungen des Expressionsprofils 
peroxisomaler Proteine nach Dexamethason-Stimulation zu untersuchen. Diese dienen dazu, 
neue Komponenten und/oder molekulare Mechanismen aufzuklären, die die Dynamik der 
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8 APPENDIX 
8.1 SUPPLEMENTARY MATERIAL 
8.1.1 Supplementary Information 
8.1.1.1 Theoretical Model explaining power law behaviour 




. Consider that two interacting organelles have a probability dtp × of 
terminating their interaction between τ and dtt + . Then, the probability that the interaction is 
terminated only after ndt=τ units of time is pdtpdt
n 1)1( −−
 . To calculate )(τN a sum over 
all types of organelle interactions has to be considered. Writing pdtP =  we have: 
∫
−
− PdPPfN np 1)1(~)(τ
. Here pf  is the number of organelles interacting with a probability 
p of terminating their contact. Assuming that pf p ~  as there are more organelles 
performing fast bindings available for making new bindings, then the integral can be 
straightforwardly integrated by parts. If the lower bound starts near zero, than the integral 
diverges as  
3−τ
  and the cumulative frequency distribution decays as 
2−τ
 , as observed. If the 
lower bound is a finite number (for instance, 0.1), then )(τN  falls exponentially to zero. 
Hence, to explain the observed data, one needs to assume that organelle interactions differ 
considerably in contact lifetimes. In particular, some contacts have to be extremely stable, i.e. 
.0≅p
 These results require further studies, because many different models have been shown 
to display power law behavior, as discussed in (Sornette, 2006). If further experiments reveal 
that power law exponent is slightly different from the one we found, then more elaborate 
theoretical models could be developed, for instance, taking into account the impact of the 
cytoskeleton on organelle traffic (Kulic et al., 2008). This may have an impact on the 
weighting factor pf  considered above. Alternatively, it could also be necessary to describe 
the details of inter-organelle interactions, which may entail a diversity of mechanisms. The 
later mechanisms, however, should only provide corrections to the exponent we found, which 
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8.1.1.2 Results Phospho-Screen HsPex11pβ 
KinasePhos 2.0 ELM 
Position Score (Motif) Position Motif 
S11 0.955 (ATM) S8 PKA 
S38 0.953 (ATM) S11 CK1             
PIKK 
S50 0.972 (ATM) S54 CK1 
S53 0.973 (ATM) T149 CK1 
S70 0.909 (ATM) S150/S151 PLK 
S78 0.960 (ATM) S154 GSK3 
S150 0.982 (ATM) T178 ProDKinase 
S151 0.983 (ATM) S246 CK1 
S154 0.908 (ATM) 
0.897 (GSK3) 
  
S160 0.894 (CK1)   
S168 0.956 (ATM)   
S243 0.940 (ATM)   








Scansite Motif Scan 
Position Score Position Score Position Score (Motif) Position  Motif Position Score (Motif) 
S11 0.949 S154 0.75 S70 0.84 (PKC) S70 T178 0.171% (Erk1) 
S38 0.981 S160 0.801 S154 0.85 (PKC) S123 I220 0.144% (Erk bdg) 




Y140 0.917 T178 0.793       
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8.1.2 Supplementary Figures 
 
Fig. 3.1 (alternative): Establishing a peroxisomal in 
vivo fusion assay.  (A) Principle of the peroxisomal in 
vivo fusion assay established in this study. CHO cell lines 
either stably expressing a matrix-targeted peroxisomal 
GFP (CHO-GFP-PTS1) or DsRed construct (CHO-
DsRed-PTS1) were generated. To assess peroxisomal 
fusion, the cell lines were mixed and fused using PEG-
6000. Hybridoma cells were incubated at 37° C in the 
presence of cycloheximide to avoid false positive events 
by peroxisomal protein import. The appearance of yellow 
peroxisomes (marker for co-localization) and 
peroxisomal dynamics were investigated by fluorescence 
microscopy and live cell imaging.  
(B) Protein translation is efficiently blocked over the 
course of the observation period. Control (-) and 
cycloheximide (Cy, +)-blocked CHO-GFP-PTS1 cells 
were pulse labeled with S35-methionine for 2 and 4 hours, 
respectively. Cell lysates were split and subjected to 
immunoprecipitation with anti-GFP. One set of samples 
was subjected to SDS-PAGE and autoradiographs were 
developed by PhosphoImaging (upper panel). As a 
loading control, the other set of samples was separated by 
SDS-PAGE, immunoblotted and incubated with anti-GFP 
(lower panel).  
(C - E) Mitochondrial fusion in CHO cells. As a positive 
control, CHO-K1 cells were transiently transfected with 
Mito-GFP (C) and Mito-DsRed (D), respectively. 
Differentially labeled cells were subjected to the in vivo 
fusion assay. After 4 hours, cells were fixed and 
processed for fluorescence microscopy. Overlay of 
fluorescent signals from (C) and (D) is shown in (E). N, 
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Fig. 3.2 (alternative): Peroxisomal matrix 
signals co-localize in fixed cells.  
CHO-GFP-PTS1 (A, F) and CHO-DsRed-
PTS1 cells (B, G) were mixed and subjected 
to the peroxisomal in vivo fusion assay. 
Hybridoma cells were incubated for 4 
hours, fixed and processed for 
epifluorescence (A – E) or confocal 
microscopy (F – H). Higher magnification 
images of the boxed regions in (C) are 
shown in (D) and (E). Arrowheads point to 
yellow peroxisomes. Asterisks highlight red 
and green peroxisomes engaged in intimate 
contacts.  
(I) Quantitative analysis of mitochondrial 
and putative peroxisomal matrix 
intermixing (yellow organelles). CHO cell 
lines either transfected with differential 
mitochondrial or peroxisomal markers were 
subjected to the in vivo fusion assay. After 
the indicated time points, cells were fixed 
and processed for fluorescence microscopy. 
The percentage of yellow peroxisomes (% 
of total organelle number per hybridoma 
cell) at different time points of a 
representative experiment is shown. To 
assess mitochondrial fusion, the overall 
number of hybridoma cells with yellow 
mitochondria (full fusion) was determined. 








Fig. 3.3 (alternative): Time-
lapse confocal microscopy 
reveals that peroxisomes 
interact extensively, but do 
not exchange matrix 
proteins.  
CHO-GFP-PTS1 and CHO-
DsRed-PTS1 cells were 
subjected to the peroxisomal 
in vivo fusion assay. 
Hybridoma cells were allowed 
to recover for 30 minutes and 
were then analyzed by time-
lapse confocal microscopy. 
Images were taken every 5 
seconds using 488 and 561 
laser lines, respectively (see 
also Movies S1 and S2). 
Arrows indicate interaction 
events. Note the close (60 – 
65s), but transient (80s) 
overlap of differentially 
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Fig. 3.4 (alternative): High resolution images of peroxisomal interactions. 
Differentially labelled CHO cell lines were subjected to the in vivo peroxisomal fusion assay and processed for 
confocal microscopy. Image deconvolution was performed using Huygens Professional software. A selection of 
peroxisomal interaction events is shown (A-E). Arrows highlight overlap of markers; a potential fission event is 
labelled by an asterisk. Note the close, intimate contacts between interacting peroxisomes. In (E, peroxisomes on 
the right) one peroxisome appears to embrace another (estimated colocalisation of signals: approx. 50% (green) 
and 24% (red)). Data analysis revealed a mean distance between interacting peroxisomes of about 0.07 µm +/- 
0.029 µm. As data evaluation only allowed for the calculation of distances between the centre of one mass to the 
nearest surface point (but not for the surface-to-surface distance), the actual distance is most probably even 
smaller. Bars, 1µm (A); 0.25µm (B); 0.5µm (C-E). 
 
 
Fig. 3.8 (alternative): Peroxisomes 
do not exchange membrane 
components.  
CHO-K1 cells stably expressing the 
peroxisomal membrane markers 
PMP70-YFP (A) or DsRed-dPex26 
(B) were subjected to the 
peroxisomal in vivo fusion assay and 
assayed for the exchange of 
membrane components (C). In a 
second set of experiments, CHO-
PMP70-YFP (D) and CHO-DsRed-
PTS1 cells (E) were fused. Overlay 
of signals is shown in (F). Higher 
magnification images of (C) and (F) 
are shown in (G) and (H), 
respectively. Arrowheads point to 
intimate interactions. (I) Quantitative 
analysis of putative peroxisomal 
membrane intermixing. The 
percentage of yellow organelles (% 
of total organelle number per 
hybridoma cell) at different time 
points of a representative experiment 
is shown. N, nucleus. Bars, 20µm.  
 
 




Fig. 3.10 (alternative): The 
mitochondrial fusion protein 
Mfn1 does not localize to 
peroxisomes.  
(A–C) Fis1 is dually targeted to 
peroxisomes and mitochondria. As 
a positive control, COS-7 cells were 
transfected with GFP-hFis1 (B) and 
processed for immunofluorescence 
with anti-PMP70 (A). (C) Overlay 
of (A, B). Note the localization of 
GFP-Fis1 at peroxisomes (asterisks) 
and clustering of mitochondria.  
(D–G) Mfn1 does not localize to 
peroxisomes. COS-7 cells stably 
expressing GFP-PTS1 (D) were 
transfected with Mfn1-myc (E) and 
processed for immunofluorescence 
using anti-myc. Higher 
magnification image of the boxed 
area in (E) is shown in (F–H). 
Overlay (Merge) of (F, G) is shown 
in (H). Note that although small 
punctuate Mfn1 positive structures 
can be seen, there is no co-
localization with peroxisomal 
markers (arrowheads). 






Fig. 3.11 (alternative): Expression of 
activity-deficient mitofusin variants 
does not affect peroxisome 
morphology.  
COS-7 cells stably expressing GFP-
PTS1 (A, D) were transfected with 
activity-deficient variants of Mfn1 
(K38T) (B) and Mfn2 (K109A) (E). 
After 24 hours, cells were processed for 
immunofluorescence using anti-myc 
antibodies. Overlays (Merge) of (A, B) 
and (D, E) are shown in (C) and (F). 
Higher magnification images of boxed 
areas in (C) and (F) are shown in (G) 
and (H). Asterisks highlight mitofusin-
positive punctuate structures that do not 
co-localize with peroxisomal markers. 
Note that although mitochondria are 
prone to fragmentation upon 
overexpression of Mfn mutants, 
peroxisomal morphology remains 












Fig. 3.12: The mitochondrial inner 
membrane fusion protein OPA1 does 
not localize to peroxisomes.  
OPA1 is not a peroxisomal protein. (A–
E) COS-7 cells stably expressing GFP-
PTS1 (A) processed for 
immunofluorescence using anti-OPA1 
(B). Higher magnification images of the 
boxed area in (B) are shown in (C–E). 
(E) Overlay (Merge) of (C, D). Note that 
some punctuate structures are positive 
for OPA1, but do not co-localize with 
the peroxisomal marker. N, nucleus. Bar, 
20µm.  
(F) Highly purified peroxisomes (PO) 
and mitochondria (Mito) were separated 
by 12.5% SDS-PAGE and 
immunoblotted using anti-OPA1, anti-
PMP70 and anti-ATP synthase 
antibodies. Equal amounts of protein 
(50µg) were applied. Multiple OPA1 






































Fig. 3.16 (alternative): The 
Pex11pβ antibody only 
recognizes its epitope after 
peroxisomal membrane 
permeabilization.  
Cos-7 cells were transfected with 
either Pex11b-myc (A-I) or YFP-
Pex11b (J – R) and fixed after 24h. 
Membrane (and organelle 
membrane) permeabilisation was 
achieved by incubating fixed cells 
with either 0.2 % Tx100 (A – C; J 
– L), 25µg/ml digitonin (D – F; M 
– O) or Methanol (MetOH; G – I; 
P – R), before immunostaining 
against the myc epitope and an 
internal part of Pex11β (A – I) or 
Pex11β alone (J – R) was 
performed.  
Note that Pex11β-myc is 
absent/extracted from the 
peroxisomal membrane after 
Tx100 permeabilisation (A – C), 
while YFP-Pex11pβ is retained 




































Fig. 3.19.: In ∆PEX19 cells, Pex11pβ mistargets 
to mitochondria and leads to their 
fragmentation.  
(A, B) ∆PEX19 fibroblasts were transfected with 
either the mitochondrial matrix marker Mito-GFP 
(A) or myc-Fis1, a tail-anchored protein known to 
fragment mitochondria (B). Cells were fixed and in 
the case of (B) processed for immunofluorescence 
against the myc epitope.  
(C-E) ∆Pex19 fibroblasts were co-transfected with 
Mito-GFP and Pex11β-myc and processed for 
immunofluorescence against the myc epitope. 
Merge of signals is seen in E. Bars, 20µm.  
(F) For statistical analysis, ∆Pex19 fibroblasts were 
either transfected with Mito-GFP alone or  co-
transfected with Mito-GFP and Pex11β-myc and 
processed for immunofluorescence. Mitochondrial 
morphology was assessed to be either tubular (A) or 
fragmented (B) and 100 cells/coverslip (2 
coverslips/condition) were grouped accordingly. 
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Fig. 3.21:  Pex11pβ retains its topology 
upon mistargeting to mitochondria.  
(A-I) ∆Pex19 fibroblasts were 
transfected with Pex11βb-myc, fixed 
after 24 hours and permeabilized using 
either Tx100 (A-C), digitonin (D-F) or 
methanol (G-I). Subsequently, they were 
co-stained with antibodies against the 
myc epitope (A, D, G) and Pex11β (B, 
E, H).  
 (J-R) In a similar approach, ∆Pex19 
fibroblasts were transfected with 
Pex11β-GFP before permeabilizion 
using either Tx100 (J-L), digitonin (M-
O) or methanol (P-R).  
Subsequently, staining against Pex11β 

















































































Fig. 3.29 (alternative): Activation of KillerRed targeted to the cytosol or mitochondria does not alter  peroxisome 
dynamics. 
COS-7-GFP-PTS1 cells were transfected with either KillerRed-C (upper panel) or KillerRed-Mito (lower panel). 24 hours 
later, cells were subjected to live cell imaging using a LSM 510 Meta confocal microscope. Before activation of KillerRed 
images of single cells were taken (Pre-bleach). After photobleaching of KillerRed, images were collected every 60 seconds 
for 30-90 minutes.  







































Fig. 3.30 (alternative): Activation of peroxisomal KillerRed does not affect peroxisome dynamics.  
(A-C) COS-7-GFP-PTS1 (B) cells were transfected with KillerRed-PO (KR-PO, A). 24 hours later, cells were fixed and 
mounted for epifluorescence microscopy. Merge of signal is shown in C.  
(D) KR-PO was transfected into COS-7-GFP-PTS1 cells.  24 hours later, cells were subjected to live cell imaging using a 
LSM 510 Meta confocal microscope. Before activation of KillerRed images of single cells were taken (Pre-bleach). After 
photobleaching of KillerRed, images were collected every 60 seconds for 30-90 minutes.  




















































Fig. 3.34 (alternative): Overexpression of the 3 human isoforms of Pex11 in AR42J cells.  
AR42J cells were transfected with myc-tagged variants of the 3 human isoforms of Pex11, Pex11α (A-C), Pex11β (D-F) and 
Pex11γ (G-I). After 24 hours, cells were fixed and processed for immunofluorescence against the myc epitope (A, D, G) and 
the peroxisomal membrane protein PMP70 (B, E, H). Images were taken using a LSM 510 Meta confocal microscope. Merge 
of signals is shown in C, F and I, respectively.  
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8.1.3 Supplementary Movies 
 
Supplementary Movie S1. Peroxisomal interaction in vivo.  
CHO-GFP-PTS1 and CHO-DsRed-PTS1 cells were subjected to the peroxisomal in vivo 
fusion assay (see Materials and Methods). After cell fusion, cells were incubated for 1 hour at 
37°C and then analyzed by time-lapse confocal microscopy. Images were acquired every 5 
seconds, shown here as two frames per second. Arrows indicate interaction events.  
 
Supplementary Movie S2. Peroxisomal interaction in vivo.  
See legend Supplementary Movie S1. 
 
Supplementary Movie S3. Peroxisomal fission in time-lapse confocal microscopy.  
COS-7 cells were transfected with YFP-Pex11β to stimulate peroxisome elongation and 
subsequent DLP1-dependent fission and analyzed by time-lapse confocal microscopy. Note 
the membrane extension/elongation of a spherical peroxisome and the subsequent division 
into two spherical organelles (arrowheads). Higher magnification view of the selected 
peroxisome is shown in the upper left corners. Bar, 10µm. 
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8.2 LIST OF ABBREVIATIONS 
µ    micro 
aa    amino acids 
AAA-ATPase   ATPase associated with various cellular activities 
ABC     ATP binding cassette 
AGT    alanine: glyoxylate aminotransferase 
ALD     adrenoleukodystrophy 
Amp    ampicillin 
AOX    Acyl-CoA oxidase 
APS    ammonium persulfate 
APX     ascorbate peroxidase 
At, A. thaliana   Arabidopsis thaliana 
ATP     adenosine triphosphate 
bp     base pair 
BSA    bovine serum albumin  
C. elegans    Caenorhabditis elegans 
CAT    catalase 
cDNA      complementary deoxyribonucleic acid  
Ci    Curie 
CL     cardiolipin 
CLSM     Confocal laser scanning microscopy  
CMV    cytomegalovirus 
DAB     3, 3’-Diaminebenzidine tetrahydrochloride 
DaM    Donkey anti-mouse  
DaR    Donkey anti-rabbit  
DBP     D-bifunctional protein 
DCF    dichlorofluorescein 
DEAE    diethylaminoethyl 
DEPC    diethylpyrocarbonate 
dH20    destilled water 
DHAP    dihydroxy acetone phosphate 
DHCA    dihydroxycholestanoic acid 
DLP     Dynamin-like protein 
DMEM   Dulbecco`s modified Eagle´s medium 
DMSO   dimethylsulfoxid 
DNA    deoxyribonucleic acid 
dNTP     desoxynucleoside triphosphate 
Drp     Dynamin-related protein 
DsRed    Discosoma species Red 
dT    desoxythymidine 
DTT     dithiothreitol 
E. coli     Escherischia coli 
e.g.     exemplia gratia (for example) 
ECL    enhanced Chemiluminescence 
EDTA    ethylenediaminetetraacetic acid 
EM     electron microscopy 
ER     endoplasmic reticulum 
Et al    et alii (and others) 
EtBr    ethidium bromide 
ETC     electron transfer chain 
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EtOH    Ethanol 
ETYA    5 ,8, 11, 14-Eicosatetraynoic Acid  
F    Farad 
FAD    flavin-adenine-dinucleotide 
FCS    fetal calf serum 
FITC    Fluorescein isothiocyanate 
FOY    Ethyl-4-( 6 - Guadininohexanoyloxy)-benzoate 
Fzo     fuzzy onions 
g     x 9,81 m/s² 
G    Gauche 
g    gram 
GaM     Goat anti-mouse 
GAPDH    glycerinaldehyde-3-phosphate dehydrogenase 
GaR     Goat anti-rabbit 
GED     GTPase effector domain  
GFP    Green Fluorescent Protein 
GSH     glutathione 
GTP     guanosine triphosphate 
HBS     Hepes buffered saline 
Hepes     4-(2-Hydroxyethyl)-1-piperazinethansulfonic acid  
Hp, H. polymorpha   Hansenula polymorpha 
HRP    horseradish peroxidase 
Hs, H. sapiens   Homo sapiens 
i.e.     id est (which means) 
IF    immunofluorescence 
IMM    inner mitochondrial membrane 
IMS     intermembrane space 
IP     immunoprecipitation 
Kana    Kanamycin 
kb    kilo base pairs 
kD    kilodalton 
l    liter 
LB    Luria - Bertani 
m    metre 
M    Molar 
mA    milliampere 
mc    monoclonal 
Mff    mitochondrial fission factor 
Mfn     mitofusin 
Mgm     mitochondrial genome maintenance 
Min    minutes 
Mito    mitochondria 
mL    milliliter 
mM    millimolar 
MOPS    3-(N-Morpholino)-propanesulfonic acid  
mPTS     peroxisomal membrane targeting signal  
mRNA   messenger RNA 
ms    millisecond  
mtDNA   mitochondrial DNA  
n    nano 
Nc, N. Crassa   Neurospora crassa 
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